syndrome	score	normalized_score
DRAVET SYNDROME	2.6698290399999993	100.0
CHILDHOOD ABSENCE EPILEPSY	1.52074085	56.96023330392722
MYOCLONIC-ASTASTIC EPILEPSY	1.223545494	45.82860833665965
EPILEPSY, FAMILIAL TEMPORAL LOBE, 3; ETL3	1.1936939999999998	44.71050326128748
MICROPHTHALMIA-BRAIN ATROPHY SYNDROME	1.1564266	43.314631112110476
RING CHROMOSOME 12 SYNDROME	1.011719094	37.89452728403914
GLYCOSYLPHOSPHATIDYLINOSITOL BIOSYNTHESIS DEFECT 17; GPIBD17	1.0038117729999998	37.59835397550399
EHLERS-DANLOS SYNDROME, TYPE I	1.00163132	37.51668383980123
HEMIDYSTONIA-HEMIATROPHY SYNDROME	1.000541419	37.47586096374172
PITUITARY DERMOID AND EPIDERMOID CYSTS	1.000541419	37.47586096374172
PAROXYSMAL KINESIGENIC DYSKINESIA	1.0	37.45558180009909
RADIAL HEMIMELIA	1.0	37.45558180009909
ANAPLASTIC THYROID CARCINOMA	1.0	37.45558180009909
HOMOZYGOUS FAMILIAL HYPERCHOLESTEROLEMIA	1.0	37.45558180009909
MYOCLONIC EPILEPSY OF LAFORA	0.93444076	35.000022323526764
LAFORA DISEASE	0.7715289599999999	28.898066072425376
EPILEPSY, LATERAL TEMPORAL LOBE, AUTOSOMAL DOMINANT	0.7706171	28.863911825605143
CRANIOSYNOSTOSIS 4; CRS4	0.75406504	28.24394478831499
FEMALE RESTRICTED EPILEPSY WITH INTELLECTUAL DISABILITY	0.7485789639999999	28.038460619935428
EARLY MYOCLONIC ENCEPHALOPATHY	0.7087289139999999	26.545853812422394
ALACRIMIA-CHOREOATHETOSIS-LIVER DYSFUNCTION SYNDROME	0.688410474	25.78481482095199
MENTAL RETARDATION, AUTOSOMAL DOMINANT 36; MRD36	0.6544702729999999	24.51356484608468
GENERALIZED EPILEPSY WITH FEBRILE SEIZURES-PLUS	0.59705175	22.36292066101731
ROLANDIC EPILEPSY	0.5906213	22.122064415030867
PARTIAL DELETION OF THE SHORT ARM OF CHROMOSOME 7	0.5720198999999999	21.4253381557345
SPORADIC INFANTILE BILATERAL STRIATAL NECROSIS	0.55880235	20.930267130512604
ISOLATED SUCCINATE-COQ REDUCTASE DEFICIENCY	0.5552363	20.79669865303436
COG5-CDG	0.546916009	20.48505731288323
BRACHYDACTYLY TYPE A2	0.5397618	20.217092252468724
TRICHO-DENTO-OSSEOUS SYNDROME	0.5357143	20.065490785132823
172500 PHOTOMYOCLONUS, DIABETES MELLITUS, DEAFNESS, NEPHROPATHY, AND CEREBRALDYSFUNCTION;;HERRMANN SYNDROME	0.5333330000000001	19.97629780819225
MENINGIOMA	0.5277778	19.768224560176336
EPILEPSY, FAMILIAL TEMPORAL LOBE, 4	0.527027	19.740102909360825
DEVELOPMENTAL DELAY AND SEIZURES WITH OR WITHOUT MOVEMENT ABNORMALITIES; DEDSM	0.520093814	19.48041639400252
TRICHODENTOOSSEOUS SYNDROME	0.52	19.476902536051526
W SYNDROME	0.517208404	19.3723416837207
46,XY DISORDER OF SEX DEVELOPMENT-ADRENAL INSUFFICIENCY DUE TO CYP11A1 DEFICIENCY	0.50840336	19.042543637925224
INHERITED ISOLATED ADRENAL INSUFFICIENCY DUE TO PARTIAL CYP11A1 DEFICIENCY	0.50840336	19.042543637925224
EPILEPSY, BENIGN NEONATAL, 2	0.50704225	18.991562470981293
SPONDYLOEPIPHYSEAL DYSPLASIA WITH CONGENITAL JOINT DISLOCATIONS	0.50475188	18.905775330093803
KYPHOSCOLIOTIC EHLERS-DANLOS SYNDROME	0.5043340199999999	18.890124140682808
BRACHYDACTYLY TYPE C	0.5027248	18.829849869338457
EHLERS-DANLOS SYNDROME, VASCULAR TYPE; EDSVASC	0.5027027	18.829022100980673
NON-PROGRESSIVE CEREBELLAR ATAXIA WITH INTELLECTUAL DISABILITY	0.500545554	18.748224942522917
THUMBS, STIFF, WITH BRACHYDACTYLY TYPE A1 AND DEVELOPMENTAL DELAY	0.500545554	18.748224942522917
PATERNAL UNIPARENTAL DISOMY OF CHROMOSOME 5	0.500545554	18.748224942522917
BRACHYDACTYLY, TYPE A2, WITH MICROCEPHALY	0.500541419	18.748070063692175
PEROXISOME BIOGENESIS DISORDER 13A (ZELLWEGER)	0.500541419	18.748070063692175
IDIOPATHIC INTRACRANIAL HYPERTENSION	0.5	18.727790900049545
INHALATIONAL ANTHRAX	0.5	18.727790900049545
BRACHYDACTYLY, TYPE D	0.5	18.727790900049545
113450 BRACHYDACTYLY-DISTAL SYMPHALANGISM SYNDROME	0.5	18.727790900049545
CREST SYNDROME	0.5	18.727790900049545
613241 PSEUDOPILI ANNULATI	0.5	18.727790900049545
THYROTROPIN-RELEASING HORMONE DEFICIENCY	0.5	18.727790900049545
RESTRICTIVE DERMOPATHY	0.5	18.727790900049545
MADELUNG DEFORMITY	0.5	18.727790900049545
HIRSCHSPRUNG DISEASE WITH TYPE D BRACHYDACTYLY	0.5	18.727790900049545
EPILEPSY, FAMILIAL TEMPORAL LOBE, 7; ETL7	0.5	18.727790900049545
PAROXYSMAL HEMICRANIA	0.5	18.727790900049545
GLOMUVENOUS MALFORMATION	0.492857	18.460245679251436
POLAND SYNDROME	0.48888859999999995	18.311606948435923
3-PHOSPHOGLYCERATE DEHYDROGENASE DEFICIENCY, INFANTILE/JUVENILE FORM	0.43744392	16.384716528516
PRIMARY HYPERALDOSTERONISM-SEIZURES-NEUROLOGICAL ABNORMALITIES SYNDROME	0.434614804	16.278750342756034
PROGRESSIVE MYOCLONIC EPILEPSY TYPE 3	0.42505119	15.920539616274462
CLCN4-RELATED X-LINKED INTELLECTUAL DISABILITY SYNDROME	0.41513130400000003	15.548984514753803
SPINOCEREBELLAR ATAXIA TYPE 10	0.4088913	15.315261534498859
RECURRENT METABOLIC ENCEPHALOMYOPATHIC CRISES-RHABDOMYOLYSIS-CARDIAC ARRHYTHMIA-INTELLECTUAL DISABILITY SYNDROME	0.40455521000000005	15.152850760811267
MENTAL RETARDATION, X-LINKED, SYNDROMIC 33	0.383130283	14.350367655001614
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IIC; CDG2C	0.381884434	14.30370365587154
PLACENTAL INSUFFICIENCY	0.3768113	14.11368647035168
OCULODENTODIGITAL DYSPLASIA, AUTOSOMAL RECESSIVE	0.36722242	13.754529391140343
PERIORAL MYOCLONIA WITH ABSENCES	0.36455991	13.654803530041763
EPILEPSY, JUVENILE ABSENCE	0.35751765999999996	13.391031959110014
EPILEPSY WITH GRAND MAL SEIZURES ON AWAKENING	0.35751765999999996	13.391031959110014
CENTRALOPATHIC EPILEPSY	0.3547009	13.285528574518768
EARLY INFANTILE EPILEPTIC ENCEPHALOPATHY	0.35182059399999993	13.177645037526448
MITOCHONDRIAL DNA DEPLETION SYNDROME 4A (ALPERS TYPE)	0.34968319400000003	13.097587476986922
MENTAL RETARDATION, X-LINKED 99, SYNDROMIC, FEMALE-RESTRICTED	0.34851417300000004	13.053801115295387
NON-DISTAL MONOSOMY 20Q	0.345635419	12.945975709366023
MITOCHONDRIAL DNA DEPLETION SYNDROME 7 (HEPATOCEREBRAL TYPE)	0.3448273	12.91570714205731
CRANIOFRONTONASAL DYSPLASIA-POLAND ANOMALY SYNDROME	0.3438593	12.879450138874812
ACITRETIN/ETRETINATE EMBRYOPATHY	0.34336768	12.861036225750249
X-LINKED INTELLECTUAL DISABILITY, SNYDER TYPE	0.34259226	12.831992418510815
EPILEPSY, FAMILIAL ADULT MYOCLONIC, 5; FAME5	0.34037525	12.748953019104178
%607004 BRACHYDACTYLY, TYPE A1, B; BDA1B	0.33888856	12.693268180197789
TRIGONOCEPHALY-SHORT STATURE-DEVELOPMENTAL DELAY SYNDROME	0.338015933	12.660583428218313
PELVIS-SHOULDER DYSPLASIA	0.3360357	12.586412649103556
EPIDERMAL NEVUS SYNDROME	0.333878554	12.505615490645802
COG4-CDG	0.333878554	12.505615490645802
DEVELOPMENTAL AND SPEECH DELAY DUE TO SOX5 DEFICIENCY	0.333874419	12.505460611815057
THUMB STIFFNESS-BRACHYDACTYLY-INTELLECTUAL DISABILITY SYNDROME	0.333333	12.48518144817243
%173800 POLAND SYNDROME;;POLAND SYNDACTYLY;;POLAND ANOMALY;;POLAND SEQUENCEPECTORALIS MUSCLE, ABSENCE OF, INCLUDED	0.333333	12.48518144817243
ROLANDIC EPILEPSY-PAROXYSMAL EXERCISE-INDUCED DYSTONIA-WRITER'S CRAMP SYNDROME	0.333333	12.48518144817243
PERIPARTUM CARDIOMYOPATHY	0.333333	12.48518144817243
MULTIPLE ENDOCRINE NEOPLASIA, TYPE IIA; MEN2A	0.333333	12.48518144817243
OROFACIODIGITAL SYNDROME TYPE 3	0.333333	12.48518144817243
BRACHYDACTYLY, TYPE A6	0.333333	12.48518144817243
SPINOCEREBELLAR ATAXIA TYPE 42	0.333333	12.48518144817243
THUMB AGENESIS, SHORT STATURE, AND IMMUNODEFICIENCY	0.333333	12.48518144817243
NEUROMYELITIS OPTICA	0.333333	12.48518144817243
EPILEPSY, ROLANDIC, WITH PAROXYSMAL EXERCISE-INDUCED DYSTONIA AND WRITER'S CRAMP; EPRPDC	0.333333	12.48518144817243
NEPHROPATHIC INFANTILE CYSTINOSIS	0.333333	12.48518144817243
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 52; EIEE52	0.301281414	11.28467064692652
DOORS SYNDROME	0.29093556400000004	10.897160815959966
MITOCHONDRIAL DNA DEPLETION SYNDROME 14	0.28834590000000004	10.800163444173194
PALLISTER-HALL SYNDROME	0.277419384	10.3909044303451
UNDIFFERENTIATED PLEOMORPHIC SARCOMA	0.2751151	10.304596132492442
NEUROGENIC ARTHROGRYPOSIS MULTIPLEX CONGENITA	0.27238595	10.2023742314227
WILLIAMS SYNDROME	0.27180458	10.180598679831578
MATERNAL UNIPARENTAL DISOMY OF CHROMOSOME 1	0.266670419	9.988295692521199
%611694 DYSTONIA WITH CEREBELLAR ATROPHY; DYTCA	0.2635135	9.870051454680413
DYSTONIA 6, TORSION	0.2635135	9.870051454680413
KEPPEN-LUBINSKY SYNDROME	0.260580429	9.760191573914414
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 34; EIEE34	0.259940294	9.736214945058808
OTOFACIOCERVICAL SYNDROME 2	0.25555556	9.571982182050132
THIAMINE METABOLISM DYSFUNCTION SYNDROME 2 (BIOTIN- OR THIAMINE-RESPONSIVE TYPE); THMD2	0.254333723	9.526217566350244
STRIATONIGRAL DEGENERATION, CHILDHOOD-ONSET	0.25431034	9.525341742481013
INTELLECTUAL DISABILITY-CRANIOFACIAL DYSMORPHISM-CRYPTORCHIDISM SYNDROME	0.253270354	9.486388461787053
HYPERPHOSPHATASIA WITH MENTAL RETARDATION SYNDROME 2; HPMRS2	0.252506059	9.457761347895147
INFANTILE MYOFIBROMATOSIS	0.25225810000000004	9.448473899287578
SPONDYLOEPIPHYSEAL DYSPLASIA, NISHIMURA TYPE	0.252176874	9.445431532200281
DERMOID CYSTS, FAMILIAL FRONTONASAL	0.25196464	9.43748218425252
CHROMOSOME 1P36 DELETION SYNDROME	0.251879933	9.434309434284978
DYSTONIA 28, CHILDHOOD-ONSET	0.250545554	9.384329492498143
FETAL AND NEONATAL ALLOIMMUNE THROMBOCYTOPENIA	0.250545554	9.384329492498143
HYPERPARATHYROIDISM 2	0.25	9.363895450024772
CRYPTOMICROTIA-BRACHYDACTYLY-EXCESS FINGERTIP ARCH SYNDROME	0.25	9.363895450024772
CONGENITAL FACTOR II DEFICIENCY	0.25	9.363895450024772
METAPHYSEAL CHONDRODYSPLASIA, SPAHR TYPE	0.25	9.363895450024772
HYPOTRICHOSIS WITH JUVENILE MACULAR DEGENERATION	0.25	9.363895450024772
RICHIERI-COSTA/GUION-ALMEIDA SYNDROME	0.25	9.363895450024772
NIJMEGEN BREAKAGE SYNDROME	0.25	9.363895450024772
HYPEROSTOSIS CRANIALIS INTERNA; HCIN	0.25	9.363895450024772
SEVERE HEMOPHILIA A	0.25	9.363895450024772
DYSTONIA, CHILDHOOD-ONSET, WITH OPTIC ATROPHY AND BASAL GANGLIA ABNORMALITIES; DYTOABG	0.25	9.363895450024772
HYPEREKPLEXIA 1; HKPX1	0.25	9.363895450024772
HEMOPHILIA B	0.25	9.363895450024772
DYSPLASTIC CORTICAL HYPEROSTOSIS	0.25	9.363895450024772
SUPRANUCLEAR PALSY, PROGRESSIVE, 1; PSNP1	0.25	9.363895450024772
DYSTONIA 16; DYT16	0.25	9.363895450024772
SEVERE COMBINED IMMUNODEFICIENCY, AUTOSOMAL RECESSIVE, T CELL-NEGATIVE, B CELL-NEGATIVE, NK CELL-POSITIVE	0.25	9.363895450024772
CAUDAL APPENDAGE-DEAFNESS SYNDROME	0.25	9.363895450024772
123560 CRYPTOMICROTIA-BRACHYDACTYLY SYNDROME	0.25	9.363895450024772
KLIPPEL-FEIL SYNDROME 1, AUTOSOMAL DOMINANT; KFS1	0.25	9.363895450024772
SUPRANUCLEAR PALSY, PROGRESSIVE, 2; PSNP2	0.25	9.363895450024772
SKELETAL DYSPLASIA-T-CELL IMMUNODEFICIENCY-DEVELOPMENTAL DELAY SYNDROME	0.24649359	9.232560823445088
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 19; EIEE19	0.243045154	9.103397646764682
TRICHOTHIODYSTROPHY	0.239213874	8.959894825325597
LENNOX-GASTAUT SYNDROME	0.23257130999999998	8.711093726061204
EPILEPSY, FAMILIAL TEMPORAL LOBE, 2; ETL2	0.22592915000000002	8.462307758851859
EARLY-ONSET EPILEPTIC ENCEPHALOPATHY AND INTELLECTUAL DISABILITY DUE TO GRIN2A MUTATION	0.22510605000000003	8.431478069472197
OCULOCEREBRAL HYPOPIGMENTATION SYNDROME, PREUS TYPE	0.221920273	8.31215293845182
SPASTIC PARAPLEGIA-SEVERE DEVELOPMENTAL DELAY-EPILEPSY SYNDROME	0.220093814	8.243741853972795
JUVENILE HYALINE FIBROMATOSIS	0.22	8.2402279960218
PYCR2-RELATED MICROCEPHALY-PROGRESSIVE LEUKOENCEPHALOPATHY	0.21876	8.193783074589678
8P INVERTED DUPLICATION/DELETION SYNDROME	0.216703309	8.11674851660165
KOOLEN-DE VRIES SYNDROME; KDVS	0.210782813	7.89499289437649
OCULAR ANOMALIES-AXONAL NEUROPATHY-DEVELOPMENTAL DELAY SYNDROME	0.20915149300000002	7.833890854674353
WIEDEMANN-RAUTENSTRAUCH SYNDROME	0.209151493	7.833890854674353
HOLOPROSENCEPHALY-CAUDAL DYSGENESIS SYNDROME	0.20840336	7.805869097895498
DIFFUSE NEONATAL HEMANGIOMATOSIS	0.20840336	7.805869097895498
6P22 MICRODELETION SYNDROME	0.20718688	7.760305131747314
HERPES SIMPLEX VIRUS ENCEPHALITIS	0.2051883	7.6854471550732715
NORRIE DISEASE	0.204851759	7.672841816118685
PEROXISOME BIOGENESIS DISORDER 12A (ZELLWEGER)	0.20468293299999998	7.666518340065701
CHROMOSOME 16P13.3 DELETION SYNDROME	0.203811773	7.633888535424727
BROOKE-SPIEGLER SYNDROME	0.203704	7.629851835007385
HOLT-ORAM SYNDROME	0.20238130000000001	7.580309336960394
PROGRESSIVE NON-INFECTIOUS ANTERIOR VERTEBRAL FUSION	0.20196464	7.564703094247564
PRIMARY NON-ESSENTIAL CUTIS VERTICIS GYRATA	0.201086973	7.5318295661358174
PROXIMAL 16P11.2 MICRODUPLICATION SYNDROME	0.201086973	7.5318295661358174
SAY-BARBER-MILLER SYNDROME	0.20054555400000001	7.5115504024931905
ROMANO-WARD SYNDROME	0.200541419	7.511395523662445
AUTOSOMAL RECESSIVE SPASTIC PARAPLEGIA TYPE 35	0.200541419	7.511395523662445
ATHEROSCLEROSIS, PREMATURE, WITH DEAFNESS, NEPHROPATHY, DIABETES MELLITUS,PHOTOMYOCLONUS, AND DEGENERATIVE NEUROLOGIC DISEASE	0.2	7.491116360019818
XERODERMA PIGMENTOSUM, COMPLEMENTATION GROUP F; XPF	0.2	7.491116360019818
BETA-THALASSEMIA	0.2	7.491116360019818
CONGENITAL LIPOID ADRENAL HYPERPLASIA DUE TO STAR DEFICENCY	0.2	7.491116360019818
SOLITARY FIBROUS TUMOUR/HEMANGIOPERICYTOMA	0.2	7.491116360019818
LETHAL INTRAUTERINE GROWTH RESTRICTION-CORTICAL MALFORMATION-CONGENITAL CONTRACTURES SYNDROME	0.2	7.491116360019818
POLYARTERITIS NODOSA	0.2	7.491116360019818
CONGENITAL ADRENAL HYPERPLASIA DUE TO 11-BETA-HYDROXYLASE DEFICIENCY	0.2	7.491116360019818
ATHEROSCLEROSIS-DEAFNESS-DIABETES-EPILEPSY-NEPHROPATHY SYNDROME	0.2	7.491116360019818
ECTODERMAL DYSPLASIA 11B, HYPOHIDROTIC/HAIR/TOOTH TYPE, AUTOSOMAL RECESSIVE; ECTD11B	0.2	7.491116360019818
EHLERS-DANLOS SYNDROME, AUTOSOMAL DOMINANT, TYPE UNSPECIFIED	0.2	7.491116360019818
BENIGN SCHWANNOMA	0.2	7.491116360019818
MALARIA	0.2	7.491116360019818
FAMILIAL HYPERALDOSTERONISM TYPE I	0.2	7.491116360019818
ECTODERMAL DYSPLASIA 11A, HYPOHIDROTIC/HAIR/TOOTH TYPE, AUTOSOMAL DOMINANT; ECTD11A	0.2	7.491116360019818
46,XY OVOTESTICULAR DISORDER OF SEX DEVELOPMENT	0.2	7.491116360019818
SAGLIKER SYNDROME	0.1909091	7.150611411433297
BILATERAL POLYMICROGYRIA	0.19069676400000005	7.142658243016194
TRISOMY 18	0.190529324	7.136386680399583
SCHINZEL-GIEDION SYNDROME	0.19047620000000004	7.134396890072035
MYOCLONIC EPILEPSY OF INFANCY	0.18559615399999999	6.951611927930787
FAMILIAL INFANTILE MYOCLONIC EPILEPSY	0.18559615399999999	6.951611927930787
SPONDYLOPERIPHERAL DYSPLASIA-SHORT ULNA SYNDROME	0.1851855	6.93623064344225
JUVENILE MYOCLONIC EPILEPSY	0.18297529999999998	6.853446316547671
PERIPHERAL PRIMITIVE NEUROECTODERMAL TUMOR	0.180721919	6.769044620175382
ROIFMAN SYNDROME; RFMN	0.18038989400000002	6.756608430628205
TBCK-RELATED INTELLECTUAL DISABILITY SYNDROME	0.17803989999999995	6.6685880381314595
MUCOLIPIDOSIS TYPE II	0.17570573	6.581160342761125
UNILATERAL POLYMICROGYRIA	0.17540910999999998	6.570050268087578
AURICULOOSTEODYSPLASIA	0.17473152	6.544670740415651
AURICULOOSTEODYSPLASIA	0.17473152	6.544670740415651
FAMILIAL REACTIVE PERFORATING COLLAGENOSIS	0.17460351000000002	6.53987605138942
PEROXISOMAL ACYL-COA OXIDASE DEFICIENCY	0.173695633	6.505870990151491
COMBINED MALONIC AND METHYLMALONIC ACIDEMIA	0.17367630399999998	6.505147011210875
CEREBROOCULONASAL SYNDROME	0.17236336	6.455969929819927
MICROTRIPLICATION 11Q24.1	0.1720945	6.445899622097154
CAMPTODACTYLY SYNDROME, GUADALAJARA TYPE 1	0.171434473	6.421177926808379
268650 RUDIGER SYNDROME	0.17073204	6.394867890117791
LÉRI-WEILL DYSCHONDROSTEOSIS	0.17042891999999998	6.383514354162544
PATENT DUCTUS ARTERIOSUS-BICUSPID AORTIC VALVE-HAND ANOMALIES SYNDROME	0.1693918	6.344668421166025
AUTOSOMAL RECESSIVE DOPA-RESPONSIVE DYSTONIA	0.1693697	6.343840652808243
RETINITIS PIGMENTOSA-JUVENILE CATARACT-SHORT STATURE-INTELLECTUAL DISABILITY SYNDROME	0.169261734	6.339796723463613
INTELLECTUAL DISABILITY-FACIAL DYSMORPHISM-HAND ANOMALIES SYNDROME	0.16871618000000002	6.319362680990243
BRACHYDACTYLY, TYPE E	0.16871618000000002	6.319362680990243
COMBINED OXIDATIVE PHOSPHORYLATION DEFECT TYPE 27	0.168466454	6.31000904836963
ADULT-ONSET DYSTONIA-PARKINSONISM	0.167753973	6.283322657993113
BRANCHIOSKELETOGENITAL SYNDROME	0.167208419	6.262888615519743
CARNITINE PALMITOYL TRANSFERASE II DEFICIENCY, NEONATAL FORM	0.167208419	6.262888615519743
PIERRE ROBIN SEQUENCE WITH PECTUS EXCAVATUM AND RIB AND SCAPULAR ANOMALIES	0.166667	6.242609451877115
106990 ANONYCHIA-ONYCHODYSTROPHY WITH BRACHYDACTYLY TYPE B AND ECTRODACTYLY	0.166667	6.242609451877115
BRACHYDACTYLY, TYPE B1	0.166667	6.242609451877115
BRACHYDACTYLY TYPE E	0.166667	6.242609451877115
DERMATOLEUKODYSTROPHY	0.166667	6.242609451877115
PROGRESSIVE SUPRANUCLEAR PALSY-CORTICOBASAL SYNDROME	0.166667	6.242609451877115
EXOSTOSES WITH ANETODERMIA AND BRACHYDACTYLY, TYPE E	0.166667	6.242609451877115
BRACHYDACTYLY TYPE B2	0.166667	6.242609451877115
BRACHYDACTYLY, TYPE E, WITH ATRIAL SEPTAL DEFECT, TYPE II	0.166667	6.242609451877115
EXOSTOSES-ANETODERMIA-BRACHYDACTYLY TYPE E SYNDROME	0.166667	6.242609451877115
BRACHYDACTYLY TYPE B	0.166667	6.242609451877115
CHRONIC INTESTINAL PSEUDOOBSTRUCTION	0.166667	6.242609451877115
120400 COLOBOMA OF MACULA WITH TYPE B BRACHYDACTYLY;;APICAL DYSTROPHY;;SORSBY SYNDROME	0.166667	6.242609451877115
COLOBOMA OF MACULA-BRACHYDACTYLY TYPE B SYNDROME	0.166667	6.242609451877115
SPINOCEREBELLAR ATAXIA 14	0.166667	6.242609451877115
SCALP-EAR-NIPPLE SYNDROME	0.166667	6.242609451877115
AUTOSOMAL DOMINANT SPASTIC PARAPLEGIA TYPE 9B	0.166667	6.242609451877115
PYRIDOXAL PHOSPHATE-RESPONSIVE SEIZURES	0.16330021399999997	6.116504523450685
PHOSPHOSERINE AMINOTRANSFERASE DEFICIENCY	0.1597745	5.984446854319932
SEIZURES, BENIGN FAMILIAL INFANTILE, 1; BFIS1	0.1595057	5.974378793932066
SEIZURES, BENIGN FAMILIAL INFANTILE, 3; BFIS3	0.1595057	5.974378793932066
RESTRICTIVE DERMOPATHY, LETHAL	0.15919687	5.9628113866047405
FREE SIALIC ACID STORAGE DISEASE	0.158229673	5.926584460254429
MENTAL RETARDATION, X-LINKED, SYNDROMIC, CHRISTIANSON TYPE	0.15768825399999997	5.9063052966118015
WRINKLY SKIN SYNDROME	0.156528174	5.862853825277143
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 25, WITH AMELOGENESIS IMPERFECTA; EIEE25	0.15489685399999997	5.801751785575005
CDKL5-RELATED EPILEPTIC ENCEPHALOPATHY	0.15484175	5.799687833195493
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IA; CDG1A	0.15362699299999996	5.754188403014749
RIGIDITY AND MULTIFOCAL SEIZURE SYNDROME, LETHAL NEONATAL; RMFSL	0.15266181399999998	5.718037062028512
CONGENITAL MUSCULAR DYSTROPHY WITH INTELLECTUAL DISABILITY AND SEVERE EPILEPSY	0.15266181399999998	5.718037062028512
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 4	0.15260886	5.71605363914987
KCNQ2-RELATED EPILEPTIC ENCEPHALOPATHY	0.15205635	5.695359055649497
DE BARSY SYNDROME	0.15180161399999997	5.685817770564066
EARLY-ONSET EPILEPTIC ENCEPHALOPATHY-CORTICAL BLINDNESS-INTELLECTUAL DISABILITY-FACIAL DYSMORPHISM SYNDROME	0.1515915	5.677947828449721
INFANTILE HYPOTONIA-OCULOMOTOR ANOMALIES-HYPERKINETIC MOVEMENTS-DEVELOPMENTAL DELAY SYNDROME	0.14980677999999997	5.611100102499448
PHACE SYNDROME	0.14956195299999997	5.601929964774074
CUTIS MARMORATA TELANGIECTATICA CONGENITA	0.14901639899999997	5.581495922300703
TUBEROUS SCLEROSIS COMPLEX	0.1484533	5.56040472164465
EHLERS-DANLOS SYNDROME, TYPE VI	0.14719101999999998	5.51312528985002
DISTAL MONOSOMY 7Q36	0.14612321899999997	5.473130182148292
PIEBALDISM	0.14482163999999997	5.424378783444501
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IK; CDG1K	0.14394397299999998	5.3915052553327545
INTELLECTUAL DISABILITY-SPARSE HAIR-BRACHYDACTYLY SYNDROME	0.143921334	5.390657298416382
MOEBIUS SYNDROME-AXONAL NEUROPATHY-HYPOGONADOTROPIC HYPOGONADISM SYNDROME	0.14354070000000002	5.376400430493485
MITOCHONDRIAL TRIFUNCTIONAL PROTEIN DEFICIENCY; MTPD	0.143402554	5.371226091690127
FAMILIAL MULTIPLE NEVI FLAMMEI	0.14339841899999997	5.371071212859382
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 5; COXPD5	0.14339841899999997	5.371071212859382
EPILEPSY, PHOTOGENIC, WITH SPASTIC DIPLEGIA AND MENTAL RETARDATION	0.14285699999999998	5.350792049216755
CONGENITAL FACTOR XIII DEFICIENCY	0.14285699999999998	5.350792049216755
PYRUVATE KINASE DEFICIENCY OF RED CELLS	0.14285699999999998	5.350792049216755
PERIODIC FEVER, MENSTRUAL CYCLE-DEPENDENT	0.14285699999999998	5.350792049216755
LIPODYSTROPHY DUE TO PEPTIDIC GROWTH FACTORS DEFICIENCY	0.14285699999999998	5.350792049216755
COMBINED SAPOSIN DEFICIENCY	0.14285699999999998	5.350792049216755
DELAYED ENCEPHALOPATHY DUE TO CARBON MONOXIDE POISONING	0.14285699999999998	5.350792049216755
PACMAN DYSPLASIA	0.14285699999999998	5.350792049216755
MACROSOMIA-MICROPHTHALMIA-CLEFT PALATE SYNDROME	0.14285699999999998	5.350792049216755
INCLUSION BODY MYOPATHY WITH PAGET DISEASE OF BONE AND FRONTOTEMPORAL DEMENTIA	0.14285699999999998	5.350792049216755
HEREDITARY THROMBOPHILIA DUE TO CONGENITAL ANTITHROMBIN DEFICIENCY	0.14285699999999998	5.350792049216755
223540 DWARFISM, MENTAL RETARDATION, AND EYE ABNORMALITY;;MOLLICA SYNDROME	0.14285699999999998	5.350792049216755
MULTICENTRIC OSTEOLYSIS-NODULOSIS-ARTHROPATHY SPECTRUM	0.14285699999999998	5.350792049216755
GANGLIONEUROMA	0.14285699999999998	5.350792049216755
AUTOSOMAL RECESSIVE NON-SYNDROMIC INTELLECTUAL DISABILITY	0.140035704	5.245118766106463
49,XXXYY SYNDROME	0.13767359999999998	5.156644786514121
%600176 PACHYGYRIA WITH MENTAL RETARDATION, SEIZURES, AND ARACHNOID CYSTS;;PACHYGYRIA WITH MENTAL RETARDATION AND SEIZURES	0.13756670399999998	5.152640934642018
INTELLECTUAL DISABILITY-SEIZURES-ABNORMAL GAIT-FACIAL DYSMORPHISM SYNDROME	0.13602788	5.095003386434063
CHRISTIANSON SYNDROME	0.1353348	5.069043671800051
ROLANDIC EPILEPSY-SPEECH DYSPRAXIA SYNDROME	0.1324787	4.962066784620787
SMITH-MAGENIS SYNDROME; SMS	0.132084993	4.947320259877016
X-LINKED INTELLECTUAL DISABILITY, CABEZAS TYPE	0.131709139	4.933242429635121
HYPOTHYROIDISM DUE TO DEFICIENT TRANSCRIPTION FACTORS INVOLVED IN PITUITARY DEVELOPMENT OR FUNCTION	0.13149785400000003	4.925328627034489
CENTRAL CONGENITAL HYPOTHYROIDISM	0.13095230000000002	4.9048945845611165
ADNP SYNDROME	0.130009449	4.869579551805311
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 57; EIEE57	0.12522615399999998	4.690418454658805
X-LINKED INTELLECTUAL DISABILITY-CEREBELLAR HYPOPLASIA-SPONDYLO-EPIPHYSEAL DYSPLASIA SYNDROME	0.12231927	4.581539423213407
POLYMICROGYRIA, BILATERAL PERISYLVIAN	0.11815324999999999	4.425498720322557
TRISOMY 18P	0.11509595	4.310985770085115
WHITE-SUTTON SYNDROME; WHSUS	0.11370593400000001	4.258921912093669
MICROCEPHALIC OSTEODYSPLASTIC PRIMORDIAL DWARFISM TYPES I AND III	0.11157119400000001	4.178963983401726
2Q23.1 MICRODUPLICATION SYNDROME	0.111457554	4.174707531085962
ARTHROGRYPOSIS-OCULOMOTOR LIMITATION-ELECTRORETINAL ANOMALIES SYNDROME	0.1114551	4.174615615088224
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 9; EIEE9	0.111069204	4.160161655893893
CONGENITAL TRACHEAL STENOSIS	0.10927035000000002	4.092784532750458
FLYNN-AIRD SYNDROME	0.108538459	4.065371129531202
DEAFNESS-ENAMEL HYPOPLASIA-NAIL DEFECTS SYNDROME	0.10817310000000001	4.051686395620299
KUFOR-RAKEB SYNDROME	0.1051948	3.940132436345064
SECKEL SYNDROME 7; SCKL7	0.10490220900000001	3.9291732702105913
AICARDI SYNDROME; AIC	0.1036867	3.8836456734323344
BLEPHAROPHIMOSIS-INTELLECTUAL DISABILITY SYNDROME, VERLOES TYPE	0.103535369	3.8779774827829434
WITTEVEEN-KOLK SYNDROME	0.103403613	3.8730424851472898
MARINESCO-SJÖGREN SYNDROME	0.10156835400000001	3.804301791548422
CORNEODERMATOOSSEOUS SYNDROME	0.10136164	3.796559198412196
PATERNAL UNIPARENTAL DISOMY OF CHROMOSOME 6	0.10128821000000002	3.793808835040615
KAPOSI SARCOMA	0.1	3.745558180009909
NAGER SYNDROME	0.1	3.745558180009909
METAPHYSEAL ANADYSPLASIA	0.1	3.745558180009909
HYPOPHOSPHATEMIC RICKETS, AUTOSOMAL DOMINANT	0.1	3.745558180009909
AICARDI SYNDROME	0.09992303	3.7426752238787553
GENERALIZED EPILEPSY WITH FEBRILE SEIZURES PLUS, TYPE 9; GEFSP9	0.098953104	3.7063460812457123
KLEEFSTRA SYNDROME DUE TO 9Q34 MICRODELETION	0.09839385400000002	3.6853990471240077
NEUROFIBROMATOSIS TYPE 1	0.09829781900000001	3.681802000325835
FEBRILE SEIZURES, FAMILIAL, 5; FEB5	0.09812185	3.675210979052053
FEBRILE SEIZURES, FAMILIAL, 6; FEB6	0.09812185	3.675210979052053
%121210 FEBRILE SEIZURES, FAMILIAL, 1; FEB1;;CONVULSIONS, FAMILIAL FEBRILE;  1	0.09812185	3.675210979052053
FEBRILE SEIZURES, FAMILIAL, 4; FEB4	0.09812185	3.675210979052053
FEBRILE SEIZURES, FAMILIAL, 2; FEB2	0.09812185	3.675210979052053
MACROCEPHALY-INTELLECTUAL DISABILITY-NEURODEVELOPMENTAL DISORDER-SMALL THORAX SYNDROME	0.09720319399999999	3.640802184097901
OROMANDIBULAR DYSTONIA	0.09684680000000001	3.6274532394778367
DISTAL 22Q11.2 MICRODELETION SYNDROME	0.09554843300000002	3.578822148102788
MICROCEPHALY-CORPUS CALLOSUM AND CEREBELLAR VERMIS HYPOPLASIA-FACIAL DYSMORPHISM-INTELLECTUAL DISABILITY SYNDROM	0.09494657300000002	3.55627913164058
RAPID-ONSET CHILDHOOD OBESITY-HYPOTHALAMIC DYSFUNCTION-HYPOVENTILATION-AUTONOMIC DYSREGULATION SYNDROME	0.09484483300000002	3.5524684007482383
PEDIATRIC-ONSET GRAVES DISEASE	0.09456766400000001	3.5420868745962863
AARSKOG-SCOTT SYNDROME	0.094108154	3.524875660203322
CHOREOACANTHOCYTOSIS	0.09381280900000001	3.5138133413965726
BLEPHAROPHIMOSIS, PTOSIS, AND EPICANTHUS INVERSUS	0.09339324000000002	3.498098140396287
CONGENITAL ANALBUMINEMIA	0.09283541000000001	3.477204293200737
PRADER-WILLI SYNDROME	0.09193923900000002	3.443637687003361
TETRASOMY 9P	0.09147909300000003	3.426402650860373
SCHIMMELPENNING-FEUERSTEIN-MIMS SYNDROME; SFM	0.09145051900000001	3.4253323950660164
ARTHROGRYPOSIS MULTIPLEX CONGENITA-WHISTLING FACE SYNDROME	0.09128212900000002	3.4190252496466984
BECKWITH-WIEDEMANN SYNDROME	0.09094444	3.4063769116842035
POSTAXIAL TETRAMELIC OLIGODACTYLY	0.0909091	3.4050532314233886
RARE CIRCULATORY SYSTEM DISEASE	0.0909091	3.4050532314233886
BAZEX-DUPRÉ-CHRISTOL SYNDROME	0.0909091	3.4050532314233886
TENDONS, EXTENSOR, OF FINGERS, ANOMALOUS INSERTION OF	0.0909091	3.4050532314233886
X-LINKED INTELLECTUAL DISABILITY-DYSMORPHISM-CEREBRAL ATROPHY SYNDROME	0.08997722000000001	3.370149123855512
LEIGH SYNDROME WITH NEPHROTIC SYNDROME	0.08992909	3.368346386703473
ZECHI-CEIDE SYNDROME	0.08990853400000003	3.367576449763991
NIGHT BLINDNESS-SKELETAL ANOMALIES-DYSMORPHISM SYNDROME	0.08973860000000002	3.361211472926373
GUANIDINOACETATE METHYLTRANSFERASE DEFICIENCY	0.08969697	3.359652197056034
CORTICAL DYSGENESIS WITH PONTOCEREBELLAR HYPOPLASIA DUE TO TUBB3 MUTATION	0.08863413	3.3198429064956168
3P25.3 MICRODELETION SYNDROME	0.08841383000000001	3.3115914418250556
DISTAL MONOSOMY 17Q	0.08806016	3.2983445262098137
3MC SYNDROME 2	0.08745229400000001	3.2755765515233155
POLYENDOCRINE-POLYNEUROPATHY SYNDROME; PEPNS	0.08658005000000002	3.2429061450316703
POLYENDOCRINE-POLYNEUROPATHY SYNDROME	0.08658005000000002	3.2429061450316703
EARLY-ONSET PROGRESSIVE ENCEPHALOPATHY-HEARING LOSS-PONS HYPOPLASIA-BRAIN ATROPHY SYNDROME	0.0863931	3.2359038240141405
HYPERORNITHINEMIA-HYPERAMMONEMIA-HOMOCITRULLINURIA SYNDROME	0.08618236000000001	3.2280104347055882
ERMINE PHENOTYPE	0.08605810000000001	3.223356204111108
15Q13.3 MICRODELETION SYNDROME	0.085852493	3.2156550743039345
MONOSOMY 13Q34	0.08551017400000002	3.2028333169977072
CONGENITAL ENTEROVIRUS INFECTION	0.08532646	3.1959522022428835
AUTOSOMAL RECESSIVE ATAXIA DUE TO UBIQUINONE DEFICIENCY	0.08502160900000001	3.1845338306755413
ACROOTOOCULAR SYNDROME	0.08496462000000002	3.1823992745243355
3MC SYNDROME 3	0.08492067	3.1807531017042208
VELOCARDIOFACIAL SYNDROME	0.0840023	3.1463550190464638
JOUBERT SYNDROME 26	0.08387885400000002	3.1417312772955697
DOPA-RESPONSIVE DYSTONIA DUE TO SEPIAPTERIN REDUCTASE DEFICIENCY	0.08387471900000001	3.1415763984648257
SECONDARY SHORT BOWEL SYNDROME	0.08333330000000001	3.121297234822198
SCLEROSTEOSIS	0.08333330000000001	3.121297234822198
POSTORGASMIC ILLNESS SYNDROME	0.08333330000000001	3.121297234822198
HEMOLYTIC ANEMIA, LETHAL CONGENITAL NONSPHEROCYTIC, WITH GENITAL AND OTHER ABNORMALITIES	0.08333330000000001	3.121297234822198
MUCKLE-WELLS SYNDROME	0.08333330000000001	3.121297234822198
ACUTE MONOBLASTIC LEUKEMIA	0.08333330000000001	3.121297234822198
SYNDACTYLY-POLYDACTYLY-EARLOBE SYNDROME	0.08333330000000001	3.121297234822198
ALKAPTONURIA	0.08333330000000001	3.121297234822198
POLYDACTYLY, PREAXIAL IV; PPD4	0.08333330000000001	3.121297234822198
ECTODERMAL DYSPLASIA, TRICHOODONTOONYCHIAL TYPE	0.08333330000000001	3.121297234822198
DIPROSOPUS	0.08333330000000001	3.121297234822198
MECKEL SYNDROME, TYPE 1; MKS1	0.08301180999999999	3.1092556398292834
TURNPENNY-FRY SYNDROME; TPFS	0.082772514	3.1002926689268473
TRISOMY 8P	0.082238499	3.0802908264118676
STEROID-RESPONSIVE ENCEPHALOPATHY ASSOCIATED WITH AUTOIMMUNE THYROIDITIS	0.08192708	3.068626446583262
ETHYLMALONIC ENCEPHALOPATHY	0.081774859	3.0629249204660693
8Q24.3 MICRODELETION SYNDROME	0.081398943	3.048844767978103
EARLY-ONSET PROGRESSIVE DIFFUSE BRAIN ATROPHY-MICROCEPHALY-MUSCLE WEAKNESS-OPTIC ATROPHY SYNDROME	0.08103649399999999	3.0352690298102383
TRICHOHEPATOENTERIC SYNDROME 1	0.08098814000000001	3.0334579026078776
KBG SYNDROME	0.080279573	3.0069181133785263
AUTOSOMAL DOMINANT SPASTIC ATAXIA TYPE 1	0.08016985000000001	3.002808374576675
MENTAL RETARDATION, X-LINKED, SYNDROMIC, TURNER TYPE; MRXST	0.08012031300000001	3.000952937421043
DIENCEPHALIC SYNDROME	0.0798771	2.9918432530046952
XY TYPE GONADAL DYSGENESIS-ASSOCIATED ANOMALIES SYNDROME	0.0794169	2.9746061942602893
SCLEROSTEOSIS 1; SOST1	0.07930664	2.9704763418110103
CHONDRODYSPLASIA PUNCTATA 2, X-LINKED DOMINANT; CDPX2	0.07908661	2.9622349901475347
CONGENITAL PROGRESSIVE BONE MARROW FAILURE-B-CELL IMMUNODEFICIENCY-SKELETAL DYSPLASIA SYNDROME	0.07897228	2.9579526934803297
17Q23.1Q23.2 MICRODELETION SYNDROME	0.07828091999999999	2.9320574024470125
POLYHYDRAMNIOS-MEGALENCEPHALY-SYMPTOMATIC EPILEPSY SYNDROME	0.07818681	2.9285324576438057
ALPHA-THALASSEMIA-X-LINKED INTELLECTUAL DISABILITY SYNDROME	0.07762181900000001	2.907370391026986
SEVERE GROWTH DEFICIENCY-STRABISMUS-EXTENSIVE DERMAL MELANOCYTOSIS-INTELLECTUAL DISABILITY SYNDROME	0.07746865400000001	2.901633506840574
CEREBELLAR ATROPHY, DEVELOPMENTAL DELAY, AND SEIZURES; CADEDS	0.07746865400000001	2.901633506840574
N SYNDROME	0.07746865400000001	2.901633506840574
DDOST-CDG	0.07746451900000001	2.901478628009831
PYRUVATE DEHYDROGENASE E3 DEFICIENCY	0.07746451900000001	2.901478628009831
49,XYYYY SYNDROME	0.077381	2.8983503752734676
OHDO SYNDROME, SBBYS VARIANT; SBBYSS	0.07704658	2.8858244796078787
PAPILLARY TUMOR OF THE PINEAL REGION	0.07692310000000001	2.8811994643672025
ACQUIRED HYPERTRICHOSIS LANUGINOSA	0.07692310000000001	2.8811994643672025
DIAMOND-BLACKFAN ANEMIA 11; DBA11	0.07692310000000001	2.8811994643672025
SYSTEMIC PRIMARY CARNITINE DEFICIENCY	0.07692310000000001	2.8811994643672025
DERMOODONTODYSPLASIA	0.07692310000000001	2.8811994643672025
DERMATOMYOSITIS	0.07692310000000001	2.8811994643672025
CLASSIC MYCOSIS FUNGOIDES	0.07692310000000001	2.8811994643672025
PINEOCYTOMA	0.07692310000000001	2.8811994643672025
IMMUNODEFICIENCY 36; IMD36	0.07692310000000001	2.8811994643672025
MULTIPLE ENDOCRINE NEOPLASIA TYPE 2	0.07692310000000001	2.8811994643672025
ISOLATED OPTIC NERVE HYPOPLASIA/APLASIA	0.07692310000000001	2.8811994643672025
MEIER-GORLIN SYNDROME 1; MGORS1	0.0765776	2.868258560855268
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 13	0.07628449400000001	2.8572801050961685
%300612 BROOKS-WISNIEWSKI-BROWN SYNDROME;;MENTAL RETARDATION, X-LINKED, SYNDROMIC, BROOKS-WISNIEWSKI-BROWN TYPE;MRXSBWB	0.076280359	2.857125226265425
MOSAIC TRISOMY 15	0.0760649	2.8490550840663573
X-LINKED INTELLECTUAL DISABILITY, BROOKS TYPE	0.07573894	2.836846062622797
INTELLECTUAL DISABILITY-SEIZURES-HYPOPHOSPHATASIA-OPHTHALMIC-SKELETAL ANOMALIES SYNDROME	0.07485825	2.8038593062872676
SCALP-EAR-NIPPLE SYNDROME; SENS	0.07426292000000001	2.781560874774215
3MC SYNDROME 1	0.07415340000000001	2.777458739455468
KNIEST-LIKE DYSPLASIA, LETHAL	0.07372334999999999	2.7613509665023352
FRONTONASAL DYSPLASIA-SEVERE MICROPHTHALMIA-SEVERE FACIAL CLEFTING SYNDROME	0.07361754000000001	2.757387791392067
XP22.13P22.2 DUPLICATION SYNDROME	0.07345811899999999	2.7514165850859125
HYPEREKPLEXIA-EPILEPSY SYNDROME	0.07300403999999999	2.734408791957706
DEVELOPMENTAL DELAY-FACIAL DYSMORPHISM SYNDROME DUE TO MED13L DEFICIENCY	0.07297057400000001	2.7331553034571843
PSEUDOVAGINAL PERINEOSCROTAL HYPOSPADIAS; PPSH	0.0726316	2.7204588350720775
CHROMOSOME 22Q13 DUPLICATION SYNDROME	0.07251557300000001	2.7161129762825578
PROGRESSIVE EXTERNAL OPHTHALMOPLEGIA WITH MITOCHONDRIAL DNA DELETIONS, AUTOSOMAL DOMINANT 3; PEOA3	0.07251557300000001	2.7161129762825578
BAKER-GORDON SYNDROME; BAGOS	0.07234092400000001	2.7095713963767523
CORPUS CALLOSUM AGENESIS-ABNORMAL GENITALIA SYNDROME	0.072260429	2.7065564093197527
ARTHROGRYPOSIS, DISTAL, TYPE 2A	0.072232369	2.705505405694442
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 15; EIEE15	0.07197415400000001	2.6958338126399295
PEROXISOME BIOGENESIS DISORDER 4A (ZELLWEGER)	0.07197001900000001	2.695678933809186
FRONTORHINY	0.0716529	2.6838010571643203
HYPERPHOSPHATASIA WITH MENTAL RETARDATION SYNDROME 6	0.071648993	2.683654718206227
AUTISM SPECTRUM DISORDER DUE TO AUTS2 DEFICIENCY	0.07160023300000001	2.681828384037655
PRIMARY BILIARY CHOLANGITIS	0.07142860000000001	2.675399770166558
NEONATAL SEVERE PRIMARY HYPERPARATHYROIDISM	0.07142860000000001	2.675399770166558
PTERYGIUM COLLI-INTELLECTUAL DISABILITY-DIGITAL ANOMALIES SYNDROME	0.07142860000000001	2.675399770166558
GLUCAGONOMA	0.07142860000000001	2.675399770166558
PPOMA	0.07142860000000001	2.675399770166558
3MC SYNDROME	0.07142860000000001	2.675399770166558
WEISMANN-NETTER SYNDROME	0.07142860000000001	2.675399770166558
SIX2-RELATED FRONTONASAL DYSPLASIA	0.07142860000000001	2.675399770166558
MALE HYPERGONADOTROPIC HYPOGONADISM-INTELLECTUAL DISABILITY-SKELETAL ANOMALIES SYNDROME	0.07142860000000001	2.675399770166558
GRFOMA	0.07142860000000001	2.675399770166558
PTERYGIUM COLLI AND MENTAL RETARDATION WITH FACIAL AND DIGITAL ANOMALIES	0.07142860000000001	2.675399770166558
FACIAL DYSMORPHISM-ANOREXIA-CACHEXIA-EYE AND SKIN ANOMALIES SYNDROME	0.07142860000000001	2.675399770166558
MULTIPLE ENDOCRINE NEOPLASIA, TYPE I	0.07142860000000001	2.675399770166558
MALT LYMPHOMA	0.07142860000000001	2.675399770166558
HYPOPARATHYROIDISM-RETARDATION-DYSMORPHISM SYNDROME	0.071273159	2.6695776370759687
WOLF-HIRSCHHORN SYNDROME	0.07089373300000001	2.655366015495885
EMANUEL SYNDROME	0.070817583	2.652513772941807
AUTOSOMAL DOMINANT KENNY-CAFFEY SYNDROME	0.07073174	2.649298473433341
WIDOW'S PEAK SYNDROME	0.0707196	2.648843762670287
MATERNAL UNIPARENTAL DISOMY OF CHROMOSOME 2	0.06946564400000001	2.6018761111385627
ANTLEY-BIXLER SYNDROME WITH GENITAL ANOMALIES AND DISORDERED STEROIDOGENESIS; ABS1	0.06926376000000001	2.5943144284624315
PSEUDOHYPOPARATHYROIDISM TYPE 1A	0.06871588	2.5737932643057926
PSEUDOHYPOPARATHYROIDISM TYPE 1C	0.06871588	2.5737932643057926
YOU-HOOVER-FONG SYNDROME; YHFS	0.068517954	2.566379830822427
CONGENITAL CATARACT-MICROCEPHALY-NEVUS FLAMMEUS SIMPLEX-SEVERE INTELLECTUAL DISABILITY SYNDROME	0.06776730900000001	2.5382639856220917
SHORT STATURE WITH MICROCEPHALY AND DISTINCTIVE FACIES; SSMCF	0.06749318	2.527996324438812
OSTEOPETROSIS, AUTOSOMAL RECESSIVE 7; OPTB7	0.067212254	2.517474077666037
ATELOSTEOGENESIS TYPE II	0.0668384	2.503471158587743
PSEUDOHYPOPARATHYROIDISM TYPE 1B	0.0666667	2.497040035192666
VITAMIN D HYDROXYLATION-DEFICIENT RICKETS, TYPE 1A	0.0666667	2.497040035192666
AUTOSOMAL RECESSIVE KENNY-CAFFEY SYNDROME	0.0666667	2.497040035192666
VITAMIN D-DEPENDENT RICKETS, TYPE 2A	0.0666667	2.497040035192666
PSEUDOHYPOPARATHYROIDISM TYPE 2	0.0666667	2.497040035192666
HYPOCALCEMIC VITAMIN D-DEPENDENT RICKETS	0.0666667	2.497040035192666
FAMILIAL ISOLATED HYPOPARATHYROIDISM DUE TO AGENESIS OF PARATHYROID GLAND	0.0666667	2.497040035192666
HYPOPARATHYROIDISM-SENSORINEURAL DEAFNESS-RENAL DISEASE SYNDROME	0.0666667	2.497040035192666
FAMILIAL HYPOCALCIURIC HYPERCALCEMIA	0.0666667	2.497040035192666
AUTOIMMUNE HYPOPARATHYROIDISM	0.0666667	2.497040035192666
PITT-HOPKINS-LIKE SYNDROME 1; PTHSL1	0.06590177300000001	2.468389249373062
MACROTHROMBOCYTOPENIA-LYMPHEDEMA-DEVELOPMENTAL DELAY-FACIAL DYSMORPHISM-CAMPTODACTYLY SYNDROME	0.065303813	2.4459923096798746
9Q33.3Q34.11 MICRODELETION SYNDROME	0.06518522900000001	2.441550676967692
SMITH-LEMLI-OPITZ SYNDROME; SLOS	0.06517233900000001	2.4410678745182888
BANGSTAD SYNDROME	0.064982899	2.433972289102077
BENIGN ADULT FAMILIAL MYOCLONIC EPILEPSY	0.0648148	2.4276760432570628
INFANTILE CONVULSIONS AND CHOREOATHETOSIS	0.0648148	2.4276760432570628
C SYNDROME	0.06450483900000001	2.4160662736667224
ASCHER SYNDROME	0.06444148	2.4136931254594494
MICROCEPHALY-INTELLECTUAL DISABILITY-SENSORINEURAL HEARING LOSS-EPILEPSY-ABNORMAL MUSCLE TONE SYNDROME	0.06403056399999998	2.3983020276084797
HOLOPROSENCEPHALY-POSTAXIAL POLYDACTYLY SYNDROME	0.063748	2.3877184285927164
TREMOR-ATAXIA-CENTRAL HYPOMYELINATION SYNDROME	0.063658244	2.384356565392667
MITOCHONDRIAL DNA-ASSOCIATED LEIGH SYNDROME	0.06352411	2.3793324983834925
HOLMES-GANG SYNDROME	0.063504124	2.3785839111256357
FATTY ACID HYDROXYLASE-ASSOCIATED NEURODEGENERATION	0.06259785000000001	2.3446388911853333
RHIZOMELIC DYSPLASIA, PATTERSON-LOWRY TYPE	0.062504	2.3411236848333936
DISLOCATION OF THE HIP-DYSMORPHISM SYNDROME	0.06241946	2.337957189948013
X-LINKED INTELLECTUAL DISABILITY, NASCIMENTO TYPE	0.061868669	2.317326992592755
611961 STEVENSON-CAREY SYNDROME	0.061783093	2.3141216937246294
BOR-DUANE HYDROCEPHALUS CONTIGUOUS GENE SYNDROME	0.0616699	2.3098819840539306
HAMAMY SYNDROME; HMMS	0.06156175999999999	2.305831537438068
PENILE AGENESIS	0.06132725	2.297047828950127
THYMIC-RENAL-ANAL-LUNG DYSPLASIA	0.06132725	2.297047828950127
FANCONI ANEMIA	0.061216323999999996	2.292893031083369
SEVERE CONGENITAL NEMALINE MYOPATHY	0.06103496	2.2860999369457757
DOUBLE UTERUS-HEMIVAGINA-RENAL AGENESIS SYNDROME	0.06103496	2.2860999369457757
%609939 SYSTEMIC LUPUS ERYTHEMATOSUS, SUSCEPTIBILITY TO, 6; SLEB6	0.0607197	2.274291690227477
SEIZURES-SCOLIOSIS-MACROCEPHALY SYNDROME	0.06070761300000001	2.2738389646102593
ISOLATED SEDOHEPTULOKINASE DEFICIENCY	0.06069612	2.2734084876086302
17Q21.31 MICRODUPLICATION SYNDROME	0.060457274	2.264462371718004
RING CHROMOSOME 8 SYNDROME	0.06045482	2.2643704557202664
1P36 DELETION SYNDROME	0.060176413000000005	2.2539425595580465
CONGENITAL ICHTHYOSIS-MICROCEPHALUS-TETRAPLEGIA SYNDROME	0.0600359	2.248679563392569
GRUBBEN-DE COCK-BORGHGRAEF SYNDROME	0.059910473	2.243981622134128
INCONTINENTIA PIGMENTI	0.059910473	2.243981622134128
HYPOTONIA, INFANTILE, WITH PSYCHOMOTOR RETARDATION AND CHARACTERISTIC FACIES 2; IHPRF2	0.05988578900000001	2.2430570685529743
POTOCKI-LUPSKI SYNDROME	0.059336553	2.222485114627415
OROMANDIBULAR-LIMB HYPOGENESIS SYNDROME	0.0588235	2.203268416018129
ANOPHTHALMIA PLUS SYNDROME	0.0588235	2.203268416018129
CRANIO-OSTEOARTHROPATHY	0.0588235	2.203268416018129
VON WILLEBRAND DISEASE	0.0588235	2.203268416018129
MICROCEPHALY-CARDIOMYOPATHY SYNDROME	0.058821819000000004	2.203205453185123
ULNAR/FIBULAR RAY DEFECT AND BRACHYDACTYLY	0.05874582	2.200358866423897
AMISH INFANTILE EPILEPSY SYNDROME	0.058561190000000006	2.193443442356145
DISTAL MONOSOMY 10Q	0.05818289299999999	2.1792741081279123
15Q OVERGROWTH SYNDROME	0.057862459000000005	2.16727206622938
MYOCLONIC EPILEPSY, FAMILIAL INFANTILE	0.057777909999999995	2.164105234243763
CHIME SYNDROME	0.057728339000000004	2.162248523598351
PEROXISOME BIOGENESIS DISORDER 1A (ZELLWEGER)	0.057507038999999996	2.1539596033459887
LETHAL KNIEST-LIKE DYSPLASIA	0.05738348	2.14933162911435
AUTOSOMAL RECESSIVE ATAXIA, BEAUCE TYPE	0.05694194	2.1327934915263342
CHROMOSOME 2P16.1-P15 DELETION SYNDROME	0.05677311399999999	2.1264700154733505
2P15P16.1 MICRODELETION SYNDROME	0.05677311399999999	2.1264700154733505
ACROFACIAL DYSOSTOSIS, CATANIA TYPE	0.05665564000000001	2.1220699584569664
MENTAL RETARDATION, AUTOSOMAL DOMINANT 13	0.056654840000000005	2.122039993991526
7P22.1 MICRODUPLICATION SYNDROME	0.056101154	2.1013013627269563
CRYPTOCOCCOSIS	0.056097019000000005	2.101146483896213
CROSSED POLYSYNDACTYLY	0.055555600000000004	2.0808673202535855
GITELMAN SYNDROME	0.055555600000000004	2.0808673202535855
FAMILIAL GLUCOCORTICOID DEFICIENCY	0.055555600000000004	2.0808673202535855
3-HYDROXYACYL-COA DEHYDROGENASE DEFICIENCY	0.055555600000000004	2.0808673202535855
HYPOINSULINEMIC HYPOGLYCEMIA AND BODY HEMIHYPERTROPHY	0.055555600000000004	2.0808673202535855
WILDERVANCK SYNDROME	0.055555600000000004	2.0808673202535855
HYPERINSULINISM DUE TO SHORT CHAIN 3-HYDROXYLACYL-COA DEHYDROGENASE DEFICIENCY	0.055555600000000004	2.0808673202535855
OBESITY DUE TO PROHORMONE CONVERTASE I DEFICIENCY	0.055555600000000004	2.0808673202535855
OBESITY DUE TO PRO-OPIOMELANOCORTIN DEFICIENCY	0.055555600000000004	2.0808673202535855
ACROCRANIOFACIAL DYSOSTOSIS	0.055555600000000004	2.0808673202535855
OBESITY, EARLY-ONSET, WITH ADRENAL INSUFFICIENCY AND RED HAIR; OBAIRH	0.055555600000000004	2.0808673202535855
HYPERINSULINEMIC HYPOGLYCEMIA, FAMILIAL, 6; HHF6	0.055555600000000004	2.0808673202535855
HYPERINSULINEMIC HYPOGLYCEMIA, FAMILIAL, 3; HHF3	0.055555600000000004	2.0808673202535855
AGNATHIA-OTOCEPHALY COMPLEX	0.055555600000000004	2.0808673202535855
CONGENITAL ISOLATED ACTH DEFICIENCY	0.055555600000000004	2.0808673202535855
HYPERINSULINEMIC HYPOGLYCEMIA, FAMILIAL, 7; HHF7	0.055555600000000004	2.0808673202535855
GLYCOGEN STORAGE DISEASE DUE TO LIVER PHOSPHORYLASE KINASE DEFICIENCY	0.055555600000000004	2.0808673202535855
HYPERINSULINEMIC HYPOGLYCEMIA, FAMILIAL, 5; HHF5	0.055555600000000004	2.0808673202535855
HYPERINSULINEMIC HYPOGLYCEMIA, FAMILIAL, 4; HHF4	0.055555600000000004	2.0808673202535855
EHLERS-DANLOS SYNDROME, ARTHROCHALASIA TYPE, 2; EDSARTH2	0.0553343	2.072578400001223
BRACHYDACTYLY-SHORT STATURE-RETINITIS PIGMENTOSA SYNDROME	0.055226334	2.0685344706565933
PDE4D HAPLOINSUFFICIENCY SYNDROME	0.055222199	2.0683795918258503
MOWAT-WILSON SYNDROME; MOWS	0.055137659000000006	2.06521309694047
2Q31.1 MICRODELETION SYNDROME	0.055111273	2.0642247939590925
TARP SYNDROME	0.054788173	2.0521228954794806
SILVER-RUSSELL SYNDROME; SRS	0.054593054	2.044814599814227
NEURODEVELOPMENTAL DISORDER WITH OR WITHOUT ANOMALIES OF THE BRAIN, EYE, OR HEART; NEDBEH	0.053702223	2.0114480064236626
AXENFELD-RIEGER SYNDROME	0.053648680000000004	2.00944252220734
POLYCYSTIC LIPOMEMBRANOUS OSTEODYSPLASIA WITH SCLEROSING LEUKOENCEPHALOPATHY; PLOSL	0.053288619	1.9959562279688148
SEVERE CONGENITAL HYPOCHROMIC ANEMIA WITH RINGED SIDEROBLASTS	0.05323698	1.9940220591802393
BETA-THALASSEMIA MAJOR	0.05323698	1.9940220591802393
MENTAL RETARDATION, AUTOSOMAL DOMINANT 26	0.053177154	1.9917812415434666
MICROCEPHALY, FACIAL DYSMORPHISM, RENAL AGENESIS, AND AMBIGUOUS GENITALIA SYNDROME; MFRG	0.053173019	1.9916263627127233
8P11.2 DELETION SYNDROME	0.053039993	1.9866437964881831
YUNIS-VARON SYNDROME	0.05284777	1.9794439721878228
CONGENITAL ERYTHROPOIETIC PORPHYRIA	0.0527472	1.9756770643261867
NEUROPATHY, HEREDITARY MOTOR AND SENSORY, RUSSE TYPE; HMSNR	0.0527472	1.9756770643261867
OCULODENTODIGITAL DYSPLASIA; ODDD	0.052701808999999995	1.9739769180126983
CUTIS VERTICIS GYRATA, THYROID APLASIA, AND MENTAL RETARDATION	0.0526316	1.9713471990700953
%601356 LETHAL SHORT-LIMB SKELETAL DYSPLASIA, AL GAZALI TYPE	0.0526316	1.9713471990700953
46,XY DISORDER OF SEX DEVELOPMENT DUE TO 5-ALPHA-REDUCTASE 2 DEFICIENCY	0.0526316	1.9713471990700953
STEINERT MYOTONIC DYSTROPHY	0.0526316	1.9713471990700953
THIOUREA TASTINGPHENYLTHIOCARBAMIDE TASTING, INCLUDED	0.0526316	1.9713471990700953
HUMEROFEMORAL HYPOPLASIA WITH RADIOTIBIAL RAY DEFICIENCY; HHRRD	0.0526316	1.9713471990700953
EHLERS-DANLOS SYNDROME, ARTHROCHALASIA TYPE, 1; EDSARTH1	0.0526316	1.9713471990700953
PYGMY	0.0526316	1.9713471990700953
THREE M SYNDROME 2; 3M2	0.0526316	1.9713471990700953
CANDIDIASIS, FAMILIAL CHRONIC MUCOCUTANEOUS, AUTOSOMAL DOMINANT	0.0526316	1.9713471990700953
CHILDHOOD-ONSET NEMALINE MYOPATHY	0.0526316	1.9713471990700953
MENOPAUSE, NATURAL, AGE AT, QUANTITATIVE TRAIT LOCUS 1	0.0526316	1.9713471990700953
BIEMOND SYNDROME II	0.0526316	1.9713471990700953
ECTODERMAL DYSPLASIA WITH ADRENAL CYST	0.0526316	1.9713471990700953
274210 THYMIC APLASIA WITH FETAL DEATH	0.0526316	1.9713471990700953
MYASTHENIA GRAVIS; MG	0.0526316	1.9713471990700953
XQ12-Q13.3 DUPLICATION SYNDROME	0.05255727999999999	1.9685635002307116
PATERNAL 20Q13.2Q13.3 MICRODELETION SYNDROME	0.05232698999999999	1.9599378542979666
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IIH	0.052088174	1.9509928620747945
16Q24.3 MICRODELETION SYNDROME	0.052084239000000004	1.9508454743604113
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 57; MRT57	0.051281214	1.9207677057853867
GLYCOSYLPHOSPHATIDYLINOSITOL DEFICIENCY	0.051181119000000004	1.917018589325106
TRISOMY 20P	0.05116909999999999	1.9165684106874497
MOLYBDENUM COFACTOR DEFICIENCY, COMPLEMENTATION GROUP C; MOCODC	0.051066104	1.9127106355843675
TMEM70-RELATED MITOCHONDRIAL ENCEPHALO-CARDIO-MYOPATHY	0.050903768999999995	1.9066302837128482
HYPOGONADOTROPIC HYPOGONADISM-SEVERE MICROCEPHALY-SENSORINEURAL HEARING LOSS-DYSMORPHISM SYNDROME	0.050903768999999995	1.9066302837128482
HYPOTONIA, INFANTILE, WITH PSYCHOMOTOR RETARDATION AND CHARACTERISTIC FACIES 3; IHPRF3	0.050893029000000006	1.9062280107643155
TRISOMY 17P	0.050649353999999994	1.897101021869176
CEREBELLAR ATAXIA-HYPOGONADISM SYNDROME	0.0503438	1.8856563190278286
MICROCEPHALY-MICROMELIA SYNDROME; MIMIS	0.049859850000000004	1.8675296902156708
PITT-HOPKINS-LIKE SYNDROME	0.049725129	1.8624836367799793
CRANIOFRONTONASAL DYSPLASIA	0.04952302	1.8549135265979435
ERYTHERMALGIA, PRIMARY	0.0494995	1.8540325713140051
NEURODEVELOPMENTAL DISORDER WITH MICROCEPHALY, HYPOTONIA, AND VARIABLE BRAIN ANOMALIES; NMIHBA	0.04948471900000001	1.8534789403594183
HYPOMAGNESEMIA, SEIZURES, AND MENTAL RETARDATION 2; HOMGSMR2	0.049076854	1.8382021194885203
CONGENITAL LABIOSCROTAL AGENESIS-CEREBELLAR MALFORMATION-CORNEAL DYSTROPHY-FACIAL DYSMORPHISM SYNDROME	0.04907410999999999	1.8380993413720605
MICROCEPHALIC PRIMORDIAL DWARFISM, DAUBER TYPE	0.048913293	1.832075847073714
JOUBERT SYNDROME WITH RENAL DEFECT	0.048705973	1.8243105558549177
JOUBERT SYNDROME WITH OCULORENAL DEFECT	0.048705973	1.8243105558549177
JOUBERT SYNDROME	0.048705973	1.8243105558549177
JOUBERT SYNDROME WITH OCULAR DEFECT	0.048705973	1.8243105558549177
MICROPHTHALMIA WITH BRAIN AND DIGIT ANOMALIES	0.048705973	1.8243105558549177
FRONTOMETAPHYSEAL DYSPLASIA 2; FMD2	0.048318150000000004	1.809784419754458
ZELLWEGER SYNDROME	0.048255039000000007	1.8074205605314722
RING CHROMOSOME 1 SYNDROME	0.04816774000000001	1.8041507256959053
ANTERIOR SEGMENT DEVELOPMENTAL ANOMALY	0.048164554	1.8040313922122897
GRANULOMATOSIS WITH POLYANGIITIS	0.048160419	1.8038765133815464
JOUBERT SYNDROME WITH HEPATIC DEFECT	0.048160419	1.8038765133815464
MICROHYDRANENCEPHALY; MHAC	0.047676260000000005	1.7857420563527924
MOSAIC TRISOMY 9	0.047658204	1.7850657583678098
HYDROCEPHALUS-OBESITY-HYPOGONADISM SYNDROME	0.047619	1.7835973497389186
SYMPTOMATIC FORM OF HEMOCHROMATOSIS TYPE 1	0.047619	1.7835973497389186
CORPUS CALLOSUM AGENESIS-MACROCEPHALY-HYPERTELORISM SYNDROME	0.0475633	1.781511073832653
INFANTILE SPASMS-PSYCHOMOTOR RETARDATION-PROGRESSIVE BRAIN ATROPHY-BASAL GANGLIA DISEASE SYNDROME	0.04754470399999999	1.7808145498334982
OKUR-CHUNG NEURODEVELOPMENTAL SYNDROME; OCNDS	0.047460554	1.77766266262502
FOCAL FACIAL DERMAL DYSPLASIA TYPE III	0.04707426	1.7631937961091324
DISTAL TRISOMY 18Q	0.04674865400000001	1.7509980339415299
POLYMICROGYRIA WITH OPTIC NERVE HYPOPLASIA	0.04670776	1.7494663253793963
SPASTIC PARAPLEGIA 52, AUTOSOMAL RECESSIVE	0.046689294000000006	1.7487746706058758
PROMINENT GLABELLA-MICROCEPHALY-HYPOGENITALISM SYNDROME	0.04661445300000001	1.7459714574083747
HAND-FOOT-GENITAL SYNDROME	0.046203100000000004	1.7305639914681585
8Q22.1 MICRODELETION SYNDROME	0.045988494000000005	1.7225257988803664
SEVERE X-LINKED MITOCHONDRIAL ENCEPHALOMYOPATHY	0.04597704	1.722096782646428
MITOCHONDRIAL DNA-RELATED CARDIOMYOPATHY AND HEARING LOSS	0.045956699999999996	1.7213349361126138
WAC-RELATED FACIAL DYSMORPHISM-DEVELOPMENTAL DELAY-BEHAVIORAL ABNORMALITIES SYNDROME	0.04592198399999999	1.720034628134841
METHYLCOBALAMIN DEFICIENCY TYPE CBLE	0.045762489	1.7140606501156348
LISSENCEPHALY, X-LINKED, 2	0.04562776900000001	1.7090146341355261
MOSAIC TRISOMY 1	0.04561545	1.70855321882333
HALLERMANN-STREIFF SYNDROME; HSS	0.04550375	1.704369430336259
FRASER SYNDROME	0.04544294	1.702091756406995
OROFACIODIGITAL SYNDROME TYPE 2	0.045266744	1.6954922327161444
BRADDOCK SYNDROME	0.04510962	1.689607061881386
ANGEL-SHAPED PHALANGO-EPIPHYSEAL DYSPLASIA	0.04510152	1.689303671668805
TETRAMELIC DEFICIENCIES, ECTODERMAL DYSPLASIA, DEFORMED EARS, ANDOTHER ABNORMALITIES	0.04497351	1.6845089826425745
DISTAL MONOSOMY 12Q	0.04493705399999999	1.6831435019524696
EPILEPSY, IDIOPATHIC GENERALIZED, SUSCEPTIBILITY TO, 14	0.044925509999999995	1.6827111147161695
ALSTROM SYNDROME; ALMS	0.044625034	1.6714566113192033
SEVERE ACHONDROPLASIA-DEVELOPMENTAL DELAY-ACANTHOSIS NIGRICANS SYNDROME	0.044444410000000004	1.664691234312142
ALLAN-HERNDON-DUDLEY SYNDROME	0.044444410000000004	1.664691234312142
PYRIDOXINE-DEPENDENT EPILEPSY	0.044297953999999994	1.6592056396240265
PGM3-CDG	0.04425729899999999	1.6576828829459433
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IIE; CDG2E	0.044192229000000006	1.6552456482382114
HYPERPHOSPHATASIA-INTELLECTUAL DISABILITY SYNDROME	0.044025794	1.6490117284813115
ABLEPHARON MACROSTOMIA SYNDROME	0.044023854	1.6489390646526196
FAMILIAL THROMBOCYTOSIS	0.044019719000000006	1.6487841858218764
LASSA FEVER	0.044019719000000006	1.6487841858218764
VIRAL HEMORRHAGIC FEVER	0.044019719000000006	1.6487841858218764
KEUTEL SYNDROME; KTLS	0.044019719000000006	1.6487841858218764
ATYPICAL WERNER SYNDROME	0.04377882	1.639761173621814
HYPERGLYCINEMIA, LACTIC ACIDOSIS, AND SEIZURES	0.04366312900000001	1.6354278999077794
PRIMARY CILIARY DYSKINESIA	0.043478300000000004	1.6285050221792485
PLACENTAL SITE TROPHOBLASTIC TUMOR	0.043478300000000004	1.6285050221792485
GESTATIONAL TROPHOBLASTIC NEOPLASM	0.043478300000000004	1.6285050221792485
MATERNAL UNIPARENTAL DISOMY OF CHROMOSOME 6	0.043478300000000004	1.6285050221792485
OCULOTRICHOANAL SYNDROME	0.043478300000000004	1.6285050221792485
ASHERMAN SYNDROME	0.043478300000000004	1.6285050221792485
RINGED HAIR DISEASE	0.043478300000000004	1.6285050221792485
AUTOSOMAL DOMINANT CENTRONUCLEAR MYOPATHY	0.043478300000000004	1.6285050221792485
YELLOW FEVER	0.043478300000000004	1.6285050221792485
WERNER SYNDROME	0.043478300000000004	1.6285050221792485
CRANIODIGITAL-INTELLECTUAL DISABILITY SYNDROME	0.043478300000000004	1.6285050221792485
PACHYDERMOPERIOSTOSIS	0.043478300000000004	1.6285050221792485
JOHANSON-BLIZZARD SYNDROME	0.043478300000000004	1.6285050221792485
HYDATIDIFORM MOLE	0.043478300000000004	1.6285050221792485
FAMILIAL AFIBRINOGENEMIA	0.043478300000000004	1.6285050221792485
GESTATIONAL CHORIOCARCINOMA	0.043478300000000004	1.6285050221792485
FRONTONASAL DYSPLASIA 1; FND1	0.0434588	1.6277746383341463
FABRY DISEASE	0.04331325900000001	1.6223233155033785
SUCCINIC SEMIALDEHYDE DEHYDROGENASE DEFICIENCY	0.04326676399999999	1.6205818182275824
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 18	0.04324875399999999	1.6199072431993624
CUTIS LAXA	0.043219494	1.6188112928758918
15Q26 OVERGROWTH SYNDROME	0.043200329999999995	1.6180934941062746
MICROCEPHALY 10, PRIMARY, AUTOSOMAL RECESSIVE; MCPH10	0.04312171000000001	1.615148736265151
HYPERTELORISM, TEEBI TYPE	0.04306176	1.6129032741362348
SECKEL SYNDROME	0.043047419999999996	1.6123661610932216
NEURODEVELOPMENTAL DISORDER-CRANIOFACIAL DYSMORPHISM-CARDIAC DEFECT-SKELETAL ANOMALIES SYNDROME	0.042843859	1.6047416654064113
TEMPLE-BARAITSER SYNDROME	0.04279478899999999	1.6029037200074803
MENTAL RETARDATION, X-LINKED, SYNDROMIC, CABEZAS TYPE; MRXSC	0.042785209	1.6025448955338357
X-LINKED INTELLECTUAL DISABILITY, HEDERA TYPE	0.042756550000000004	1.601471456015027
PSEUDOLEPRECHAUNISM SYNDROME, PATTERSON TYPE	0.042756550000000004	1.601471456015027
X-LINKED INTELLECTUAL DISABILITY-LIMB SPASTICITY-RETINAL DYSTROPHY-DIABETES INSIPIDUS SYNDROME	0.042756550000000004	1.601471456015027
LAMININ SUBUNIT ALPHA 2-RELATED CONGENITAL MUSCULAR DYSTROPHY	0.0427032	1.5994732007259913
GORLIN SYNDROME	0.04268214	1.5986843861732813
ANOPHTHALMIA-MEGALOCORNEA-CARDIOPATHY-SKELETAL ANOMALIES SYNDROME	0.04264079999999999	1.597135972421665
PALATAL ANOMALIES-WIDELY SPACED TEETH-FACIAL DYSMORPHISM-DEVELOPMENTAL DELAY SYNDROME	0.042599213999999996	1.5955783445969263
COG2-CDG	0.04221225399999999	1.5810845326635596
FAMILIAL PRIMARY HYPOMAGNESEMIA WITH NORMOCALCIURIA AND NORMOCALCEMIA	0.042208118999999995	1.5809296538328164
SPONDYLOMETAPHYSEAL DYSPLASIA, KOZLOWSKI TYPE	0.042063500000000004	1.5755128650484684
3Q13 MICRODELETION SYNDROME	0.042057460000000005	1.5752866333343958
100050 AARSKOG SYNDROME, AUTOSOMAL DOMINANT	0.04182748	1.5666725986320087
HYPERTELORISM AND OTHER FACIAL DYSMORPHISM, BRACHYDACTYLY, GENITAL ABNORMALITIES, MENTAL RETARDATION, AND RECURRENT INFLAMMATORY EPISODES	0.04182748	1.5666725986320087
CAMPTODACTYLY SYNDROME, GUADALAJARA, TYPE II	0.04178888	1.5652268131745246
HISTIDINEMIA	0.041666699999999994	1.5606504901901885
PATERNAL UNIPARENTAL DISOMY OF CHROMOSOME X	0.041666699999999994	1.5606504901901885
DISTAL 17P13.1 MICRODELETION SYNDROME	0.041666699999999994	1.5606504901901885
AUTOIMMUNE HEMOLYTIC ANEMIA-AUTOIMMUNE THROMBOCYTOPENIA-PRIMARY IMMUNODEFICIENCY SYNDROME	0.041666699999999994	1.5606504901901885
GLYCOSYLPHOSPHATIDYLINOSITOL BIOSYNTHESIS DEFECT 18; GPIBD18	0.041575253	1.557225289601315
MERRF	0.041517359999999996	1.555056873604162
FILIPPI SYNDROME; FLPIS	0.041467109	1.5531746931631252
MITOCHONDRIAL DNA DEPLETION SYNDROME, MYOPATHIC FORM	0.04134734	1.5486886755865092
CANAVAN DISEASE	0.04134734	1.5486886755865092
INTELLECTUAL DISABILITY-MICROCEPHALY-STRABISMUS-BEHAVIORAL ABNORMALITIES SYNDROME	0.041271154	1.5458350846314866
SPASTIC TETRAPLEGIA-THIN CORPUS CALLOSUM-PROGRESSIVE POSTNATAL MICROCEPHALY SYNDROME	0.04126499	1.545604208425271
ENCEPHALOPATHY DUE TO SULFITE OXIDASE DEFICIENCY	0.041174899	1.5422297976053183
DERMATOOSTEOLYSIS, KIRGHIZIAN TYPE	0.04051068	1.5173510885176382
OROFACIODIGITAL SYNDROME TYPE 6	0.040481773	1.5162683600145426
OPITZ GBBB SYNDROME, TYPE II; GBBB2	0.040464653999999996	1.5156271579097067
CHAR SYNDROME	0.040307354	1.5097353948925512
PROTEUS SYNDROME	0.040303219	1.5095805160618079
16P13.11 MICRODELETION SYNDROME	0.040285254	1.508907626534769
LEUKODYSTROPHY AND ACQUIRED MICROCEPHALY WITH OR WITHOUT DYSTONIA; LDAMD	0.040048023	1.5000220014087497
SARCOSINEMIA	0.039845903999999994	1.4924515166708954
ATYPICAL RETT SYNDROME	0.039834659	1.4920303286535535
GROWTH RESTRICTION, SEVERE, WITH DISTINCTIVE FACIES; GRDF	0.03977934	1.4899583233239537
BRACHYDACTYLY, TYPE A3	0.0397618	1.48930135241918
BRACHYDACTYLY, TYPE A1, D	0.0397618	1.48930135241918
CLEIDORHIZOMELIC SYNDROME	0.0397618	1.48930135241918
BRACHYDACTYLY, TYPE A2; BDA2	0.0397618	1.48930135241918
CLEIDORHIZOMELIC SYNDROME	0.0397618	1.48930135241918
SYNPOLYDACTYLY 1	0.0397618	1.48930135241918
PIERPONT SYNDROME	0.039744382999999994	1.4886489885509675
BRACHYDACTYLY TYPE A4	0.0397397	1.4884735840613978
ALPERS-HUTTENLOCHER SYNDROME	0.039675944	1.4860855659881507
BRACHYMORPHISM-ONYCHODYSPLASIA-DYSPHALANGISM SYNDROME	0.03961994	1.4839879035850179
CRANIOFRONTONASAL SYNDROME; CFNS	0.039542273999999995	1.4810788783689313
DISTAL MONOSOMY 15Q	0.039503973000000005	1.479644292130406
SLC39A8-CDG	0.039502469000000005	1.4795879589353789
ENCEPHALOPATHY, NEONATAL SEVERE, WITH LACTIC ACIDOSIS AND BRAIN ABNORMALITIES; NELABA	0.039502469000000005	1.4795879589353789
EPILEPSY, NOCTURNAL FRONTAL LOBE, 5; ENFL5	0.039272100000000004	1.4709593540116717
OCULODENTODIGITAL DYSPLASIA	0.039204818999999995	1.4684393050125788
CLEIDOCRANIAL DYSPLASIA; CCD	0.03908618	1.463995612243397
GLOBAL DEVELOPMENTAL DELAY-NEURO-OPHTHALMOLOGICAL ABNORMALITIES-SEIZURES-INTELLECTUAL DISABILITY SYNDROME	0.038925143999999995	1.457963915172636
BRACHYCEPHALY, DEAFNESS, CATARACT, MICROSTOMIA, AND MENTAL RETARDATION	0.038850453	1.4551663203124052
OPITZ GBBB SYNDROME, TYPE I; GBBB1	0.038833334	1.4545251182075691
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 75; EIEE75	0.038765913	1.4519998254270245
9P13 MICRODELETION SYNDROME	0.03857886	1.4449936464845707
MILLER-DIEKER LISSENCEPHALY SYNDROME; MDLS	0.03857886	1.4449936464845707
CONTRACTURES-DEVELOPMENTAL DELAY-PIERRE ROBIN SYNDROME	0.03854502	1.4437261495964555
POLYMICROGYRIA, BILATERAL TEMPOROOCCIPITAL; BTOP	0.038521299999999994	1.4428377031961568
EPISODIC ATAXIA, TYPE 1; EA1	0.0384615	1.4405978594045112
BLACKFAN-DIAMOND ANEMIA	0.0384615	1.4405978594045112
WILSON DISEASE	0.0384615	1.4405978594045112
MUCOLIPIDOSIS III GAMMA	0.0384615	1.4405978594045112
HYPERTRICHOSIS-ACROMEGALOID FACIAL APPEARANCE SYNDROME	0.0384615	1.4405978594045112
EPIPHYSEAL DYSPLASIA, MULTIPLE, WITH SEVERE PROXIMAL FEMORAL DYSPLASIA	0.0384615	1.4405978594045112
MYCETOMA	0.0384615	1.4405978594045112
FIBULAR APLASIA, TIBIAL CAMPOMELIA, AND OLIGOSYNDACTYLY SYNDROME	0.0384615	1.4405978594045112
245800 LAURENCE-MOON SYNDROME	0.0384615	1.4405978594045112
CHARCOT-MARIE-TOOTH DISEASE, AXONAL, TYPE 2X; CMT2X	0.0384615	1.4405978594045112
MITOCHONDRIAL NEUROGASTROINTESTINAL ENCEPHALOMYOPATHY	0.0384615	1.4405978594045112
DERMOCHONDROCORNEAL DYSTROPHY	0.0384615	1.4405978594045112
TUBEROUS SCLEROSIS 2; TSC2	0.038417498999999994	1.4389497763497248
TUBEROUS SCLEROSIS-1	0.038417498999999994	1.4389497763497248
MOEBIUS SYNDROME; MBS	0.03839377	1.4380609928491903
PROGRESSIVE EPILEPSY-INTELLECTUAL DISABILITY SYNDROME, FINNISH TYPE	0.03837959	1.437529872699265
HELSMOORTEL-VAN DER AA SYNDROME	0.038366653	1.437045309837517
20Q11.2 MICRODELETION SYNDROME	0.038309034	1.4348871566697772
HYPERTELORISM, TEEBI TYPE; TBHS	0.03828778	1.434091075734198
WIEACKER-WOLFF SYNDROME	0.03828642299999999	1.4340402485096948
EPILEPSY, JUVENILE MYOCLONIC, SUSCEPTIBILITY TO, 10; EJM10	0.037883259999999995	1.4189395437844217
HAREL-YOON SYNDROME; HAYOS	0.03782117399999999	1.4166140765327806
MEIER-GORLIN SYNDROME 5; MGORS5	0.03781366	1.416332635291135
GRANGE SYNDROME; GRNG	0.03776348	1.414453114196406
SPONDYLOMETAEPIPHYSEAL DYSPLASIA, SHORT LIMB-HAND TYPE	0.037582554	1.4076764256036411
NEURODEVELOPMENTAL DISORDER WITH PROGRESSIVE MICROCEPHALY, SPASTICITY, AND BRAIN ANOMALIES; NDMSBA	0.037582554	1.4076764256036411
LISSENCEPHALY 2; LIS2	0.037582554	1.4076764256036411
JAWAD SYNDROME	0.037582554	1.4076764256036411
HYPERTRICHOSIS CUBITI	0.037582554	1.4076764256036411
HYPOPARATHYROIDISM, X-LINKED	0.037578419	1.4075215467728979
EHLERS-DANLOS SYNDROME, SPONDYLODYSPLASTIC TYPE, 1; EDSSPD1	0.037470993999999994	1.4034978808980219
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IIG; CDG2G	0.037470993999999994	1.4034978808980219
NEURODEGENERATION DUE TO 3-HYDROXYISOBUTYRYL-COA HYDROLASE DEFICIENCY	0.037136169999999996	1.3909568531773857
NEURONAL CEROID LIPOFUSCINOSIS	0.037109859	1.3899713593646434
KIKUCHI-FUJIMOTO DISEASE	0.037037	1.38724238313027
PAROTIDOMEGALY, HEREDITARY BILATERAL	0.037037	1.38724238313027
ALOPECIA-CONTRACTURES-DWARFISM MENTAL RETARDATION SYNDROME	0.037037	1.38724238313027
MANDIBULOACRAL DYSPLASIA WITH TYPE B LIPODYSTROPHY; MADB	0.037037	1.38724238313027
BRACHYMORPHISM-ONYCHODYSPLASIA-DYSPHALANGISM SYNDROME	0.037037	1.38724238313027
FIBROSCLEROSIS, MULTIFOCAL	0.037037	1.38724238313027
EPILEPSY, PROGRESSIVE MYOCLONIC, 4, WITH OR WITHOUT RENAL FAILURE; EPM4	0.037037	1.38724238313027
ADULT-ONSET AUTOSOMAL RECESSIVE CEREBELLAR ATAXIA	0.037037	1.38724238313027
EMERY-DREIFUSS MUSCULAR DYSTROPHY 1, X-LINKED; EDMD1	0.037037	1.38724238313027
BRACHYDACTYLY, TYPE A4	0.037037	1.38724238313027
OSTEOPETROSIS, AUTOSOMAL RECESSIVE 5; OPTB5	0.037037	1.38724238313027
CERVICAL VERTEBRAE, AGENESIS OF	0.037037	1.38724238313027
BRANCHIAL CLEFT ANOMALIESBRANCHIAL CYSTS, INCLUDED	0.037037	1.38724238313027
PAROXYSMAL TONIC UPGAZE, BENIGN CHILDHOOD, WITH ATAXIA	0.037037	1.38724238313027
CARCINOMA OF ESOPHAGUS	0.037037	1.38724238313027
KAPOSIFORM LYMPHANGIOMATOSIS	0.037037	1.38724238313027
MCLEOD SYNDROME; MCLDS	0.037037	1.38724238313027
METAPHYSEAL DYSPLASIA WITH MAXILLARY HYPOPLASIA AND BRACHYDACTYLY	0.037037	1.38724238313027
MYOCLONUS AND ATAXIA	0.037037	1.38724238313027
MALAKOPLAKIA	0.037037	1.38724238313027
DIABETIC EMBRYOPATHY	0.037037	1.38724238313027
BRACHYDACTYLY-SYNDACTYLY, ZHAO TYPE	0.037037	1.38724238313027
AUTOSOMAL RECESSIVE FACIODIGITOGENITAL SYNDROME	0.037032079999999995	1.3870581016678132
DIGITOTALAR DYSMORPHISM	0.0369623	1.3844444511698024
FRONTONASAL DYSPLASIA	0.03694754	1.3838916067824332
NASOPALPEBRAL LIPOMA-COLOBOMA SYNDROME; NPLCS	0.03694754	1.3838916067824332
COG1-CDG	0.036925440000000004	1.383063838424651
INTELLECTUAL DEVELOPMENTAL DISORDER WITH SEVERE SPEECH AND AMBULATION DEFECTS; IDDSSAD	0.036868694	1.3809383839798226
BLEPHAROCHEILODONTIC SYNDROME 1; BCDS1	0.03680556	1.378573663278455
XP21 MICRODELETION SYNDROME	0.036801273	1.3784130911992782
PITT-HOPKINS SYNDROME	0.036801273	1.3784130911992782
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 14; COXPD14	0.036801273	1.3784130911992782
MENTAL RETARDATION, X-LINKED 98; MRX98	0.036765932999999994	1.3770894109384624
TRICHOHEPATONEURODEVELOPMENTAL SYNDROME; THNS	0.03663744	1.3722766308662224
HUNTINGTON DISEASE	0.03656844	1.3696921957220156
WEST SYNDROME	0.03656844	1.3696921957220156
NEURODEVELOPMENTAL DISORDER, X-LINKED, WITH CRANIOFACIAL ABNORMALITIES; NEDXCF	0.03648499399999999	1.3665666772431242
LUSCAN-LUMISH SYNDROME; LLS	0.036402013	1.3634585756097704
CONGENITAL HEART DEFECTS AND SKELETAL MALFORMATIONS SYNDROME; CHDSKM	0.036259854	1.3581339275566502
47,XYY SYNDROME	0.036255719000000006	1.357979048725907
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 49; EIEE49	0.036255719000000006	1.357979048725907
ASPARAGINE SYNTHETASE DEFICIENCY; ASNSD	0.036255719000000006	1.357979048725907
MICROCEPHALY, GROWTH DEFICIENCY, SEIZURES, AND BRAIN MALFORMATIONS; MIGSB	0.036255719000000006	1.357979048725907
THUMBS, CONGENITAL CLASPED	0.0361093	1.352494839894318
DIABETES MELLITUS, PERMANENT NEONATAL; PNDM	0.036054333	1.3504360189295121
15Q24 MICRODELETION SYNDROME	0.03593293299999999	1.3458889112989798
CORNELIA DE LANGE SYNDROME	0.035863098999999996	1.3432732381995518
EPIPHYSEAL CHONDRODYSPLASIA, MIURA TYPE; ECDM	0.035714300000000004	1.337699885083279
EPIDERMOLYSIS BULLOSA, LETHAL ACANTHOLYTIC; EBLA	0.035714300000000004	1.337699885083279
EPILEPSY, CHILDHOOD ABSENCE, SUSCEPTIBILITY TO, 1; ECA1	0.03566625	1.335900144377784
FEBRILE SEIZURES, FAMILIAL, 8; FEB8	0.03566625	1.335900144377784
JUVENILE ABSENCE EPILEPSY	0.03566625	1.335900144377784
NON-RHIZOMELIC CHONDRODYSPLASIA PUNCTATA	0.03564196	1.3349903482958598
AXIAL MESODERMAL DYSPLASIA SPECTRUM	0.03561751	1.3340745593208474
INTELLECTUAL DISABILITY-DEVELOPMENTAL DELAY-CONTRACTURES SYNDROME	0.035528453999999994	1.3307389150280575
HEPATIC FIBROSIS-RENAL CYSTS-INTELLECTUAL DISABILITY SYNDROME	0.035524319	1.3305840361973142
SLC35A2-CDG	0.035506354	1.3299111466702753
FBLN1-RELATED DEVELOPMENTAL DELAY-CENTRAL NERVOUS SYSTEM ANOMALY-SYNDACTYLY SYNDROME	0.03550485	1.3298548134752481
OKAMOTO SYNDROME	0.035399363999999996	1.3259037739734827
HEREDITARY CRYOHYDROCYTOSIS WITH REDUCED STOMATIN	0.035394252999999994	1.3257123384949023
RAMOS-ARROYO SYNDROME	0.03531504	1.3227453694937714
NASOPALPEBRAL LIPOMA-COLOBOMA SYNDROME	0.0349829	1.3103048725546862
SECKEL SYNDROME 2; SCKL2	0.0349829	1.3103048725546862
X-LINKED INTELLECTUAL DISABILITY, STOLL TYPE	0.0349829	1.3103048725546862
FACIODIGITOGENITAL SYNDROME, AUTOSOMAL RECESSIVE	0.0349829	1.3103048725546862
JUVENILE NEURONAL CEROID LIPOFUSCINOSIS	0.034820050000000005	1.3042052310585406
%613608 EPILEPSY, FAMILIAL ADULT MYOCLONIC, 3; FAME3;;CORTICAL MYOCLONIC TREMOR WITH EPILEPSY, FAMILIAL, 3; FCMTE3	0.034820050000000005	1.3042052310585406
SWEENEY-COX SYNDROME; SWCOS	0.034768294	1.3022666799668943
ACROFRONTOFACIONASAL DYSOSTOSIS 1	0.034764158999999996	1.302111801136151
INTELLECTUAL DEVELOPMENTAL DISORDER, X-LINKED 108; MRX108	0.034520353999999996	1.2929799430153777
MULTIPLE BENIGN CIRCUMFERENTIAL SKIN CREASES ON LIMBS	0.03443497399999999	1.289781985441285
PEHO SYNDROME	0.03443497399999999	1.289781985441285
LEUKODYSTROPHY, HYPOMYELINATING, 12	0.03443441	1.28976086049315
ZIMMERMANN-LABAND SYNDROME 2; ZLS2	0.03422274	1.2818326374935232
SPONDYLOMETAPHYSEAL DYSPLASIA, X-LINKED	0.03422274	1.2818326374935232
ARTHROGRYPOSIS, DISTAL, TYPE 2B	0.034079139999999994	1.2764540159470288
CEROID LIPOFUSCINOSIS, NEURONAL, 8, NORTHERN EPILEPSY VARIANT	0.034069249999999995	1.2760835802430257
SINGLETON-MERTEN SYNDROME 1; SGMRT1	0.0339527	1.2717181321842246
RETINITIS PIGMENTOSA WITH OR WITHOUT SKELETAL ANOMALIES	0.033844733999999994	1.2676742028395946
INTELLECTUAL DEVELOPMENTAL DISORDER WITH HYPERTELORISM AND DISTINCTIVE FACIES; IDDHDF	0.033760194	1.2645077079542144
THOC6-RELATED DEVELOPMENTAL DELAY-MICROCEPHALY-FACIAL DYSMORPHISM SYNDROME	0.033426873999999995	1.2520230134286052
COCKAYNE SYNDROME	0.033345619	1.2489795601294384
DONNAI-BARROW SYNDROME	0.033345072999999996	1.2489591093817753
GRISCELLI SYNDROME TYPE 1	0.033345072999999996	1.2489591093817753
DESMOSTEROLOSIS	0.033319659999999994	1.2480072506814894
MÜLLERIAN APLASIA AND HYPERANDROGENISM	0.03329918	1.2472401603662235
DERMOCHONDROCORNEAL DYSTROPHY	0.0331536	1.2417873767677652
NOONAN SYNDROME 4; NS4	0.03288132	1.2315889709552341
OROFACIAL CLEFT 15	0.03288132	1.2315889709552341
ANIRIDIA-CEREBELLAR ATAXIA-INTELLECTUAL DISABILITY SYNDROME	0.032803653999999995	1.2286799457391475
HYDROXYKYNURENINURIA	0.032803653999999995	1.2286799457391475
MACROCEPHALY/MEGALENCEPHALY SYNDROME, AUTOSOMAL RECESSIVE	0.032803653999999995	1.2286799457391475
NETHERTON SYNDROME; NETH	0.032803653999999995	1.2286799457391475
OXOGLUTARIC ACIDURIA	0.032803653999999995	1.2286799457391475
PROGRESSIVE HEMIFACIAL ATROPHY	0.032799519	1.2285250669084042
MENTAL RETARDATION, X-LINKED, SYNDROMIC 34; MRXS34	0.032799519	1.2285250669084042
SEVERE MICROBRACHYCEPHALY-INTELLECTUAL DISABILITY-ATHETOID CEREBRAL PALSY SYNDROME	0.032799519	1.2285250669084042
LEIGH SYNDROME	0.032799519	1.2285250669084042
EARLY-ONSET PARKINSONISM-INTELLECTUAL DISABILITY SYNDROME	0.032799519	1.2285250669084042
DEND SYNDROME	0.032799519	1.2285250669084042
ISOLATED CEREBELLAR AGENESIS	0.032799519	1.2285250669084042
212067 CONGENITAL DISORDER OF GLYCOSYLATION, TYPE I/IIX;;CDG-X	0.032799519	1.2285250669084042
SANDHOFF DISEASE	0.032799519	1.2285250669084042
ISOTRETINOIN-LIKE SYNDROME	0.0322581	1.2082459032657764
TREMOR-NYSTAGMUS-DUODENAL ULCER SYNDROME	0.0322581	1.2082459032657764
SPINOCEREBELLAR ATAXIA TYPE 34	0.0322581	1.2082459032657764
HEREDITARY LEIOMYOMATOSIS AND RENAL CELL CANCER	0.0322581	1.2082459032657764
PERONEUS TERTIUS MUSCLE, ABSENCE OF	0.0322581	1.2082459032657764
FAMILIAL OR SPORADIC HEMIPLEGIC MIGRAINE	0.0322581	1.2082459032657764
LUNG DISEASE, IMMUNODEFICIENCY, AND CHROMOSOME BREAKAGE SYNDROME; LICS	0.0322581	1.2082459032657764
ALG13-CDG	0.0322581	1.2082459032657764
APLASIA OF EXTENSOR MUSCLES OF FINGERS, UNILATERAL, WITH GENERALIZEDPOLYNEUROPATHY	0.0322581	1.2082459032657764
LIPODYSTROPHY, FAMILIAL PARTIAL, TYPE 1	0.0322581	1.2082459032657764
OSTEOSCLEROSIS-DEVELOPMENTAL DELAY-CRANIOSYNOSTOSIS SYNDROME	0.0322581	1.2082459032657764
9Q31.1Q31.3 MICRODELETION SYNDROME	0.0322581	1.2082459032657764
AUTOIMMUNE POLYENDOCRINOPATHY TYPE 2	0.0322581	1.2082459032657764
DESMOID TUMOR	0.0322581	1.2082459032657764
MYALGIA-EOSINOPHILIA SYNDROME ASSOCIATED WITH TRYPTOPHAN	0.0322581	1.2082459032657764
GLYCOGEN STORAGE DISEASE DUE TO GLYCOGEN BRANCHING ENZYME DEFICIENCY	0.0322581	1.2082459032657764
OSSEOUS HETEROPLASIA, PROGRESSIVE; POH	0.0322581	1.2082459032657764
WIDOW'S PEAK	0.0322581	1.2082459032657764
239710 ACROFRONTOFACIONASAL DYSOSTOSIS 2;;AFFN DYSOSTOSIS 2; AFFND2;;ACROFRONTOFACIONASAL DYSOSTOSIS WITH GENITOURINARY ANOMALIES;;NAGUIB-RICHIERI-COSTA SYNDROME;;HYPERTELORISM, HYPOSPADIAS, AND POLYSYNDACTYLY SYNDROME	0.0322581	1.2082459032657764
ATTENUATED CHÉDIAK-HIGASHI SYNDROME	0.0322581	1.2082459032657764
ISOBUTYRYL-COA DEHYDROGENASE DEFICIENCY	0.0322581	1.2082459032657764
MILD CANAVAN DISEASE	0.0322581	1.2082459032657764
STORMORKEN-SJAASTAD-LANGSLET SYNDROME	0.0322581	1.2082459032657764
HSD10 DISEASE, ATYPICAL TYPE	0.0322581	1.2082459032657764
DENT DISEASE	0.0322581	1.2082459032657764
DYSTONIA, JUVENILE-ONSET	0.0322581	1.2082459032657764
3-METHYLCROTONYL-COA CARBOXYLASE DEFICIENCY	0.0322581	1.2082459032657764
ANIRIDIA-RENAL AGENESIS-PSYCHOMOTOR RETARDATION SYNDROME	0.0322581	1.2082459032657764
ROWLEY-ROSENBERG SYNDROME	0.0322581	1.2082459032657764
LESCH-NYHAN SYNDROME	0.0322581	1.2082459032657764
%606242 MENTAL RETARDATION, MICROCEPHALY, GROWTH RETARDATION, JOINT CONTRACTURES,AND FACIAL DYSMORPHISM;;KONDOH SYNDROME	0.0322581	1.2082459032657764
THROMBOCYTOPENIA 1	0.0322581	1.2082459032657764
ACROFACIAL DYSOSTOSIS, CATANIA TYPE	0.0322581	1.2082459032657764
%153300 YELLOW NAIL SYNDROME;;YNS;;LYMPHEDEMA AND YELLOW NAILS	0.0322581	1.2082459032657764
LYMPHEDEMA-DISTICHIASIS SYNDROME; LPHDST	0.0322581	1.2082459032657764
CRAMPS, FAMILIAL ADOLESCENT	0.0322581	1.2082459032657764
TRISMUS-PSEUDOCAMPTODACTYLY SYNDROME	0.0322581	1.2082459032657764
FEBRILE INFECTION-RELATED EPILEPSY SYNDROME	0.03208814	1.2018799525830317
BEAULIEU-BOYCOTT-INNES SYNDROME; BBIS	0.031795554	1.1909209737264677
CLEFT PALATE, CARDIAC DEFECTS, AND MENTAL RETARDATION; CPCMR	0.031795554	1.1909209737264677
AL KAISSI SYNDROME; ALKAS	0.031688503	1.1869113162391853
RARS-RELATED AUTOSOMAL RECESSIVE HYPOMYELINATING LEUKODYSTROPHY	0.031570104	1.1824766128096356
AASE-SMITH SYNDROME	0.031472509999999995	1.1788211727594364
ECTODERMAL DYSPLASIA WITH MENTAL RETARDATION AND SYNDACTYLY	0.03137644	1.175222815015901
EPILEPSY, IDIOPATHIC GENERALIZED	0.031226909999999997	1.1696220818693321
MITOCHONDRIAL MYOPATHY WITH LACTIC ACIDOSIS; MMLA	0.030815169	1.1542000831633776
CRANIOFACIOFRONTODIGITAL SYNDROME	0.030543479999999998	1.1440238135996905
MENTAL RETARDATION WITH OPTIC ATROPHY, FACIAL DYSMORPHISM, MICROCEPHALY, AND SHORT STATURE	0.030498773	1.1423492869041536
DEVELOPMENTAL DELAY WITH VARIABLE INTELLECTUAL IMPAIRMENT AND BEHAVIORAL ABNORMALITIES; DDVIBA	0.030255092999999997	1.1332221107311051
CRANIOECTODERMAL DYSPLASIA 2; CED2	0.030209064	1.1314980677564286
ROSSELLI-GULIENETTI SYNDROME	0.029957354	1.1220701232615256
CEREBROOCULOFACIOSKELETAL SYNDROME 1	0.029953219	1.1219152444307823
SCAPULOPERONEAL SPINAL MUSCULAR ATROPHY; SPSMA	0.02983628	1.1175352261506604
GENERALIZED EPILEPSY WITH FEBRILE SEIZURES PLUS, TYPE 10; GEFSP10	0.029710972999999998	1.1128417795620353
48,XXYY SYNDROME	0.029636612999999996	1.1100565824993798
FETAL AKINESIA DEFORMATION SEQUENCE; FADS	0.02962456	1.1096051303719436
MENTAL RETARDATION, AUTOSOMAL DOMINANT 7	0.029583939	1.1080836471836417
19P13.3 MICRODUPLICATION SYNDROME	0.029495553999999997	1.1047731355862398
MIETENS SYNDROME	0.029428513999999996	1.1022621133823611
211200 BOWEN SYNDROME OF MULTIPLE MALFORMATIONS	0.0294118	1.1016360807881544
DARWINIAN POINT OF PINNA	0.0294118	1.1016360807881544
EAR FOLDING	0.0294118	1.1016360807881544
EAR ANTITRAGUS, TAG AT BASE OF	0.0294118	1.1016360807881544
OTOONYCHOPERONEAL SYNDROME	0.0294118	1.1016360807881544
PLASMINOGEN DEFICIENCY, TYPE ILIGNEOUS CONJUNCTIVITIS, INCLUDED	0.0294118	1.1016360807881544
DARWINIAN TUBERCLE OF PINNA	0.0294118	1.1016360807881544
AREDYLD	0.0294118	1.1016360807881544
OSTEOMA OF MIDDLE EAR	0.0294118	1.1016360807881544
CLEFT LIP/PALATE-ECTODERMAL DYSPLASIA SYNDROME; CLPED1	0.0294118	1.1016360807881544
MULTICENTRIC OSTEOLYSIS, NODULOSIS, AND ARTHROPATHY; MONA	0.0294118	1.1016360807881544
EAR WAX, WET/DRY	0.0294118	1.1016360807881544
HAIRY EARS, Y-LINKED	0.0294118	1.1016360807881544
MUSICAL PERFECT PITCH	0.0294118	1.1016360807881544
FRYNS MICROPHTHALMIA SYNDROME	0.0294118	1.1016360807881544
ALKAPTONURIA	0.0294118	1.1016360807881544
RETINITIS PIGMENTOSA, DEAFNESS, MENTAL RETARDATION, AND HYPOGONADISM	0.0294118	1.1016360807881544
EAR WITHOUT HELIX	0.0294118	1.1016360807881544
OSSIFIED EAR CARTILAGES	0.0294118	1.1016360807881544
BLAU SYNDROME	0.0294118	1.1016360807881544
EXCHONDROSIS OF PINNA, POSTERIOR	0.0294118	1.1016360807881544
SPLIT-FOOT DEFORMITY WITH MANDIBULOFACIAL DYSOSTOSIS	0.0294118	1.1016360807881544
EAR MALFORMATION	0.0294118	1.1016360807881544
JACOBSEN SYNDROME	0.029215292999999996	1.0942757967753622
AUTOSOMAL RECESSIVE ROBINOW SYNDROME	0.02920324	1.0938243446479257
PROGRESSIVE MYOCLONIC EPILEPSY WITH DYSTONIA	0.028856204	1.0808259093623465
CHROMOSOME 17Q12 DELETION SYNDROME	0.028658319999999998	1.0734140490134156
%614280 EPILEPSY, JUVENILE MYOCLONIC, SUSCEPTIBILITY TO, 9; EJM9	0.028623999999999997	1.0721285734460362
FEBRILE CONVULSIONS, FAMILIAL, 9	0.028623999999999997	1.0721285734460362
NEURODEVELOPMENTAL DISORDER WITH ATAXIC GAIT, ABSENT SPEECH, AND DECREASED CORTICAL WHITE MATTER; NDAGSCW	0.028593013	1.0709679373327967
MENTAL RETARDATION, AUTOSOMAL DOMINANT 51; MRD51	0.028529854	1.0686022802418842
CARTILAGE-HAIR HYPOPLASIA	0.028494299999999997	1.0672705844865633
PETERS-PLUS SYNDROME; PTRPLS	0.028444493	1.065405034323846
EPILEPSY, PYRIDOXINE-DEPENDENT	0.028341363999999997	1.0615422776283836
SUCCINIC SEMIALDEHYDE DEHYDROGENASE DEFICIENCY	0.028341363999999997	1.0615422776283836
BRACHMANN-DE LANGE-LIKE FACIAL CHANGES WITH MICROCEPHALY, METATARSUSADDUCTUS, AND DEVELOPMENTAL DELAY	0.028323354000000002	1.0608677026001638
POLYMICROGYRIA DUE TO TUBB2B MUTATION	0.028323354000000002	1.0608677026001638
AROMATIC L-AMINO ACID DECARBOXYLASE DEFICIENCY	0.028323354000000002	1.0608677026001638
MENKES DISEASE	0.028319219000000003	1.0607128237694206
TRICHORHINOPHALANGEAL SYNDROME TYPE 2	0.028207339999999997	1.056522330733207
ANTERIOR CHAMBER CLEAVAGE DISORDER, CEREBELLAR HYPOPLASIA, HYPOTHYROIDISM, AND TRACHEAL STENOSIS	0.028064520000000003	1.051172924540517
VAN BOGAERT-HOZAY SYNDROME	0.02793651	1.0463782355142863
PREMATURE AGING SYNDROME, OKAMOTO TYPE	0.02793651	1.0463782355142863
LIPODYSTROPHY, FAMILIAL PARTIAL, TYPE 7; FPLD7	0.027777800000000002	1.0404336601267927
CUTIS LAXA, AUTOSOMAL DOMINANT 1; ADCL1	0.027777800000000002	1.0404336601267927
OROFACIAL CLEFT 3	0.027777800000000002	1.0404336601267927
FIBULAR DIMELIA-DIPLOPODIA SYNDROME	0.027777800000000002	1.0404336601267927
NASAL ALAR COLLAPSE, BILATERAL	0.027777800000000002	1.0404336601267927
GANGLIOCYTOMA	0.027777800000000002	1.0404336601267927
DIMPLES, FACIAL	0.027777800000000002	1.0404336601267927
CYANIDE, INABILITY TO SMELL	0.027777800000000002	1.0404336601267927
DWARFISM, LEVI TYPE	0.027777800000000002	1.0404336601267927
208081 ARTHROGRYPOSIS, DISTAL, WITH MENTAL RETARDATION AND CHARACTERISTICFACIES	0.027777800000000002	1.0404336601267927
15Q24 RECURRENT MICRODELETION SYNDROME	0.027777800000000002	1.0404336601267927
SPEECH-LANGUAGE DISORDER 1	0.027777800000000002	1.0404336601267927
GROWTH HORMONE DEFICIENCY, ISOLATED, TYPE IA	0.027777800000000002	1.0404336601267927
EPILEPSY, NOCTURNAL FRONTAL LOBE, TYPE 1	0.027777800000000002	1.0404336601267927
CLEFT CHIN	0.027777800000000002	1.0404336601267927
22Q11.2 DISTAL DELETION SYNDROME	0.027777800000000002	1.0404336601267927
OSTEOPENIA AND SPARSE HAIR	0.027777800000000002	1.0404336601267927
NASAL BONES, ABSENCE OF	0.027777800000000002	1.0404336601267927
FOCAL FACIAL DERMAL DYSPLASIA TYPE IV	0.027777800000000002	1.0404336601267927
PERIVENTRICULAR NODULAR HETEROTOPIA	0.027777800000000002	1.0404336601267927
%135750 LAURIN-SANDROW SYNDROME;;LSS;;SANDROW SYNDROME;;MIRROR HANDS AND FEET WITH NASAL DEFECTS;;TETRAMELIC MIRROR-IMAGE POLYDACTYLY; TMIP;;MIRROR-IMAGE POLYDACTYLY; MIP;;FIBULA AND ULNA, DUPLICATION OF, WITH ABSENCE OF TIBIA AND RADIUSLAURIN-SANDROW SYNDROME, SEGMENTAL, INCLUDED	0.027777800000000002	1.0404336601267927
TESTICULAR REGRESSION SYNDROME	0.027777800000000002	1.0404336601267927
WAARDENBURG SYNDROME, TYPE IIB	0.027777800000000002	1.0404336601267927
FALLOT COMPLEX WITH SEVERE MENTAL AND GROWTH RETARDATION	0.027777800000000002	1.0404336601267927
EDINBURGH MALFORMATION SYNDROME	0.027777800000000002	1.0404336601267927
212540 CATARACT, MICROCEPHALY, FAILURE TO THRIVE, KYPHOSCOLIOSIS SYNDROME;;CAMFAK SYNDROMECATARACT, MICROCEPHALY, ARTHROGRYPOSIS, KYPHOSIS SYNDROME, INCLUDED;;CAMAK SYNDROME, INCLUDED	0.027777800000000002	1.0404336601267927
NASAL GROOVE, FAMILIAL TRANSVERSE	0.027777800000000002	1.0404336601267927
OPHTHALMOPLEGIA, FAMILIAL TOTAL, WITH IRIS TRANSILLUMINATION	0.027777800000000002	1.0404336601267927
211930 CAMPTODACTYLY WITH FIBROUS TISSUE HYPERPLASIA AND SKELETAL DYSPLASIA	0.027777800000000002	1.0404336601267927
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 47	0.027572554	1.0327460517846494
SPLENOGONADAL FUSION-LIMB DEFECTS-MICROGNATHIA SYNDROME	0.027535599	1.0313618807592269
AYMÉ-GRIPP SYNDROME	0.027495253999999997	1.0298507353115016
BRAIN MALFORMATIONS-MUSCULOSKELETAL ABNORMALITIES-FACIAL DYSMORPHISM-INTELLECTUAL DISABILITY SYNDROME	0.027442293999999996	1.0278670876993683
SECKEL SYNDROME 1; SCKL1	0.027331729	1.0237258112976404
PROGRESSIVE SPONDYLOEPIMETAPHYSEAL DYSPLASIA-SHORT STATURE-SHORT FOURTH METATARSALS-INTELLECTUAL DISABILITY SYNDROME	0.027238599999999998	1.0202376104201791
APHALANGY-HEMIVERTEBRAE-UROGENITAL-INTESTINAL DYSGENESIS SYNDROME	0.02721415	1.0193218214451667
ADAMS-OLIVER SYNDROME	0.027122959000000002	1.015906209485234
FOCAL CORTICAL DYSPLASIA OF TAYLOR	0.027027	1.012312009311278
APNEA, OBSTRUCTIVE SLEEP	0.027027	1.012312009311278
EPILEPSY, FAMILIAL TEMPORAL LOBE, 8; ETL8	0.027027	1.012312009311278
BENIGN OCCIPITAL EPILEPSY	0.027027	1.012312009311278
OSTEOGENESIS IMPERFECTA, TYPE IIA	0.02692186	1.0083739294408156
RENPENNING SYNDROME 1; RENS1	0.026862179	1.006138542863404
TRISOMY 13	0.026467329	0.991349206389635
CONGENITAL HYPOTHYROIDISM	0.026163534	0.9799703879166738
COFS SYNDROME	0.026042469	0.9754358279060448
AUTOSOMAL DOMINANT HYPER-IGE SYNDROME	0.02602968	0.9749568084704032
SPONDYLOCARPOTARSAL SYNOSTOSIS SYNDROME; SCT	0.02599518	0.9736645908982998
6Q25 MICRODELETION SYNDROME	0.025870543	0.9689962395494809
DYRK1A-RELATED INTELLECTUAL DISABILITY SYNDROME	0.025664603999999997	0.9612826744891503
INTELLECTUAL DISABILITY-STRABISMUS SYNDROME	0.025630313	0.959998285133643
COFFIN-SIRIS SYNDROME	0.025516233	0.9557253523618877
INFANTILE SIALIC ACID STORAGE DISEASE	0.025407353	0.9516471886154931
3C SYNDROME	0.025392674	0.9510973781302494
CONDUCTIVE DEAFNESS-PTOSIS-SKELETAL ANOMALIES SYNDROME	0.025189419999999997	0.9434843813070519
MUCOPOLYSACCHARIDOSIS TYPE 1	0.02514364	0.9417696647722434
LETHAL CONGENITAL CONTRACTURE SYNDROME 10; LCCS10	0.02491185	0.9330878354667985
MULTIPLE METAPHYSEAL DYSPLASIA	0.02484712	0.9306633356568781
MECKEL SYNDROME	0.024824649999999997	0.9298217087338297
TERMINAL TRANSVERSE LIMB DEFECT	0.024824649999999997	0.9298217087338297
AICARDI-GOUTIÈRES SYNDROME	0.024788343	0.9284618089254136
9Q21.13 MICRODELETION SYNDROME	0.024734938999999997	0.9264615310349611
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 67; EIEE67	0.024730213999999997	0.9262845534109556
COHEN SYNDROME	0.024645073	0.9230955477209134
RING CHROMOSOME 7 SYNDROME	0.024254469999999997	0.9084652851030492
HOLOPROSENCEPHALY	0.024143223	0.9042984639945337
ISOLATED SPINA BIFIDA	0.024077419	0.90183373688976
138920 GRANDDAD SYNDROME;;GROWTH RETARDATION, AGED FACIES, NORMAL DEVELOPMENT, DECREASED SUBCUTANEOUSFAT, AUTOSOMAL DOMINANT INHERITANCE	0.02406504	0.9013700742426566
MITOCHONDRIAL DNA DEPLETION SYNDROME 13 (ENCEPHALOMYOPATHIC TYPE); MTDPS13	0.023898753	0.8951416979118635
PENTASOMY X	0.023825814	0.8924097252309461
INTELLECTUAL DISABILITY-MYOPATHY-SHORT STATURE-ENDOCRINE DEFECT SYNDROME	0.0235581	0.8823823416049142
INTELLECTUAL DISABILITY-SPASTICITY-ECTRODACTYLY SYNDROME	0.0235581	0.8823823416049142
EYE DEFECTS-ARACHNODACTYLY-CARDIOPATHY SYNDROME	0.0235581	0.8823823416049142
KYPHOSCOLIOTIC EHLERS-DANLOS SYNDROME DUE TO LYSYL HYDROXYLASE 1 DEFICIENCY	0.023535999999999998	0.881554573247132
MENTAL RETARDATION AND DISTINCTIVE FACIAL FEATURES WITH OR WITHOUT CARDIAC DEFECTS	0.023395153999999998	0.8762791043729153
SALT AND PEPPER DEVELOPMENTAL REGRESSION SYNDROME; SPDRS	0.023392444	0.8761775997462371
SALT-AND-PEPPER SYNDROME	0.023392444	0.8761775997462371
INTELLECTUAL DISABILITY-EPILEPSY-EXTRAPYRAMIDAL SYNDROME	0.023212049999999998	0.8694208375229899
INTELLECTUAL DISABILITY, BUENOS-AIRES TYPE	0.02320794	0.8692668950817917
CONGENITAL INSENSITIVITY TO PAIN WITH SEVERE INTELLECTUAL DISABILITY	0.02314531	0.8669210519936514
CHARGE SYNDROME	0.023079853999999997	0.8644693594313441
AUTISM SPECTRUM DISORDER-EPILEPSY-ARTHROGRYPOSIS SYNDROME	0.022989919999999997	0.8611008291377339
BRACHYDACTYLOUS DWARFISM, MSELENI TYPE	0.02288248	0.8570766014291316
FIBULAR APLASIA-COMPLEX BRACHYDACTYLY SYNDROME	0.02288248	0.8570766014291316
SHELDON-HALL SYNDROME	0.02279794	0.853910106543751
NEURODEVELOPMENTAL DELAY-SEIZURES-OPHTHALMIC ANOMALIES-OSTEOPENIA-CEREBELLAR ATROPHY SYNDROME	0.022601589999999998	0.8465557030573014
PAROXYSMAL NONKINESIGENIC DYSKINESIA, 3, WITH OR WITHOUT GENERALIZED EPILEPSY; PNKD3	0.022513204	0.8432451540043179
X-LINKED NON-SYNDROMIC INTELLECTUAL DISABILITY	0.022513204	0.8432451540043179
GENERALIZED EPILEPSY-PAROXYSMAL DYSKINESIA SYNDROME	0.022513204	0.8432451540043179
EPILEPSY, IDIOPATHIC GENERALIZED, SUSCEPTIBILITY TO, 15; EIG15	0.022513204	0.8432451540043179
MUCOPOLYSACCHARIDOSIS-PLUS SYNDROME; MPSPS	0.022492254	0.842460459565606
SNIJDERS BLOK-CAMPEAU SYNDROME; SNIBCPS	0.022492254	0.842460459565606
609945 BRACHYPHALANGY, POLYDACTYLY, AND TIBIAL APLASIA/HYPOPLASIA	0.022406894	0.8392632511031496
MICROCEPHALY-CORPUS CALLOSUM HYPOPLASIA-INTELLECTUAL DISABILITY-FACIAL DYSMORPHISM SYNDROME	0.022402593000000002	0.8391021546458273
KNOBLOCH SYNDROME	0.022172739	0.8304928393467473
CAMPTODACTYLY SYNDROME, GUADALAJARA, TYPE III	0.021995564000000002	0.8238566466413149
MYOCLONIC EPILEPSY OF UNVERRICHT AND LUNDBORG	0.02196765	0.8228111115309467
AUTOSOMAL DOMINANT DOPA-RESPONSIVE DYSTONIA	0.02183418	0.8178119150280876
INCLUSION BODY MYOPATHY WITH EARLY-ONSET PAGET DISEASE WITH OR WITHOUT FRONTOTEMPORAL DEMENTIA 1	0.02176525	0.8152301017746068
VATER-LIKE DEFECTS WITH PULMONARY HYPERTENSION, LARYNGEAL WEBS, AND GROWTH DEFICIENCY	0.02163132	0.8102136757041195
EPILEPTIC ENCEPHALOPATHY, INFANTILE OR EARLY CHILDHOOD, 1; IECEE1	0.021526313	0.8062805774260363
MICROPHTHALMIA, SYNDROMIC 6; MCOPS6	0.021463813999999998	0.803939641019112
QAZI-MARKOUIZOS SYNDROME	0.021462329	0.8038840194801389
ZUNICH NEUROECTODERMAL SYNDROME	0.021453518999999997	0.8035540358044799
TEMTAMY PREAXIAL BRACHYDACTYLY SYNDROME	0.021401393999999997	0.8016016636031498
CONGENITAL UNILATERAL HYPOPLASIA OF DEPRESSOR ANGULI ORIS	0.021378854	0.8007574147893757
BORJESON-FORSSMAN-LEHMANN SYNDROME	0.021374719	0.8006025359586323
INTELLECTUAL DISABILITY-DYSMORPHISM-HYPOGONADISM-DIABETES MELLITUS SYNDROME	0.021286404	0.7972946462519565
6Q TERMINAL DELETION SYNDROME	0.021233873	0.7953270670844155
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 64; EIEE64	0.021228264	0.7951169787260987
ACROFACIAL DYSOSTOSIS, RODRÍGUEZ TYPE	0.0212212	0.7948523924962628
ATELOSTEOGENESIS, TYPE II	0.0212212	0.7948523924962628
CHROMOSOME 14Q11-Q22 DELETION SYNDROME	0.021181103	0.7933505360328241
MARFAN LIPODYSTROPHY SYNDROME; MFLS	0.021164049999999997	0.7927118059963871
OHDO SYNDROME	0.021147878999999998	0.7921061117830976
NEURODEVELOPMENTAL DISORDER WITH IMPAIRED SPEECH AND HYPERKINETIC MOVEMENTS; NEDISHM	0.021101304	0.7903616180607581
AUTOSOMAL DOMINANT ROBINOW SYNDROME	0.021045053999999997	0.7882547415845025
ACROCALLOSAL SYNDROME; ACLS	0.020912908999999997	0.7833051737275283
NEURODEVELOPMENTAL DISORDER WITH SEIZURES AND SPEECH AND WALKING IMPAIRMENT; NEDSSWI	0.020910783000000002	0.7832255431606215
COOPER-JABS SYNDROME	0.0208333	0.7803233723160043
LETHAL CONGENITAL CONTRACTURE SYNDROME TYPE 1	0.0208333	0.7803233723160043
MESOMELIC DWARFISM-CLEFT PALATE-CAMPTODACTYLY SYNDROME	0.0208333	0.7803233723160043
MUCOPOLYSACCHARIDOSIS TYPE 7	0.0208333	0.7803233723160043
PSEUDOHYPOPARATHYROIDISM WITH ALBRIGHT HEREDITARY OSTEODYSTROPHY	0.0208333	0.7803233723160043
MICROCEPHALY-CERVICAL SPINE FUSION ANOMALIES SYNDROME	0.0208333	0.7803233723160043
CAMPTODACTYLY-JOINT CONTRACTURES-FACIAL SKELETAL DEFECTS SYNDROME	0.0208333	0.7803233723160043
AORTIC ARCH ANOMALY-FACIAL DYSMORPHISM-INTELLECTUAL DISABILITY SYNDROME	0.0208333	0.7803233723160043
HEREDITARY SENSORY AND AUTONOMIC NEUROPATHY TYPE 2	0.0208333	0.7803233723160043
HEREDITARY ACROKERATOTIC POIKILODERMA	0.0208333	0.7803233723160043
TRICHODERMODYSPLASIA-DENTAL ALTERATIONS SYNDROME	0.0208333	0.7803233723160043
ULNA METAPHYSEAL DYSPLASIA SYNDROME	0.0208333	0.7803233723160043
PSEUDOACHONDROPLASIA	0.0208333	0.7803233723160043
SATOYOSHI SYNDROME	0.0208333	0.7803233723160043
PROLIDASE DEFICIENCY	0.0208333	0.7803233723160043
HYPOCALCEMIC VITAMIN D-RESISTANT RICKETS	0.0208333	0.7803233723160043
BEEMER LETHAL MALFORMATION SYNDROME	0.02083254	0.7802949060738363
GENERALIZED EPILEPSY WITH FEBRILE SEIZURES PLUS, TYPE 4; GEFSP4	0.020740849999999998	0.7768606037785851
FEBRILE SEIZURES, FAMILIAL, 11; FEB11	0.020740849999999998	0.7768606037785851
MEDIUM CHAIN ACYL-COA DEHYDROGENASE DEFICIENCY	0.020740849999999998	0.7768606037785851
CUTIS LAXA, AUTOSOMAL RECESSIVE, TYPE IB	0.0206972	0.7752256676330108
MENTAL RETARDATION, X-LINKED, SYNDROMIC, 35; MRXS35	0.020691032999999998	0.7749946790600496
X SMALL RINGS	0.020639573999999997	0.7730672522761983
GAUCHER DISEASE	0.020611849999999998	0.7720288337263723
SPASTIC PARAPLEGIA AND PSYCHOMOTOR RETARDATION WITH OR WITHOUT SEIZURES	0.020606022999999998	0.7718105800512232
POLYNEUROPATHY-INTELLECTUAL DISABILITY-ACROMICRIA-PREMATURE MENOPAUSE SYNDROME	0.02056768	0.7703744206782621
PYCNODYSOSTOSIS	0.02056768	0.7703744206782621
HYPOCHONDROPLASIA	0.02056768	0.7703744206782621
HYPOCHONDROPLASIA	0.02056768	0.7703744206782621
JEUNE SYNDROME	0.02056768	0.7703744206782621
AREDYLD SYNDROME	0.02056768	0.7703744206782621
SHORT RIB-POLYDACTYLY SYNDROME	0.02056768	0.7703744206782621
MICROPHTHALMIA WITH CYST, BILATERAL FACIAL CLEFTS, AND LIMB ANOMALIES	0.020545554	0.7695456784753532
COFFIN-LOWRY SYNDROME; CLS	0.020541419	0.7693907996446098
NEVUS COMEDONICUS SYNDROME	0.020541419	0.7693907996446098
GYRATE ATROPHY OF CHOROID AND RETINA	0.020541419	0.7693907996446098
JOUBERT SYNDROME 1	0.020527614	0.7688737253378592
MEGAEPIPHYSEAL DWARFISM	0.02049922	0.7678102115482273
RHIZOMELIC CHONDRODYSPLASIA PUNCTATA, TYPE 2	0.02048314	0.7672079257928818
AURICULAR ABNORMALITIES-CLEFT LIP WITH OR WITHOUT CLEFT PALATE-OCULAR ABNORMALITIES SYNDROME	0.02042745	0.7651220244424342
COFFIN-SIRIS SYNDROME 6; CSS6	0.020307913999999996	0.7606447340163773
INTELLECTUAL DISABILITY-COARSE FACE-MACROCEPHALY-CEREBELLAR HYPOTROPHY SYNDROME	0.020220909	0.7573859111218598
MELAS	0.02021732	0.7572514830387794
MITOCHONDRIAL COMPLEX V (ATP SYNTHASE) DEFICIENCY, NUCLEAR TYPE 2; MC5DN2	0.020150623	0.7547533080994582
CARDIOCRANIAL SYNDROME, PFEIFFER TYPE	0.020088734	0.7524352195974318
FG SYNDROME TYPE 1	0.020016633	0.7497346346940629
FAMILIAL MALE-LIMITED PRECOCIOUS PUBERTY	0.02	0.7491116360019818
DISSECTING CELLULITIS OF THE SCALP	0.02	0.7491116360019818
ICHTHYOSIS, CONGENITAL, AUTOSOMAL RECESSIVE 2	0.02	0.7491116360019818
DARIER DISEASE	0.02	0.7491116360019818
ICHTHYOSIS, SPLIT HAIRS, AND AMINO ACIDURIA	0.02	0.7491116360019818
AMELOONYCHOHYPOHIDROTIC SYNDROME	0.02	0.7491116360019818
TRICHODISCOMAS, FAMILIAL MULTIPLE	0.02	0.7491116360019818
611426 TENTED EYEBROWS	0.02	0.7491116360019818
RINGED HAIR	0.02	0.7491116360019818
ALBINISM, OCULOCUTANEOUS, TYPE VI; OCA6	0.02	0.7491116360019818
STRIATE PALMOPLANTAR KERATODERMA	0.02	0.7491116360019818
%152800 LYMPHANGIECTASIA, INTESTINAL	0.02	0.7491116360019818
MANITOBA OCULOTRICHOANAL SYNDROME	0.02	0.7491116360019818
SKIN/HAIR/EYE PIGMENTATION, VARIATION IN, 6	0.02	0.7491116360019818
FAMILIAL MELANOMA	0.02	0.7491116360019818
HAIRY NOSE TIP	0.02	0.7491116360019818
122430 CORNEAL HYPESTHESIA WITH RETINAL ABNORMALITIES, SENSORINEURAL DEAFNESS,UNUSUAL FACIES, PERSISTENT DUCTUS ARTERIOSUS, AND MENTAL RETARDATION;;RAMOS-ARROYO SYNDROME	0.02	0.7491116360019818
RED SKIN PIGMENT ANOMALY OF NEW GUINEA	0.02	0.7491116360019818
CATATRICHY	0.02	0.7491116360019818
EPIDERMOLYSIS BULLOSA ACQUISITA	0.02	0.7491116360019818
CHONDROECTODERMAL DYSPLASIA WITH NIGHT BLINDNESS	0.02	0.7491116360019818
HERMANSKY-PUDLAK SYNDROME 1; HPS1	0.02	0.7491116360019818
ALPORT SYNDROME-INTELLECTUAL DISABILITY-MIDFACE HYPOPLASIA-ELLIPTOCYTOSIS SYNDROME	0.02	0.7491116360019818
WERNER SYNDROME; WRN	0.02	0.7491116360019818
INHERITED EPIDERMOLYSIS BULLOSA	0.02	0.7491116360019818
HAIR WHORL	0.02	0.7491116360019818
MIDPHALANGEAL HAIR	0.02	0.7491116360019818
BAND HETEROTOPIA; BH	0.019954873	0.7474213779620889
HEART DEFECTS, CONGENITAL, AND OTHER CONGENITAL ANOMALIES; HDCA	0.019954873	0.7474213779620889
ALKURAYA-KUCINSKAS SYNDROME; ALKKUCS	0.019871533	0.7442998297748685
AMINOPTERIN/METHOTREXATE EMBRYOFETOPATHY	0.019724959999999996	0.7388098527836824
NEUROPATHY, CONGENITAL HYPOMYELINATING, 3; CHN3	0.019705188999999998	0.7380693184759127
16P13.2 MICRODELETION SYNDROME	0.019677793000000002	0.7370431853569174
KEIPERT SYNDROME; KPTS	0.019606290000000002	0.7343649988914649
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 16; EIEE16	0.019596944	0.7340149390239611
HERMANSKY-PUDLAK SYNDROME 10; HPS10	0.019548259999999998	0.732191451479605
EARLY-ONSET SPASTIC ATAXIA-MYOCLONIC EPILEPSY-NEUROPATHY SYNDROME	0.019548259999999998	0.732191451479605
SPASTIC ATAXIA 5, AUTOSOMAL RECESSIVE	0.019548259999999998	0.732191451479605
WOLFRAM SYNDROME, MITOCHONDRIAL FORM	0.019409319	0.7269873354887175
COPPER DEFICIENCY, FAMILIAL BENIGN	0.019409319	0.7269873354887175
HHHH SYNDROME	0.019409319	0.7269873354887175
266910 RENAL DYSPLASIA-LIMB DEFECTS SYNDROME;;RL SYNDROME	0.01933486	0.7241984303234639
TRICHORHINOPHALANGEAL SYNDROME, TYPE III; TRPS3	0.01929058	0.7225398971613556
AGENESIS OF THE CORPUS CALLOSUM AND CONGENITAL LYMPHEDEMA	0.019275884	0.7219894499312213
MICROCEPHALIC OSTEODYSPLASTIC PRIMORDIAL DWARFISM, TYPE I	0.019222759	0.7199996221480909
MUENKE SYNDROME	0.019218013	0.7198218579568677
ANKYLOBLEPHARON-ECTODERMAL DEFECTS-CLEFT LIP/PALATE	0.01920604	0.7193734022759751
BOHRING-OPITZ SYNDROME	0.019180613	0.718421019197544
PANTOTHENATE KINASE-ASSOCIATED NEURODEGENERATION	0.019137459	0.7168046610205425
ACERULOPLASMINEMIA	0.01913148	0.7165807140969597
X-LINKED INTELLECTUAL DISABILITY DUE TO GRIA3 MUTATIONS	0.019082104	0.714731307289998
HARROD SYNDROME	0.019059919	0.7139003552077628
CHROMOSOME 19Q13.11 DELETION SYNDROME, DISTAL	0.018933593999999998	0.7091687788368652
MENTAL RETARDATION, AUTOSOMAL DOMINANT 5	0.018910813000000002	0.7083155032278773
NEURODEVELOPMENTAL DISORDER WITH MOVEMENT ABNORMALITIES, ABNORMAL GAIT, AND AUTISTIC FEATURES; NEDMAGA	0.018896294	0.7077716856357217
SCAPULA, CONTOUR OF VERTEBRAL BORDER OF	0.0188679	0.7067081718460896
MONOPHALANGY OF GREAT TOE	0.0188679	0.7067081718460896
PALMARIS LONGUS MUSCLE, ABSENCE OF	0.0188679	0.7067081718460896
KNUCKLE PADS	0.0188679	0.7067081718460896
CIRCUMVALLATE PLACENTA SYNDROME	0.0188679	0.7067081718460896
SPINAL ARACHNOIDITIS	0.0188679	0.7067081718460896
RAYNAUD DISEASE	0.0188679	0.7067081718460896
TRACHEOPATHIA OSTEOPLASTICA	0.0188679	0.7067081718460896
PUBIC BONE DYSPLASIA	0.0188679	0.7067081718460896
TOES, RELATIVE LENGTH OF FIRST AND SECOND	0.0188679	0.7067081718460896
TOE, MISSHAPEN	0.0188679	0.7067081718460896
TOE, FIFTH, NUMBER OF PHALANGES IN	0.0188679	0.7067081718460896
THROMBOCYTHEMIA, ESSENTIAL	0.0188679	0.7067081718460896
VESICOURETERAL REFLUX 1	0.0188679	0.7067081718460896
TRACHEOBRONCHOMEGALY	0.0188679	0.7067081718460896
%122450 CORNEAL HYPESTHESIA, FAMILIAL;;TRIGEMINAL ANESTHESIA, FAMILIAL	0.0188679	0.7067081718460896
OSTEOPETROSIS AND INFANTILE NEUROAXONAL DYSTROPHY	0.0188679	0.7067081718460896
109740 BIFID NOSE, AUTOSOMAL DOMINANT	0.0188679	0.7067081718460896
VAN DEN BOSCH SYNDROME	0.0188679	0.7067081718460896
HYPOURICEMIA, HYPERCALCINURIA, AND DECREASED BONE DENSITY	0.0188679	0.7067081718460896
FACIAL CLEFTING, OBLIQUE, 1; OBLFC1	0.0188679	0.7067081718460896
NEPHROSIALIDOSIS	0.0188679	0.7067081718460896
PRIMARY HYPEROXALURIA TYPE 1	0.0188679	0.7067081718460896
%600343 PAROTID SALIVARY GLANDS, POLYCYSTIC DYSGENETIC DISEASE OF; PDDP	0.0188679	0.7067081718460896
THROMBOCYTOPENIA 3	0.0188679	0.7067081718460896
PACHYDERMODACTYLY, FAMILIAL	0.0188679	0.7067081718460896
ECTODERMAL DYSPLASIA, HYPOHIDROTIC, WITH HYPOTHYROIDISM AND AGENESISOF THE CORPUS CALLOSUM	0.0188679	0.7067081718460896
DYSPLASIA EPIPHYSEALIS HEMIMELICA	0.0188679	0.7067081718460896
LETTERER-SIWE DISEASE	0.0188679	0.7067081718460896
DOUBLE NAIL FOR FIFTH TOE	0.0188679	0.7067081718460896
271322 SPINOCEREBELLAR DEGENERATION WITH SLOW EYE MOVEMENTS; SDSEM	0.0188679	0.7067081718460896
HYPERBILIRUBINEMIA, ROTOR TYPE	0.0188679	0.7067081718460896
256020 NAIL-PATELLA-LIKE RENAL DISEASE;;GLOMERULAR BASEMENT MEMBRANE DISEASE, NAIL-PATELLA SYNDROME TYPE	0.0188679	0.7067081718460896
248100 MACROSOMIA ADIPOSA CONGENITA	0.0188679	0.7067081718460896
MICROPHTHALMIA, SYNDROMIC 4	0.0188679	0.7067081718460896
275230 TIBIA, ABSENCE OF, WITH CONGENITAL DEAFNESS	0.0188679	0.7067081718460896
113480 BRACHYTELEPHALANGY WITH CHARACTERISTIC FACIES AND KALLMANN SYNDROME	0.0188679	0.7067081718460896
CARPAL DISPLACEMENT	0.0188679	0.7067081718460896
THALIDOMIDE SUSCEPTIBILITY	0.0188679	0.7067081718460896
275220 TIBIAL HEMIMELIA;;THM;;TIBIA, ABSENCE OF	0.0188679	0.7067081718460896
GORDON SYNDROME	0.018853799999999997	0.7061800481427082
MESOMELIC DYSPLASIA, KANTAPUTRA TYPE	0.018853799999999997	0.7061800481427082
MICROCEPHALIC OSTEODYSPLASTIC PRIMORDIAL DWARFISM, TYPE III	0.018853799999999997	0.7061800481427082
MIDFACE HYPOPLASIA, HEARING IMPAIRMENT, ELLIPTOCYTOSIS, AND NEPHROCALCINOSIS; MFHIEN	0.018853799999999997	0.7061800481427082
LATHOSTEROLOSIS	0.018847292999999998	0.7059363246719349
10Q22.3Q23.3 MICRODELETION SYNDROME	0.018847292999999998	0.7059363246719349
COGNITIVE IMPAIRMENT-COARSE FACIES-HEART DEFECTS-OBESITY-PULMONARY INVOLVEMENT-SHORT STATURE-SKELETAL DYSPLASIA SYNDROME	0.018739014	0.701880671730202
CONGENITAL ARTHROGRYPOSIS WITH ANTERIOR HORN CELL DISEASE; CAAHD	0.018620428999999997	0.6974390015624372
AUTOSOMAL DOMINANT INTELLECTUAL DISABILITY-CRANIOFACIAL ANOMALIES-CARDIAC DEFECTS SYNDROME	0.018540523	0.6944460758431186
EPILEPSY, NOCTURNAL FRONTAL LOBE, 2; ENFL2	0.01853655	0.6942972648166268
THORACOMELIC DYSPLASIA	0.0185185	0.693621191565135
GHOSAL HEMATODIAPHYSEAL DYSPLASIA	0.0185185	0.693621191565135
ISOLATED EPISPADIAS	0.0185185	0.693621191565135
OSTEOPETROSIS, AUTOSOMAL DOMINANT 2	0.0185185	0.693621191565135
OSTEOPATHIA STRIATA-PIGMENTARY DERMOPATHY-WHITE FORELOCK SYNDROME	0.0185185	0.693621191565135
OSTEODYSPLASTY, PRECOCIOUS, OF DANKS, MAYNE, AND KOZLOWSKI	0.0185185	0.693621191565135
EXSTROPHY OF BLADDER	0.0185185	0.693621191565135
CRANIOMETAPHYSEAL DYSPLASIA, AUTOSOMAL DOMINANT	0.0185185	0.693621191565135
ELLIS VAN CREVELD SYNDROME	0.0185185	0.693621191565135
DYSSEGMENTAL DYSPLASIA, SILVERMAN-HANDMAKER TYPE	0.0185185	0.693621191565135
OSTEOPETROSIS, AUTOSOMAL DOMINANT 1; OPTA1	0.0185185	0.693621191565135
OSTEOGENESIS IMPERFECTA, TYPE V	0.0185185	0.693621191565135
OSTEOARTHRITIS	0.0185185	0.693621191565135
GAPO SYNDROME	0.0185185	0.693621191565135
THIN RIBS-TUBULAR BONES-DYSMORPHISM SYNDROME	0.0185185	0.693621191565135
SEVERE COMBINED IMMUNODEFICIENCY, AUTOSOMAL RECESSIVE, T CELL-NEGATIVE, B CELL-NEGATIVE, NK CELL-NEGATIVE, DUE TO ADENOSINE DEAMINASE DEFICIENCY	0.0185185	0.693621191565135
GRANT SYNDROME	0.0185185	0.693621191565135
VERLOOVE VANHORICK-BRUBAKK SYNDROME	0.0185185	0.693621191565135
CARTILAGE-HAIR HYPOPLASIA; CHH	0.0185185	0.693621191565135
CHONDRODYSPLASIA-DISORDER OF SEX DEVELOPMENT SYNDROME	0.0185185	0.693621191565135
ENDOSTEAL HYPEROSTOSIS, AUTOSOMAL DOMINANT	0.0185185	0.693621191565135
PAGET DISEASE OF BONE 2, EARLY-ONSET; PDB2	0.0185185	0.693621191565135
CAMURATI-ENGELMANN DISEASE	0.0185185	0.693621191565135
SPASTIC PARAPLEGIA 9A, AUTOSOMAL DOMINANT; SPG9A	0.0185185	0.693621191565135
FOUNTAIN SYNDROME	0.018507619	0.6932136373795681
HENNEKAM SYNDROME	0.018423079	0.6900471424941876
CRANIOMETADIAPHYSEAL DYSPLASIA, WORMIAN BONE TYPE	0.01835074	0.6873376431623504
DUANE RETRACTION SYNDROME	0.018329792999999997	0.6865530610903836
OSTEOPATHIA STRIATA WITH CRANIAL SCLEROSIS	0.018260528999999998	0.6839587376725815
FACIOCARDIORENAL SYNDROME	0.0180465	0.6759421569554882
TEMPLE SYNDROME	0.01802396	0.6750979081417139
RECESSIVE INTELLECTUAL DISABILITY-MOTOR DYSFUNCTION-MULTIPLE JOINT CONTRACTURES SYNDROME	0.018008939999999998	0.6745353253030764
SPORADIC FETAL BRAIN DISRUPTION SEQUENCE	0.01793371	0.6717175418842549
ACRO-RENAL-OCULAR SYNDROME	0.017760319999999996	0.6652231185559357
INFANTILE-ONSET AXONAL MOTOR AND SENSORY NEUROPATHY-OPTIC ATROPHY-NEURODEGENERATIVE SYNDROME	0.01769641	0.6628293323230916
SPINAL MUSCULAR ATROPHY WITH CONGENITAL BONE FRACTURES 1; SMABF1	0.017644564	0.6608874102290836
RUBINSTEIN-TAYBI SYNDROME	0.017521433	0.6562754669864556
3-METHYLGLUTACONIC ACIDURIA, TYPE I; MGCA1	0.017490903999999998	0.6551319855296803
SAETHRE-CHOTZEN SYNDROME	0.017473018999999996	0.6544620924491855
CARDIOFACIOCUTANEOUS SYNDROME 1; CFC1	0.017365939	0.650451348750031
GALLOWAY-MOWAT SYNDROME 1; GAMOS1	0.017363392999999998	0.6503559868387678
COCHLEOSACCULAR DEGENERATION OF THE INNER EAR WITH PROGRESSIVE CATARACTS	0.0172414	0.6457866680482285
SICKLE CELL ANEMIA	0.0172414	0.6457866680482285
MOTION SICKNESS	0.0172414	0.6457866680482285
304950 DYGGVE-MELCHIOR-CLAUSEN SYNDROME, X-LINKED	0.0172414	0.6457866680482285
MODIFIER, X-LINKED, FOR NEUROFUNCTIONAL DEFECTS	0.0172414	0.6457866680482285
CARDIAC ARRHYTHMIA	0.0172414	0.6457866680482285
TRICARBOXYLIC ACID CYCLE, DEFECT OF	0.0172414	0.6457866680482285
601668 SPONDYLOEPIMETAPHYSEAL DYSPLASIA WITH ABNORMAL DENTITION; SEMDAD	0.0172414	0.6457866680482285
COGNITIVE FUNCTION 1, SOCIAL	0.0172414	0.6457866680482285
RHEUMATOID ARTHRITIS	0.0172414	0.6457866680482285
CEREBRAL SCLEROSIS SIMILAR TO PELIZAEUS-MERZBACHER DISEASE	0.0172414	0.6457866680482285
CERVICAL RIB	0.0172414	0.6457866680482285
269800 SENILE PLAQUE FORMATION	0.0172414	0.6457866680482285
HYPEREOSINOPHILIC SYNDROME, IDIOPATHIC	0.0172414	0.6457866680482285
NOVELTY SEEKING PERSONALITY TRAIT	0.0172414	0.6457866680482285
CEREBRAL ANGIOPATHY, DYSPHORIC	0.0172414	0.6457866680482285
GRANULOMAS, CONGENITAL CEREBRAL	0.0172414	0.6457866680482285
206600 ANHIDROSIS, FAMILIAL GENERALIZED, WITH ABNORMAL OR ABSENT SWEAT GLANDS	0.0172414	0.6457866680482285
%160700 MYOPIA 2, AUTOSOMAL DOMINANT; MYP2	0.0172414	0.6457866680482285
THROMBOPHILIA, HEREDITARY, DUE TO PROTEIN C DEFICIENCY, AUTOSOMALDOMINANT	0.0172414	0.6457866680482285
ENDOCARDIAL FIBROELASTOSIS	0.0172414	0.6457866680482285
PALMOMENTAL REFLEX	0.0172414	0.6457866680482285
TRANSSEXUALITY	0.0172414	0.6457866680482285
ANDROSTENONE, ABILITY TO SMELL	0.0172414	0.6457866680482285
223300 DISSEMINATED SCLEROSIS WITH NARCOLEPSY	0.0172414	0.6457866680482285
NEUROVISCERAL STORAGE DISEASE WITH CURVILINEAR BODIES	0.0172414	0.6457866680482285
PERONEAL NERVE, ACCESSORY DEEP	0.0172414	0.6457866680482285
JUMPING FRENCHMAN OF MAINE	0.0172414	0.6457866680482285
ALCOHOL DEPENDENCE	0.0172414	0.6457866680482285
%600511 SCHIZOPHRENIA 3; SCZD3;;SCHIZOPHRENIA SUSCEPTIBILITY LOCUS, CHROMOSOME 6-RELATED	0.0172414	0.6457866680482285
600416 MUSCULAR DYSTROPHY, SCAPULOHUMERAL	0.0172414	0.6457866680482285
POLYCYSTIC LIVER DISEASE 1 WITH OR WITHOUT KIDNEY CYSTS; PCLD1	0.0172414	0.6457866680482285
DISCRIMINATION, TWO-POINT, REDUCTION IN	0.0172414	0.6457866680482285
DIASTEMATOMYELIA	0.0172414	0.6457866680482285
SPATIAL VISUALIZATION, APTITUDE FOR	0.0172414	0.6457866680482285
INTRINSIC FACTOR AND R BINDER, COMBINED CONGENITAL DEFICIENCY OF	0.0172414	0.6457866680482285
ASPARAGUS, SPECIFIC SMELL HYPERSENSITIVITY	0.0172414	0.6457866680482285
GLUTATHIONE SYNTHETASE DEFICIENCY	0.0172414	0.6457866680482285
190400 TRIGEMINAL NEURALGIA;;TIC DOULOUREUX	0.0172414	0.6457866680482285
141405 HEMIFACIAL SPASM, FAMILIAL	0.0172414	0.6457866680482285
MEDIAN-ULNAR NERVE COMMUNICATIONS	0.0172414	0.6457866680482285
VESTIBULOCOCHLEAR DYSFUNCTION, PROGRESSIVE	0.0172414	0.6457866680482285
MERALGIA PARAESTHETICA, FAMILIAL	0.0172414	0.6457866680482285
MYOPATHY, CONGENITAL	0.0172414	0.6457866680482285
PANCREATIC TRIACYLGLYCEROL LIPASE DEFICIENCY	0.0172414	0.6457866680482285
ARTHROGRYPOSIS MULTIPLEX CONGENITA WITH WHISTLING FACE	0.0172414	0.6457866680482285
SPASTIC PSEUDOSCLEROSIS	0.0172414	0.6457866680482285
INTELLECTUAL DEVELOPMENTAL DISORDER WITH DYSMORPHIC FACIES AND BEHAVIORAL ABNORMALITIES; IDDFBA	0.017168832999999998	0.6430686288437406
SEVERE INTELLECTUAL DISABILITY-POOR LANGUAGE-STRABISMUS-GRIMACING FACE-LONG FINGERS SYNDROME	0.017102273999999997	0.6405756227747078
INDOMETHACIN EMBRYOFETOPATHY	0.017099009999999998	0.6404533677557123
RENAL TUBULAR DYSGENESIS	0.017099009999999998	0.6404533677557123
SPINOCEREBELLAR ATAXIA, AUTOSOMAL RECESSIVE 20; SCAR20	0.017090773	0.6401448461284249
STÜVE-WIEDEMANN SYNDROME	0.01701633	0.6373565402524801
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IH; CDG1H	0.01701633	0.6373565402524801
HOLOPROSENCEPHALY-CRANIOSYNOSTOSIS SYNDROME	0.016931599999999998	0.6341829288065577
POSTAXIAL POLYDACTYLY-DENTAL AND VERTEBRAL ANOMALIES SYNDROME	0.016931599999999998	0.6341829288065577
SUMMITT SYNDROME	0.016931599999999998	0.6341829288065577
LEUKODYSTROPHY, HYPOMYELINATING, 3; HLD3	0.016897743	0.6329147951735518
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 24; COXPD24	0.016891613	0.6326851924571172
PERMANENT NEONATAL DIABETES MELLITUS	0.016847064	0.6310165837435046
TRANSIENT NEONATAL DIABETES MELLITUS	0.016847064	0.6310165837435046
VERTEBRAL, CARDIAC, RENAL, AND LIMB DEFECTS SYNDROME 1; VCRL1	0.016674553999999998	0.6245551213271694
MARDEN-WALKER SYNDROME	0.016674553999999998	0.6245551213271694
GERODERMA OSTEODYSPLASTICA	0.016674553999999998	0.6245551213271694
ULNA HYPOPLASIA-INTELLECTUAL DISABILITY SYNDROME	0.016674553999999998	0.6245551213271694
CONGENITAL MUSCULAR DYSTROPHY DUE TO LMNA MUTATION	0.016674553999999998	0.6245551213271694
CRANIOSYNOSTOSIS-FIBULAR APLASIA SYNDROME	0.016670419	0.624400242496426
OCULOCEREBROCUTANEOUS SYNDROME	0.016670419	0.624400242496426
INTELLECTUAL DISABILITY-HYPOPLASTIC CORPUS CALLOSUM-PREAURICULAR TAG SYNDROME	0.016670419	0.624400242496426
LINEAR VERRUCOUS NEVUS SYNDROME	0.016670419	0.624400242496426
ACROFACIAL DYSOSTOSIS 1, NAGER TYPE; AFD1	0.016661620000000002	0.624070670832167
FONTAINE PROGEROID SYNDROME; FPS	0.01663216	0.6229672293923361
236410 HUMERORADIAL SYNOSTOSIS WITH CRANIOFACIAL ANOMALIES	0.016555979999999998	0.6201138631708044
SHORT STATURE, ONYCHODYSPLASIA, FACIAL DYSMORPHISM, AND HYPOTRICHOSIS	0.016525674	0.6189787343087707
PELIZAEUS-MERZBACHER DISEASE	0.016501869000000002	0.6180871041840195
CORNELIA DE LANGE SYNDROME 3	0.016387252999999997	0.6137940952204191
UNDETERMINED EARLY-ONSET EPILEPTIC ENCEPHALOPATHY	0.016350194	0.6124060288144894
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 68; EIEE68	0.016350194	0.6124060288144894
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 50; EIEE50	0.016350194	0.6124060288144894
HEART-HAND SYNDROME, SLOVENIAN TYPE	0.01633488	0.6118324340348026
DOWN SYNDROME	0.01633362	0.6117852400017345
EPILEPSY, FAMILIAL ADULT MYOCLONIC, 1; FAME1	0.016301509999999998	0.6105825412701332
MYOCLONIC EPILEPSY, JUVENILE, SUSCEPTIBILITY TO, 4; EJM4	0.016301509999999998	0.6105825412701332
HYPOTONIA-SPEECH IMPAIRMENT-SEVERE COGNITIVE DELAY SYNDROME	0.016280613	0.6097998319772566
GABRIELE-DE VRIES SYNDROME	0.016272139999999997	0.6094824708326644
BLEPHAROPHIMOSIS WITH PTOSIS, SYNDACTYLY, AND SHORT STATURE	0.016250340000000002	0.6086659391494222
NEUROFACIODIGITORENAL SYNDROME	0.016222659999999996	0.6076291686451953
ARTHROGRYPOSIS, DISTAL, TYPE 4; DA4	0.0162162	0.6073872055867668
ULLRICH CONGENITAL MUSCULAR DYSTROPHY 1	0.0162162	0.6073872055867668
DYSTONIA, DOPA-RESPONSIVE; DRD	0.0162162	0.6073872055867668
CARDIAC, FACIAL, AND DIGITAL ANOMALIES WITH DEVELOPMENTAL DELAY; CAFDADD	0.016210363	0.6071685773557997
NEMALINE MYOPATHY 2; NEM2	0.016128999999999998	0.6041210788537982
BARTSOCAS-PAPAS SYNDROME	0.016128999999999998	0.6041210788537982
PENTALOGY OF CANTRELL	0.016128999999999998	0.6041210788537982
STUVE-WIEDEMANN SYNDROME	0.016128999999999998	0.6041210788537982
MYOPATHY, CONGENITAL, BAILEY-BLOCH; MYPBB	0.016128999999999998	0.6041210788537982
VERTEBRAL, CARDIAC, RENAL, AND LIMB DEFECTS SYNDROME 2; VCRL2	0.016128999999999998	0.6041210788537982
KUSKOKWIM SYNDROME	0.016128999999999998	0.6041210788537982
SEGMENTAL OUTGROWTH-LIPOMATOSIS-ARTERIOVENOUS MALFORMATION-EPIDERMAL NEVUS SYNDROME	0.016128999999999998	0.6041210788537982
ANTLEY-BIXLER SYNDROME	0.016128999999999998	0.6041210788537982
FACIOCARDIOMELIC DYSPLASIA, LETHAL	0.016128999999999998	0.6041210788537982
ACALVARIA	0.016128999999999998	0.6041210788537982
PHOCOMELIA, SCHINZEL TYPE	0.016128999999999998	0.6041210788537982
LAURIN-SANDROW SYNDROME	0.016128999999999998	0.6041210788537982
ARTHROGRYPOSIS MULTIPLEX CONGENITA	0.016128999999999998	0.6041210788537982
BONE DYSPLASIA, LETHAL HOLMGREN TYPE	0.016128999999999998	0.6041210788537982
INTELLECTUAL DISABILITY-OBESITY-BRAIN MALFORMATIONS-FACIAL DYSMORPHISM SYNDROME	0.016125574	0.6039927560305511
AUTOSOMAL RECESSIVE MULTIPLE PTERYGIUM SYNDROME	0.01591702	0.5961812446238133
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 14; EIEE14	0.01580464	0.591971986341118
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 47	0.01580464	0.591971986341118
ENCEPHALOPATHY, PROGRESSIVE, EARLY-ONSET, WITH EPISODIC RHABDOMYOLYSIS; PEERB	0.01580464	0.591971986341118
INTELLECTUAL DISABILITY-SEVERE SPEECH DELAY-MILD DYSMORPHISM SYNDROME	0.015779999000000003	0.591049043349982
INTELLECTUAL DISABILITY-MACROCEPHALY-HYPOTONIA-BEHAVIORAL ABNORMALITIES SYNDROME	0.015678313	0.5872403350590569
INTELLECTUAL DEVELOPMENTAL DISORDER, AUTOSOMAL RECESSIVE 70; MRT70	0.01566324	0.586675767074584
INTELLECTUAL DISABILITY-FACIAL DYSMORPHISM SYNDROME DUE TO SETD5 HAPLOINSUFFICIENCY	0.01566324	0.586675767074584
PERLMAN SYNDROME	0.015635813999999998	0.5856485102881345
MICROCEPHALY-LYMPHEDEMA-CHORIORETINOPATHY SYNDROME	0.015635813999999998	0.5856485102881345
MICROCEPHALY-CAPILLARY MALFORMATION SYNDROME	0.015553569	0.5825679759629854
21Q22.11Q22.12 MICRODELETION SYNDROME	0.015553569	0.5825679759629854
CORPUS CALLOSUM, AGENESIS OF, WITH FACIAL ANOMALIES AND ROBIN SEQUENCE	0.01554125	0.58210656065079
ENCEPHALOPATHY, PROGRESSIVE, EARLY-ONSET, WITH BRAIN ATROPHY AND SPASTICITY; PEBAS	0.015505919	0.5807832174902107
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 21; MC1DN21	0.015470953999999999	0.5794735830725701
DEFICIENCY IN ANTERIOR PITUITARY FUNCTION-VARIABLE IMMUNODEFICIENCY SYNDROME	0.015470953999999999	0.5794735830725701
MEGALOBLASTIC ANEMIA DUE TO DIHYDROFOLATE REDUCTASE DEFICIENCY	0.015470953999999999	0.5794735830725701
HYPERINSULINISM-HYPERAMMONEMIA SYNDROME	0.015470953999999999	0.5794735830725701
MENTAL RETARDATION, X-LINKED 41	0.015470953999999999	0.5794735830725701
MUCOPOLYSACCHARIDOSIS TYPE 2	0.015426473	0.57780752133852
MACROCEPHALY-INTELLECTUAL DISABILITY-LEFT VENTRICULAR NON COMPACTION SYNDROME	0.015423839	0.5777088633360585
CAREY-FINEMAN-ZITER SYNDROME; CFZS	0.015405873999999998	0.5770359738090197
INTELLECTUAL DISABILITY-CATARACTS-CALCIFIED PINNAE-MYOPATHY SYNDROME	0.015378059	0.5759941468012499
PONTOCEREBELLAR HYPOPLASIA, TYPE 1B	0.015372673	0.5757924110376746
BRAIN MALFORMATION-CONGENITAL HEART DISEASE-POSTAXIAL POLYDACTYLY SYNDROME	0.01534392	0.5747154506941765
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 38; EIEE38	0.015286603999999999	0.5725686465677219
BETA-UREIDOPROPIONASE DEFICIENCY	0.015286603999999999	0.5725686465677219
CLASSIC GLUCOSE TRANSPORTER TYPE 1 DEFICIENCY SYNDROME	0.015286603999999999	0.5725686465677219
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 27; COXPD27	0.015286603999999999	0.5725686465677219
ALTERNATING HEMIPLEGIA OF CHILDHOOD 2	0.015286603999999999	0.5725686465677219
SHPRINTZEN-GOLDBERG CRANIOSYNOSTOSIS SYNDROME; SGS	0.015249803999999999	0.5711902811574783
SILVER-RUSSELL SYNDROME	0.0151932	0.5690701454052655
X-LINKED FEMALE RESTRICTED FACIAL DYSMORPHISM-SHORT STATURE-CHOANAL ATRESIA-INTELLECTUAL DISABILITY	0.015181173	0.5686196671229556
MALAN OVERGROWTH SYNDROME	0.015132758999999999	0.5668062925856857
X-LINKED DOMINANT CHONDRODYSPLASIA PUNCTATA	0.01512334	0.5664534984607106
X-LINKED INTELLECTUAL DISABILITY-SHORT STATURE-OVERWEIGHT SYNDROME	0.01510677	0.565832859470283
HEART AND BRAIN MALFORMATION SYNDROME	0.015053163000000001	0.563824978096725
TETRASOMY X	0.015015374000000001	0.5624095691160812
MYOCLONIC-ATONIC EPILEPSY	0.014925399999999998	0.5590395405991989
CHROMOSOME XP11.23-P11.22 DUPLICATION SYNDROME	0.014925399999999998	0.5590395405991989
NIEMANN-PICK DISEASE TYPE B	0.014925399999999998	0.5590395405991989
PAROXYSMAL EXERTION-INDUCED DYSKINESIA	0.014925399999999998	0.5590395405991989
DYGGVE-MELCHIOR-CLAUSEN DISEASE	0.014884089999999999	0.5574922505150368
FRANK-TER HAAR SYNDROME; FTHS	0.01483226	0.5555509277103376
BRAIN DOPAMINE-SEROTONIN VESICULAR TRANSPORT DISEASE	0.014831254	0.5555132473950468
SPINAL MUSCULAR ATROPHY, LOWER EXTREMITY-PREDOMINANT, 1, AUTOSOMAL DOMINANT; SMALED1	0.014831254	0.5555132473950468
MICROCEPHALY-THIN CORPUS CALLOSUM-INTELLECTUAL DISABILITY SYNDROME	0.014831254	0.5555132473950468
DEXTROCARDIA	0.014831254	0.5555132473950468
YUAN-HAREL-LUPSKI SYNDROME; YUHAL	0.014831254	0.5555132473950468
JOUBERT SYNDROME 2	0.014831254	0.5555132473950468
MESOMELIC DYSPLASIA, SAVARIRAYAN TYPE	0.014831254	0.5555132473950468
NEURODEGENERATION WITH BRAIN IRON ACCUMULATION 1; NBIA1	0.014831254	0.5555132473950468
PONTOCEREBELLAR HYPOPLASIA, TYPE 1A; PCH1A	0.014831254	0.5555132473950468
SPINOCEREBELLAR ATAXIA WITH DYSMORPHISM	0.014831254	0.5555132473950468
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 40; MRT40	0.014831254	0.5555132473950468
PFEIFFER SYNDROME	0.01480314	0.5544602211683188
RUBINSTEIN-TAYBI SYNDROME 1; RSTS1	0.014798689000000002	0.5542935063737267
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 69; EIEE69	0.014741049999999999	0.5521346040943507
VELO-FACIAL-SKELETAL SYNDROME	0.014724120000000002	0.5515004810944751
IMPERFORATE OROPHARYNX-COSTOVERTEBRAL ANOMALIES SYNDROME	0.014724120000000002	0.5515004810944751
MENTAL RETARDATION, AUTOSOMAL DOMINANT 22; MRD22	0.014719843	0.551340283571116
PRADER-WILLI SYNDROME; PWS	0.014707053000000001	0.5508612266798928
SPINOCEREBELLAR ATAXIA TYPE 13	0.014600473	0.5468692107716382
300064 MENTAL RETARDATION, X-LINKED, WITH CRANIOFACIAL DYSMORPHISM;;MENTAL RETARDATION, X-LINKED, HYDE-FORSTER TYPE	0.014591339999999998	0.5465271289430578
SPASTIC PARAPLEGIA-INTELLECTUAL DISABILITY-NYSTAGMUS-OBESITY SYNDROME	0.014591339999999998	0.5465271289430578
X-LINKED INTELLECTUAL DISABILITY-PLAGIOCEPHALY SYNDROME	0.014591339999999998	0.5465271289430578
MICROGASTRIA-LIMB REDUCTION DEFECT SYNDROME	0.014591339999999998	0.5465271289430578
FAMILIAL LAMBDOID SYNOSTOSIS	0.014591339999999998	0.5465271289430578
CHROMOSOME 19Q13.11 DELETION SYNDROME, PROXIMAL	0.014578993	0.5460646648745721
MICROFORM HOLOPROSENCEPHALY	0.014562759	0.5454566109596293
CATEL-MANZKE SYNDROME; CATMANS	0.014450983	0.5412699758483414
AMISH LETHAL MICROCEPHALY	0.01444966	0.5412204221136199
EARLY-ONSET EPILEPSY-INTELLECTUAL DISABILITY-BRAIN ANOMALIES SYNDROME	0.01444966	0.5412204221136199
COMBINED OXIDATIVE PHOSPHORYLATION DEFECT TYPE 29	0.01444966	0.5412204221136199
LEUKOENCEPHALOPATHY, ARTHRITIS, COLITIS, AND HYPOGAMMAGLOBULINEMA	0.01444966	0.5412204221136199
MENTAL RETARDATION-HYPOTONIC FACIES SYNDROME, X-LINKED, 1; MRXHF1	0.014444819	0.5410390996421256
%601927 LYMPHEDEMA, CARDIAC SEPTAL DEFECTS, AND CHARACTERISTIC FACIES;;IRONS-BIANCHI SYNDROME;;LYMPHEDEMA, ATRIAL SEPTAL DEFECT, AND CHARACTERISTIC FACIES	0.014392009999999998	0.539061107822844
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 33; COXPD33	0.014313629999999999	0.5361253393213523
236640 HYDROCEPHALUS WITH ASSOCIATED MALFORMATIONS	0.0142857	0.5350792049216756
MYOPATHY, DISTAL 3	0.0142857	0.5350792049216756
EXOSTOSES, MULTIPLE, TYPE I	0.0142857	0.5350792049216756
PERIPHERAL NEUROPATHY, AUTOSOMAL RECESSIVE, WITH OR WITHOUT IMPAIRED INTELLECTUAL DEVELOPMENT; PNRIID	0.0142857	0.5350792049216756
NEUROPATHY, HEREDITARY SENSORY, WITH SPASTIC PARAPLEGIA, AUTOSOMAL RECESSIVE	0.0142857	0.5350792049216756
NEUROPATHY, CONGENITAL HYPOMYELINATING, 2; CHN2	0.0142857	0.5350792049216756
139750 HAND AND FOOT DEFORMITY WITH FLAT FACIES	0.0142857	0.5350792049216756
AUTOSOMAL RECESSIVE SPASTIC ATAXIA OF CHARLEVOIX-SAGUENAY	0.0142857	0.5350792049216756
MYASTHENIC SYNDROME, CONGENITAL, 23, PRESYNAPTIC; CMS23	0.0142857	0.5350792049216756
CHARCOT-MARIE-TOOTH DISEASE, DOMINANT INTERMEDIATE C; CMTDIC	0.0142857	0.5350792049216756
MYASTHENIC SYNDROME, CONGENITAL, 24, PRESYNAPTIC; CMS24	0.0142857	0.5350792049216756
NEUROMYOTONIA AND AXONAL NEUROPATHY, AUTOSOMAL RECESSIVE	0.0142857	0.5350792049216756
259610 OSTEOLYSIS SYNDROME, RECESSIVE;;OSTEOLYSIS, DISTAL, WITH SHORT STATURE, MENTAL RETARDATION, AND CHARACTERISTICFACIAL APPEARANCE	0.0142857	0.5350792049216756
HYPOPHOSPHATASIA, ADULT	0.0142857	0.5350792049216756
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 19	0.0142857	0.5350792049216756
NEUROPATHY, HEREDITARY SENSORY AND AUTONOMIC, TYPE IC; HSAN1C	0.0142857	0.5350792049216756
GORLIN-CHAUDHRY-MOSS SYNDROME	0.0142857	0.5350792049216756
PERIPHERAL NEUROPATHY, MYOPATHY, HOARSENESS, AND HEARING LOSS; PNMHH	0.0142857	0.5350792049216756
%609166 BRANCHIOGENIC-DEAFNESS SYNDROME	0.0142857	0.5350792049216756
SPASTIC PARAPLEGIA 73, AUTOSOMAL DOMINANT; SPG73	0.0142857	0.5350792049216756
ARTHROPATHY, PROGRESSIVE PSEUDORHEUMATOID, OF CHILDHOOD	0.0142857	0.5350792049216756
PAGANINI-MIOZZO SYNDROME; MRXSPM	0.014244153999999998	0.5335230753202086
POSTNATAL MICROCEPHALY-INFANTILE HYPOTONIA-SPASTIC DIPLEGIA-DYSARTHRIA-INTELLECTUAL DISABILITY SYNDROME	0.014244153999999998	0.5335230753202086
VPS11-RELATED AUTOSOMAL RECESSIVE HYPOMYELINATING LEUKODYSTROPHY	0.014244153999999998	0.5335230753202086
GLOBAL DEVELOPMENTAL DELAY, PROGRESSIVE ATAXIA, AND ELEVATED GLUTAMINE; GDPAG	0.014244153999999998	0.5335230753202086
NEONATAL ADRENOLEUKODYSTROPHY	0.014223809	0.5327610415084856
SPONDYLOEPIMETAPHYSEAL DYSPLASIA, GENEVIEVE TYPE; SEMDG	0.014174289000000001	0.5309062410977448
MULTINUCLEATED NEURONS, ANHYDRAMNIOS, RENAL DYSPLASIA, CEREBELLAR HYPOPLASIA, AND HYDRANENCEPHALY; MARCH	0.01412315	0.5289908001000695
OGDEN SYNDROME	0.014059054	0.5265900471290103
ZEBRA BODY MYOPATHY	0.014059054	0.5265900471290103
AUTOSOMAL SPASTIC PARAPLEGIA TYPE 58	0.014059054	0.5265900471290103
CITRULLINEMIA TYPE I	0.014054918999999999	0.5264351682982669
RAPID-ONSET DYSTONIA-PARKINSONISM	0.014054918999999999	0.5264351682982669
KUFOR-RAKEB SYNDROME	0.014054918999999999	0.5264351682982669
MICROPHTHALMIA WITH LINEAR SKIN DEFECTS SYNDROME	0.014004494	0.5245464705859969
PRIMARY MICROCEPHALY-MILD INTELLECTUAL DISABILITY-YOUNG-ONSET DIABETES SYNDROME	0.013891833000000001	0.520326687284816
CRANIOFACIAL DYSSYNOSTOSIS	0.01372817	0.5141965944006663
ROBERTS SYNDROME	0.013722894	0.513998978751089
DILATED CARDIOMYOPATHY WITH ATAXIA	0.013716489	0.5137590757496594
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 24; EIEE24	0.013698599999999998	0.5130890328468373
KEPPEN-LUBINSKY SYNDROME; KPLBS	0.013698599999999998	0.5130890328468373
CONGENITAL CEREBELLAR ATAXIA DUE TO RNU12 MUTATION	0.013698599999999998	0.5130890328468373
609438 MENTAL RETARDATION, KERATOCONUS, FEBRILE SEIZURES, AND SINOATRIALBLOCK	0.013698599999999998	0.5130890328468373
EPILEPSY, HOT WATER, 1	0.013698599999999998	0.5130890328468373
ABETA AMYLOIDOSIS, ARCTIC TYPE	0.013698599999999998	0.5130890328468373
EPILEPSY, FAMILIAL TEMPORAL LOBE, 6; ETL6	0.013698599999999998	0.5130890328468373
MENTAL RETARDATION, X-LINKED 77	0.013698599999999998	0.5130890328468373
PEHO-LIKE SYNDROME; PEHOL	0.013671174	0.5120617760603878
RING CHROMOSOME 14 SYNDROME	0.013671174	0.5120617760603878
MICROCEPHALY, PROGRESSIVE, WITH SEIZURES AND CEREBRAL AND CEREBELLAR ATROPHY	0.013671174	0.5120617760603878
HALL-RIGGS SYNDROME	0.013593969	0.5091700178675113
MENTAL RETARDATION, AUTOSOMAL DOMINANT 58; MRD58	0.013577912999999999	0.5085686310461288
DIAPHANOSPONDYLODYSOSTOSIS	0.013575223999999999	0.5084679129866684
20Q13.33 MICRODELETION SYNDROME	0.013571089	0.508313034155925
CARNOSINASE DEFICIENCY	0.013569600000000001	0.5082572627946247
BARTTER SYNDROME, ANTENATAL, TYPE 2	0.013555373	0.5077243822323546
WOLFRAM-LIKE SYNDROME	0.01355449	0.5076913089536251
FAMILIAL PAROXYSMAL ATAXIA	0.0135135	0.506156004655639
ACERULOPLASMINEMIA	0.0135135	0.506156004655639
LEUKOENCEPHALOPATHY WITH DYSTONIA AND MOTOR NEUROPATHY	0.0135135	0.506156004655639
PRIMARY DYSTONIA, DYT17 TYPE	0.0135135	0.506156004655639
DYSTONIA 13, TORSION	0.0135135	0.506156004655639
OPHTHALMOPLEGIA, EXTERNAL, WITH RIB AND VERTEBRAL ANOMALIES; EORVA	0.0135135	0.506156004655639
PRIMARY DYSTONIA, DYT4 TYPE	0.0135135	0.506156004655639
CONGENITAL MUSCULAR DYSTROPHY, ULLRICH TYPE	0.0135135	0.506156004655639
SPASMUS NUTANS	0.0135135	0.506156004655639
BETHLEM MYOPATHY 1	0.0135135	0.506156004655639
PRIMARY DYSTONIA, DYT13 TYPE	0.0135135	0.506156004655639
DYSTONIA 26, MYOCLONIC; DYT26	0.0135135	0.506156004655639
DYSTONIA 11, MYOCLONIC	0.0135135	0.506156004655639
DYSTONIA 25	0.0135135	0.506156004655639
PRIMARY DYSTONIA, DYT6 TYPE	0.0135135	0.506156004655639
MYOCLONUS-DYSTONIA SYNDROME	0.0135135	0.506156004655639
AUTOSOMAL DOMINANT FOCAL DYSTONIA, DYT25 TYPE	0.0135135	0.506156004655639
PAROXYSMAL NON-KINESIGENIC DYSKINESIA	0.0135135	0.506156004655639
DYSTONIA 7, TORSION	0.0135135	0.506156004655639
BENIGN PAROXYSMAL TORTICOLLIS OF INFANCY	0.0135135	0.506156004655639
DYSTONIA 23; DYT23	0.0135135	0.506156004655639
DYSTONIA 12; DYT12	0.0135135	0.506156004655639
BETHLEM MYOPATHY	0.0135135	0.506156004655639
ADULT-ONSET CERVICAL DYSTONIA, DYT23 TYPE	0.0135135	0.506156004655639
CRANIO-CERVICAL DYSTONIA WITH LARYNGEAL AND UPPER-LIMB INVOLVEMENT	0.0135135	0.506156004655639
DYSTONIA 2, TORSION, AUTOSOMAL RECESSIVE; DYT2	0.0135135	0.506156004655639
DYSTONIA 4, TORSION, AUTOSOMAL DOMINANT; DYT4	0.0135135	0.506156004655639
DYSTONIA 16	0.0135135	0.506156004655639
DYSTONIA 21; DYT21	0.0135135	0.506156004655639
SPRENGEL DEFORMITY	0.0135135	0.506156004655639
TORTICOLLIS, KELOIDS, CRYPTORCHIDISM, AND RENAL DYSPLASIA; TKCR	0.0135135	0.506156004655639
TORTICOLLIS	0.0135135	0.506156004655639
SANDIFER SYNDROME	0.0135135	0.506156004655639
MESOAXIAL HEXADACTYLY AND CARDIAC MALFORMATION	0.0135135	0.506156004655639
PRIMARY DYSTONIA, DYT21 TYPE	0.0135135	0.506156004655639
CONTRACTURES, CONGENITAL, TORTICOLLIS, AND MALIGNANT HYPERTHERMIA	0.0135135	0.506156004655639
PRIMARY DYSTONIA, DYT2 TYPE	0.0135135	0.506156004655639
DYSTONIA 17, TORSION, AUTOSOMAL RECESSIVE; DYT17	0.0135135	0.506156004655639
SPINOCEREBELLAR ATAXIA TYPE 17	0.0135135	0.506156004655639
SPINOCEREBELLAR ATAXIA, AUTOSOMAL RECESSIVE 27; SCAR27	0.0135135	0.506156004655639
DYSTONIA 1, TORSION, AUTOSOMAL DOMINANT	0.0135135	0.506156004655639
SPINOCEREBELLAR ATAXIA TYPE 35	0.0135135	0.506156004655639
TRISOMY X	0.013507613	0.5059355036455819
SPLIT-HAND/FOOT MALFORMATION 1; SHFM1	0.013492070000000002	0.505353331537663
AUTOSOMAL RECESSIVE SPASTIC PARAPLEGIA TYPE 77	0.013461833	0.5042207871107732
SMITH-MAGENIS SYNDROME	0.013443573	0.5035368481871035
LARSEN-LIKE OSSEOUS DYSPLASIA-SHORT STATURE SYNDROME	0.013384054000000001	0.5013075294139435
FACIAL DYSMORPHISM, HYPERTRICHOSIS, EPILEPSY, INTELLECTUAL/DEVELOPMENTAL DELAY, AND GINGIVAL OVERGROWTH SYNDROME; FHEIG	0.013379919	0.5011526505832
FREEMAN-SHELDON SYNDROME	0.013362989999999998	0.5005185650389061
RADIOULNAR SYNOSTOSIS-MICROCEPHALY-SCOLIOSIS SYNDROME	0.013305034000000002	0.49834778934009966
RAJAB INTERSTITIAL LUNG DISEASE WITH BRAIN CALCIFICATIONS; RILDBC	0.013302109	0.49823823176333426
COSTELLO SYNDROME; CSTLO	0.013282934000000001	0.49752002098231746
VASCULAR EHLERS-DANLOS SYNDROME	0.013282934000000001	0.49752002098231746
ARTHROGRYPOSIS, DISTAL, WITH IMPAIRED PROPRIOCEPTION AND TOUCH; DAIPT	0.013277414000000001	0.4973132661707809
CHROMOSOME 15Q13.3 MICRODELETION SYNDROME	0.013251909	0.4963579615569693
MENTAL RETARDATION, AUTOSOMAL DOMINANT 32; MRD32	0.013244592999999999	0.49608393652051974
NEURODEVELOPMENTAL DISORDER AND LANGUAGE DELAY WITH OR WITHOUT STRUCTURAL BRAIN ABNORMALITIES; NEDLBA	0.013244592999999999	0.49608393652051974
KLEEFSTRA SYNDROME	0.013229808999999999	0.4955301931991871
MULTIPLE PTERYGIUM-MALIGNANT HYPERTHERMIA SYNDROME	0.013228999999999998	0.4954998916335108
ATELOSTEOGENESIS, TYPE I; AO1	0.01315524	0.49273716791993555
INTELLECTUAL DEVELOPMENTAL DISORDER WITH DYSMORPHIC FACIES AND PTOSIS; IDDDFP	0.013149404	0.49251857714455016
RAINE SYNDROME	0.013121033999999998	0.49145596228888133
DESANTO-SHINAWI SYNDROME	0.013088523000000001	0.49023824386897835
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 35; COXPD35	0.013051564	0.4888539230212285
MICROCEPHALY, SEIZURES, SPASTICITY, AND BRAIN CALCIFICATIONS; MISSBC	0.013051564	0.4888539230212285
HYPERPHOSPHATASIA WITH MENTAL RETARDATION	0.013032358999999999	0.4881345885727575
ALLAN-HERNDON-DUDLEY SYNDROME	0.01302539	0.4878735606231927
22Q11.2 DELETION SYNDROME	0.013003613	0.487057890418332
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE ID; CDG1D	0.012941193	0.4847199130023698
MUCOPOLYSACCHARIDOSIS TYPE 3	0.012916279	0.483786744637402
CONGENITAL ANOMALIES OF KIDNEY AND URINARY TRACT SYNDROME WITH OR WITHOUT HEARING LOSS, ABNORMAL EARS, OR DEVELOPMENTAL DELAY; CAKUTHED	0.012837164	0.48082344628328727
EPIPHYSEAL DYSPLASIA, MULTIPLE, 4	0.0128164	0.48004571858279
GLOBAL DEVELOPMENTAL DELAY, ABSENT OR HYPOPLASTIC CORPUS CALLOSUM, AND DYSMORPHIC FACIES; GDACCF	0.012816084	0.48003388261894114
MOSAIC VARIEGATED ANEUPLOIDY SYNDROME 2; MVA2	0.01280486	0.47961348116881686
TELO2-RELATED INTELLECTUAL DISABILITY-NEURODEVELOPMENTAL DISORDER	0.012722808999999998	0.47654021322653684
TAKENOUCHI-KOSAKI SYNDROME; TKS	0.012672213000000002	0.47464511060977915
FRYNS SYNDROME	0.012638269	0.47337371834115655
INTELLECTUAL DISABILITY, WOLFF TYPE	0.012638269	0.47337371834115655
HENNEKAM-BEEMER SYNDROME	0.012638269	0.47337371834115655
HYPERPROLINEMIA, TYPE I	0.012581272999999999	0.47123890000087804
ARTHROGRYPOSIS, CLEFT PALATE, CRANIOSYNOSTOSIS, AND IMPAIRED INTELLECTUAL DEVELOPMENT; ACCIID	0.012575479999999998	0.47102191981551006
FIBROCHONDROGENESIS	0.012575479999999998	0.47102191981551006
WEBB-DATTANI SYNDROME; WEDAS	0.012559422999999998	0.4704204955385458
GAUCHER DISEASE TYPE 2	0.01250601	0.4684198805478572
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 1; EIEE1	0.01250601	0.4684198805478572
FACIOCARDIORENAL SYNDROME	0.012490939999999999	0.4678554249301297
LIG4 SYNDROME	0.012484294000000002	0.4676064951334863
MUSCULAR DYSTROPHY, LIMB-GIRDLE, AUTOSOMAL RECESSIVE 18; LGMDR18	0.012398243	0.4643834048640059
ALPHA-THALASSEMIA/MENTAL RETARDATION SYNDROME, CHROMOSOME 16-RELATED	0.012395639	0.4642858705289985
19P13.13 MICRODELETION SYNDROME	0.012338893000000002	0.46216041608417013
KAUFMAN OCULOCEREBROFACIAL SYNDROME; KOS	0.01229263	0.4604276085033521
MATERNAL PHENYLKETONURIA	0.012287673	0.460241941184369
COG8-CDG	0.012259169	0.459174307280739
COFFIN-SIRIS SYNDROME 7; CSS7	0.012215334000000001	0.4575324418525316
20P13 MICRODELETION SYNDROME	0.012211198999999999	0.45737756302178817
SYNDROMIC DIARRHEA	0.012193214	0.4567039243831134
GLUTARYL-COA DEHYDROGENASE DEFICIENCY	0.012163549	0.4555928045490135
OROFACIODIGITAL SYNDROME TYPE 1	0.012158109000000002	0.455389046184021
CHROMOSOME 3Q13.31 DELETION SYNDROME	0.01215762	0.45537073040452064
DISTAL MONOSOMY 10P	0.01209685	0.45309455469852866
CHROMOSOME 9P DELETION SYNDROME	0.012078024000000001	0.4523894159155601
CHROMOSOME 16Q22 DELETION SYNDROME	0.012078024000000001	0.4523894159155601
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 58; EIEE58	0.012039854	0.45095973635825026
NEURODEVELOPMENTAL DISORDER WITH OR WITHOUT SEIZURES AND GAIT ABNORMALITIES; NEDSGA	0.012039854	0.45095973635825026
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 35	0.012039854	0.45095973635825026
ENCEPHALOPATHY DUE TO DEFECTIVE MITOCHONDRIAL AND PEROXISOMAL FISSION 1	0.012039854	0.45095973635825026
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 48	0.012039854	0.45095973635825026
DYSKINESIA, SEIZURES, AND INTELLECTUAL DEVELOPMENTAL DISORDER	0.012039854	0.45095973635825026
FUMARASE DEFICIENCY; FMRD	0.012039854	0.45095973635825026
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 56; EIEE56	0.012039854	0.45095973635825026
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IAA	0.012039854	0.45095973635825026
EPILEPSY, PROGRESSIVE MYOCLONIC, 9; EPM9	0.012039854	0.45095973635825026
BAINBRIDGE-ROPERS SYNDROME; BRPS	0.012013869	0.44998645306517465
CLASSICAL EHLERS-DANLOS SYNDROME	0.01199932	0.449441511805565
ENDOCRINE-CEREBROOSTEODYSPLASIA; ECO	0.01195033	0.4476065628531782
VAN MALDERGEM SYNDROME 2; VMLDS2	0.01185422	0.4440067068863706
VAN MALDERGEM SYNDROME 1; VMLDS1	0.01185422	0.4440067068863706
1Q21.1 MICRODUPLICATION SYNDROME	0.011854192999999999	0.444005695585662
MONOSOMY 18P	0.011808674	0.44230075495770327
ROIFMAN-CHITAYAT SYNDROME	0.011769454	0.44083174703950345
OROFACIODIGITAL SYNDROME I; OFD1	0.011742119	0.4398078987109978
LEUKODYSTROPHY, HYPOMYELINATING, 18; HLD18	0.011741132999999999	0.43977096750734285
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 29; COXPD29	0.011741132999999999	0.43977096750734285
GABRIELE-DE VRIES SYNDROME; GADEVS	0.011728814	0.43930955219514745
SHORT STATURE, MICROCEPHALY, AND ENDOCRINE DYSFUNCTION; SSMED	0.011719094	0.4389454839400504
DISTAL XQ28 MICRODUPLICATION SYNDROME	0.011719094	0.4389454839400504
SYNDROMIC MULTISYSTEM AUTOIMMUNE DISEASE DUE TO ITCH DEFICIENCY	0.011719094	0.4389454839400504
MEGALENCEPHALY-SEVERE KYPHOSCOLIOSIS-OVERGROWTH SYNDROME	0.011652843999999999	0.4364640516457938
PELGER-HUET ANOMALY; PHA	0.011652843999999999	0.4364640516457938
MULTIPLE CONGENITAL ANOMALIES-HYPOTONIA-SEIZURES SYNDROME	0.011629328999999999	0.4355832836397645
COFFIN-LOWRY SYNDROME	0.011629328999999999	0.4355832836397645
610680 HOLOPROSENCEPHALY, RECURRENT INFECTIONS, AND MONOCYTOSIS	0.01161701	0.43512186832756916
SHORT-RIB THORACIC DYSPLASIA 12; SRTD12	0.01161701	0.43512186832756916
CONGENITAL MUSCULAR DYSTROPHY, FUKUYAMA TYPE	0.011613272999999999	0.4349818968183821
KLEEFSTRA SYNDROME 2; KLEFS2	0.011613272999999999	0.4349818968183821
CHROMOSOME 15Q11.2 DELETION SYNDROME	0.011613272999999999	0.4349818968183821
SHORT SYNDROME	0.01158524	0.43393190449377994
CRI-DU-CHAT SYNDROME	0.011532470000000001	0.4319553734421888
ALPHA-METHYLACYL-COA RACEMASE DEFICIENCY; AMACRD	0.011494299999999999	0.4305256938848789
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 53; EIEE53	0.011494299999999999	0.4305256938848789
3-METHYLGLUTACONIC ACIDURIA TYPE 9	0.011494299999999999	0.4305256938848789
X-LINKED SPASTICITY-INTELLECTUAL DISABILITY-EPILEPSY SYNDROME	0.011494299999999999	0.4305256938848789
SEVERE NEURODEGENERATIVE SYNDROME WITH LIPODYSTROPHY	0.011494299999999999	0.4305256938848789
HIRSCHSPRUNG DISEASE, CARDIAC DEFECTS, AND AUTONOMIC DYSFUNCTION	0.011494299999999999	0.4305256938848789
DEVELOPMENTAL DELAY WITH OR WITHOUT DYSMORPHIC FACIES AND AUTISM; DEDDFA	0.011472773	0.4297193875754683
NEURODEVELOPMENTAL DISORDER WITH COARSE FACIES AND MILD DISTAL SKELETAL ABNORMALITIES; NEDCFSA	0.011472773	0.4297193875754683
POLYHYDRAMNIOS, MEGALENCEPHALY, AND SYMPTOMATIC EPILEPSY; PMSE	0.011454973	0.42905267821942644
PROGEROID FACIAL APPEARANCE WITH HAND ANOMALIES	0.011420449999999999	0.4277595991689416
PONTOCEREBELLAR HYPOPLASIA, TYPE 1D; PCH1D	0.011413943	0.4275158756981684
GALLOWAY-MOWAT SYNDROME 3; GAMOS3	0.011413943	0.4275158756981684
ULBRIGHT-HODES SYNDROME	0.011398349999999998	0.4269318308111594
RENAL-HEPATIC-PANCREATIC DYSPLASIA 2; RHPD2	0.011398349999999998	0.4269318308111594
PRUNE BELLY SYNDROME	0.011398349999999998	0.4269318308111594
RENAL AGENESIS	0.011398349999999998	0.4269318308111594
ARTERIAL TORTUOSITY SYNDROME	0.011334874000000002	0.4245543003008164
2Q23.1 MICRODELETION SYNDROME	0.011330739	0.4243994214700729
SPONDYLODYSPLASTIC EHLERS-DANLOS SYNDROME	0.011312774000000001	0.4237265319430342
CHROMOSOME 18P DELETION SYNDROME	0.011312504000000001	0.4237164189359482
INTELLECTUAL DISABILITY-BRACHYDACTYLY-PIERRE ROBIN SYNDROME	0.011290383999999999	0.4228879014665299
%235830 HISTIDINURIA DUE TO A RENAL TUBULAR DEFECT	0.0112239	0.42039770456613224
CRANIOECTODERMAL DYSPLASIA 1	0.011200700000000001	0.4195287350683699
ROBINOW SYNDROME, AUTOSOMAL DOMINANT 3; DRS3	0.011200700000000001	0.4195287350683699
AICARDI-GOUTIERES SYNDROME 4; AGS4	0.011195578999999999	0.4193369250339716
BONE FRAGILITY WITH CONTRACTURES, ARTERIAL RUPTURE, AND DEAFNESS	0.011184764	0.4189318429168035
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IG; CDG1G	0.011184764	0.4189318429168035
PMP22-RAI1 CONTIGUOUS GENE DUPLICATION SYNDROME	0.011184764	0.4189318429168035
MENTAL RETARDATION, X-LINKED, SYNDROMIC, SNYDER-ROBINSON TYPE	0.011180629000000001	0.41877696408606013
TEMPLE SYNDROME	0.011128160000000002	0.41681170716459076
SPINAL MUSCULAR ATROPHY, DISTAL, AUTOSOMAL RECESSIVE, 1; DSMA1	0.011106060000000001	0.41598393880680856
COFFIN-SIRIS SYNDROME 2; CSS2	0.011072663	0.4147330347414306
ISOLATED PLAGIOCEPHALY	0.011071853999999999	0.41470273317575423
CRANIOSYNOSTOSIS 6; CRS6	0.011071853999999999	0.41470273317575423
CRANIOSYNOSTOSIS-ANAL ANOMALIES-POROKERATOSIS SYNDROME	0.011071853999999999	0.41470273317575423
BRESEK SYNDROME	0.011071853999999999	0.41470273317575423
LINEAR NEVUS SEBACEUS SYNDROME	0.011067718999999998	0.4145478543450108
SEVERE INTELLECTUAL DISABILITY-EPILEPSY-ANAL ANOMALIES-DISTAL PHALANGEAL HYPOPLASIA	0.011067718999999998	0.4145478543450108
19P13.12 MICRODELETION SYNDROME	0.011061073	0.41429892454836736
MOSAIC VARIEGATED ANEUPLOIDY SYNDROME	0.011061073	0.41429892454836736
MONOSOMY 18Q	0.011038973	0.4134711561905853
NEPHROTIC SYNDROME, TYPE 14; NPHS14	0.011015293	0.41258420801355894
MONOSOMY 5P	0.01100337	0.4121376251117563
CINCA SYNDROME	0.010998094	0.411940009462179
MENTAL RETARDATION, X-LINKED 104; MRX104	0.010988123	0.41156653985605024
ALPHA-THALASSEMIA/MENTAL RETARDATION SYNDROME, X-LINKED; ATRX	0.010976553	0.411133178774623
WEAVER SYNDROME	0.010976553	0.411133178774623
PALLISTER-KILLIAN SYNDROME	0.010927219	0.409285345102097
RARE NON-SYNDROMIC INTELLECTUAL DISABILITY	0.010834554	0.40581452361459075
RETT SYNDROME	0.010823309	0.40539333559724866
RETT SYNDROME, CONGENITAL VARIANT	0.010801208999999999	0.40456556723946646
RADIO-ULNAR SYNOSTOSIS-AMEGAKARYOCYTIC THROMBOCYTOPENIA SYNDROME	0.010789320000000002	0.40412025782744515
RERE-RELATED NEURODEVELOPMENTAL SYNDROME	0.010782813	0.4038765343566719
CONGENITAL HYPOTONIA, EPILEPSY, DEVELOPMENTAL DELAY, AND DIGITAL ANOMALIES; CHEDDA	0.010782813	0.4038765343566719
CHROMOSOME 6PTER-P24 DELETION SYNDROME	0.010782813	0.4038765343566719
FUCOSIDOSIS	0.010769993	0.4033963537979946
TARP SYNDROME; TARPS	0.010768454	0.40333870965760427
TIBIAL HEMIMELIA	0.010767220000000001	0.40329248946966295
FAMILIAL CLUBFOOT DUE TO 17Q23.1Q23.2 MICRODUPLICATION	0.010767220000000001	0.40329248946966295
CUTIS LAXA, AUTOSOMAL RECESSIVE, TYPE IIC; ARCL2C	0.010767220000000001	0.40329248946966295
FEMORAL-FACIAL SYNDROME	0.010767220000000001	0.40329248946966295
SCHWARTZ-JAMPEL SYNDROME	0.010767220000000001	0.40329248946966295
CAMPOMELIA, CUMMING TYPE	0.010744829999999999	0.40245385899315866
CRANIOSYNOSTOSIS, HERRMANN-OPITZ TYPE	0.010744829999999999	0.40245385899315866
BOWEN-CONRADI SYNDROME	0.010673628999999999	0.39978698411340985
FIBROCHONDROGENESIS 1; FBCG1	0.01066131	0.3993255688012144
PTOSIS-UPPER OCULAR MOVEMENT LIMITATION-ABSENCE OF LACRIMAL PUNCTUM SYNDROME	0.01066131	0.3993255688012144
TOE SYNDACTYLY, TELECANTHUS, AND ANOGENITAL AND RENAL MALFORMATIONS; STAR	0.01066131	0.3993255688012144
MECKEL SYNDROME 12; MKS12	0.01066029	0.3992873641077783
OCCIPITAL HORN SYNDROME	0.010659254	0.3992485601250334
THANATOPHORIC DYSPLASIA	0.010655119	0.39909368129429
SKELETAL DYSPLASIA-EPILEPSY-SHORT STATURE SYNDROME	0.010655119	0.39909368129429
AICARDI-GOUTIERES SYNDROME 3; AGS3	0.01065416	0.3990577613913437
1Q41Q42 MICRODELETION SYNDROME	0.010651529	0.39895921575562765
MEHMO SYNDROME	0.010651529	0.39895921575562765
134780 FEMORAL-FACIAL SYNDROME; FFS;;FEMORAL HYPOPLASIA-UNUSUAL FACIES SYNDROME; FHUFS	0.01063921	0.3984978004434322
SPINAL MUSCULAR ATROPHY, LOWER EXTREMITY-PREDOMINANT, 2B, PRENATAL ONSET, AUTOSOMAL DOMINANT; SMALED2B	0.01063921	0.3984978004434322
AASE-SMITH SYNDROME I	0.01063921	0.3984978004434322
HYDROLETHALUS SYNDROME 1	0.01063921	0.3984978004434322
CARDIOFACIOCUTANEOUS SYNDROME	0.010580234	0.39628882005118965
HEREDITARY OROTIC ACIDURIA	0.010574714	0.39608206523965306
SPECIFIC GRANULE DEFICIENCY 2; SGD2	0.010531244	0.3944538710988027
ROBINOW-SORAUF SYNDROME	0.010526299999999999	0.394268690702383
GALLOWAY-MOWAT SYNDROME 6; GAMOS6	0.010519654000000002	0.3940197609057397
WHIPPLE DISEASE	0.010469739	0.39215016554018767
ADIPOSIS DOLOROSA	0.010469739	0.39215016554018767
3-METHYLGLUTACONIC ACIDURIA TYPE 7	0.010469739	0.39215016554018767
ALEXANDER DISEASE	0.010469739	0.39215016554018767
CORNEODERMATOOSSEOUS SYNDROME	0.01045254	0.39150596698880774
AUTOSOMAL DOMINANT MYOPIA-MIDFACIAL RETRUSION-SENSORINEURAL HEARING LOSS-RHIZOMELIC DYSPLASIA SYNDROME	0.01045254	0.39150596698880774
FIBULO-ULNAR HYPOPLASIA-RENAL ANOMALIES SYNDROME	0.010368	0.3883394721034274
%263210 POLYCYSTIC KIDNEY DISEASE, POTTER TYPE I, WITH MICROBRACHYCEPHALY,HYPERTELORISM, AND BRACHYMELIA	0.01032697	0.3868026695821693
ACRORENAL-MANDIBULAR SYNDROME	0.01032697	0.3868026695821693
RENAL AGENESIS, BILATERAL	0.01032697	0.3868026695821693
ARTHROGRYPOSIS, DISTAL, TYPE 2B2; DA2B2	0.01030744	0.38607116206961334
MEGALOCORNEA-INTELLECTUAL DISABILITY SYNDROME	0.010300913	0.3858266894872041
KOOLEN-DE VRIES SYNDROME	0.010300913	0.3858266894872041
PAROXYSMAL DYSTONIC CHOREATHETOSIS WITH EPISODIC ATAXIA AND SPASTICITY	0.010289	0.3853804811412195
ENCEPHALOPATHY DUE TO PROSAPOSIN DEFICIENCY	0.010289	0.3853804811412195
3-HYDROXYISOBUTYRYL-COA HYDROLASE DEFICIENCY	0.010275383	0.38487044848384766
C SYNDROME	0.010238493000000001	0.38348871207124197
CONGENITAL HEART DEFECTS, DYSMORPHIC FACIAL FEATURES, AND INTELLECTUAL DEVELOPMENTAL DISORDER; CHDFIDD	0.010238493000000001	0.38348871207124197
CHROMOSOME 10Q26 DELETION SYNDROME	0.010238493000000001	0.38348871207124197
ACROFACIAL DYSOSTOSIS SYNDROME OF RODRIGUEZ	0.0102229	0.382904667184233
ROBINOW SYNDROME, AUTOSOMAL RECESSIVE 2; RRS2	0.010114934	0.3788607378396035
MULTIPLE EPIPHYSEAL DYSPLASIA	0.0101137	0.3788145176516622
CHROMOSOME 6Q11-Q14 DELETION SYNDROME	0.010113384000000001	0.3788026816878134
CHROMOSOME 22Q11.2 DUPLICATION SYNDROME	0.010113384000000001	0.3788026816878134
FETAL HYDANTOIN SYNDROME	0.010113384000000001	0.3788026816878134
16P11.2P12.2 MICRODELETION SYNDROME	0.010113384000000001	0.3788026816878134
TETRASOMY 5P	0.010110433	0.37869215026592123
SIMPSON-GOLABI-BEHMEL SYNDROME	0.010110433	0.37869215026592123
1Q21.1 MICRODELETION SYNDROME	0.010110433	0.37869215026592123
MECKEL SYNDROME, TYPE 10; MKS10	0.010109249	0.37864780285706995
LARSEN-LIKE SYNDROME	0.010038094000000001	0.3759826509340839
GMS SYNDROME	0.01003468	0.3758547775778184
DIAMOND-BLACKFAN ANEMIA 1	0.01003468	0.3758547775778184
CONO-SPONDYLAR DYSPLASIA	0.009998008999999999	0.3744812439376269
FOCAL DERMAL HYPOPLASIA; FDH	0.00998569	0.3740198286254315
PELVISCAPULAR DYSPLASIA	0.00998569	0.3740198286254315
WILLIAMS-BEUREN SYNDROME; WBS	0.009974100000000001	0.3735857184323684
METABOLIC ENCEPHALOMYOPATHIC CRISES, RECURRENT, WITH RHABDOMYOLYSIS, CARDIAC ARRHYTHMIAS, AND NEURODEGENERATION; MECRCN	0.009951703	0.3727468257667915
MICROCEPHALIC PRIMORDIAL DWARFISM DUE TO RTTN DEFICIENCY	0.009913469	0.3713147490522465
X-LINKED INTELLECTUAL DISABILITY, NAJM TYPE	0.009913469	0.3713147490522465
GLUTAMINE DEFICIENCY, CONGENITAL	0.009913469	0.3713147490522465
PEROXISOME BIOGENESIS DISORDER 6A (ZELLWEGER); PBD6A	0.009913469	0.3713147490522465
TRISOMY 18-LIKE SYNDROME	0.009901150000000001	0.37085333374005114
BRANCHIO-OCULO-FACIAL SYNDROME	0.009901150000000001	0.37085333374005114
SIMOSA CRANIOFACIAL SYNDROME	0.009901150000000001	0.37085333374005114
BARBER-SAY SYNDROME	0.009901150000000001	0.37085333374005114
SIMPSON-GOLABI-BEHMEL SYNDROME, TYPE 2; SGBS2	0.00988958	0.370419972658624
PRIETO X-LINKED MENTAL RETARDATION SYNDROME; PRS	0.00988958	0.370419972658624
FILIPPI SYNDROME	0.009841453	0.3686173478733306
WOLCOTT-RALLISON SYNDROME	0.009839899000000001	0.3685591418992133
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 63; EIEE63	0.009804814	0.36724501281175675
MACROCEPHALY AND EPILEPTIC ENCEPHALOPATHY	0.009804814	0.36724501281175675
MICROCEPHALY, EPILEPSY, AND DIABETES SYNDROME	0.009804814	0.36724501281175675
HYPERORNITHINEMIA-HYPERAMMONEMIA-HOMOCITRULLINURIA SYNDROME	0.009804814	0.36724501281175675
NEURODEVELOPMENTAL DISORDER WITH EPILEPSY AND HYPOPLASIA OF THE CORPUS CALLOSUM; NEDEHCC	0.009804814	0.36724501281175675
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 63; MRT63	0.009804814	0.36724501281175675
X-LINKED NEURODEGENERATIVE SYNDROME, BERTINI TYPE	0.009804814	0.36724501281175675
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 12; MC1DN12	0.009804814	0.36724501281175675
MENTAL RETARDATION, AUTOSOMAL DOMINANT 55, WITH SEIZURES; MRD55	0.009804814	0.36724501281175675
BIOTINIDASE DEFICIENCY	0.009804814	0.36724501281175675
KRABBE DISEASE	0.009804814	0.36724501281175675
ATAXIA WITH MYOCLONIC EPILEPSY AND PRESENILE DEMENTIA	0.009800679	0.36709013398101337
MYOCLONIC EPILEPSY ASSOCIATED WITH RAGGED-RED FIBERS	0.009800679	0.36709013398101337
IFAP SYNDROME WITH OR WITHOUT BRESHECK SYNDROME	0.009782622999999999	0.3664138359960307
17Q12 MICRODELETION SYNDROME	0.009782622999999999	0.3664138359960307
ADAMS-OLIVER SYNDROME 2; AOS2	0.009782622999999999	0.3664138359960307
CHROMOSOME 16P12.2-P11.2 DELETION SYNDROME, 7.1- TO 8.7-MB	0.009781614000000001	0.3663760433139945
OROFACIODIGITAL SYNDROME VI	0.009781614000000001	0.3663760433139945
OLIVER SYNDROME	0.00976705	0.3658305402206578
OCULOSKELETODENTAL SYNDROME; OCSKD	0.009759494	0.3655475258445763
METAPHYSEAL ACROSCYPHODYSPLASIA	0.00971018	0.3637004412836862
METAPHYSEAL ACROSCYPHODYSPLASIA	0.009710179999999999	0.36370044128368617
LAMB-SHAFFER SYNDROME	0.009697074000000002	0.3632095484286142
MONOSOMY X	0.00969584	0.36316332824067277
MOSAIC MONOSOMY X	0.00969584	0.36316332824067277
ARTHROCHALASIA EHLERS-DANLOS SYNDROME	0.00969584	0.36316332824067277
TURNER SYNDROME DUE TO STRUCTURAL X CHROMOSOME ANOMALIES	0.00969584	0.36316332824067277
TURNER SYNDROME	0.00969584	0.36316332824067277
DERMATOSPARAXIS EHLERS-DANLOS SYNDROME	0.00969584	0.36316332824067277
PITUITARY HORMONE DEFICIENCY, COMBINED, 1	0.00968302	0.3626831476819955
DUPLICATION/INVERSION 15Q11	0.009649419000000001	0.36142460267793036
DAHLBERG-BORER-NEWCOMER SYNDROME	0.0096318	0.3607646727821944
PEROXISOME BIOGENESIS DISORDER 10A (ZELLWEGER); PBD10A	0.009580149	0.3588300545266375
ROBERTS SYNDROME; RBS	0.00956938	0.3584266953662323
BRACHYCEPHALY, TRICHOMEGALY, AND DEVELOPMENTAL DELAY; BTDD	0.009567830000000001	0.3583686392144421
ACROCEPHALOPOLYDACTYLOUS DYSPLASIA	0.009567830000000001	0.3583686392144421
MICROPHTHALMIA WITH LIMB ANOMALIES	0.00949254	0.3555486084607126
PROLIFERATIVE VASCULOPATHY AND HYDRANENCEPHALY-HYDROCEPHALY SYNDROME; PVHH	0.009490333	0.3554659439916798
CONGENITAL TOXOPLASMOSIS	0.009490333	0.3554659439916798
PACHYGYRIA-INTELLECTUAL DISABILITY-EPILEPSY SYNDROME	0.009490333	0.3554659439916798
GALLOWAY-MOWAT SYNDROME	0.009490333	0.3554659439916798
KAGAMI-OGATA SYNDROME	0.009490333	0.3554659439916798
BARTTER SYNDROME, TYPE 1, ANTENATAL	0.009490333	0.3554659439916798
KAGAMI-OGATA SYNDROME	0.009490333	0.3554659439916798
PYRIDOXAMINE 5-PRIME-PHOSPHATE OXIDASE DEFICIENCY	0.009490333	0.3554659439916798
NEURODEGENERATION WITH BRAIN IRON ACCUMULATION 2A	0.009462353	0.354417936812913
BLEPHAROPHIMOSIS-INTELLECTUAL DISABILITY SYNDROME, SBBYS TYPE	0.009429752999999999	0.3531968848462298
NEUROLOGIC, ENDOCRINE, AND PANCREATIC DISEASE, MULTISYSTEM, INFANTILE-ONSET; IMNEPD	0.009407653	0.3523691164884476
PETERS PLUS SYNDROME	0.009384574	0.35150467911608313
FALLOT COMPLEX-INTELLECTUAL DISABILITY-GROWTH DELAY SYNDROME	0.00937205	0.35103558540961866
SPINOCEREBELLAR ATAXIA 42, EARLY-ONSET, SEVERE, WITH NEURODEVELOPMENTAL DEFICITS; SCA42ND	0.009347864	0.35012968470820155
CLEFT PALATE, PSYCHOMOTOR RETARDATION, AND DISTINCTIVE FACIAL FEATURES	0.009300034	0.3483381842307028
MACROCEPHALY-DEVELOPMENTAL DELAY SYNDROME	0.009295899	0.34818330539995934
HYDROXYLYSINURIA	0.00925926	0.3468109703383855
CARNOSINEMIA	0.00925926	0.3468109703383855
GAUCHER DISEASE TYPE 3	0.00925926	0.3468109703383855
PAINE SYNDROME	0.00925926	0.3468109703383855
EPILEPSY, PROGRESSIVE MYOCLONIC, 3, WITH OR WITHOUT INTRACELLULAR INCLUSIONS	0.00925926	0.3468109703383855
SEIZURES-INTELLECTUAL DISABILITY DUE TO HYDROXYLYSINURIA SYNDROME	0.00925926	0.3468109703383855
EPILEPSY, PROGRESSIVE MYOCLONIC, 10	0.00925926	0.3468109703383855
SPINAL MUSCULAR ATROPHY-PROGRESSIVE MYOCLONIC EPILEPSY SYNDROME	0.00925926	0.3468109703383855
ADULT NEURONAL CEROID LIPOFUSCINOSIS	0.00925926	0.3468109703383855
DEAFNESS, CONGENITAL, AND FAMILIAL MYOCLONIC EPILEPSY	0.00925926	0.3468109703383855
GLYCINE ENCEPHALOPATHY	0.00925926	0.3468109703383855
310370 MYOCLONIC EPILEPSY, PROGRESSIVE	0.00925926	0.3468109703383855
SPINAL MUSCULAR ATROPHY WITH PROGRESSIVE MYOCLONIC EPILEPSY	0.00925926	0.3468109703383855
MYOCLONIC EPILEPSY, HARTUNG TYPE	0.00925926	0.3468109703383855
COENZYME Q10 DEFICIENCY, PRIMARY, 8; COQ10D8	0.009241204	0.3461346723534029
MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (CONGENITAL WITH BRAIN AND EYE ANOMALIES), TYPE A, 14; MDDGA14	0.009241204	0.3461346723534029
EVEN-PLUS SYNDROME	0.009241204	0.3461346723534029
OROFACIODIGITAL SYNDROME TYPE 4	0.009241204	0.3461346723534029
HYDROPS, LACTIC ACIDOSIS, AND SIDEROBLASTIC ANEMIA; HLASA	0.009237068999999999	0.34597979352265945
HADDAD SYNDROME	0.009237068999999999	0.34597979352265945
PANCREATIC HYPOPLASIA-DIABETES-CONGENITAL HEART DISEASE SYNDROME	0.009237068999999999	0.34597979352265945
OROFACIODIGITAL SYNDROME IV; OFD4	0.00923606	0.3459420008406232
1Q44 MICRODELETION SYNDROME	0.009219124	0.34530765310725675
DEAFNESS-INTELLECTUAL DISABILITY SYNDROME, MARTIN-PROBST TYPE	0.00921394	0.345113483371205
MENTAL RETARDATION, X-LINKED, SYNDROMIC, MARTIN-PROBST TYPE	0.00921394	0.345113483371205
MOEBIUS SYNDROME	0.009108	0.3411454390353025
14Q11.2 MICRODELETION SYNDROME	0.00903873	0.3385508908840097
TRISOMY XQ28	0.00903873	0.3385508908840097
COFFIN-SIRIS SYNDROME 1; CSS1	0.009023483	0.3379798056283036
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 23; EIEE23	0.009023483	0.3379798056283036
PONTOCEREBELLAR HYPOPLASIA, TYPE 9	0.009023483	0.3379798056283036
SPASTIC PARAPLEGIA 47, AUTOSOMAL RECESSIVE; SPG47	0.009001063	0.33714005148434534
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 25; MC1DN25	0.008948914	0.33518678034905197
TYSHCHENKO SYNDROME	0.008948914	0.33518678034905197
SPINAL MUSCULAR ATROPHY WITH CONGENITAL BONE FRACTURES 2	0.008948914	0.33518678034905197
VENTRICULOMEGALY WITH CYSTIC KIDNEY DISEASE; VMCKD	0.008944779	0.33503190151830853
GAUCHER DISEASE, PERINATAL LETHAL	0.008944779	0.33503190151830853
DYSOSTEOSCLEROSIS	0.008916799	0.3339838943395418
WOODHOUSE-SAKATI SYNDROME	0.00886473	0.33203361965079237
MICROPHTHALMIA, SYNDROMIC 2; MCOPS2	0.008862099	0.3319350740150764
SYNDROMIC X-LINKED INTELLECTUAL DISABILITY DUE TO JARID1C MUTATION	0.008799679	0.3295970965991141
SIALURIA	0.008747973000000001	0.3276604182865583
TEEBI-SHALTOUT SYNDROME; TBSH	0.00873238	0.32707637339954926
HOLZGREVE SYNDROME	0.00869565	0.3257006298800316
46,XX DISORDER OF SEX DEVELOPMENT-ANORECTAL ANOMALIES SYNDROME	0.00869565	0.3257006298800316
HB BART'S HYDROPS FETALIS	0.00869565	0.3257006298800316
LETHAL HEMOLYTIC ANEMIA-GENITAL ANOMALIES SYNDROME	0.00869565	0.3257006298800316
THOMAS SYNDROME	0.00869565	0.3257006298800316
TRANSALDOLASE DEFICIENCY	0.00869565	0.3257006298800316
46,XX SEX REVERSAL WITH DYSGENESIS OF KIDNEYS, ADRENALS, AND LUNGS; SERKAL	0.00869565	0.3257006298800316
POSTERIOR URETHRAL VALVE	0.00869565	0.3257006298800316
ACRO-RENAL-MANDIBULAR SYNDROME	0.00869565	0.3257006298800316
FRONTONASAL DYSPLASIA-ALOPECIA-GENITAL ANOMALIES SYNDROME	0.00869565	0.3257006298800316
NPHP3-RELATED MECKEL-LIKE SYNDROME	0.00869565	0.3257006298800316
SERKAL SYNDROME	0.00869565	0.3257006298800316
COLE-CARPENTER SYNDROME 2; CLCRP2	0.00869565	0.3257006298800316
ABSENT RADIUS-ANOGENITAL ANOMALIES SYNDROME	0.00869565	0.3257006298800316
SPONDYLOCOSTAL DYSOSTOSIS WITH ANAL ATRESIA AND UROGENITAL ANOMALIES	0.00869565	0.3257006298800316
POLYCYSTIC KIDNEY DISEASE 4 WITH OR WITHOUT POLYCYSTIC LIVER DISEASE; PKD4	0.00869565	0.3257006298800316
HEMOCHROMATOSIS, NEONATAL	0.00869565	0.3257006298800316
SPONDYLOCOSTAL DYSOSTOSIS-ANAL ATRESIA-GENITOURINARY MALFORMATION SYNDROME	0.00869565	0.3257006298800316
SCHAAF-YANG SYNDROME; SHFYNG	0.008691713	0.32555316725448463
MYHRE SYNDROME	0.008691713	0.32555316725448463
CORNELIA DE LANGE SYNDROME 2; CDLS2	0.008691713	0.32555316725448463
CONGENITAL DISORDER OF GLYCOSYLATION WITH DEFECTIVE FUCOSYLATION 1; CDGF1	0.008669593	0.32472464978506643
NIEMANN-PICK DISEASE TYPE C	0.008644063	0.32376840878171
AICARDI-GOUTIERES SYNDROME 7	0.008644063	0.32376840878171
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 12; COXPD12	0.008644063	0.32376840878171
NEURODEVELOPMENTAL DISORDER WITH REGRESSION, ABNORMAL MOVEMENTS, LOSS OF SPEECH, AND SEIZURES; NEDAMSS	0.008644063	0.32376840878171
LEIGH SYNDROME WITH CARDIOMYOPATHY	0.008644063	0.32376840878171
METABOLIC CRISES, RECURRENT, WITH VARIABLE ENCEPHALOMYOPATHIC FEATURES AND NEUROLOGIC REGRESSION; MECREN	0.008644063	0.32376840878171
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 17; MC1DN17	0.008644063	0.32376840878171
LOPES-MACIEL-RODAN SYNDROME; LOMARS	0.008644063	0.32376840878171
MULTIPLE MITOCHONDRIAL DYSFUNCTIONS SYNDROME 6; MMDS6	0.008644063	0.32376840878171
LEUKODYSTROPHY, HYPOMYELINATING, 15; HLD15	0.008644063	0.32376840878171
NEURODEVELOPMENTAL DISORDER WITH SEIZURES AND NONEPILEPTIC HYPERKINETIC MOVEMENTS; NEDNEH	0.008644063	0.32376840878171
NEURODEGENERATION, CHILDHOOD-ONSET, WITH BRAIN ATROPHY; CONDBA	0.008644063	0.32376840878171
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 5; MC1DN5	0.008644063	0.32376840878171
3-METHYLGLUTACONIC ACIDURIA WITH DEAFNESS, ENCEPHALOPATHY, AND LEIGH-LIKE SYNDROME; MEGDEL	0.008644063	0.32376840878171
CHILDHOOD-ONSET MOTOR AND COGNITIVE REGRESSION SYNDROME WITH EXTRAPYRAMIDAL MOVEMENT DISORDER	0.008644063	0.32376840878171
ARTHROGRYPOSIS, RENAL DYSFUNCTION, AND CHOLESTASIS 1	0.008610074	0.3224953310119064
AU-KLINE SYNDROME; AUKS	0.008610074	0.3224953310119064
ARTHROGRYPOSIS, RENAL DYSFUNCTION, AND CHOLESTASIS 2	0.008610074	0.3224953310119064
ALPHA-MANNOSIDOSIS	0.008610074	0.3224953310119064
NEURODEVELOPMENTAL DISORDER WITH MICROCEPHALY AND STRUCTURAL BRAIN ANOMALIES; NEDMIBA	0.008494383	0.3181620572978711
CORTICAL DYSPLASIA, COMPLEX, WITH OTHER BRAIN MALFORMATIONS 5; CDCBM5	0.008494383	0.3181620572978711
ADENYLOSUCCINASE DEFICIENCY	0.008494383	0.3181620572978711
PUERTO RICAN INFANT HYPOTONIA SYNDROME	0.008494383	0.3181620572978711
HYPERMETHIONINEMIA DUE TO ADENOSINE KINASE DEFICIENCY	0.008494383	0.3181620572978711
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 65; MRT65	0.008482064000000001	0.31770064198567577
OTOPALATODIGITAL SYNDROME TYPE 2	0.008482064000000001	0.31770064198567577
MICROPHTHALMIA, SYNDROMIC 13; MCOPS13	0.008482064000000001	0.31770064198567577
OROFACIODIGITAL SYNDROME XIV; OFD14	0.008482064000000001	0.31770064198567577
GLOBAL DEVELOPMENTAL DELAY-VISUAL ANOMALIES-PROGRESSIVE CEREBELLAR ATROPHY-TRUNCAL HYPOTONIA SYNDROME	0.008482064000000001	0.31770064198567577
COCKAYNE SYNDROME A; CSA	0.008477929	0.31754576315493227
BARAITSER-WINTER SYNDROME 2; BRWS2	0.008477929	0.31754576315493227
MENTAL RETARDATION, AUTOSOMAL DOMINANT 48; MRD48	0.008477929	0.31754576315493227
MULTIPLE ACYL-COA DEHYDROGENASE DEFICIENCY	0.008477929	0.31754576315493227
PANCREATIC AND CEREBELLAR AGENESIS; PACA	0.008477929	0.31754576315493227
BARTTER SYNDROME, TYPE 5, ANTENATAL, TRANSIENT	0.00840336	0.3147527378756807
FATCO SYNDROME	0.00840336	0.3147527378756807
CONGENITAL HERPES SIMPLEX VIRUS INFECTION	0.00840336	0.3147527378756807
DIETHYLSTILBESTROL SYNDROME	0.00840336	0.3147527378756807
CHOLESTASIS, INTRAHEPATIC, OF PREGNANCY, 1; ICP1	0.00840336	0.3147527378756807
LOWER LIMB MALFORMATION-HYPOSPADIAS SYNDROME	0.00840336	0.3147527378756807
CHOLESTASIS, INTRAHEPATIC, OF PREGNANCY 3	0.00840336	0.3147527378756807
INTERMEDIATE NEMALINE MYOPATHY	0.00840336	0.3147527378756807
RETINOPATHY OF PREMATURITY	0.00840336	0.3147527378756807
BLOMSTRAND LETHAL CHONDRODYSPLASIA	0.00840336	0.3147527378756807
VACTERL/VATER ASSOCIATION	0.00840336	0.3147527378756807
PULMONARY ATRESIA-INTACT VENTRICULAR SEPTUM SYNDROME	0.00840336	0.3147527378756807
HEC SYNDROME	0.00840336	0.3147527378756807
OMPHALOCELE	0.00840336	0.3147527378756807
CONGENITAL PULMONARY AIRWAY MALFORMATION	0.00840336	0.3147527378756807
FIBULAR APLASIA-ECTRODACTYLY SYNDROME	0.00840336	0.3147527378756807
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 30; MC1DN30	0.00840336	0.3147527378756807
PTOSIS-VOCAL CORD PARALYSIS SYNDROME	0.00840336	0.3147527378756807
HYPERURICEMIA, PULMONARY HYPERTENSION, RENAL FAILURE, AND ALKALOSIS SYNDROME	0.00840336	0.3147527378756807
SCHISIS ASSOCIATION	0.00840336	0.3147527378756807
ICHTHYOSIS-PREMATURITY SYNDROME	0.00840336	0.3147527378756807
BARTTER SYNDROME, TYPE 4A, NEONATAL, WITH SENSORINEURAL DEAFNESS	0.00840336	0.3147527378756807
EBSTEIN MALFORMATION	0.00840336	0.3147527378756807
HYDROLETHALUS	0.00840336	0.3147527378756807
PEMPHIGOID GESTATIONIS	0.00840336	0.3147527378756807
EPIDERMOLYSIS BULLOSA SIMPLEX WITH PYLORIC ATRESIA	0.00840336	0.3147527378756807
BARTTER SYNDROME, TYPE 4B, NEONATAL, WITH SENSORINEURAL DEAFNESS	0.00840336	0.3147527378756807
NEMALINE MYOPATHY 10	0.00840336	0.3147527378756807
BRONCHOPULMONARY DYSPLASIA	0.00840336	0.3147527378756807
HYPOPIGMENTATION, ORGANOMEGALY, AND DELAYED MYELINATION AND DEVELOPMENT; HOD	0.00840336	0.3147527378756807
601976 OTOFACIOOSSEOUS-GONADAL SYNDROME	0.00839906	0.3145916788739403
MONOSOMY 13Q14	0.008369940000000001	0.3135009723319214
NON-DISTAL MONOSOMY 10Q	0.00836994	0.3135009723319213
HALLERMANN-STREIFF SYNDROME	0.008342780000000001	0.31248367873023075
JOHANSON-BLIZZARD SYNDROME; JBS	0.008342780000000001	0.31248367873023075
TOWNES-BROCKS SYNDROME	0.008342780000000001	0.31248367873023075
POTOCKI-SHAFFER SYNDROME	0.008336273	0.3122399552594574
MIDFACE HYPOPLASIA, OBESITY, DEVELOPMENTAL DELAY, AND NEONATAL HYPOTONIA	0.008291094	0.3105477495293108
MENTAL RETARDATION, AUTOSOMAL DOMINANT 49; MRD49	0.008273853000000001	0.30990197784349527
MENTAL RETARDATION, X-LINKED 91; MRX91	0.008273853	0.30990197784349527
FIBULAR APLASIA OR HYPOPLASIA, FEMORAL BOWING AND POLY-, SYN-, AND OLIGODACTYLY	0.00825826	0.3093179329564863
OGDEN SYNDROME; OGDNS	0.008206554	0.30738125464393035
OSTEOPATHIA STRIATA-CRANIAL SCLEROSIS SYNDROME	0.008206554	0.30738125464393035
OPITZ G/BBB SYNDROME	0.008206554	0.30738125464393035
PEROXISOME BIOGENESIS DISORDER 2B; PBD2B	0.008202419	0.307226375813187
%600325 AMINOPTERIN SYNDROME SINE AMINOPTERIN; ASSA;;PSEUDOAMINOPTERIN SYNDROME	0.008150294	0.3052740036118568
BRACHYDACTYLY, COLOBOMA, AND ANTERIOR SEGMENT DYSGENESIS	0.008150294	0.3052740036118568
MENTAL RETARDATION, AUTOSOMAL DOMINANT 44; MRD44	0.008146159	0.3051191247811134
48,XXXY SYNDROME	0.008145793	0.3051054160381746
49,XXXXY SYNDROME	0.008145793	0.3051054160381746
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 39; COXPD39	0.008102644	0.30348924513908215
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 32; COXPD32	0.008102644	0.30348924513908215
NEURODEGENERATION, CHILDHOOD-ONSET, WITH CEREBELLAR ATROPHY; CONDCA	0.008102644	0.30348924513908215
AICARDI-GOUTIERES SYNDROME 6	0.008102644	0.30348924513908215
KLEEFSTRA SYNDROME	0.008100013	0.30339069950336606
CEREBROTENDINOUS XANTHOMATOSIS	0.008098509	0.30333436630833865
RETT SYNDROME; RTT	0.008098509	0.30333436630833865
ENCEPHALOPATHY, PROGRESSIVE, WITH OR WITHOUT LIPODYSTROPHY; PELD	0.008098509	0.30333436630833865
METACHROMATIC LEUKODYSTROPHY, ADULT FORM	0.008098509	0.30333436630833865
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 3; MC1DN3	0.008098509	0.30333436630833865
ENCEPHALOPATHY, PROGRESSIVE, EARLY-ONSET, WITH BRAIN EDEMA AND/OR LEUKOENCEPHALOPATHY, 2; PEBEL2	0.008098509	0.30333436630833865
GM2 GANGLIOSIDOSIS, AB VARIANT	0.008098509	0.30333436630833865
METACHROMATIC LEUKODYSTROPHY, JUVENILE FORM	0.008098509	0.30333436630833865
METACHROMATIC LEUKODYSTROPHY, LATE INFANTILE FORM	0.008098509	0.30333436630833865
NEURODEVELOPMENTAL DISORDER WITH POOR LANGUAGE AND LOSS OF HAND SKILLS; NDPLHS	0.008098509	0.30333436630833865
SHORT SYNDROME	0.00807886	0.30259840158154855
NEUTROPENIA, SEVERE CONGENITAL, 4, AUTOSOMAL RECESSIVE; SCN4	0.008065754000000001	0.30210750872647646
INSULIN-LIKE GROWTH FACTOR I, RESISTANCE TO; IGF1RES	0.008065754000000001	0.30210750872647646
GOLDBERG-SHPRINTZEN SYNDROME	0.008065754000000001	0.30210750872647646
NABLUS MASK-LIKE FACIAL SYNDROME; NMLFS	0.008065754000000001	0.30210750872647646
HIP DYSPLASIA, BEUKES TYPE	0.00806452	0.30206128853853514
CHARCOT-MARIE-TOOTH DISEASE, X-LINKED RECESSIVE, 3; CMTX3	0.00806452	0.30206128853853514
CLASSIC MULTIMINICORE MYOPATHY	0.00806452	0.30206128853853514
MULTIPLE EPIPHYSEAL DYSPLASIA TYPE 5	0.00806452	0.30206128853853514
DIASTROPHIC DWARFISM	0.00806452	0.30206128853853514
MULTIPLE EPIPHYSEAL DYSPLASIA DUE TO COLLAGEN 9 ANOMALY	0.00806452	0.30206128853853514
CAT-EYE SYNDROME	0.00806452	0.30206128853853514
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 73; EIEE73	0.00806452	0.30206128853853514
BICD2-RELATED AUTOSOMAL DOMINANT CHILDHOOD-ONSET PROXIMAL SPINAL MUSCULAR ATROPHY	0.00806452	0.30206128853853514
SPONDYLOMETAPHYSEAL DYSPLASIA	0.00806452	0.30206128853853514
SPONASTRIME DYSPLASIA	0.00806452	0.30206128853853514
CRANIOECTODERMAL DYSPLASIA 4	0.00806452	0.30206128853853514
MULTIPLE EPIPHYSEAL DYSPLASIA TYPE 1	0.00806452	0.30206128853853514
BRITTLE CORNEA SYNDROME	0.00806452	0.30206128853853514
DEVELOPMENTAL DYSPLASIA OF THE HIP 2; DDH2	0.00806452	0.30206128853853514
13Q12.3 MICRODELETION SYNDROME	0.00806452	0.30206128853853514
HIP DYSPLASIA, BEUKES TYPE	0.00806452	0.30206128853853514
COXOPODOPATELLAR SYNDROME	0.00806452	0.30206128853853514
METAPHYSEAL CHONDRODYSPLASIA, SPAHR TYPE	0.00806452	0.30206128853853514
MUCOPOLYSACCHARIDOSIS, TYPE VI; MPS6	0.00806452	0.30206128853853514
MEIER-GORLIN SYNDROME 6; MGORS6	0.00806452	0.30206128853853514
ARTERIOSCLEROSIS, SEVERE JUVENILE	0.00806452	0.30206128853853514
GONADAL DYSGENESIS, DYSMORPHIC FACIES, RETINAL DYSTROPHY, AND MYOPATHY; GDRM	0.00806452	0.30206128853853514
PITT-HOPKINS SYNDROME	0.008061619	0.30195262989573307
SPINOCEREBELLAR ATAXIA 47; SCA47	0.008061619	0.30195262989573307
311450 PALLISTER W SYNDROME;;W SYNDROME	0.008061619	0.30195262989573307
275595 TRIGONOBRACHYCEPHALY, BULBOUS BIFID NOSE, MICROGNATHIA, AND ABNORMALITIESOF THE HANDS AND FEET	0.007952964	0.2978828936552433
300270 ADRENOMYODYSTROPHY	0.007952964	0.2978828936552433
3-@METHYLGLUTACONIC ACIDURIA, TYPE IV	0.007952964	0.2978828936552433
CORTICAL DYSPLASIA, COMPLEX, WITH OTHER BRAIN MALFORMATIONS 9; CDCBM9	0.007948829	0.29772801482449984
ADRENOMYODYSTROPHY	0.007948829	0.29772801482449984
LISSENCEPHALY 5; LIS5	0.007948829	0.29772801482449984
HEREDITARY METHEMOGLOBINEMIA	0.007948829	0.29772801482449984
MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (CONGENITAL WITH BRAIN AND EYE ANOMALIES), TYPE A, 3; MDDGA3	0.007948829	0.29772801482449984
COMBINED PITUITARY HORMONE DEFICIENCIES, GENETIC FORMS	0.007948829	0.29772801482449984
PONTOCEREBELLAR HYPOPLASIA, TYPE 2A; PCH2A	0.007948829	0.29772801482449984
OSTEOGENESIS IMPERFECTA-RETINOPATHY-SEIZURES-INTELLECTUAL DISABILITY SYNDROME	0.007948829	0.29772801482449984
LUBS X-LINKED MENTAL RETARDATION SYNDROME; MRXSL	0.007948829	0.29772801482449984
LETHAL INFANTILE MITOCHONDRIAL MYOPATHY	0.007948829	0.29772801482449984
LOWRY-MACLEAN SYNDROME	0.007948829	0.29772801482449984
INFANTILE CEREBELLAR-RETINAL DEGENERATION	0.007948829	0.29772801482449984
2Q24 MICRODELETION SYNDROME	0.007948829	0.29772801482449984
DPM1-CDG	0.007948829	0.29772801482449984
OBESITY, HYPERPHAGIA, AND DEVELOPMENTAL DELAY; OBHD	0.007948829	0.29772801482449984
X-LINKED INTELLECTUAL DISABILITY, CANTAGREL TYPE	0.007948829	0.29772801482449984
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IE	0.007948829	0.29772801482449984
4Q21 MICRODELETION SYNDROME	0.007948829	0.29772801482449984
PEROXISOME BIOGENESIS DISORDER 8A (ZELLWEGER); PBD8A	0.007948829	0.29772801482449984
ADENYLOSUCCINATE LYASE DEFICIENCY	0.007948829	0.29772801482449984
SMITH-FINEMAN-MYERS SYNDROME	0.007948829	0.29772801482449984
NEURODEVELOPMENTAL DISORDER WITH MICROCEPHALY, CATARACTS, AND RENAL ABNORMALITIES; NEDMCR	0.007948829	0.29772801482449984
CROME SYNDROME	0.007948829	0.29772801482449984
PONTOCEREBELLAR HYPOPLASIA, TYPE 4; PCH4	0.007948829	0.29772801482449984
EARLOBES, THICKENED, WITH CONDUCTIVE DEAFNESS FROM INCUDOSTAPEDIALABNORMALITIES	0.00793651	0.29726659951230444
MANDIBULOFACIAL DYSOSTOSIS WITH MENTAL RETARDATION	0.00793651	0.29726659951230444
CRANIAL NERVES, CONGENITAL PARESIS OF	0.00793651	0.29726659951230444
CAMPTODACTYLY SYNDROME, GUADALAJARA TYPE 3	0.00793651	0.29726659951230444
SHORT-RIB THORACIC DYSPLASIA 14 WITH POLYDACTYLY	0.00793651	0.29726659951230444
ANTLEY-BIXLER SYNDROME WITHOUT GENITAL ANOMALIES OR DISORDERED STEROIDOGENESIS; ABS2	0.00793651	0.29726659951230444
ACROCRANIOFACIAL DYSOSTOSIS	0.00793651	0.29726659951230444
MULTIPLE ACYL-COA DEHYDROGENASE DEFICIENCY; MADD	0.00793651	0.29726659951230444
PILI TORTI-ONYCHODYSPLASIA SYNDROME	0.00793651	0.29726659951230444
BRANCHIOOTIC SYNDROME 2	0.00793651	0.29726659951230444
BARBER-SAY SYNDROME; BBRSAY	0.00793651	0.29726659951230444
ACROCEPHALOPOLYSYNDACTYLY TYPE III	0.00793651	0.29726659951230444
NEU-LAXOVA SYNDROME 2; NLS2	0.00793651	0.29726659951230444
228940 FIBULOULNAR APLASIA OR HYPOPLASIA WITH RENAL ABNORMALITIES	0.00793651	0.29726659951230444
184705 STEINFELD SYNDROME	0.00793651	0.29726659951230444
KLIPPEL-FEIL SYNDROME, AUTOSOMAL RECESSIVE	0.00793651	0.29726659951230444
KENNERKNECHT SYNDROME	0.00793651	0.29726659951230444
DEAFNESS, CONDUCTIVE, WITH MALFORMED EXTERNAL EAR	0.00793651	0.29726659951230444
POLYVALVULAR HEART DISEASE SYNDROME	0.00793651	0.29726659951230444
MAXILLOFACIAL DYSOSTOSIS	0.00793651	0.29726659951230444
PYRUVATE DEHYDROGENASE DEFICIENCY	0.007929683	0.29701089025535515
CUTIS LAXA, AUTOSOMAL RECESSIVE, TYPE IIIA	0.007854713	0.2942028452878017
MICROCEPHALIC OSTEODYSPLASTIC PRIMORDIAL DWARFISM TYPE II	0.007825593	0.29311213874578285
LYMPHEDEMA, HEREDITARY, III	0.007794854	0.2919607916168296
MICROCEPHALY, SHORT STATURE, AND IMPAIRED GLUCOSE METABOLISM 2	0.007790719	0.2918059127860862
DEVELOPMENTAL DELAY, INTELLECTUAL DISABILITY, OBESITY, AND DYSMORPHIC FEATURES; DIDOD	0.007732434	0.28962281420086744
NEURODEVELOPMENTAL DISORDER WITH DYSMORPHIC FACIES AND DISTAL LIMB ANOMALIES; NEDDFL	0.007732434	0.28962281420086744
WARSAW BREAKAGE SYNDROME; WABS	0.007732434	0.28962281420086744
AUTOSOMAL RECESSIVE SPASTIC PARAPLEGIA TYPE 20	0.007732434	0.28962281420086744
FANCONI ANEMIA, COMPLEMENTATION GROUP S; FANCS	0.007732434	0.28962281420086744
SHORT STATURE, HEARING LOSS, RETINITIS PIGMENTOSA, AND DISTINCTIVE FACIES; SHRF	0.007667159999999999	0.28717793855444773
HYPERTRICHOTIC OSTEOCHONDRODYSPLASIA	0.007660999999999999	0.2869472121705591
GLOBAL DEVELOPMENTAL DELAY-OSTEOPENIA-ECTODERMAL DEFECT SYNDROME	0.007660999999999999	0.2869472121705591
BENIGN SAMARITAN CONGENITAL MYOPATHY	0.007660999999999999	0.2869472121705591
PROTEASOME-ASSOCIATED AUTOINFLAMMATORY SYNDROME 2; PRAAS2	0.0076047400000000005	0.2848399611384856
233270 GOMBO SYNDROME;;GROWTH RETARDATION, OCULAR ABNORMALITIES, MICROCEPHALY, BRACHYDACTYLY,AND OLIGOPHRENIA	0.0076047400000000005	0.2848399611384856
SYMPHALANGISM WITH MULTIPLE ANOMALIES OF HANDS AND FEET	0.0076047400000000005	0.2848399611384856
ROBINOW SYNDROME, AUTOSOMAL DOMINANT 2; DRS2	0.0076047400000000005	0.2848399611384856
DISTAL MONOSOMY 6P	0.0076043740000000005	0.28482625239554676
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 49; MRT49	0.007587804	0.2842056134051191
AUTOSOMAL RECESSIVE FRONTOTEMPORAL PACHYGYRIA	0.007587804	0.2842056134051191
PRIMARY ALDOSTERONISM, SEIZURES, AND NEUROLOGIC ABNORMALITIES	0.007587804	0.2842056134051191
CORTICAL MALFORMATIONS, OCCIPITAL; OCCM	0.007587804	0.2842056134051191
3-PHOSPHOSERINE PHOSPHATASE DEFICIENCY	0.007587804	0.2842056134051191
EPILEPSY, IDIOPATHIC GENERALIZED, SUSCEPTIBILITY TO, 3; EIG3	0.0075836689999999995	0.28405073457437563
EPILEPSY, FAMILIAL ADULT MYOCLONIC, 4; FAME4	0.0075836689999999995	0.28405073457437563
JUNG SYNDROME	0.00758262	0.28401144366906733
BIRK-LANDAU-PEREZ SYNDROME; BILAPES	0.007557090000000001	0.2830552026657108
LEUKODYSTROPHY, PROGRESSIVE, EARLY CHILDHOOD-ONSET; PLDECO	0.007557090000000001	0.2830552026657108
FAMILIAL INFANTILE BILATERAL STRIATAL NECROSIS	0.007557090000000001	0.2830552026657108
ATAXIA WITH VITAMIN E DEFICIENCY	0.007557090000000001	0.2830552026657108
NEUROFERRITINOPATHY	0.007557090000000001	0.2830552026657108
CUTANEOUS MASTOCYTOSIS, CONDUCTIVE HEARING LOSS AND MICROTIA	0.0075202	0.2816734662531052
GROWTH DELAY DUE TO INSULIN-LIKE GROWTH FACTOR I RESISTANCE	0.0075202	0.2816734662531052
11Q22.2Q22.3 MICRODELETION SYNDROME	0.007492273000000001	0.2806274442201738
20Q11.2 MICRODUPLICATION SYNDROME	0.007407733	0.2774609493347934
WIEDEMANN-STEINER SYNDROME; WDSTS	0.007407733	0.2774609493347934
MAN1B1-CDG	0.007407733	0.2774609493347934
MONOSOMY 22Q13.3	0.007407733	0.2774609493347934
PHELAN-MCDERMID SYNDROME	0.007407733	0.2774609493347934
TRIGONOCEPHALY WITH SHORT STATURE AND DEVELOPMENTAL DELAY	0.007407733	0.2774609493347934
WARBURG MICRO SYNDROME 2; WARBM2	0.00740741	0.277448851181872
MUSCULAR DYSTROPHY, CONGENITAL, WITH SEVERE CENTRAL NERVOUS SYSTEM ATROPHY AND ABSENCE OF LARGE MYELINATED FIBERS	0.00740741	0.277448851181872
INTELLECTUAL DISABILITY-OBESITY-PROGNATHISM-EYE AND SKIN ANOMALIES SYNDROME	0.00740741	0.277448851181872
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 74; EIEE74	0.00740741	0.277448851181872
KID SYNDROME	0.00740741	0.277448851181872
ZTTK SYNDROME; ZTTKS	0.007361953000000001	0.27574623279998495
EHLERS-DANLOS SYNDROME, SPONDYLODYSPLASTIC TYPE, 2; EDSSPD2	0.007313294	0.2739236816451739
CUTIS LAXA, AUTOSOMAL DOMINANT 3; ADCL3	0.007313294	0.2739236816451739
SAUL-WILSON SYNDROME; SWILS	0.007313294	0.2739236816451739
SCHINZEL-GIEDION MIDFACE-RETRACTION SYNDROME	0.007309159	0.27376880281443045
FLOATING-HARBOR SYNDROME	0.007284174	0.27283297510315496
ECTODERMAL DYSPLASIA-INTELLECTUAL DISABILITY-CENTRAL NERVOUS SYSTEM MALFORMATION SYNDROME	0.0072493	0.27152674914345837
45,X/46,XY MIXED GONADAL DYSGENESIS	0.0072493	0.27152674914345837
SHORT STATURE-CRANIOFACIAL ANOMALIES-GENITAL HYPOPLASIA SYNDROME	0.0072493	0.27152674914345837
SHORT STATURE-BRACHYDACTYLY-OBESITY-GLOBAL DEVELOPMENTAL DELAY SYNDROME	0.007201193	0.26972487346980095
GRACILE BONE DYSPLASIA; GCLEB	0.007201193	0.26972487346980095
MULCHANDANI-BHOJ-CONLIN SYNDROME	0.00718688	0.2691887717274961
COFFIN-SIRIS SYNDROME 10; CSS10	0.00718688	0.2691887717274961
%164220 SCHILBACH-ROTT SYNDROME;;OCULAR HYPOTELORISM, SUBMUCOSAL CLEFT PALATE, AND HYPOSPADIAS;;CLEFT PALATE, HYPOTELORISM, AND HYPOSPADIAS;;BLEPHAROFACIOSKELETAL SYNDROME; BRSS	0.00718688	0.2691887717274961
BOHRING-OPITZ SYNDROME	0.0071166530000000006	0.2665583785844206
LEIGH SYNDROME, FRENCH CANADIAN TYPE; LSFC	0.0071166530000000006	0.2665583785844206
GLYCOSYLPHOSPHATIDYLINOSITOL BIOSYNTHESIS DEFECT 15; GPIBD15	0.0071166530000000006	0.2665583785844206
MYOCLONIC EPILEPSY, JUVENILE, 2	0.00704225	0.2637715709317478
MITOCHONDRIAL MYOPATHY, ENCEPHALOPATHY, LACTIC ACIDOSIS, AND STROKE-LIKE EPISODES; MELAS	0.00704225	0.2637715709317478
608278 GROWTH FAILURE, MICROCEPHALY, MENTAL RETARDATION, CATARACTS, LARGEJOINT CONTRACTURES, OSTEOPOROSIS, CORTICAL DYSPLASIA, AND CEREBELLARATROPHY	0.00704225	0.2637715709317478
EPILEPSY, BENIGN NEONATAL, 3	0.00704225	0.2637715709317478
MENTAL RETARDATION, X-LINKED, SYNDROMIC, HEDERA TYPE; MRXSH	0.00704225	0.2637715709317478
EPILEPSY, IDIOPATHIC GENERALIZED, SUSCEPTIBILITY TO, 12	0.00704225	0.2637715709317478
HEPATIC VENO-OCCLUSIVE DISEASE-IMMUNODEFICIENCY SYNDROME	0.00704225	0.2637715709317478
BEHAVIORAL VARIANT OF FRONTOTEMPORAL DEMENTIA	0.00704225	0.2637715709317478
SEIZURES, BENIGN FAMILIAL INFANTILE, 5	0.00704225	0.2637715709317478
TUBULAR RENAL DISEASE-CARDIOMYOPATHY SYNDROME	0.00704225	0.2637715709317478
ALOPECIA-MENTAL RETARDATION SYNDROME WITH CONVULSIONS AND HYPERGONADOTROPICHYPOGONADISM	0.00704225	0.2637715709317478
269720 SEIZURES, BENIGN FAMILIAL NEONATAL, AUTOSOMAL RECESSIVE;;BFNS, AUTOSOMAL RECESSIVE;;CONVULSIONS, BENIGN FAMILIAL NEONATAL, AUTOSOMAL RECESSIVE;;EPILEPSY, BENIGN FAMILIAL NEONATAL, AUTOSOMAL RECESSIVE	0.00704225	0.2637715709317478
EPILEPSY, PROGRESSIVE MYOCLONIC, 8; EPM8	0.00704225	0.2637715709317478
AUTOSOMAL DOMINANT SPASTIC PARAPLEGIA TYPE 6	0.00704225	0.2637715709317478
%249650 MERCAPTOLACTATE-CYSTEINE DISULFIDURIA; MCDU;;DISULFIDURIA, MIXED	0.00704225	0.2637715709317478
TRAPPC11-RELATED  LIMB-GIRDLE MUSCULAR DYSTROPHY R18	0.00704225	0.2637715709317478
GLYCOGEN STORAGE DISEASE 0, MUSCLE; GSD0B	0.00704225	0.2637715709317478
JABERI-ELAHI SYNDROME; JABELS	0.007036423	0.26355331725659864
MENTAL RETARDATION, X-LINKED, SYNDROMIC, BAIN TYPE; MRXSB	0.007028633000000001	0.26326153827437593
RING CHROMOSOME 22 SYNDROME	0.007028633000000001	0.26326153827437593
DUBOWITZ SYNDROME	0.0069467190000000005	0.26019340174680256
TRISOMY 12P	0.006866314	0.25718178569216554
WIEDEMANN-STEINER SYNDROME	0.006862179000000001	0.25702690686142227
CEREBROFACIOARTICULAR SYNDROME	0.0068442139999999995	0.25635401733438334
LATHOSTEROLOSIS	0.006840079000000001	0.25619913850364
HENNEKAM LYMPHANGIECTASIA-LYMPHEDEMA SYNDROME	0.006840079000000001	0.25619913850364
GROWTH DELAY DUE TO INSULIN-LIKE GROWTH FACTOR TYPE 1 DEFICIENCY	0.00678984	0.2543174075295848
CRANIOFACIAL DYSPLASIA-SHORT STATURE-ECTODERMAL ANOMALIES-INTELLECTUAL DISABILITY SYNDROME	0.006783333000000001	0.2540736840588116
PMM2-CDG	0.006783333000000001	0.2540736840588116
NEURODEVELOPMENTAL DISORDER WITH HYPOTONIA, SEIZURES, AND ABSENT LANGUAGE; NDHSAL	0.006783333000000001	0.2540736840588116
DISTAL MONOSOMY 1Q	0.006783332999999999	0.25407368405881153
MULTIPLE JOINT DISLOCATIONS, SHORT STATURE, AND CRANIOFACIAL DYSMORPHISM WITH OR WITHOUT CONGENITAL HEART DEFECTS	0.0067677399999999995	0.2534896391718026
SPONDYLOEPIMETAPHYSEAL DYSPLASIA WITH JOINT LAXITY, TYPE 1, WITH OR WITHOUT FRACTURES; SEMDJL1	0.0067677399999999995	0.2534896391718026
FRANK-TER HAAR SYNDROME	0.006738620000000001	0.25239893262978375
SMITH-LEMLI-OPITZ SYNDROME	0.006732113	0.25215520915901046
SHORT STATURE, BRACHYDACTYLY, INTELLECTUAL DEVELOPMENTAL DISABILITY, AND SEIZURES; SBIDDS	0.006732113	0.25215520915901046
ALSTRÖM SYNDROME	0.006704953	0.2511379155573198
PITUITARY STALK INTERRUPTION SYNDROME	0.006704953	0.2511379155573198
AUTOSOMAL DOMINANT OPTIC ATROPHY, CLASSIC FORM	0.006704953	0.2511379155573198
SRD5A3-CDG	0.006704953	0.2511379155573198
TIMOTHY SYNDROME; TS	0.006704953	0.2511379155573198
DIGEORGE SYNDROME; DGS	0.006704953	0.2511379155573198
AUTOSOMAL RECESSIVE CEREBELLAR ATAXIA DUE TO STUB1 DEFICIENCY	0.006704953	0.2511379155573198
CATARACTS, GROWTH HORMONE DEFICIENCY, SENSORY NEUROPATHY, SENSORINEURAL HEARING LOSS, AND SKELETAL DYSPLASIA; CAGSSS	0.006659774	0.24944570982717312
KBG SYNDROME	0.006642533000000001	0.24879993814135765
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IIF; CDG2F	0.006642533000000001	0.24879993814135765
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IY; CDG1Y	0.006642533000000001	0.24879993814135765
STEEL SYNDROME; STLS	0.006575234	0.24627921494179272
IMMUNODEFICIENCY 26 WITH OR WITHOUT NEUROLOGIC ABNORMALITIES; IMD26	0.006571099	0.24612433611104936
14Q12 MICRODELETION SYNDROME	0.006483079000000001	0.24282749580100466
CRANIOECTODERMAL DYSPLASIA	0.006405300000000001	0.23991423810417475
263540 POLYDACTYLY, POSTAXIAL, WITH DENTAL AND VERTEBRAL ANOMALIES	0.006405300000000001	0.23991423810417475
JACOBSEN SYNDROME	0.006405300000000001	0.23991423810417475
URBAN-ROGERS-MEYER SYNDROME	0.006405300000000001	0.23991423810417475
CAREY-FINEMAN-ZITER SYNDROME	0.0063832	0.2390864697463925
DUBOWITZ SYNDROME	0.00632076	0.23674774321879433
ALPHA-THALASSEMIA-INTELLECTUAL DISABILITY SYNDROME LINKED TO CHROMOSOME 16	0.006298659999999999	0.23591997486101213
SIMPSON-GOLABI-BEHMEL SYNDROME, TYPE 1	0.006298659999999999	0.23591997486101213
PYRUVATE DEHYDROGENASE E1-ALPHA DEFICIENCY; PDHAD	0.006298363	0.23590885055321753
FETAL TRIMETHADIONE SYNDROME	0.0062419139999999994	0.23379452041618368
NOONAN SYNDROME 5; NS5	0.0062419139999999994	0.23379452041618368
DEVELOPMENTAL DELAY WITH SHORT STATURE, DYSMORPHIC FEATURES, AND SPARSE HAIR	0.0062419139999999994	0.23379452041618368
HYPOTONIA, ATAXIA, AND DELAYED DEVELOPMENT SYNDROME; HADDS	0.0062419139999999994	0.23379452041618368
INTELLECTUAL DISABILITY-BALDING-PATELLA LUXATION-ACROMICRIA SYNDROME	0.006237779000000001	0.23363964158544032
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 36; MRT36	0.006237779000000001	0.23363964158544032
MICROCEPHALY WITH OR WITHOUT CHORIORETINOPATHY, LYMPHEDEMA, OR MENTAL RETARDATION; MCLMR	0.006237779000000001	0.23363964158544032
DISTAL MONOSOMY 9P	0.006190694	0.23187604551638263
HYDROCEPHALUS, SKELETAL ANOMALIES, AND MENTAL DISTURBANCE	0.006190694	0.23187604551638263
POTOCKI-SHAFFER SYNDROME	0.0061865589999999995	0.23172116668563922
THYROID ECTOPIA	0.006163534	0.23085875191469193
ATHYREOSIS	0.006163534	0.23085875191469193
PROGRESSIVE ESSENTIAL TREMOR-SPEECH IMPAIRMENT-FACIAL DYSMORPHISM-INTELLECTUAL DISABILITY-ABNORMAL BEHAVIOR SYNDROME	0.006163534	0.23085875191469193
THYROID HYPOPLASIA	0.006163534	0.23085875191469193
TOWNES-BROCKS SYNDROME 1; TBS1	0.006163534	0.23085875191469193
LIG4 SYNDROME	0.006163534	0.23085875191469193
PRIMARY CONGENITAL HYPOTHYROIDISM	0.006163534	0.23085875191469193
PERMANENT CONGENITAL HYPOTHYROIDISM	0.006163534	0.23085875191469193
RABSON-MENDENHALL SYNDROME	0.006163534	0.23085875191469193
HNF1B-RELATED AUTOSOMAL DOMINANT TUBULOINTERSTITIAL KIDNEY DISEASE	0.006163534	0.23085875191469193
IDIOPATHIC CONGENITAL HYPOTHYROIDISM	0.006163534	0.23085875191469193
FANCONI ANEMIA, COMPLEMENTATION GROUP I; FANCI	0.006163534	0.23085875191469193
FAMILIAL THYROID DYSHORMONOGENESIS	0.006163534	0.23085875191469193
PERIPHERAL HYPOTHYROIDISM	0.006163534	0.23085875191469193
CONGENITAL HYPOTHYROIDISM DUE TO TRANSPLACENTAL PASSAGE OF TSH-BINDING INHIBITORY ANTIBODIES	0.006163534	0.23085875191469193
PRIMARY CONGENITAL HYPOTHYROIDISM WITHOUT THYROID DEVELOPMENTAL ANOMALY	0.006163534	0.23085875191469193
RESISTANCE TO THYROTROPIN-RELEASING HORMONE SYNDROME	0.006163534	0.23085875191469193
AUTOSOMAL DOMINANT PROGRESSIVE EXTERNAL OPHTHALMOPLEGIA	0.006159398999999999	0.23070387308394852
ISOLATED BILIARY ATRESIA	0.006159398999999999	0.23070387308394852
COWDEN SYNDROME 6; CWS6	0.006159398999999999	0.23070387308394852
AUTOIMMUNE POLYENDOCRINE SYNDROME, TYPE II	0.006159398999999999	0.23070387308394852
COWDEN SYNDROME 5; CWS5	0.006159398999999999	0.23070387308394852
ODONTOCHONDRODYSPLASIA; ODCD	0.00611422	0.22901166735380188
ACROMESOMELIC DYSPLASIA, MAROTEAUX TYPE	0.00611422	0.22901166735380188
SPONDYLOEPIPHYSEAL DYSPLASIA, KONDO-FU TYPE; SEDKF	0.00611422	0.22901166735380188
SHORT-RIB THORACIC DYSPLASIA 19 WITH OR WITHOUT POLYDACTYLY; SRTD19	0.00611422	0.22901166735380188
LARSEN SYNDROME	0.00611422	0.22901166735380188
KHAN-KHAN-KATSANIS SYNDROME; 3KS	0.006101114	0.22852077449872976
SHORT ULNA-DYSMORPHISM-HYPOTONIA-INTELLECTUAL DISABILITY SYNDROME	0.006101114	0.22852077449872976
NEPHROTIC SYNDROME, TYPE 11; NPHS11	0.006101114	0.22852077449872976
RITSCHER-SCHINZEL SYNDROME 2; RTSC2	0.006101114	0.22852077449872976
AUTOIMMUNE DISEASE, MULTISYSTEM, WITH FACIAL DYSMORPHISM; ADMFD	0.006101114	0.22852077449872976
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 35	0.006101114	0.22852077449872976
ABNORMAL HAIR, JOINT LAXITY, AND DEVELOPMENTAL DELAY; HJDD	0.006101114	0.22852077449872976
GALLOWAY-MOWAT SYNDROME 7; GAMOS7	0.006101114	0.22852077449872976
INTRAUTERINE GROWTH RETARDATION, METAPHYSEAL DYSPLASIA, ADRENAL HYPOPLASIA CONGENITA, GENITAL ANOMALIES, AND IMMUNODEFICIENCY; IMAGEI	0.006096979000000001	0.22836589566798637
MICROPHTHALMIA, SYNDROMIC 1	0.006096979000000001	0.22836589566798637
KOSAKI OVERGROWTH SYNDROME; KOGS	0.00602968	0.22584517246842148
HUMERORADIAL SYNOSTOSISHUMERORADIAL/MULTIPLE SYNOSTOSIS SYNDROME	0.00602968	0.22584517246842148
ZECHI-CEIDE SYNDROME	0.00602968	0.22584517246842148
OSTEOCHONDRODYSPLASIA, COMPLEX LETHAL, SYMOENS-BARNES-GISTELINCK TYPE	0.00602968	0.22584517246842148
2Q32Q33 MICRODELETION SYNDROME	0.005973054	0.22372421269340909
ROBIN SEQUENCE WITH CLEFT MANDIBLE AND LIMB ANOMALIES	0.005973054	0.22372421269340909
MICROCEPHALY, CEREBELLAR HYPOPLASIA, AND CARDIAC CONDUCTION DEFECT SYNDROME; MCHCCD	0.005971550000000001	0.22366787949838177
BLEPHAROPHIMOSIS WITH FACIAL AND GENITAL ANOMALIES AND MENTAL RETARDATION	0.005968919	0.22356933386266567
X-LINKED INTELLECTUAL DISABILITY-GLOBAL DEVELOPMENT DELAY-FACIAL DYSMORPHISM-SACRAL CAUDAL REMNANT SYNDROME	0.005965043	0.22342415602760848
NEURODEVELOPMENTAL DISORDER WITH SEVERE MOTOR IMPAIRMENT AND ABSENT LANGUAGE; NEDMIAL	0.005965043	0.22342415602760848
PYRUVATE DEHYDROGENASE E3-BINDING PROTEIN DEFICIENCY	0.005965043	0.22342415602760848
PARKINSONIAN-PYRAMIDAL SYNDROME	0.00594945	0.2228401111405995
PARKINSON DISEASE 15, AUTOSOMAL RECESSIVE EARLY-ONSET	0.00594945	0.2228401111405995
2Q37 MICRODELETION SYNDROME	0.005860953	0.21952540451803618
RUVALCABA SYNDROME	0.005860953	0.21952540451803618
ADAMS-OLIVER SYNDROME 1; AOS1	0.005838853	0.21869763616025398
TEMTAMY SYNDROME; TEMTYS	0.005838853	0.21869763616025398
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 66; EIEE66	0.005776413	0.21635890963265578
INTELLECTUAL DEVELOPMENTAL DISORDER WITH DYSMORPHIC FACIES, SEIZURES, AND DISTAL LIMB ANOMALIES	0.005754313	0.21553114127487358
DEAFNESS-GENITAL ANOMALIES-METACARPAL AND METATARSAL SYNOSTOSIS SYNDROME	0.005696359999999999	0.21336047794281243
CEREBROOCULONASAL SYNDROME	0.005696359999999999	0.21336047794281243
MICROPHTHALMIA/COLOBOMA AND SKELETAL DYSPLASIA SYNDROME; MCSKS	0.005696359999999999	0.21336047794281243
MUCOPOLYSACCHARIDOSIS-LIKE SYNDROME WITH CONGENITAL HEART DEFECTS AND HEMATOPOIETIC DISORDERS	0.005696359999999999	0.21336047794281243
NASODIGITOACOUSTIC SYNDROME	0.005696359999999999	0.21336047794281243
ACRODYSOSTOSIS	0.00564514	0.2114420030430114
PRECOCIOUS PUBERTY, CENTRAL	0.00561798	0.2104247094413207
AA AMYLOIDOSIS	0.00561798	0.2104247094413207
POEMS SYNDROME	0.00561798	0.2104247094413207
HYPOTHYROIDISM, CENTRAL, AND TESTICULAR ENLARGEMENT	0.00561798	0.2104247094413207
MITOCHONDRIAL DNA-RELATED PROGRESSIVE EXTERNAL OPHTHALMOPLEGIA	0.00561798	0.2104247094413207
THYROID LYMPHOMA	0.00561798	0.2104247094413207
SPONDYLOENCHONDRODYSPLASIA WITH IMMUNE DYSREGULATION; SPENCDI	0.00561798	0.2104247094413207
STIFF PERSON SYNDROME AND RELATED DISORDERS	0.00561798	0.2104247094413207
BETA-THALASSEMIA INTERMEDIA	0.00561798	0.2104247094413207
INTERSTITIAL LUNG AND LIVER DISEASE; ILLD	0.00561798	0.2104247094413207
IMMUNODYSREGULATION, POLYENDOCRINOPATHY, AND ENTEROPATHY, X-LINKED; IPEX	0.00561798	0.2104247094413207
MITOCHONDRIAL MYOPATHY, EPISODIC, WITH OR WITHOUT OPTIC ATROPHY AND REVERSIBLE LEUKOENCEPHALOPATHY; MEOAL	0.00561798	0.2104247094413207
SARCOIDOSIS	0.00561798	0.2104247094413207
17-@BETA HYDROXYSTEROID DEHYDROGENASE III DEFICIENCY	0.00561798	0.2104247094413207
MUSCULAR PSEUDOHYPERTROPHY-HYPOTHYROIDISM SYNDROME	0.00561798	0.2104247094413207
268040 RETINOHEPATOENDOCRINOLOGIC SYNDROME;;RHE SYNDROME	0.00561798	0.2104247094413207
OBESITY-COLITIS-HYPOTHYROIDISM-CARDIAC HYPERTROPHY-DEVELOPMENTAL DELAY SYNDROME	0.00561798	0.2104247094413207
AUTOSOMAL RECESSIVE CUTIS LAXA TYPE 1	0.00561798	0.2104247094413207
HYPOTHYROIDISM DUE TO TSH RECEPTOR MUTATIONS	0.00561798	0.2104247094413207
AUTOIMMUNE POLYENDOCRINE SYNDROME, TYPE I	0.00561798	0.2104247094413207
THYROID HORMONOGENESIS, GENETIC DEFECT IN, 5	0.00561798	0.2104247094413207
THYROID HORMONOGENESIS, GENETIC DEFECT IN, 4	0.00561798	0.2104247094413207
THYROID HORMONOGENESIS, GENETIC DEFECT IN, 2A	0.00561798	0.2104247094413207
AUTOIMMUNE DISEASE, MULTISYSTEM, INFANTILE-ONSET, 1; ADMIO1	0.00561798	0.2104247094413207
METHIMAZOLE EMBRYOFETOPATHY	0.00561798	0.2104247094413207
ISOLATED THYROID-STIMULATING HORMONE DEFICIENCY	0.00561798	0.2104247094413207
DIARRHEA 10, PROTEIN-LOSING ENTEROPATHY TYPE; DIAR10	0.00561798	0.2104247094413207
PENDRED SYNDROME	0.00561798	0.2104247094413207
FRAGILE X TREMOR/ATAXIA SYNDROME; FXTAS	0.00561798	0.2104247094413207
FETAL IODINE SYNDROME	0.00561798	0.2104247094413207
HAWKINSINURIA	0.00561798	0.2104247094413207
THYROID HORMONOGENESIS, GENETIC DEFECT IN, 1	0.00561798	0.2104247094413207
CYSTINOSIS	0.00561798	0.2104247094413207
FRAGILE X-ASSOCIATED TREMOR/ATAXIA SYNDROME	0.00561798	0.2104247094413207
OMENN SYNDROME	0.00561798	0.2104247094413207
CONGENITAL ATRANSFERRINEMIA	0.00561798	0.2104247094413207
HYPOHIDROTIC ECTODERMAL DYSPLASIA-HYPOTHYROIDISM-CILIARY DYSKINESIA SYNDROME	0.00561798	0.2104247094413207
PITUITARY DWARFISM WITH LARGE SELLA TURCICA	0.00561798	0.2104247094413207
CHARGE SYNDROME	0.00561798	0.2104247094413207
IMMUNE DYSREGULATION-POLYENDOCRINOPATHY-ENTEROPATHY-X-LINKED SYNDROME	0.00561798	0.2104247094413207
SUBCORNEAL PUSTULAR DERMATOSIS	0.00561798	0.2104247094413207
CENANI-LENZ SYNDROME	0.00561798	0.2104247094413207
MYXEDEMA	0.00561798	0.2104247094413207
CILIARY DYSKINESIA, PRIMARY, 37; CILD37	0.00561798	0.2104247094413207
CONGENITAL MACROGLOSSIA	0.00561798	0.2104247094413207
NEPHROTIC SYNDROME, TYPE 1; NPHS1	0.00561798	0.2104247094413207
PSEUDOXANTHOMA ELASTICUM	0.00561798	0.2104247094413207
DYSBETALIPOPROTEINEMIA	0.00561798	0.2104247094413207
46,XY DISORDER OF SEX DEVELOPMENT DUE TO 17-BETA-HYDROXYSTEROID DEHYDROGENASE 3 DEFICIENCY	0.00561798	0.2104247094413207
PITUITARY DWARFISM WITH SMALL SELLA TURCICA	0.00561798	0.2104247094413207
MÜLLERIAN DUCT ANOMALIES-LIMB ANOMALIES SYNDROME	0.00561798	0.2104247094413207
GNE MYOPATHY	0.00561798	0.2104247094413207
ACETAZOLAMIDE-RESPONSIVE MYOTONIA	0.00561798	0.2104247094413207
184000 SPONDYLOEPIPHYSEAL DYSPLASIA, MYOPIA, AND SENSORINEURAL DEAFNESS	0.00555556	0.20808673202535852
HYPOGONADOTROPIC HYPOGONADISM 2 WITH OR WITHOUT ANOSMIA	0.00555556	0.20808673202535852
ECTODERMAL DYSPLASIA, SENSORINEURAL HEARING LOSS, AND DISTINCTIVE FACIAL FEATURES	0.00555556	0.20808673202535852
MENTAL RETARDATION, AUTOSOMAL DOMINANT 27	0.00555556	0.20808673202535852
MCDONOUGH SYNDROME	0.00555556	0.20808673202535852
109300 BANKI SYNDROME	0.00555556	0.20808673202535852
DISPROPORTIONATE SHORT STATURE WITH PTOSIS AND VALVULAR HEART LESIONS	0.00555556	0.20808673202535852
MULTIPLE EPIPHYSEAL DYSPLASIA, AL-GAZALI TYPE	0.00555556	0.20808673202535852
ANTENATAL MULTIMINICORE DISEASE WITH ARTHROGRYPOSIS MULTIPLEX CONGENITA	0.00555556	0.20808673202535852
201020 ACROCEPHALOPOLYSYNDACTYLY TYPE IV;;ACPS IV;;GOODMAN SYNDROME	0.00555556	0.20808673202535852
201310 ACRORENAL SYNDROME, AUTOSOMAL RECESSIVE	0.00555556	0.20808673202535852
XYLT1-CDG	0.00555556	0.20808673202535852
AL-GAZALI-BAKALINOVA SYNDROME; AGBK	0.00555556	0.20808673202535852
WAHAB SYNDROME	0.00555556	0.20808673202535852
CONGENITAL ADRENAL HYPERPLASIA DUE TO CYTOCHROME P450 OXIDOREDUCTASE DEFICIENCY	0.00555556	0.20808673202535852
%165660 OSLAM SYNDROME;;OSTEOSARCOMA, LIMB ANOMALIES, AND MACROCYTOSIS;;OSTEOSARCOMA, LIMB ANOMALIES, AND ERYTHROID MACROCYTOSIS WITH MEGALOBLASTICMARROW	0.00555556	0.20808673202535852
RUIJS-AALFS SYNDROME; RJALS	0.00555556	0.20808673202535852
OROFACIODIGITAL SYNDROME XVII	0.00555556	0.20808673202535852
ESOPHAGEAL ATRESIA	0.00555556	0.20808673202535852
CRANIOSYNOSTOSIS AND DENTAL ANOMALIES; CRSDA	0.00555556	0.20808673202535852
HYPOGONADOTROPIC HYPOGONADISM 9 WITH OR WITHOUT ANOSMIA; HH9	0.00555556	0.20808673202535852
HISTIOCYTOSIS-LYMPHADENOPATHY PLUS SYNDROME	0.00555556	0.20808673202535852
251190 MICROCEPHALIC PRIMORDIAL DWARFISM, TORIELLO TYPE	0.00555556	0.20808673202535852
INTELLECTUAL DISABILITY-SEIZURES-MACROCEPHALY-OBESITY SYNDROME	0.0054430929999999995	0.20387421510704673
MICROGNATHIA-RECURRENT INFECTIONS-BEHAVIORAL ABNORMALITIES-MILD INTELLECTUAL DISABILITY SYNDROME	0.0054430929999999995	0.20387421510704673
NEURODEVELOPMENTAL DISORDER WITH CEREBELLAR ATROPHY AND WITH OR WITHOUT SEIZURES; NEDCAS	0.0054430929999999995	0.20387421510704673
15Q11Q13 MICRODUPLICATION SYNDROME	0.0054430929999999995	0.20387421510704673
BRACHYDACTYLY TYPE A1	0.0054275	0.20329017022003784
NAIL-PATELLA SYNDROME	0.0054275	0.20329017022003784
MULTIPLE EPIPHYSEAL DYSPLASIA TYPE 4	0.0054275	0.20329017022003784
METHYLMALONATE SEMIALDEHYDE DEHYDROGENASE DEFICIENCY	0.005423624	0.20314499238498063
STOCCO DOS SANTOS X-LINKED MENTAL RETARDATION SYNDROME; SDSX	0.005420992999999999	0.20304644674926453
D-BIFUNCTIONAL PROTEIN DEFICIENCY	0.005420992999999999	0.20304644674926453
PEROXISOME BIOGENESIS DISORDER 5A (ZELLWEGER)	0.005420992999999999	0.20304644674926453
OPTIC PATHWAY GLIOMA	0.005397313000000001	0.20215949857223825
CANAVAN DISEASE	0.005397313000000001	0.20215949857223825
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 31; EIEE31	0.005397313000000001	0.20215949857223825
HSD10 DISEASE	0.005397313000000001	0.20215949857223825
ENCEPHALOPATHY, PROGRESSIVE, EARLY-ONSET, WITH BRAIN ATROPHY AND THIN CORPUS CALLOSUM; PEBAT	0.005397313000000001	0.20215949857223825
SEVERE INTELLECTUAL DISABILITY-PROGRESSIVE POSTNATAL MICROCEPHALY-MIDLINE STEREOTYPIC HAND MOVEMENTS SYNDROME	0.005397313000000001	0.20215949857223825
MULTIPLE MITOCHONDRIAL DYSFUNCTIONS SYNDROME 5; MMDS5	0.005397313000000001	0.20215949857223825
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 37; EIEE37	0.005397313000000001	0.20215949857223825
ENCEPHALOPATHY, ETHYLMALONIC; EE	0.005397313000000001	0.20215949857223825
HSD10 MITOCHONDRIAL DISEASE; HSD10MD	0.005397313000000001	0.20215949857223825
TAY-SACHS DISEASE	0.005397313000000001	0.20215949857223825
ENCEPHALOPATHY, ACUTE, INFECTION-INDUCED, SUSCEPTIBILITY TO, 9; IIAE9	0.005397313000000001	0.20215949857223825
3-METHYLGLUTACONIC ACIDURIA WITH CATARACTS, NEUROLOGIC INVOLVEMENT, AND NEUTROPENIA; MEGCANN	0.005397313000000001	0.20215949857223825
ALPHA-N-ACETYLGALACTOSAMINIDASE DEFICIENCY TYPE 1	0.005397313000000001	0.20215949857223825
SEVERE NEURODEVELOPMENTAL DISORDER WITH FEEDING DIFFICULTIES-STEREOTYPIC HAND MOVEMENT-BILATERAL CATARACT	0.005397313000000001	0.20215949857223825
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 4; MC1DN4	0.005397313000000001	0.20215949857223825
NON-PROGRESSIVE PREDOMINANTLY POSTERIOR CAVITATING LEUKOENCEPHALOPATHY WITH PERIPHERAL NEUROPATHY	0.005397313000000001	0.20215949857223825
CHÉDIAK-HIGASHI SYNDROME	0.005397313000000001	0.20215949857223825
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 1; MC1DN1	0.005397313000000001	0.20215949857223825
MENTAL RETARDATION, AUTOSOMAL DOMINANT 45; MRD45	0.005397313000000001	0.20215949857223825
SCHINDLER DISEASE, TYPE I	0.005397313000000001	0.20215949857223825
MULTIPLE CONGENITAL ANOMALIES-HYPOTONIA-SEIZURES SYNDROME 3; MCAHS3	0.005397313000000001	0.20215949857223825
EARLY-ONSET PROGRESSIVE ENCEPHALOPATHY-SPASTIC ATAXIA-DISTAL SPINAL MUSCULAR ATROPHY SYNDROME	0.005397313000000001	0.20215949857223825
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 45	0.005397313000000001	0.20215949857223825
ALPHA-N-ACETYLGALACTOSAMINIDASE DEFICIENCY	0.005397313000000001	0.20215949857223825
METACHROMATIC LEUKODYSTROPHY DUE TO SAPOSIN B DEFICIENCY	0.005397313000000001	0.20215949857223825
MULTIPLE SULFATASE DEFICIENCY	0.005397313000000001	0.20215949857223825
MULTIPLE MITOCHONDRIAL DYSFUNCTIONS SYNDROME 2 WITH HYPERGLYCINEMIA; MMDS2	0.005397313000000001	0.20215949857223825
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 6; COXPD6	0.005397313000000001	0.20215949857223825
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 41; EIEE41	0.005397313000000001	0.20215949857223825
KERATOCONUS POSTICUS CIRCUMSCRIPTUS	0.005319534000000001	0.19924624087540835
MICROCEPHALY, SHORT STATURE, AND LIMB ABNORMALITIES; MISSLA	0.005319534000000001	0.19924624087540835
TRISOMY 9P	0.005319534	0.19924624087540832
TEMTAMY SYNDROME	0.005319534	0.19924624087540832
MICROCEPHALIC OSTEODYSPLASTIC PRIMORDIAL DWARFISM, TYPE II; MOPD2	0.005319534	0.19924624087540832
%300712 CRANIOFACIOSKELETAL SYNDROME	0.005319534	0.19924624087540832
GENITOPATELLAR SYNDROME; GTPTS	0.005297434	0.19841847251762615
600123 ATRIOVENTRICULAR SEPTAL DEFECT WITH BLEPHAROPHIMOSIS AND ANAL ANDRADIAL DEFECTS	0.005234994000000001	0.19607974599002795
SYNDACTYLY-TELECANTHUS-ANOGENITAL AND RENAL MALFORMATIONS SYNDROME	0.005230859000000001	0.1959248671592846
CUTIS LAXA, AUTOSOMAL RECESSIVE, TYPE IID; ARCL2D	0.005208759	0.19509709880150236
ACROMELIC FRONTONASAL DYSOSTOSIS; AFND	0.005208759	0.19509709880150236
X-LINKED LISSENCEPHALY WITH ABNORMAL GENITALIA	0.005152013	0.19297164435667394
HYPOTONIA, HYPERVENTILATION, IMPAIRED INTELLECTUAL DEVELOPMENT, DYSAUTONOMIA, EPILEPSY, AND EYE ABNORMALITIES; HIDEA	0.005152013	0.19297164435667394
ENCEPHALOMYOPATHY, MITOCHONDRIAL, DUE TO VOLTAGE-DEPENDENT ANION CHANNEL DEFICIENCY	0.005152013	0.19297164435667394
O'DONNELL-LURIA-RODAN SYNDROME; ODLURO	0.005152013	0.19297164435667394
X-LINKED INTELLECTUAL DISABILITY-CEREBELLAR HYPOPLASIA SYNDROME	0.005152013	0.19297164435667394
HYPOTONIA, INFANTILE, WITH PSYCHOMOTOR RETARDATION AND CHARACTERISTIC FACIES 1; IHPRF1	0.005152013	0.19297164435667394
MENTAL RETARDATION, AUTOSOMAL DOMINANT 31; MRD31	0.005152013	0.19297164435667394
D-2-HYDROXYGLUTARIC ACIDURIA 1	0.005152013	0.19297164435667394
MACROCEPHALY, DYSMORPHIC FACIES, AND PSYCHOMOTOR RETARDATION; MDFPMR	0.005152013	0.19297164435667394
MENTAL RETARDATION, X-LINKED, WITH CEREBELLAR HYPOPLASIA AND DISTINCTIVE FACIAL APPEARANCE	0.005152013	0.19297164435667394
SOTOS SYNDROME	0.005152013	0.19297164435667394
PETTIGREW SYNDROME	0.005152013	0.19297164435667394
SEVERE FEEDING DIFFICULTIES-FAILURE TO THRIVE-MICROCEPHALY DUE TO ASXL3 DEFICIENCY SYNDROME	0.005152013	0.19297164435667394
14Q22Q23 MICRODELETION SYNDROME	0.004901674	0.1835950514644189
6Q16 MICRODELETION SYNDROME	0.004901674	0.1835950514644189
DISTAL MONOSOMY 3P	0.004897539	0.1834401726336755
RENPENNING SYNDROME	0.004897539	0.1834401726336755
MILLER-DIEKER SYNDROME	0.004897538999999999	0.18344017263367546
ARTHROGRYPOSIS, DISTAL, TYPE 3; DA3	0.004879573999999999	0.1827672831066367
ROTHMUND-THOMSON SYNDROME	0.004879573999999999	0.1827672831066367
TALL STATURE-INTELLECTUAL DISABILITY-RENAL ANOMALIES SYNDROME	0.004879573999999999	0.1827672831066367
MARDEN-WALKER SYNDROME	0.004875439	0.18261240427589331
CHROMOSOME 18Q DELETION SYNDROME	0.004875439	0.18261240427589331
PEROXISOME BIOGENESIS DISORDER 2A (ZELLWEGER); PBD2A	0.004875439	0.18261240427589331
X-LINKED INTELLECTUAL DISABILITY, STOCCO DOS SANTOS TYPE	0.004875438999999999	0.18261240427589326
COMBINED OXIDATIVE PHOSPHORYLATION DEFECT TYPE 7	0.004855894	0.1818803349296104
MITOCHONDRIAL COMPLEX III DEFICIENCY, NUCLEAR TYPE 8; MC3DN8	0.004855894	0.1818803349296104
NEURODEGENERATION WITH BRAIN IRON ACCUMULATION 6; NBIA6	0.004855894	0.1818803349296104
DYSTONIA-PARKINSONISM-HYPERMANGANESEMIA SYNDROME	0.004855894	0.1818803349296104
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 7; COXPD7	0.004855894	0.1818803349296104
PSYCHOMOTOR DELAY DUE TO S-ADENOSYLHOMOCYSTEINE HYDROLASE DEFICIENCY	0.004855894	0.1818803349296104
HYPERMANGANESEMIA WITH DYSTONIA 2	0.004855894	0.1818803349296104
MENKES DISEASE	0.004851759000000001	0.181725456098867
TALL STATURE-INTELLECTUAL DISABILITY-FACIAL DYSMORPHISM SYNDROME	0.004851759000000001	0.181725456098867
LEUKOENCEPHALOPATHY WITH VANISHING WHITE MATTER; VWM	0.004851759000000001	0.181725456098867
SEVERE INTELLECTUAL DISABILITY-PROGRESSIVE SPASTIC DIPLEGIA SYNDROME	0.004851759000000001	0.181725456098867
XERODERMA PIGMENTOSUM	0.004851759000000001	0.181725456098867
AMELOCEREBROHYPOHIDROTIC SYNDROME	0.004851759000000001	0.181725456098867
CADASIL	0.004851759000000001	0.181725456098867
LYNCH SYNDROME	0.004851759000000001	0.181725456098867
CEROID LIPOFUSCINOSIS, NEURONAL, 8	0.004851759000000001	0.181725456098867
CENTRAL NERVOUS SYSTEM CALCIFICATION-DEAFNESS-TUBULAR ACIDOSIS-ANEMIA SYNDROME	0.004851759000000001	0.181725456098867
NASU-HAKOLA DISEASE	0.004851759000000001	0.181725456098867
ALEXANDER DISEASE	0.004851759000000001	0.181725456098867
CEROID LIPOFUSCINOSIS, NEURONAL, 2	0.004851759000000001	0.181725456098867
FAMILIAL ACUTE NECROTIZING ENCEPHALOPATHY	0.004851759000000001	0.181725456098867
FAMILIAL COLORECTAL CANCER TYPE X	0.004851759000000001	0.181725456098867
ENCEPHALOPATHY, PROGRESSIVE, EARLY-ONSET, WITH BRAIN EDEMA AND/OR LEUKOENCEPHALOPATHY, 1; PEBEL1	0.004851759000000001	0.181725456098867
ASPARTYLGLUCOSAMINURIA; AGU	0.004851759000000001	0.181725456098867
AUTISM, SUSCEPTIBILITY TO, X-LINKED 6	0.004851759000000001	0.181725456098867
MULTIPLE MITOCHONDRIAL DYSFUNCTIONS SYNDROME 3; MMDS3	0.004851759000000001	0.181725456098867
METHYLMALONIC ACIDEMIA WITH HOMOCYSTINURIA TYPE CBLF	0.004851759000000001	0.181725456098867
BEHÇET DISEASE	0.004851759000000001	0.181725456098867
LATE INFANTILE NEURONAL CEROID LIPOFUSCINOSIS	0.004851759000000001	0.181725456098867
CHILDHOOD DISINTEGRATIVE DISORDER	0.004851759000000001	0.181725456098867
TRIPLE A SYNDROME	0.004851759000000001	0.181725456098867
NEURODEGENERATION DUE TO CEREBRAL FOLATE TRANSPORT DEFICIENCY	0.004851759000000001	0.181725456098867
SNEDDON SYNDROME	0.004851759000000001	0.181725456098867
KRABBE DISEASE	0.004851759000000001	0.181725456098867
WOLFRAM SYNDROME	0.004851759000000001	0.181725456098867
ICHTHYOSIS FOLLICULARIS-ALOPECIA-PHOTOPHOBIA SYNDROME	0.004851759000000001	0.181725456098867
NEURODEGENERATION, CHILDHOOD-ONSET, STRESS-INDUCED, WITH VARIABLE ATAXIA AND SEIZURES; CONDSIAS	0.004851759000000001	0.181725456098867
INFANTILE NEUROAXONAL DYSTROPHY	0.004851759000000001	0.181725456098867
METACHROMATIC LEUKODYSTROPHY	0.004851759000000001	0.181725456098867
ALOPECIA-CONTRACTURES-DWARFISM-INTELLECTUAL DISABILITY SYNDROME	0.004773980000000001	0.17881219840203708
HAND-FOOT-GENITAL SYNDROME; HFG	0.004773980000000001	0.17881219840203708
NOONAN SYNDROME	0.004773980000000001	0.17881219840203708
FEINGOLD SYNDROME	0.004773980000000001	0.17881219840203708
ROIFMAN SYNDROME	0.004773980000000001	0.17881219840203708
CLEIDOCRANIAL DYSPLASIA	0.004773980000000001	0.17881219840203708
MESOMELIA-SYNOSTOSES SYNDROME	0.004773980000000001	0.17881219840203708
269870 SHORT STATURE-OBESITY SYNDROME; SSOS	0.004773980000000001	0.17881219840203708
BANKI SYNDROME	0.004773980000000001	0.17881219840203708
WEYERS ACROFACIAL DYSOSTOSIS	0.004773980000000001	0.17881219840203708
ANDERSEN CARDIODYSRHYTHMIC PERIODIC PARALYSIS	0.004773980000000001	0.17881219840203708
TETRALOGY OF FALLOT	0.004773980000000001	0.17881219840203708
PROXIMAL SYMPHALANGISM	0.004773980000000001	0.17881219840203708
PERIPHERAL DYSOSTOSIS	0.004773980000000001	0.17881219840203708
%252100 MOHR SYNDROME;;OROFACIODIGITAL SYNDROME II; OFD2;;OFDS II;;ORAL-FACIAL-DIGITAL SYNDROME, TYPE II	0.004773980000000001	0.17881219840203708
BRACHYDACTYLY-ELBOW WRIST DYSPLASIA SYNDROME	0.004773980000000001	0.17881219840203708
604381 PATENT DUCTUS ARTERIOSUS AND BICUSPID AORTIC VALVE WITH HAND ANOMALIES	0.004773980000000001	0.17881219840203708
ATELOSTEOGENESIS TYPE I	0.00475188	0.17798443004425488
CARPENTER SYNDROME	0.00475188	0.17798443004425488
613005 SANTOS SYNDROME;;FIBULAR AGENESIS/HYPOPLASIA, OLIGODACTYLOUS CLUBFEET, AND ANONYCHIA/NAILHYPOPLASIA SYNDROME	0.00475188	0.17798443004425488
ACROMESOMELIC DYSPLASIA, DEMIRHAN TYPE; AMDD	0.00475188	0.17798443004425488
SPONDYLOMETAPHYSEAL DYSPLASIA, SEDAGHATIAN TYPE; SMDS	0.00475188	0.17798443004425488
DESBUQUOIS DYSPLASIA 1	0.00475188	0.17798443004425488
MULTIPLE EPIPHYSEAL DYSPLASIA WITH ROBIN PHENOTYPE	0.00475188	0.17798443004425488
ULNAR/FIBULA RAY DEFECT-BRACHYDACTYLY SYNDROME	0.00475188	0.17798443004425488
MULTIPLE SYNOSTOSES SYNDROME 2	0.00475188	0.17798443004425488
ATRIOVENTRICULAR DEFECT-BLEPHAROPHIMOSIS-RADIAL AND ANAL DEFECT SYNDROME	0.0046894400000000004	0.1756457035166567
ANKYLOBLEPHARON-ECTODERMAL DEFECTS-CLEFT LIP/PALATE SYNDROME	0.0046894400000000004	0.1756457035166567
MENTAL RETARDATION, BUENOS AIRES TYPE	0.0046894400000000004	0.1756457035166567
FRONTONASAL DYSPLASIA-BIFID NOSE-UPPER LIMB ANOMALIES SYNDROME	0.0046894400000000004	0.1756457035166567
INTELLECTUAL DISABILITY-CARDIAC ANOMALIES-SHORT STATURE-JOINT LAXITY SYNDROME	0.0046894400000000004	0.1756457035166567
PEROXISOME BIOGENESIS DISORDER 1B; PBD1B	0.004682933	0.17540198004588342
CHROMOSOME 5P13 DUPLICATION SYNDROME	0.004682933	0.17540198004588342
PONTOCEREBELLAR HYPOPLASIA, TYPE 7; PCH7	0.004682933	0.17540198004588342
MENTAL RETARDATION AND MICROCEPHALY WITH PONTINE AND CEREBELLAR HYPOPLASIA; MICPCH	0.004682933	0.17540198004588342
CHROMOSOME 3PTER-P25 DELETION SYNDROME	0.004682933	0.17540198004588342
8P23.1 MICRODELETION SYNDROME	0.004682933	0.17540198004588342
20P12.3 MICRODELETION SYNDROME	0.004682933	0.17540198004588342
BARAITSER-WINTER CEREBROFRONTOFACIAL SYNDROME	0.004682933	0.17540198004588342
BARAITSER-WINTER SYNDROME 1; BRWS1	0.004682933	0.17540198004588342
PONTOCEREBELLAR HYPOPLASIA TYPE 7	0.004682933	0.17540198004588342
OCULOECTODERMAL SYNDROME; OES	0.004682933	0.17540198004588342
DYSSEGMENTAL DYSPLASIA, SILVERMAN-HANDMAKER TYPE; DDSH	0.00466734	0.17481793515887448
PECTUS EXCAVATUM-MACROCEPHALY-DYSPLASTIC NAILS SYNDROME	0.004610594	0.17269248071404608
CUTIS LAXA, AUTOSOMAL RECESSIVE, TYPE IIB; ARCL2B	0.004610594	0.17269248071404608
SPASTIC PARAPLEGIA, INTELLECTUAL DISABILITY, NYSTAGMUS, AND OBESITY; SINO	0.004610594	0.17269248071404608
MENTAL RETARDATION, X-LINKED 99	0.004610594	0.17269248071404608
CORTICAL BLINDNESS, RETARDATION, AND POSTAXIAL POLYDACTYLY	0.004610594	0.17269248071404608
MEGALENCEPHALY-POLYMICROGYRIA-POLYDACTYLY-HYDROCEPHALUS SYNDROME 3; MPPH3	0.004610594	0.17269248071404608
CONGENITAL HEART DEFECTS AND ECTODERMAL DYSPLASIA	0.004610594	0.17269248071404608
MYELODYSPLASIA, IMMUNODEFICIENCY, FACIAL DYSMORPHISM, SHORT STATURE,	0.004610594	0.17269248071404608
608279 CRANIOSYNOSTOSIS WITH OCULAR ABNORMALITIES AND HALLUCAL DEFECTS	0.004610594	0.17269248071404608
PECTUS EXCAVATUM, MACROCEPHALY, SHORT STATURE, AND DYSPLASTIC NAILS	0.004610594	0.17269248071404608
SPONDYLOMETAPHYSEAL DYSPLASIA, MEGARBANE-DAGHER-MELKI TYPE; SMDMDM	0.004610594	0.17269248071404608
NOONAN SYNDROME-LIKE DISORDER WITH LOOSE ANAGEN HAIR 2; NSLH2	0.004610594	0.17269248071404608
CLARK-BARAITSER SYNDROME	0.004606459	0.17253760188330267
AICA-RIBOSIDURIA	0.004606459	0.17253760188330267
NOONAN SYNDROME 7; NS7	0.004606459	0.17253760188330267
%300261 ARMFIELD X-LINKED MENTAL RETARDATION SYNDROME; MRXSA;;MENTAL RETARDATION, X-LINKED, SYNDROMIC, ARMFIELD TYPE	0.004606459	0.17253760188330267
ATKIN-FLAITZ SYNDROME	0.004606459	0.17253760188330267
AICAR TRANSFORMYLASE/IMP CYCLOHYDROLASE DEFICIENCY	0.004606459	0.17253760188330267
KENNY-CAFFEY SYNDROME, TYPE 2; KCS2	0.004606459	0.17253760188330267
MICROCEPHALIC PRIMORDIAL DWARFISM, ALAZAMI TYPE	0.004606459	0.17253760188330267
ELSAHY-WATERS SYNDROME; ESWS	0.004559374	0.17077400581424498
TONNE-KALSCHEUER SYNDROME; TOKAS	0.004559374	0.17077400581424498
TRISOMY 8Q	0.004559374	0.17077400581424498
DEAFNESS, ONYCHODYSTROPHY, OSTEODYSTROPHY, MENTAL RETARDATION, AND SEIZURES SYNDROME; DOORS	0.004555239	0.17061912698350157
AYME-GRIPP SYNDROME; AYGRP	0.004555239	0.17061912698350157
KEIPERT SYNDROME	0.00435612	0.16316100899104763
CEREBROCOSTOMANDIBULAR SYNDROME; CCMS	0.00435612	0.16316100899104763
PENOSCROTAL TRANSPOSITION	0.00435612	0.16316100899104763
WHITE FORELOCK WITH MALFORMATIONS	0.00435612	0.16316100899104763
MONOSOMY 22	0.00435612	0.16316100899104763
INTELLECTUAL DISABILITY-FEEDING DIFFICULTIES-DEVELOPMENTAL DELAY-MICROCEPHALY SYNDROME	0.00435612	0.16316100899104763
FRAXE INTELLECTUAL DISABILITY	0.00435612	0.16316100899104763
WHISTLING FACE SYNDROME, RECESSIVE FORM	0.004334019999999999	0.16233324063326543
MARTSOLF SYNDROME	0.004334019999999999	0.16233324063326543
CRANIOFACIAL DYSMORPHISM, SKELETAL ANOMALIES, AND MENTAL RETARDATION SYNDROME	0.004334019999999999	0.16233324063326543
EHLERS-DANLOS SYNDROME, CLASSIC TYPE, 2; EDSCL2	0.004334019999999999	0.16233324063326543
HYPERTELORISM AND TETRALOGY OF FALLOT	0.004334019999999999	0.16233324063326543
CREATINE DEFICIENCY SYNDROME, X-LINKED	0.004333723	0.16232211632547083
GM2-GANGLIOSIDOSIS, AB VARIANT	0.004333723	0.16232211632547083
HYPERPHENYLALANINEMIA, BH4-DEFICIENT, B; HPABH4B	0.004333723	0.16232211632547083
VITAMIN B12-UNRESPONSIVE METHYLMALONIC ACIDEMIA TYPE MUT-	0.004333723	0.16232211632547083
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 3	0.004333723	0.16232211632547083
SEVERE INTELLECTUAL DISABILITY AND PROGRESSIVE SPASTIC PARAPLEGIA	0.004333723	0.16232211632547083
HYPOXANTHINE GUANINE PHOSPHORIBOSYLTRANSFERASE PARTIAL DEFICIENCY	0.004333723	0.16232211632547083
PELIZAEUS-MERZBACHER DISEASE	0.004333723	0.16232211632547083
HYPERPHENYLALANINEMIA, BH4-DEFICIENT, A; HPABH4A	0.004333723	0.16232211632547083
PROGRESSIVE ENCEPHALOPATHY WITH LEUKODYSTROPHY DUE TO DECR DEFICIENCY	0.004333723	0.16232211632547083
HYPERPHENYLALANINEMIA, BH4-DEFICIENT, C; HPABH4C	0.004333723	0.16232211632547083
16P11.2P12.2 MICRODUPLICATION SYNDROME	0.004333723	0.16232211632547083
BETA-PROPELLER PROTEIN-ASSOCIATED NEURODEGENERATION	0.004333723	0.16232211632547083
LEIGH SYNDROME WITH LEUKODYSTROPHY	0.004333723	0.16232211632547083
NIEMANN-PICK DISEASE, TYPE C2	0.004333723	0.16232211632547083
PROPIONIC ACIDEMIA	0.004333723	0.16232211632547083
NIEMANN-PICK DISEASE, TYPE C1; NPC1	0.004333723	0.16232211632547083
LEIGH SYNDROME; LS	0.004333723	0.16232211632547083
MITOCHONDRIAL DNA DEPLETION SYNDROME 5 (ENCEPHALOMYOPATHIC WITH OR WITHOUT METHYLMALONIC ACIDURIA); MTDPS5	0.004333723	0.16232211632547083
METHYLMALONIC ACIDURIA AND HOMOCYSTINURIA, CBLD TYPE	0.004333723	0.16232211632547083
PLAA-ASSOCIATED NEURODEVELOPMENTAL DISORDER	0.004333723	0.16232211632547083
NEURODEVELOPMENTAL DISORDER, MITOCHONDRIAL, WITH ABNORMAL MOVEMENTS AND LACTIC ACIDOSIS, WITH OR WITHOUT SEIZURES; NEMMLAS	0.004333723	0.16232211632547083
FIBROSIS, NEURODEGENERATION, AND CEREBRAL ANGIOMATOSIS; FINCA	0.004333723	0.16232211632547083
CEREBELLAR ATROPHY, VISUAL IMPAIRMENT, AND PSYCHOMOTOR RETARDATION; CAVIPMR	0.004333723	0.16232211632547083
X-LINKED CREATINE TRANSPORTER DEFICIENCY	0.004333723	0.16232211632547083
NKX6-2-RELATED AUTOSOMAL RECESSIVE HYPOMYELINATING LEUKODYSTROPHY	0.004333723	0.16232211632547083
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 51; EIEE51	0.004333723	0.16232211632547083
NEURODEGENERATION, EARLY-ONSET, WITH CHOREOATHETOID MOVEMENTS AND MICROCYTIC ANEMIA; NDCAMA	0.004333723	0.16232211632547083
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 16; MC1DN16	0.004333722999999999	0.1623221163254708
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 7	0.004333722999999999	0.1623221163254708
MENTAL RETARDATION, AUTOSOMAL DOMINANT 6, WITH OR WITHOUT SEIZURES; MRD6	0.004333722999999999	0.1623221163254708
NEURODEVELOPMENTAL DISORDER WITH INVOLUNTARY MOVEMENTS; NEDIM	0.004333722999999999	0.1623221163254708
3-METHYLGLUTACONIC ACIDURIA TYPE 1	0.004333722999999999	0.1623221163254708
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 2; MC1DN2	0.004333722999999999	0.1623221163254708
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 6; MRT6	0.004333722999999999	0.1623221163254708
DIHYDROLIPOAMIDE DEHYDROGENASE DEFICIENCY	0.004333722999999999	0.1623221163254708
2,4-DIENOYL-COA REDUCTASE DEFICIENCY; DECRD	0.004333722999999999	0.1623221163254708
DEAFNESS, DYSTONIA, AND CEREBRAL HYPOMYELINATION; DDCH	0.004333722999999999	0.1623221163254708
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 10	0.004333722999999999	0.1623221163254708
COENZYME Q10 DEFICIENCY, PRIMARY, 5; COQ10D5	0.004333722999999999	0.1623221163254708
NEURODEVELOPMENTAL DISORDER WITH OR WITHOUT HYPERKINETIC MOVEMENTS AND SEIZURES, AUTOSOMAL RECESSIVE; NDHMSR	0.004333722999999999	0.1623221163254708
LEUKOENCEPHALOPATHY, BRAIN CALCIFICATIONS, AND CYSTS	0.004333722999999999	0.1623221163254708
EPILEPTIC ENCEPHALOPATHY, INFANTILE OR EARLY CHILDHOOD, 2; IECEE2	0.004333722999999999	0.1623221163254708
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 27; EIEE27	0.004333722999999999	0.1623221163254708
THIAMINE METABOLISM DYSFUNCTION SYNDROME 5 (EPISODIC ENCEPHALOPATHY TYPE)	0.004333722999999999	0.1623221163254708
PANDAS	0.00431034	0.16144629245623912
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 4; COXPD4	0.00431034	0.16144629245623912
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 6; MC1DN6	0.00431034	0.16144629245623912
DUCHENNE AND BECKER MUSCULAR DYSTROPHY	0.00431034	0.16144629245623912
RENAL TUBULOPATHY, DIABETES MELLITUS, AND CEREBELLAR ATAXIA	0.00431034	0.16144629245623912
PITT-HOPKINS-LIKE SYNDROME 2; PTHSL2	0.00431034	0.16144629245623912
REFSUM DISEASE	0.00431034	0.16144629245623912
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 7; MC1DN7	0.00431034	0.16144629245623912
DYSOSTEOSCLEROSIS	0.00431034	0.16144629245623912
CHILDHOOD-ONSET SPASTICITY WITH HYPERGLYCINEMIA	0.00431034	0.16144629245623912
SPASTIC TETRAPLEGIA-RETINITIS PIGMENTOSA-INTELLECTUAL DISABILITY SYNDROME	0.00431034	0.16144629245623912
TRISOMY 5P	0.00431034	0.16144629245623912
CODAS SYNDROME	0.004226054	0.15828931128863594
JOUBERT SYNDROME WITH JEUNE ASPHYXIATING THORACIC DYSTROPHY	0.004226054	0.15828931128863594
PHENOBARBITAL EMBRYOPATHY	0.004226054	0.15828931128863594
PSEUDOAMINOPTERIN SYNDROME	0.004226054	0.15828931128863594
BARATELA-SCOTT SYNDROME	0.004226054	0.15828931128863594
234250 HALL-RIGGS MENTAL RETARDATION SYNDROME	0.004221918999999999	0.15813443245789252
211910 CAMPTODACTYLY SYNDROME, GUADALAJARA, TYPE I; GCS1;;FACIOTHORACOSKELETAL SYNDROME; FTSS	0.004221918999999999	0.15813443245789252
AGAMMAGLOBULINEMIA-MICROCEPHALY-CRANIOSYNOSTOSIS-SEVERE DERMATITIS SYNDROME	0.004141514000000001	0.1551228164032556
ZELLWEGER-LIKE SYNDROME WITHOUT PEROXISOMAL ANOMALIES	0.004141514000000001	0.1551228164032556
JOUBERT SYNDROME 10	0.004141514000000001	0.1551228164032556
COHEN-GIBSON SYNDROME; COGIS	0.004141514000000001	0.1551228164032556
B4GALT7-RELATED SPONDYLODYSPLASTIC EHLERS-DANLOS SYNDROME	0.004141514000000001	0.1551228164032556
HYPOTRICHOSIS-LYMPHEDEMA-TELANGIECTASIA-RENAL DEFECT SYNDROME; HLTRS	0.004141514000000001	0.1551228164032556
8Q12 MICRODUPLICATION SYNDROME	0.004141514000000001	0.1551228164032556
INTELLECTUAL DEVELOPMENTAL DISORDER WITH ABNORMAL BEHAVIOR, MICROCEPHALY, AND SHORT STATURE; IDDABS	0.004141514000000001	0.1551228164032556
NOONAN SYNDROME 6; NS6	0.004141514000000001	0.1551228164032556
MOWAT-WILSON SYNDROME	0.004137379	0.15496793757251218
FACIAL DYSMORPHISM-MACROCEPHALY-MYOPIA-DANDY-WALKER MALFORMATION SYNDROME	0.004137379	0.15496793757251218
MEGALOCORNEA-MENTAL RETARDATION SYNDROME	0.004137379	0.15496793757251218
EPIPHYSEAL DYSPLASIA-HEARING LOSS-DYSMORPHISM SYNDROME	0.004137379	0.15496793757251218
CATARACT-GROWTH HORMONE DEFICIENCY-SENSORY NEUROPATHY-SENSORINEURAL HEARING LOSS-SKELETAL DYSPLASIA SYNDROME	0.00406504	0.1522584382406748
PLATYSPONDYLIC DYSPLASIA, TORRANCE TYPE	0.00406504	0.1522584382406748
MENTAL RETARDATION, X-LINKED 93	0.00406504	0.1522584382406748
MARSHALL-SMITH SYNDROME; MRSHSS	0.00406504	0.1522584382406748
%217990 CORPUS CALLOSUM, AGENESIS OF;;ACC	0.00406504	0.1522584382406748
MELANOCYTIC NEVUS SYNDROME, CONGENITAL; CMNS	0.00406504	0.1522584382406748
LENZ-MAJEWSKI HYPEROSTOTIC DWARFISM	0.00406504	0.1522584382406748
256690 NEUROFACIODIGITORENAL SYNDROME;;NFDR SYNDROME	0.00406504	0.1522584382406748
MARSHALL-SMITH SYNDROME	0.00406504	0.1522584382406748
CORTICAL BLINDNESS-INTELLECTUAL DISABILITY-POLYDACTYLY SYNDROME	0.00406504	0.1522584382406748
MENTAL RETARDATION WITH LANGUAGE IMPAIRMENT AND WITH OR WITHOUT AUTISTIC FEATURES	0.00406504	0.1522584382406748
TRICHOHEPATOENTERIC SYNDROME 2	0.00406504	0.1522584382406748
TETRASOMY 12P	0.00406504	0.1522584382406748
HYPER-IGE RECURRENT INFECTION SYNDROME, AUTOSOMAL DOMINANT	0.00406504	0.1522584382406748
FG SYNDROME 2; FGS2	0.00406504	0.1522584382406748
INTERSTITIAL LUNG DISEASE, NEPHROTIC SYNDROME, AND EPIDERMOLYSIS BULLOSA, CONGENITAL; ILNEB	0.00406504	0.1522584382406748
ACROFACIAL DYSOSTOSIS, PALAGONIA TYPE	0.00406504	0.1522584382406748
OSTEOGENESIS IMPERFECTA, TYPE X	0.00406504	0.1522584382406748
SHORT-RIB THORACIC DYSPLASIA 9 WITH OR WITHOUT POLYDACTYLY; SRTD9	0.00406504	0.1522584382406748
CRANIOMETADIAPHYSEAL DYSPLASIA; CRMDD	0.00406504	0.1522584382406748
OSTEOGENESIS IMPERFECTA, TYPE XII; OI12	0.00406504	0.1522584382406748
HUTCHINSON-GILFORD PROGERIA SYNDROME	0.00406504	0.1522584382406748
NOONAN SYNDROME-LIKE DISORDER WITH LOOSE ANAGEN HAIR 1; NSLH1	0.00406504	0.1522584382406748
MENTAL RETARDATION, X-LINKED 19	0.00406504	0.1522584382406748
GASTROINTESTINAL DEFECTS AND IMMUNODEFICIENCY SYNDROME; GIDID	0.00406504	0.1522584382406748
CRANIOFACIOFRONTODIGITAL SYNDROME	0.00406504	0.1522584382406748
AUTOSOMAL DOMINANT HYPOHIDROTIC ECTODERMAL DYSPLASIA	0.00406504	0.1522584382406748
ACROOSTEOLYSIS DOMINANT TYPE	0.0040138199999999995	0.1503399633408737
CARPENTER-WAZIRI SYNDROME	0.0040138199999999995	0.1503399633408737
HYPOGLOSSIA-HYPODACTYLY SYNDROME	0.0040138199999999995	0.1503399633408737
608028 THAI SYMPHALANGISM SYNDROME	0.0040138199999999995	0.1503399633408737
OROFACIODIGITAL SYNDROME XVIII; OFD18	0.0040138199999999995	0.1503399633408737
BRACHYDACTYLY-PREAXIAL HALLUX VARUS SYNDROME	0.0040138199999999995	0.1503399633408737
SPONDYLOEPIPHYSEAL DYSPLASIA, CANTU TYPE	0.0040138199999999995	0.1503399633408737
14Q24.1Q24.3 MICRODELETION SYNDROME	0.0040138199999999995	0.1503399633408737
GELEOPHYSIC DYSPLASIA 3; GPHYSD3	0.0040138199999999995	0.1503399633408737
CARDIOSPONDYLOCARPOFACIAL SYNDROME; CSCF	0.0040138199999999995	0.1503399633408737
CHARLIE M SYNDROME	0.0040138199999999995	0.1503399633408737
SHORT STATURE-WORMIAN BONES-DEXTROCARDIA SYNDROME	0.0040138199999999995	0.1503399633408737
SHORT-RIB THORACIC DYSPLASIA 16 WITH OR WITHOUT POLYDACTYLY; SRTD16	0.0040138199999999995	0.1503399633408737
HYDROCEPHALUS-COSTOVERTEBRAL DYSPLASIA-SPRENGEL ANOMALY SYNDROME	0.0040138199999999995	0.1503399633408737
CHONDRODYSPLASIA WITH JOINT DISLOCATIONS, GPAPP TYPE	0.0040138199999999995	0.1503399633408737
OCULOMAXILLOFACIAL DYSOSTOSIS	0.0040138199999999995	0.1503399633408737
BASAL CELL NEVUS SYNDROME	0.0040138199999999995	0.1503399633408737
GENITOPALATOCARDIAC SYNDROME	0.0040138199999999995	0.1503399633408737
LYMPHEDEMA-HYPOPARATHYROIDISM SYNDROME	0.0040138199999999995	0.1503399633408737
SPONDYLOEPIPHYSEAL DYSPLASIA-BRACHYDACTYLY AND DISTINCTIVE SPEECH	0.0040138199999999995	0.1503399633408737
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 41; MRT41	0.0038117730000000005	0.14277217540490914
DPAGT1-CDG	0.0038117730000000005	0.14277217540490914
CHROMOSOME 16P13.2 DELETION SYNDROME	0.003811773	0.1427721754049091
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IJ; CDG1J	0.003811773	0.1427721754049091
GLYCOSYLPHOSPHATIDYLINOSITOL BIOSYNTHESIS DEFECT 18	0.003811773	0.1427721754049091
RECOMBINANT CHROMOSOME 8 SYNDROME	0.003811773	0.1427721754049091
RECOMBINANT 8 SYNDROME	0.003811773	0.1427721754049091
NEURODEVELOPMENTAL DISORDER WITH OR WITHOUT VARIABLE BRAIN ABNORMALITIES; NEDBA	0.003811773	0.1427721754049091
CORNELIA DE LANGE SYNDROME 5; CDLS5	0.003811773	0.1427721754049091
SEIZURES, SCOLIOSIS, AND MACROCEPHALY/MICROCEPHALY SYNDROME; SSMS	0.003811773	0.1427721754049091
STAG1-RELATED INTELLECTUAL DISABILITY-FACIAL DYSMORPHISM-GASTROESOPHAGEAL REFLUX SYNDROME	0.003811773	0.1427721754049091
GLUT1 DEFICIENCY SYNDROME 2; GLUT1DS2	0.003792304	0.14204295268284298
CHOREOATHETOSIS, HYPOTHYROIDISM, AND NEONATAL RESPIRATORY DISTRESSCHOREOATHETOSIS AND CONGENITAL HYPOTHYROIDISM, INCLUDED	0.003792304	0.14204295268284298
BRAIN-LUNG-THYROID SYNDROME	0.003792304	0.14204295268284298
MITOCHONDRIAL COMPLEX III DEFICIENCY, NUCLEAR TYPE 2; MC3DN2	0.003792304	0.14204295268284298
PROXIMAL MYOPATHY WITH EXTRAPYRAMIDAL SIGNS	0.003792304	0.14204295268284298
TRIOSEPHOSPHATE ISOMERASE DEFICIENCY	0.003792304	0.14204295268284298
SPASTIC PARAPLEGIA 53, AUTOSOMAL RECESSIVE	0.003792304	0.14204295268284298
NAVAJO NEUROHEPATOPATHY	0.003792304	0.14204295268284298
AUTOSOMAL RECESSIVE CEREBELLAR ATAXIA DUE TO CWF19L1 DEFICIENCY	0.003792304	0.14204295268284298
VITAMIN B12-UNRESPONSIVE METHYLMALONIC ACIDEMIA TYPE MUT0	0.003792304	0.14204295268284298
MITOCHONDRIAL COMPLEX III DEFICIENCY, NUCLEAR TYPE 4; MC3DN4	0.003792304	0.14204295268284298
LIPOYLTRANSFERASE 1 DEFICIENCY; LIPT1D	0.003792304	0.14204295268284298
AUTOSOMAL RECESSIVE SPASTIC PARAPLEGIA TYPE 56	0.003792304	0.14204295268284298
MITOCHONDRIAL SHORT-CHAIN ENOYL-COA HYDRATASE 1 DEFICIENCY; ECHS1D	0.003792304	0.14204295268284298
MUCOLIPIDOSIS IV; ML4	0.003792304	0.14204295268284298
MICROCEPHALY 15, PRIMARY, AUTOSOMAL RECESSIVE	0.003789673	0.1419444070471269
GLASS SYNDROME	0.0037896729999999995	0.1419444070471269
RHIZOMELIC CHONDRODYSPLASIA PUNCTATA, TYPE 5; RCDP5	0.0037896729999999995	0.1419444070471269
MIRAGE SYNDROME; MIRAGE	0.0037896729999999995	0.1419444070471269
MENTAL RETARDATION, AUTOSOMAL DOMINANT 9; MRD9	0.0037896729999999995	0.1419444070471269
CHROMOSOME 1Q41-Q42 DELETION SYNDROME	0.0037896729999999995	0.1419444070471269
ACROMELIC FRONTONASAL DYSPLASIA	0.0037896729999999995	0.1419444070471269
EARLY-ONSET SEIZURES-DISTAL LIMB ANOMALIES-FACIAL DYSMORPHISM-GLOBAL DEVELOPMENTAL DELAY SYNDROME	0.0037896729999999995	0.1419444070471269
PONTOCEREBELLAR HYPOPLASIA, TYPE 11; PCH11	0.0037896729999999995	0.1419444070471269
GENITOPATELLAR SYNDROME	0.0037896729999999995	0.1419444070471269
LISSENCEPHALY 8; LIS8	0.0037896729999999995	0.1419444070471269
HYPEREKPLEXIA 4; HKPX4	0.0037896729999999995	0.1419444070471269
EPILEPSY, NOCTURNAL FRONTAL LOBE, 4; ENFL4	0.003788169	0.14188807385209956
NEURODEGENERATION WITH BRAIN IRON ACCUMULATION 2B; NBIA2B	0.003788169	0.14188807385209956
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 44	0.003788169	0.14188807385209956
3-METHYLGLUTACONIC ACIDURIA, TYPE VIII; MGCA8	0.003788169	0.14188807385209956
ATYPICAL JUVENILE PARKINSONISM	0.003788169	0.14188807385209956
HUNTINGTON DISEASE-LIKE 3	0.003788169	0.14188807385209956
%604802 HUNTINGTON DISEASE-LIKE 3; HDL3;;HUNTINGTON DISEASE-LIKE NEURODEGENERATIVE DISORDER, AUTOSOMAL RECESSIVE	0.003788169	0.14188807385209956
PONTOCEREBELLAR HYPOPLASIA, TYPE 2B; PCH2B	0.003788169	0.14188807385209956
MERCURY POISONING	0.003788169	0.14188807385209956
JUVENILE HUNTINGTON DISEASE	0.003788169	0.14188807385209956
SPASTIC PARAPLEGIA 35, AUTOSOMAL RECESSIVE	0.003788169	0.14188807385209956
LIPOID PROTEINOSIS	0.003788169	0.14188807385209956
CEREBELLAR ATAXIA-AREFLEXIA-PES CAVUS-OPTIC ATROPHY-SENSORINEURAL HEARING LOSS SYNDROME	0.003788169	0.14188807385209956
METACHROMATIC LEUKODYSTROPHY	0.003788169	0.14188807385209956
GLUTARIC ACIDEMIA I; GA1	0.003788169	0.14188807385209956
LEUKODYSTROPHY, HYPOMYELINATING, 14; HLD14	0.003788169	0.14188807385209956
LEUKODYSTROPHY, HYPOMYELINATING, 16; HLD16	0.003788169	0.14188807385209956
PARKINSON DISEASE 19A, JUVENILE-ONSET	0.003788169	0.14188807385209956
ALZHEIMER DISEASE 3; AD	0.003788169	0.14188807385209956
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 15; MC1DN15	0.003788169	0.14188807385209956
DISTAL TRISOMY 5Q	0.0036804999999999997	0.1378552688152647
SHORT-RIB THORACIC DYSPLASIA 7 WITH OR WITHOUT POLYDACTYLY; SRTD7	0.0036804999999999997	0.1378552688152647
ACROCEPHALOPOLYDACTYLY	0.0036804999999999997	0.1378552688152647
NOONAN SYNDROME-LIKE DISORDER WITH LOOSE ANAGEN HAIR	0.0036804999999999997	0.1378552688152647
SILLENCE SYNDROME	0.0036804999999999997	0.1378552688152647
SHORT STATURE, OPTIC NERVE ATROPHY, AND PELGER-HUET ANOMALY; SOPH	0.0036804999999999997	0.1378552688152647
SHORT-RIB THORACIC DYSPLASIA 15 WITH POLYDACTYLY; SRTD15	0.0036804999999999997	0.1378552688152647
TORIELLO-LACASSIE-DROSTE SYNDROME	0.0036804999999999997	0.1378552688152647
SHORT-RIB THORACIC DYSPLASIA 18 WITH POLYDACTYLY; SRTD18	0.0036804999999999997	0.1378552688152647
TERMINAL OSSEOUS DYSPLASIA; TOD	0.0036804999999999997	0.1378552688152647
16P12.1P12.3 TRIPLICATION SYNDROME	0.0036804999999999997	0.1378552688152647
LAURENCE-MOON SYNDROME	0.0036804999999999997	0.1378552688152647
613627 BRACHYDACTYLY, TYPE A1, WITH SHORT STATURE, SCOLIOSIS, MICROCEPHALY,PTOSIS, HEARING LOSS, AND MENTAL RETARDATION;;TSUKAHARA SYNDROME	0.0036804999999999997	0.1378552688152647
ABRUZZO-ERICKSON SYNDROME	0.0036804999999999997	0.1378552688152647
BLEPHARONASOFACIAL MALFORMATION SYNDROME	0.00359596	0.13468877392988432
SCARF SYNDROME	0.00359596	0.13468877392988432
FACIAL DYSMORPHISM-SHAWL SCROTUM-JOINT LAXITY SYNDROME	0.00359596	0.13468877392988432
AMASTIA, BILATERAL, WITH URETERAL TRIPLICATION AND DYSMORPHISM	0.00359596	0.13468877392988432
SHPRINTZEN OMPHALOCELE SYNDROME	0.00359596	0.13468877392988432
271960 SUBAORTIC STENOSIS--SHORT STATURE SYNDROME;;ONAT SYNDROME	0.00359596	0.13468877392988432
FEINGOLD SYNDROME 1; FGLDS1	0.00359596	0.13468877392988432
601450 DISLOCATION OF HIP, CONGENITAL, WITH HYPEREXTENSIBILITY OF FINGERSAND FACIAL DYSMORPHISM;;HIP, CONGENITAL DISLOCATION OF, WITH HYPEREXTENSIBILITY OF FINGERSAND FACIAL DYSMORPHISM	0.00359596	0.13468877392988432
RING CHROMOSOME 13 SYNDROME	0.00359596	0.13468877392988432
RING CHROMOSOME 6 SYNDROME	0.00359596	0.13468877392988432
JOUBERT SYNDROME 3; JBTS3	0.00359596	0.13468877392988432
157980 MOMO SYNDROME;;MACROSOMIA, OBESITY, MACROCEPHALY, AND OCULAR ABNORMALITIES	0.00359596	0.13468877392988432
600736 VELOFACIOSKELETAL SYNDROME	0.00359596	0.13468877392988432
OMODYSPLASIA 1; OMOD1	0.00359596	0.13468877392988432
CHROMOSOME 8Q21.11 DELETION SYNDROME	0.00359596	0.13468877392988432
HYPERTRICHOTIC OSTEOCHONDRODYSPLASIA, CANTU TYPE	0.00359596	0.13468877392988432
HIRSUTISM, SKELETAL DYSPLASIA, AND MENTAL RETARDATION	0.00359596	0.13468877392988432
612948 STARGARDT MACULAR DEGENERATION, ABSENT OR HYPOPLASTIC CORPUS CALLOSUM,MENTAL RETARDATION, AND DYSMORPHIC FEATURES	0.0032703540000000005	0.12249301176228126
17P13.3 MICRODUPLICATION SYNDROME	0.0032703540000000005	0.12249301176228126
12Q14 MICRODELETION SYNDROME	0.0032703540000000005	0.12249301176228126
EAR-PATELLA-SHORT STATURE SYNDROME	0.0032703540000000005	0.12249301176228126
OCULOFACIOCARDIODENTAL SYNDROME	0.0032703540000000005	0.12249301176228126
CHAR SYNDROME	0.0032703540000000005	0.12249301176228126
3Q29 MICRODELETION SYNDROME	0.0032703540000000005	0.12249301176228126
INTELLECTUAL DEVELOPMENTAL DISORDER WITH SHORT STATURE AND VARIABLE SKELETAL ANOMALIES; IDDSSA	0.0032703540000000005	0.12249301176228126
PARTIAL TRISOMY/TETRASOMY OF THE SHORT ARM OF CHROMOSOME 9	0.0032703540000000005	0.12249301176228126
POPOV-CHANG SYNDROME; POPCHAS	0.0032703540000000005	0.12249301176228126
FIBRODYSPLASIA OSSIFICANS PROGRESSIVA	0.0032662190000000003	0.12233813293153785
MATERNAL HYPERTHERMIA-INDUCED BIRTH DEFECTS	0.0032662190000000003	0.12233813293153785
BRANCHIOOCULOFACIAL SYNDROME	0.0032662190000000003	0.12233813293153785
WARBURG MICRO SYNDROME 3; WARBM3	0.0032662190000000003	0.12233813293153785
CORNELIA DE LANGE SYNDROME 1	0.0032662190000000003	0.12233813293153785
FAMILIAL OSTEODYSPLASIA, ANDERSON TYPE	0.0032662190000000003	0.12233813293153785
MICROPHTHALMIA, LENZ TYPE	0.0032662190000000003	0.12233813293153785
CONGENITAL CATARACTS, FACIAL DYSMORPHISM, AND NEUROPATHY; CCFDN	0.003248254	0.12166524340449907
GLYCINE ENCEPHALOPATHY WITH NORMAL SERUM GLYCINE	0.003248254	0.12166524340449907
RAHMAN SYNDROME	0.003248254	0.12166524340449907
SPONDYLOEPIMETAPHYSEAL DYSPLASIA WITH JOINT LAXITY	0.003248254	0.12166524340449907
RICHARDS-RUNDLE SYNDROME; RRNS	0.003248254	0.12166524340449907
JOUBERT SYNDROME 24	0.003248254	0.12166524340449907
CHROMOSOME 17Q23.1-Q23.2 DELETION SYNDROME	0.003248254	0.12166524340449907
LOEYS-DIETZ SYNDROME, TYPE 1A LOEYS-DIETZ AORTIC ANEURYSM SYNDROME	0.003248254	0.12166524340449907
ATELOSTEOGENESIS TYPE III	0.003248254	0.12166524340449907
EHLERS-DANLOS SYNDROME, MUSCULOCONTRACTURAL TYPE, 1; EDSMC1	0.003248254	0.12166524340449907
SYNAPTIC CONGENITAL MYASTHENIC SYNDROMES	0.003248254	0.12166524340449907
CEREBROOCULOFACIOSKELETAL SYNDROME 3; COFS3	0.003248254	0.12166524340449907
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 61; MRT61	0.003248254	0.12166524340449907
WEAVER SYNDROME	0.003248254	0.12166524340449907
SECKEL SYNDROME 9; SCKL9	0.003248254	0.12166524340449907
SPASTIC PARAPLEGIA 55, AUTOSOMAL RECESSIVE; SPG55	0.003248254	0.12166524340449907
ACUTE INFANTILE LIVER FAILURE-CEREBELLAR ATAXIA-PERIPHERAL SENSORY MOTOR NEUROPATHY SYNDROME	0.003248254	0.12166524340449907
PONTOCEREBELLAR HYPOPLASIA, TYPE 8	0.003248254	0.12166524340449907
MANGANESE POISONING	0.00324675	0.12160891020947173
CHARCOT-MARIE-TOOTH DISEASE, TYPE 4K; CMT4K	0.00324675	0.12160891020947173
MACHADO-JOSEPH DISEASE TYPE 2	0.00324675	0.12160891020947173
MACHADO-JOSEPH DISEASE TYPE 3	0.00324675	0.12160891020947173
MYOPATHY WITH EXTRAPYRAMIDAL SIGNS	0.00324675	0.12160891020947173
WOODHOUSE-SAKATI SYNDROME	0.00324675	0.12160891020947173
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 8; MC1DN8	0.00324675	0.12160891020947173
ATAXIA-OCULOMOTOR APRAXIA TYPE 4	0.00324675	0.12160891020947173
BASAL GANGLIA CALCIFICATION, IDIOPATHIC, 1; IBGC1	0.00324675	0.12160891020947173
PARALYSIS AGITANS, JUVENILE, OF HUNT	0.00324675	0.12160891020947173
PARKINSON DISEASE, LATE-ONSET; PD	0.00324675	0.12160891020947173
YOUNG-ONSET PARKINSON DISEASE	0.00324675	0.12160891020947173
SPINOCEREBELLAR ATAXIA WITH AXONAL NEUROPATHY TYPE 2	0.00324675	0.12160891020947173
SPINOCEREBELLAR ATAXIA TYPE 8	0.00324675	0.12160891020947173
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 13; COXPD13	0.00324675	0.12160891020947173
AMYOTROPHIC LATERAL SCLEROSIS 15 WITH OR WITHOUT FRONTOTEMPORAL DEMENTIA; ALS15	0.00324675	0.12160891020947173
LEUKOENCEPHALOPATHY, PROGRESSIVE, WITH OVARIAN FAILURE; LKENP	0.00324675	0.12160891020947173
ATP13A2-RELATED JUVENILE NEURONAL CEROID LIPOFUSCINOSIS	0.00324675	0.12160891020947173
AUTOSOMAL RECESSIVE SPASTIC ATAXIA WITH LEUKOENCEPHALOPATHY	0.00324675	0.12160891020947173
PARKINSON DISEASE 1, AUTOSOMAL DOMINANT; PARK1	0.00324675	0.12160891020947173
NEURODEGENERATION WITH ATAXIA, DYSTONIA, AND GAZE PALSY, CHILDHOOD-ONSET	0.00324675	0.12160891020947173
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 23; MC1DN23	0.00324675	0.12160891020947173
NEURODEGENERATION WITH BRAIN IRON ACCUMULATION	0.00324675	0.12160891020947173
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 26; MC1DN26	0.00324675	0.12160891020947173
HUNTINGTON DISEASE-LIKE 2	0.00324675	0.12160891020947173
MITOCHONDRIAL MEMBRANE PROTEIN-ASSOCIATED NEURODEGENERATION	0.00324675	0.12160891020947173
SPINOCEREBELLAR ATAXIA TYPE 11	0.00324675	0.12160891020947173
MACHADO-JOSEPH DISEASE TYPE 1	0.00324675	0.12160891020947173
SPINOCEREBELLAR ATAXIA, AUTOSOMAL RECESSIVE 1; SCAR1	0.00324675	0.12160891020947173
CEREBRORETINAL MICROANGIOPATHY WITH CALCIFICATIONS AND CYSTS 2	0.00324675	0.12160891020947173
ATAXIA, EARLY-ONSET, WITH OCULOMOTOR APRAXIA AND HYPOALBUMINEMIA; EAOH	0.00324675	0.12160891020947173
ATAXIA-TELANGIECTASIA-LIKE DISORDER 1; ATLD1	0.00324675	0.12160891020947173
ATAXIA-TELANGIECTASIA-LIKE DISORDER	0.00324675	0.12160891020947173
METHIONINE ADENOSYLTRANSFERASE I/III DEFICIENCY	0.00324675	0.12160891020947173
AUTOSOMAL RECESSIVE SPASTIC PARAPLEGIA TYPE 78	0.00324675	0.12160891020947173
PARKINSON DISEASE 20, EARLY-ONSET; PARK20	0.00324675	0.12160891020947173
SPINOCEREBELLAR ATAXIA TYPE 1	0.00324675	0.12160891020947173
SPINOCEREBELLAR ATAXIA TYPE 2	0.00324675	0.12160891020947173
AMYOTROPHIC LATERAL SCLEROSIS 2, JUVENILE; ALS2	0.00324675	0.12160891020947173
SPASTIC PARAPLEGIA, ATAXIA, AND MENTAL RETARDATION	0.00324675	0.12160891020947173
224550 DYSTONIA WITH RINGBINDEN	0.00324675	0.12160891020947173
SPASTIC PARAPLEGIA 26, AUTOSOMAL RECESSIVE; SPG26	0.00324675	0.12160891020947173
CEREBELLAR ATAXIA, AREFLEXIA, PES CAVUS, OPTIC ATROPHY, AND SENSORINEURAL HEARING LOSS; CAPOS	0.00324675	0.12160891020947173
DYSTONIA 15, MYOCLONIC; DYT15	0.00324675	0.12160891020947173
SPASTIC ATAXIA 8, AUTOSOMAL RECESSIVE, WITH HYPOMYELINATING LEUKODYSTROPHY; SPAX8	0.00324675	0.12160891020947173
FRONTOTEMPORAL DEMENTIA, CHROMOSOME 3-LINKED; FTD3	0.00324675	0.12160891020947173
SPINOCEREBELLAR ATAXIA TYPE 3	0.00324675	0.12160891020947173
AUTOSOMAL RECESSIVE SPASTIC PARAPLEGIA TYPE 26	0.00324675	0.12160891020947173
AICARDI-GOUTIERES SYNDROME 2; AGS2	0.00324675	0.12160891020947173
HUNTINGTON DISEASE-LIKE 2	0.00324675	0.12160891020947173
FAMILIAL DYSKINESIA AND FACIAL MYOKYMIA	0.00324675	0.12160891020947173
PARKINSON DISEASE 6, AUTOSOMAL RECESSIVE EARLY-ONSET	0.00324675	0.12160891020947173
LEBER OPTIC ATROPHY AND DYSTONIA	0.00324675	0.12160891020947173
SPINOCEREBELLAR ATAXIA, AUTOSOMAL RECESSIVE 4; SCAR4	0.00324675	0.12160891020947173
%611031 EPISODIC KINESIGENIC DYSKINESIA 2; EKD2;;DYSTONIA 19; DYT19	0.00324675	0.12160891020947173
CARIBBEAN PARKINSONISM	0.00324675	0.12160891020947173
HYPOPREBETALIPOPROTEINEMIA, ACANTHOCYTOSIS, RETINITIS PIGMENTOSA,AND PALLIDAL DEGENERATION	0.00324675	0.12160891020947173
ATAXIA-TELANGIECTASIA WITH GENERALIZED SKIN PIGMENTATION AND EARLY DEATH	0.00324675	0.12160891020947173
PARKINSON DISEASE 14, AUTOSOMAL RECESSIVE; PARK14	0.00324675	0.12160891020947173
HEREDITARY LATE-ONSET PARKINSON DISEASE	0.00324675	0.12160891020947173
MACHADO-JOSEPH DISEASE; MJD	0.00324675	0.12160891020947173
CIRRHOSIS-DYSTONIA-POLYCYTHEMIA-HYPERMANGANESEMIA SYNDROME	0.00324675	0.12160891020947173
AMYOTROPHIC DYSTONIC PARAPLEGIA	0.00324675	0.12160891020947173
FRIEDREICH ATAXIA	0.00324675	0.12160891020947173
HUNTINGTON DISEASE-LIKE SYNDROME DUE TO C9ORF72 EXPANSIONS	0.00324675	0.12160891020947173
HEMIPARKINSONISM-HEMIATROPHY SYNDROME	0.00324675	0.12160891020947173
EPISODIC ATAXIA, TYPE 2	0.00324675	0.12160891020947173
LESCH-NYHAN SYNDROME; LNS	0.00324675	0.12160891020947173
HYPERMANGANESEMIA WITH DYSTONIA 1; HMNDYT1	0.00324675	0.12160891020947173
BASAL GANGLIA CALCIFICATION, IDIOPATHIC, 7, AUTOSOMAL RECESSIVE; IBGC7	0.00324675	0.12160891020947173
SPASTIC ATAXIA 1, AUTOSOMAL DOMINANT; SPAX1	0.00324675	0.12160891020947173
PROGRESSIVE SUPRANUCLEAR PALSY-PARKINSONISM SYNDROME	0.00324675	0.12160891020947173
ATAXIA-OCULOMOTOR APRAXIA 4; AOA4	0.00324675	0.12160891020947173
WILSON DISEASE	0.00324675	0.12160891020947173
CYSTATHIONINURIA	0.0032441189999999997	0.12151036457375565
POLYMICROGYRIA WITH OR WITHOUT VASCULAR-TYPE EHLERS-DANLOS SYNDROME; PMGEDSV	0.0032441189999999997	0.12151036457375565
X-LINKED INTELLECTUAL DISABILITY-ATAXIA-APRAXIA SYNDROME	0.0032441189999999997	0.12151036457375565
PEROXISOME BIOGENESIS DISORDER 7A (ZELLWEGER); PBD7A	0.0032441189999999997	0.12151036457375565
CRISPONI/COLD-INDUCED SWEATING SYNDROME 1; CISS1	0.0032441189999999997	0.12151036457375565
ARTHROGRYPOSIS MULTIPLEX CONGENITA, NEUROGENIC, WITH MYELIN DEFECT	0.0032441189999999997	0.12151036457375565
COWDEN SYNDROME	0.003136153	0.11746643522912617
SPONDYLOEPIMETAPHYSEAL DYSPLASIA, KRAKOW TYPE; SEMDK	0.003136153	0.11746643522912617
AMINOACYLASE 1 DEFICIENCY; ACY1D	0.0030516130000000003	0.1142999403437458
INTELLECTUAL DEVELOPMENTAL DISORDER, AUTOSOMAL RECESSIVE 68; MRT68	0.0030516130000000003	0.1142999403437458
GLYCOSYLPHOSPHATIDYLINOSITOL BIOSYNTHESIS DEFECT 11; GPIBD11	0.0030516130000000003	0.1142999403437458
HYPERPHOSPHATASIA WITH MENTAL RETARDATION SYNDROME 4	0.0030516130000000003	0.1142999403437458
HYPERPHOSPHATASIA WITH MENTAL RETARDATION SYNDROME 3; HPMRS3	0.0030516130000000003	0.1142999403437458
3Q29 MICRODUPLICATION SYNDROME	0.003051613	0.11429994034374577
MOSAIC TRISOMY 14	0.003051613	0.11429994034374577
PONTOCEREBELLAR HYPOPLASIA TYPE 10	0.003051613	0.11429994034374577
MENTAL RETARDATION, AUTOSOMAL DOMINANT 43; MRD43	0.003051613	0.11429994034374577
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 5	0.003051613	0.11429994034374577
AUTOSOMAL RECESSIVE CUTIS LAXA TYPE 2	0.003051613	0.11429994034374577
NEURODEVELOPMENTAL DISORDER WITH CENTRAL AND PERIPHERAL MOTOR DYSFUNCTION; NEDCPMD	0.003051613	0.11429994034374577
MICRO SYNDROME	0.003051613	0.11429994034374577
PONTOCEREBELLAR HYPOPLASIA, TYPE 10; PCH10	0.003051613	0.11429994034374577
INTELLECTUAL DEVELOPMENTAL DISORDER WITH CARDIAC DEFECTS AND DYSMORPHIC FACIES; IDDCDF	0.003051613	0.11429994034374577
CHROMOSOME 1P35 DELETION SYNDROME	0.003051613	0.11429994034374577
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IIM; CDG2M	0.003051613	0.11429994034374577
KABUKI SYNDROME 1	0.003051613	0.11429994034374577
PERIPHERAL DEMYELINATING NEUROPATHY-CENTRAL DYSMYELINATING LEUKODYSTROPHY-WAARDENBURG SYNDROME-HIRSCHSPRUNG DISEASE	0.003051613	0.11429994034374577
DESBUQUOIS SYNDROME	0.0027248000000000003	0.10205896928891002
ANONYCHIA-MICROCEPHALY SYNDROME	0.0027248000000000003	0.10205896928891002
SYNDACTYLY, MESOAXIAL SYNOSTOTIC, WITH PHALANGEAL REDUCTION	0.0027248000000000003	0.10205896928891002
311895 PIERRE ROBIN SEQUENCE WITH FACIAL AND DIGITAL ANOMALIES	0.0027248000000000003	0.10205896928891002
SYNDACTYLY TYPE 2	0.0027248000000000003	0.10205896928891002
129540 ECTODERMAL DYSPLASIA SYNDROME WITH DISTINCTIVE FACIAL APPEARANCE ANDPREAXIAL POLYDACTYLY OF FEET	0.0027248000000000003	0.10205896928891002
PELVIS-SHOULDER DYSPLASIA	0.0027248000000000003	0.10205896928891002
MICROCEPHALY-CARDIOMYOPATHY	0.0027248000000000003	0.10205896928891002
METATROPIC DYSPLASIA	0.0027248000000000003	0.10205896928891002
TALONAVICULAR COALITION	0.0027248000000000003	0.10205896928891002
METAPHYSEAL CHONDRODYSPLASIA, JANSEN TYPE	0.0027248000000000003	0.10205896928891002
HALLUX VARUS-PREAXIAL POLYSYNDACTYLY SYNDROME	0.0027248000000000003	0.10205896928891002
EXTERNAL AUDITORY CANAL ATRESIA-VERTICAL TALUS-HYPERTELORISM SYNDROME	0.0027248000000000003	0.10205896928891002
OSLAM SYNDROME	0.0027248000000000003	0.10205896928891002
FIBRODYSPLASIA OSSIFICANS PROGRESSIVA; FOP	0.0027248000000000003	0.10205896928891002
X-LINKED INTELLECTUAL DISABILITY, VAN ESCH TYPE	0.0027248000000000003	0.10205896928891002
ROBIN SEQUENCE-OLIGODACTYLY SYNDROME	0.0027248000000000003	0.10205896928891002
DEAFNESS, CONDUCTIVE, WITH PTOSIS AND SKELETAL ANOMALIES	0.0027248000000000003	0.10205896928891002
APLASIA CUTIS CONGENITA-INTESTINAL LYMPHANGIECTASIA SYNDROME	0.0027248000000000003	0.10205896928891002
X-LINKED INTELLECTUAL DISABILITY, CILLIERS TYPE	0.0027248000000000003	0.10205896928891002
MESOAXIAL SYNOSTOTIC SYNDACTYLY WITH PHALANGEAL REDUCTION	0.0027248000000000003	0.10205896928891002
SYNDACTYLY TYPE 5	0.0027248000000000003	0.10205896928891002
EPIPHYSEAL DYSPLASIA, BAUMANN TYPE	0.0027248000000000003	0.10205896928891002
19Q13.11 MICRODELETION SYNDROME	0.0027248000000000003	0.10205896928891002
INTELLECTUAL DISABILITY-SHORT STATURE-HYPERTELORISM SYNDROME	0.0027248000000000003	0.10205896928891002
MICROCEPHALY 24, PRIMARY, AUTOSOMAL RECESSIVE; MCPH24	0.0027248000000000003	0.10205896928891002
MASA SYNDROME	0.0027248000000000003	0.10205896928891002
TETRALOGY OF FALLOT	0.0027248000000000003	0.10205896928891002
KERATOSIS PALMARIS ET PLANTARIS WITH CLINODACTYLY	0.0027248000000000003	0.10205896928891002
LACRIMOAURICULODENTODIGITAL SYNDROME; LADD	0.0027248000000000003	0.10205896928891002
SHORT STATURE, FACIAL DYSMORPHISM, AND SKELETAL ANOMALIES WITH OR WITHOUT CARDIAC ANOMALIES; SSFSC	0.0027248000000000003	0.10205896928891002
CLEFT LIP/PALATE-INTESTINAL MALROTATION-CARDIOPATHY SYNDROME	0.0027248000000000003	0.10205896928891002
MOLAR I REINCLUSION	0.0027248000000000003	0.10205896928891002
DENTAL ANKYLOSIS	0.0027248000000000003	0.10205896928891002
INTELLECTUAL DISABILITY-POLYDACTYLY-UNCOMBABLE HAIR SYNDROME	0.0027248000000000003	0.10205896928891002
SECKEL SYNDROME 5; SCKL5	0.0027248000000000003	0.10205896928891002
SHORT STATURE-VALVULAR HEART DISEASE-CHARACTERISTIC FACIES SYNDROME	0.0027248000000000003	0.10205896928891002
ACROFACIAL DYSOSTOSIS, WEYERS TYPE	0.0027248000000000003	0.10205896928891002
BOWEN-CONRADI SYNDROME	0.0027248000000000003	0.10205896928891002
SPASTIC PARAPLEGIA-NEPHRITIS-DEAFNESS SYNDROME	0.0027248000000000003	0.10205896928891002
KERATOSIS PALMARIS ET PLANTARIS-CLINODACTYLY SYNDROME	0.0027248000000000003	0.10205896928891002
FETAL MINOXIDIL SYNDROME	0.0027248000000000003	0.10205896928891002
LIMB-MAMMARY SYNDROME	0.0027248000000000003	0.10205896928891002
HUNTER-MACDONALD SYNDROME	0.0027248000000000003	0.10205896928891002
THROMBOCYTOPENIA-ABSENT RADIUS SYNDROME	0.0027248000000000003	0.10205896928891002
CEREBROCOSTOMANDIBULAR SYNDROME	0.0027248000000000003	0.10205896928891002
RADIOULNAR SYNOSTOSIS WITH AMEGAKARYOCYTIC THROMBOCYTOPENIA	0.0027248000000000003	0.10205896928891002
HYPOPLASTIC TIBIAE-POSTAXIAL POLYDACTYLY SYNDROME	0.0027248000000000003	0.10205896928891002
CATEL-MANZKE SYNDROME	0.0027248000000000003	0.10205896928891002
WT LIMB-BLOOD SYNDROME	0.0027248000000000003	0.10205896928891002
HYPOSPADIAS-INTELLECTUAL DISABILITY, GOLDBLATT TYPE SYNDROME	0.0027248000000000003	0.10205896928891002
ATAXIA-PHOTOSENSITIVITY-SHORT STATURE SYNDROME	0.0027248000000000003	0.10205896928891002
MOSAIC TRISOMY 8	0.0027248000000000003	0.10205896928891002
MESOMELIC DYSPLASIA, NIEVERGELT TYPE	0.0027248000000000003	0.10205896928891002
ALAGILLE SYNDROME	0.0027248000000000003	0.10205896928891002
DIAPHRAGMATIC DEFECTS, LIMB DEFICIENCIES, AND OSSIFICATION DEFECTS OF SKULL	0.0027248000000000003	0.10205896928891002
BRACHYDACTYLY TYPE A7	0.0027248000000000003	0.10205896928891002
TRICHORHINOPHALANGEAL SYNDROME TYPE 1 AND 3	0.0027248000000000003	0.10205896928891002
BLOOM SYNDROME	0.0027248000000000003	0.10205896928891002
SKELETAL DYSPLASIA WITH DELAYED EPIPHYSEAL AND CARPAL BONE OSSIFICATION	0.0027248000000000003	0.10205896928891002
3M SYNDROME	0.0027248000000000003	0.10205896928891002
DIAPHRAGMATIC DEFECT-LIMB DEFICIENCY-SKULL DEFECT SYNDROME	0.0027248000000000003	0.10205896928891002
FLOATING-HARBOR SYNDROME	0.0027248000000000003	0.10205896928891002
MANDIBULOFACIAL DYSOSTOSIS, GUION-ALMEIDA TYPE; MFDGA	0.002718293	0.10181524581813677
DISTAL 22Q11.2 MICRODUPLICATION SYNDROME	0.002718293	0.10181524581813677
OPTIC ATROPHY-INTELLECTUAL DISABILITY SYNDROME	0.002718293	0.10181524581813677
PEHO SYNDROME; PEHO	0.002718293	0.10181524581813677
MONOSOMY 9P	0.002718293	0.10181524581813677
MICROCEPHALY-SEIZURES-INTELLECTUAL DISABILITY-HEART DISEASE SYNDROME	0.002718293	0.10181524581813677
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IIL; CDG2L	0.002718293	0.10181524581813677
CK SYNDROME	0.002718293	0.10181524581813677
HOLOPROSENCEPHALY 12 WITH OR WITHOUT PANCREATIC AGENESIS; HPE12	0.002718293	0.10181524581813677
MEGALENCEPHALY-CAPILLARY MALFORMATION-POLYMICROGYRIA SYNDROME	0.002718293	0.10181524581813677
X-LINKED INTELLECTUAL DISABILITY, ARMFIELD TYPE	0.002718293	0.10181524581813677
DISTAL TRISOMY 17Q	0.002718293	0.10181524581813677
BASEL-VANAGAITE-SMIRIN-YOSEF SYNDROME; BVSYS	0.002718293	0.10181524581813677
MENTAL RETARDATION, AUTOSOMAL DOMINANT 57; MRD57	0.002718293	0.10181524581813677
TEMPLE-BARAITSER SYNDROME; TMBTS	0.002718293	0.10181524581813677
22Q11.2 MICRODUPLICATION SYNDROME	0.002718293	0.10181524581813677
MICROCEPHALY, GROWTH RETARDATION, CATARACT, HEARING LOSS, AND UNUSUAL APPEARANCE	0.002718293	0.10181524581813677
MULTIPLE CONGENITAL ANOMALIES-HYPOTONIA-SEIZURES SYNDROME 1; MCAHS1	0.002718293	0.10181524581813677
MONOSOMY 9Q22.3	0.002718293	0.10181524581813677
MENTAL RETARDATION, AUTOSOMAL DOMINANT 38; MRD38	0.0027182929999999997	0.10181524581813675
XQ25 MICRODUPLICATION SYNDROME	0.0027182929999999997	0.10181524581813675
MENTAL RETARDATION, AUTOSOMAL DOMINANT 53; MRD53	0.0027182929999999997	0.10181524581813675
X-LINKED INTELLECTUAL DISABILITY, PAI TYPE	0.0027182929999999997	0.10181524581813675
XQ25 DUPLICATION SYNDROME	0.0027182929999999997	0.10181524581813675
MITOCHONDRIAL COMPLEX III DEFICIENCY, NUCLEAR TYPE 7; MC3DN7	0.0027182929999999997	0.10181524581813675
MITOCHONDRIAL PYRUVATE CARRIER DEFICIENCY	0.0027182929999999997	0.10181524581813675
ELLIS-VAN CREVELD SYNDROME	0.0027026999999999997	0.1012312009311278
AUTOSOMAL RECESSIVE CENTRONUCLEAR MYOPATHY	0.0027026999999999997	0.1012312009311278
CONTRACTURES, PTERYGIA, AND VARIABLE SKELETAL FUSIONS SYNDROME 1B	0.0027026999999999997	0.1012312009311278
JOINT LAXITY, SHORT STATURE, AND MYOPIA; JLSM	0.0027026999999999997	0.1012312009311278
LARYNGEAL ABDUCTOR PARALYSIS	0.0027026999999999997	0.1012312009311278
CHARCOT-MARIE-TOOTH DISEASE, AXONAL, TYPE 2K; CMT2K	0.0027026999999999997	0.1012312009311278
CHARCOT-MARIE-TOOTH DISEASE, TYPE 4H; CMT4H	0.0027026999999999997	0.1012312009311278
ERYTHEMA OF ACRAL REGIONS	0.0027026999999999997	0.1012312009311278
CHARCOT-MARIE-TOOTH DISEASE, AXONAL, TYPE 2S; CMT2S	0.0027026999999999997	0.1012312009311278
LISSENCEPHALY TYPE 3-METACARPAL BONE DYSPLASIA SYNDROME	0.0027026999999999997	0.1012312009311278
BRUCK SYNDROME 2	0.0027026999999999997	0.1012312009311278
MYOPATHIC EHLERS-DANLOS SYNDROME	0.0027026999999999997	0.1012312009311278
258040 OEIS COMPLEX;;OMPHALOCELE-EXSTROPHY-IMPERFORATE ANUS-SPINAL DEFECTS	0.0027026999999999997	0.1012312009311278
CERVICAL RIBS, SPRENGEL ANOMALY, ANAL ATRESIA, AND URETHRAL OBSTRUCTION	0.0027026999999999997	0.1012312009311278
CHARCOT-MARIE-TOOTH DISEASE, TYPE 4B1; CMT4B1	0.0027026999999999997	0.1012312009311278
CRANE-HEISE SYNDROME	0.0027026999999999997	0.1012312009311278
APROSENCEPHALY AND CEREBELLAR DYSGENESIS	0.0027026999999999997	0.1012312009311278
FIBULAR HEMIMELIA	0.0027026999999999997	0.1012312009311278
SPONDYLOEPIMETAPHYSEAL DYSPLASIA CONGENITA, STRUDWICK TYPE	0.0027026999999999997	0.1012312009311278
ULNAR HYPOPLASIA WITH MENTAL RETARDATION	0.0027026999999999997	0.1012312009311278
ARTHROGRYPOSIS, DISTAL, TYPE 1B	0.0027026999999999997	0.1012312009311278
SPONDYLOEPIPHYSEAL DYSPLASIA CONGENITA	0.0027026999999999997	0.1012312009311278
CHARCOT-MARIE-TOOTH DISEASE, AXONAL, TYPE 2R; CMT2R	0.0027026999999999997	0.1012312009311278
NATIVE AMERICAN MYOPATHY	0.0027026999999999997	0.1012312009311278
AUTOSOMAL DOMINANT CHARCOT-MARIE-TOOTH DISEASE TYPE 2F	0.0027026999999999997	0.1012312009311278
EHLERS-DANLOS SYNDROME, MUSCULOCONTRACTURAL TYPE, 2; EDSMC2	0.0027026999999999997	0.1012312009311278
%217100 CONSTRICTING BANDS, CONGENITAL;;AMNIOTIC BAND SEQUENCE; ABS;;STREETER ANOMALYADAM COMPLEX, INCLUDED;;TERMINAL TRANSVERSE DEFECTS OF ARM, INCLUDED;;AMPUTATION, CONGENITAL, INCLUDED	0.0027026999999999997	0.1012312009311278
KYPHOMELIC DYSPLASIA	0.0027026999999999997	0.1012312009311278
ABLEPHARON-MACROSTOMIA SYNDROME	0.0027026999999999997	0.1012312009311278
ARTHROGRYPOSIS, DISTAL, TYPE 7	0.0027026999999999997	0.1012312009311278
CONGENITAL FIBER-TYPE DISPROPORTION MYOPATHY	0.0027026999999999997	0.1012312009311278
AUTOSOMAL RECESSIVE SPASTIC PARAPLEGIA TYPE 66	0.0027026999999999997	0.1012312009311278
ISOLATED CLEFT LIP	0.0027026999999999997	0.1012312009311278
PSEUDODIASTROPHIC DYSPLASIA	0.0027026999999999997	0.1012312009311278
AURAL ATRESIA, MULTIPLE CONGENITAL ANOMALIES, AND MENTAL RETARDATION	0.0027026999999999997	0.1012312009311278
CAMPOMELIC DYSPLASIA	0.0027026999999999997	0.1012312009311278
BRUCK SYNDROME	0.0027026999999999997	0.1012312009311278
MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (LIMB-GIRDLE), TYPE C, 4; MDDGC4	0.0027026999999999997	0.1012312009311278
SPONDYLOEPIPHYSEAL DYSPLASIA CONGENITA	0.0027026999999999997	0.1012312009311278
GIANT AXONAL NEUROPATHY	0.0027026999999999997	0.1012312009311278
AUTOSOMAL RECESSIVE SPASTIC PARAPLEGIA TYPE 55	0.0027026999999999997	0.1012312009311278
MUSCULAR DYSTROPHY, LIMB-GIRDLE, TYPE 2W; LGMD2W	0.0027026999999999997	0.1012312009311278
MASA SYNDROME	0.0027026999999999997	0.1012312009311278
CHROMOSOME 2Q31.1 DUPLICATION SYNDROME	0.0027026999999999997	0.1012312009311278
BARTH SYNDROME; BTHS	0.0027026999999999997	0.1012312009311278
PSEUDODIASTROPHIC DYSPLASIA	0.0027026999999999997	0.1012312009311278
MODERATE MULTIMINICORE DISEASE WITH HAND INVOLVEMENT	0.0027026999999999997	0.1012312009311278
SPASTIC PARAPLEGIA 64, AUTOSOMAL RECESSIVE; SPG64	0.0027026999999999997	0.1012312009311278
ARTHROGRYPOSIS, DISTAL, TYPE 1A; DA1A	0.0027026999999999997	0.1012312009311278
MECKEL SYNDROME, TYPE 6; MKS6	0.0027026999999999997	0.1012312009311278
BILIARY MALFORMATION WITH RENAL TUBULAR INSUFFICIENCY	0.0027026999999999997	0.1012312009311278
MUCOPOLYSACCHARIDOSIS, TYPE VII; MPS7	0.0027026999999999997	0.1012312009311278
AMYLOIDOSIS	0.0027026999999999997	0.1012312009311278
ARTHROGRYPOSIS, DISTAL, TYPE 5D; DA5D	0.0027026999999999997	0.1012312009311278
%211960 CAMPTODACTYLY WITH MUSCULAR HYPOPLASIA, SKELETAL DYSPLASIA, AND ABNORMALPALMAR CREASES;;TEL HASHOMER CAMPTODACTYLY SYNDROME	0.0027026999999999997	0.1012312009311278
SPINOCEREBELLAR ATAXIA, AUTOSOMAL RECESSIVE 21	0.0027026999999999997	0.1012312009311278
LOEYS-DIETZ SYNDROME 3; LDS3	0.0027026999999999997	0.1012312009311278
KYPHOSCOLIOSIS-LATERAL TONGUE ATROPHY-HEREDITARY SPASTIC PARAPLEGIA SYNDROME	0.0027026999999999997	0.1012312009311278
MYOPATHY, MYOFIBRILLAR, 7; MFM7	0.0027026999999999997	0.1012312009311278
MEIER-GORLIN SYNDROME 3; MGORS3	0.0027026999999999997	0.1012312009311278
MELNICK-NEEDLES SYNDROME	0.0027026999999999997	0.1012312009311278
NEMALINE MYOPATHY 11, AUTOSOMAL RECESSIVE; NEM11	0.0027026999999999997	0.1012312009311278
ARTHROGRYPOSIS MULTIPLEX CONGENITA, MYOGENIC TYPE; AMCM	0.0027026999999999997	0.1012312009311278
CHARCOT-MARIE-TOOTH DISEASE, TYPE 4B2; CMT4B2	0.0027026999999999997	0.1012312009311278
TIBIA, ABSENCE OR HYPOPLASIA OF, WITH POLYDACTYLY, RETROCEREBELLAR ARACHNOID CYST, AND OTHER ANOMALIES	0.0027026999999999997	0.1012312009311278
VAN DEN ENDE-GUPTA SYNDROME; VDEGS	0.0027026999999999997	0.1012312009311278
CAUDAL REGRESSION SEQUENCE	0.0027026999999999997	0.1012312009311278
CENTRAL CORE DISEASE	0.0027026999999999997	0.1012312009311278
LETHAL CONGENITAL CONTRACTURE SYNDROME 9; LCCS9	0.0027026999999999997	0.1012312009311278
LOEYS-DIETZ SYNDROME 5	0.0027026999999999997	0.1012312009311278
ARTHROGRYPOSIS, DISTAL, TYPE 2B3; DA2B3	0.0027026999999999997	0.1012312009311278
CAMPTODACTYLY SYNDROME, GUADALAJARA TYPE 2	0.0027026999999999997	0.1012312009311278
MICROCEPHALIC OSTEODYSPLASTIC DYSPLASIA, SAUL-WILSON TYPE	0.0027026999999999997	0.1012312009311278
NIEVERGELT SYNDROME	0.0027026999999999997	0.1012312009311278
SPASTIC PARAPLEGIA 33, AUTOSOMAL DOMINANT	0.0027026999999999997	0.1012312009311278
CLOACAL EXSTROPHY	0.0027026999999999997	0.1012312009311278
LAMBERT SYNDROME	0.0027026999999999997	0.1012312009311278
ARTHROGRYPOSIS, DISTAL, TYPE 2E	0.0027026999999999997	0.1012312009311278
POLYMICROGYRIA, PERISYLVIAN, WITH CEREBELLAR HYPOPLASIA AND ARTHROGRYPOSIS; PMGYCHA	0.0027026999999999997	0.1012312009311278
ACHONDROGENESIS TYPE 1B	0.0027026999999999997	0.1012312009311278
CONTRACTURAL ARACHNODACTYLY, CONGENITAL	0.0027026999999999997	0.1012312009311278
POPLITEAL PTERYGIUM SYNDROME	0.0027026999999999997	0.1012312009311278
CAMPOMELIC DYSPLASIA	0.0027026999999999997	0.1012312009311278
EHLERS-DANLOS SYNDROME, KYPHOSCOLIOTIC TYPE, 2; EDSKSCL2	0.0027026999999999997	0.1012312009311278
CHONDRODYSPLASIA PUNCTATA, AUTOSOMAL DOMINANTCHONDRODYSPLASIA PUNCTATA DUE TO VITAMIN K DEFICIENCY, INCLUDED	0.0027026999999999997	0.1012312009311278
ARTHROGRYPOSIS MULTIPLEX CONGENITA, NEUROGENIC TYPE; AMCN	0.0027026999999999997	0.1012312009311278
SPINAL MUSCULAR ATROPHY, DISTAL, AUTOSOMAL RECESSIVE, 4	0.0027026999999999997	0.1012312009311278
INIENCEPHALY	0.0027026999999999997	0.1012312009311278
SCAPULOPERONEAL SYNDROME, NEUROGENIC, KAESER TYPE	0.0027026999999999997	0.1012312009311278
SCHWARTZ-JAMPEL SYNDROME, TYPE 1; SJS1	0.0027026999999999997	0.1012312009311278
AUTOSOMAL RECESSIVE SPASTIC PARAPLEGIA TYPE 59	0.0027026999999999997	0.1012312009311278
INTELLECTUAL DEVELOPMENTAL DISORDER 59; MRD59	0.0025947339999999996	0.0971872715864983
ACRODYSOSTOSIS 2 WITH OR WITHOUT HORMONE RESISTANCE	0.0025947339999999996	0.0971872715864983
MCKUSICK-KAUFMAN SYNDROME	0.0025947339999999996	0.0971872715864983
LENZ-MAJEWSKI HYPEROSTOTIC DWARFISM	0.0025947339999999996	0.0971872715864983
DEAFNESS-EPIPHYSEAL DYSPLASIA-SHORT STATURE SYNDROME	0.0025947339999999996	0.0971872715864983
BARDET-BIEDL SYNDROME 3; BBS3	0.0025947339999999996	0.0971872715864983
CHOPS SYNDROME; CHOPS	0.0025947339999999996	0.0971872715864983
MICROBRACHYCEPHALY-PTOSIS-CLEFT LIP SYNDROME	0.0025947339999999996	0.0971872715864983
AL-RAQAD SYNDROME; ARS	0.0025947339999999996	0.0971872715864983
BARDET-BIEDL SYNDROME 1; BBS1	0.0025947339999999996	0.0971872715864983
BARDET-BIEDL SYNDROME 17; BBS17	0.0025947339999999996	0.0971872715864983
ACRODYSOSTOSIS WITH MULTIPLE HORMONE RESISTANCE	0.0025947339999999996	0.0971872715864983
INTELLECTUAL DEVELOPMENTAL DISORDER WITH GASTROINTESTINAL DIFFICULTIES AND HIGH PAIN THRESHOLD	0.0025947339999999996	0.0971872715864983
THANATOPHORIC DYSPLASIA TYPE 2	0.002590599	0.0970323927557549
CHROMOSOME 17Q12 DUPLICATION SYNDROME	0.002590599	0.0970323927557549
IMMUNOSKELETAL DYSPLASIA WITH NEURODEVELOPMENTAL ABNORMALITIES; ISDNA	0.002590599	0.0970323927557549
ALOPECIA-INTELLECTUAL DISABILITY SYNDROME	0.002590599	0.0970323927557549
VITAMIN K ANTAGONIST EMBRYOFETOPATHY	0.002590599	0.0970323927557549
X-LINKED INTELLECTUAL DISABILITY WITH MARFANOID HABITUS	0.002590599	0.0970323927557549
CRANIOSYNOSTOSIS 2	0.002590599	0.0970323927557549
ADAMS-OLIVER SYNDROME 5; AOS5	0.002590599	0.0970323927557549
THANATOPHORIC DYSPLASIA TYPE 1	0.002590599	0.0970323927557549
NICOLAIDES-BARAITSER SYNDROME; NCBRS	0.002590599	0.0970323927557549
SKELETAL DYSPLASIA AND PROGRESSIVE CENTRAL NERVOUS SYSTEM DEGENERATION, LETHAL	0.002590599	0.0970323927557549
300232 SPONDYLOEPIMETAPHYSEAL DYSPLASIA, X-LINKED, WITH MENTAL DETERIORATION;;SEMD, X-LINKED, WITH MENTAL DETERIORATION	0.002590599	0.0970323927557549
ALAZAMI SYNDROME; ALAZS	0.0025101940000000003	0.09402077670111794
MENTAL RETARDATION, AUTOSOMAL DOMINANT 18; MRD18	0.0025101940000000003	0.09402077670111794
CONGENITAL CONTRACTURES OF THE LIMBS AND FACE, HYPOTONIA, AND DEVELOPMENTAL DELAY	0.0025101940000000003	0.09402077670111794
TREACHER-COLLINS SYNDROME	0.0025101940000000003	0.09402077670111794
NOONAN SYNDROME WITH MULTIPLE LENTIGINES	0.0025101940000000003	0.09402077670111794
HAMEL CEREBRO-PALATO-CARDIAC SYNDROME	0.0025101940000000003	0.09402077670111794
CEREBELLAR-FACIAL-DENTAL SYNDROME	0.0025101940000000003	0.09402077670111794
FANCONI ANEMIA, COMPLEMENTATION GROUP L	0.0025101940000000003	0.09402077670111794
GERMAN SYNDROME	0.0025101940000000003	0.09402077670111794
SPONDYLOEPIPHYSEAL DYSPLASIA TARDA WITH CHARACTERISTIC FACIES	0.0025101940000000003	0.09402077670111794
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 25; COXPD25	0.0025101940000000003	0.09402077670111794
HURLER SYNDROME	0.0025101940000000003	0.09402077670111794
INTELLECTUAL DEVELOPMENTAL DISORDER WITH SHORT STATURE, FACIAL ANOMALIES, AND SPEECH DEFECTS; IDDSFAS	0.0025101940000000003	0.09402077670111794
17Q24.2 MICRODELETION SYNDROME	0.002506059	0.09386589787037453
PEROXISOME BIOGENESIS DISORDER 3A (ZELLWEGER); PBD3A	0.002506059	0.09386589787037453
GOLDBERG-SHPRINTZEN MEGACOLON SYNDROME	0.002506059	0.09386589787037453
ZLOTOGORA-OGUR SYNDROME	0.002506059	0.09386589787037453
ZIMMERMANN-LABAND SYNDROME 1	0.002506059	0.09386589787037453
AUTOSOMAL RECESSIVE CHORIORETINOPATHY-MICROCEPHALY SYNDROME	0.002506059	0.09386589787037453
INFANTILE-ONSET X-LINKED SPINAL MUSCULAR ATROPHY	0.002506059	0.09386589787037453
ACROCARDIOFACIAL SYNDROME	0.002506059	0.09386589787037453
ASPARTYLGLUCOSAMINURIA	0.002506059	0.09386589787037453
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 13; MRT13	0.002506059	0.09386589787037453
SIALIDOSIS TYPE 1	0.002506059	0.09386589787037453
FRYNS SYNDROME; FRNS	0.002506059	0.09386589787037453
GREIG CEPHALOPOLYSYNDACTYLY SYNDROME	0.002506059	0.09386589787037453
FAMILIAL BENIGN COPPER DEFICIENCY	0.002506059	0.09386589787037453
RING CHROMOSOME 10 SYNDROME	0.002506059	0.09386589787037453
GREIG CEPHALOPOLYSYNDACTYLY SYNDROME	0.002506059	0.09386589787037453
INTELLECTUAL DEVELOPMENTAL DISORDER WITH PERSISTENCE OF FETAL HEMOGLOBIN	0.0021768739999999996	0.0815360821755089
VERTEBRAL ANOMALIES AND VARIABLE ENDOCRINE AND T-CELL DYSFUNCTION; VETD	0.0021768739999999996	0.0815360821755089
MENTAL RETARDATION, AUTOSOMAL DOMINANT 40; MRD40	0.0021768739999999996	0.0815360821755089
NEURODEVELOPMENTAL DISORDER WITH IMPAIRED INTELLECTUAL DEVELOPMENT, HYPOTONIA, AND ATAXIA; NEDIDHA	0.0021768739999999996	0.0815360821755089
MENTAL RETARDATION, AUTOSOMAL DOMINANT 21	0.0021768739999999996	0.0815360821755089
HADZISELIMOVIC SYNDROME	0.0021768739999999996	0.0815360821755089
JOUBERT SYNDROME 14	0.0021768739999999996	0.0815360821755089
ICF SYNDROME	0.0021768739999999996	0.0815360821755089
CHROMOSOME 17P13.1 DELETION SYNDROME	0.0021768739999999996	0.0815360821755089
LATERAL MENINGOCELE SYNDROME	0.0021768739999999996	0.0815360821755089
48,XYYY SYNDROME	0.0021768739999999996	0.0815360821755089
THAUVIN-ROBINET-FAIVRE SYNDROME	0.0021768739999999996	0.0815360821755089
UPPER LIMB DEFECT-EYE AND EAR ABNORMALITIES SYNDROME	0.0021768739999999996	0.0815360821755089
FETAL ALCOHOL SYNDROME	0.0021768739999999996	0.0815360821755089
TOLUENE EMBRYOPATHY	0.0021768739999999996	0.0815360821755089
BONE MARROW FAILURE SYNDROME 3; BMFS3	0.0021768739999999996	0.0815360821755089
DIAMOND-BLACKFAN ANEMIA 15 WITH MANDIBULOFACIAL DYSOSTOSIS; DBA15	0.0021768739999999996	0.0815360821755089
SPINOCEREBELLAR ATAXIA-DYSMORPHISM SYNDROME	0.0021768739999999996	0.0815360821755089
MANNOSIDOSIS, ALPHA B, LYSOSOMAL	0.0021768739999999996	0.0815360821755089
NOONAN SYNDROME-LIKE DISORDER WITH OR WITHOUT JUVENILE MYELOMONOCYTIC LEUKEMIA	0.0021768739999999996	0.0815360821755089
METHYLMALONIC ACIDURIA AND HOMOCYSTINURIA, CBLF TYPE	0.0021768739999999996	0.0815360821755089
NOONAN SYNDROME 3; NS3	0.0021768739999999996	0.0815360821755089
DESBUQUOIS DYSPLASIA 2; DBQD2	0.0021768739999999996	0.0815360821755089
IMMUNODEFICIENCY-CENTROMERIC INSTABILITY-FACIAL ANOMALIES SYNDROME 3; ICF3	0.0021768739999999996	0.0815360821755089
IMMUNODEFICIENCY-CENTROMERIC INSTABILITY-FACIAL ANOMALIES SYNDROME 4; ICF4	0.0021768739999999996	0.0815360821755089
DIABETES MELLITUS, NEONATAL, WITH CONGENITAL HYPOTHYROIDISM; NDH	0.0021768739999999996	0.0815360821755089
GALLOWAY-MOWAT SYNDROME 5; GAMOS5	0.0021768739999999996	0.0815360821755089
INTELLECTUAL DEVELOPMENTAL DISORDER WITH SPEECH DELAY, DYSMORPHIC FACIES, AND T-CELL ABNORMALITIES; IDDSFTA	0.0021768739999999996	0.0815360821755089
OCULOCEREBROFACIAL SYNDROME, KAUFMAN TYPE	0.0021768739999999996	0.0815360821755089
FRONTOOCULAR SYNDROME	0.0021768739999999996	0.0815360821755089
NEUROFIBROMATOSIS-NOONAN SYNDROME; NFNS	0.0021768739999999996	0.0815360821755089
TRICHOTHIODYSTROPHY 4, NONPHOTOSENSITIVE; TTD4	0.0021768739999999996	0.0815360821755089
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 66; MRT66	0.0021768739999999996	0.0815360821755089
HARTSFIELD SYNDROME; HRTFDS	0.0021768739999999996	0.0815360821755089
CONGENITAL BILE ACID SYNTHESIS DEFECT TYPE 4	0.002172739	0.0813812033447655
MOMO SYNDROME	0.002172739	0.0813812033447655
X-LINKED INTELLECTUAL DISABILITY, SEEMANOVA TYPE	0.002172739	0.0813812033447655
MANDIBULOFACIAL DYSOSTOSIS-MICROCEPHALY SYNDROME	0.002172739	0.0813812033447655
X-LINKED INTELLECTUAL DISABILITY, GOLABI-ITO-HALL TYPE	0.002172739	0.0813812033447655
TETRASOMY 18P	0.002172739	0.0813812033447655
SKIN CREASES, CONGENITAL SYMMETRIC CIRCUMFERENTIAL, 2; CSCSC2	0.002172739	0.0813812033447655
SPONDYLOPERIPHERAL DYSPLASIA	0.00204918	0.07675322911312704
CARDIOSPONDYLOCARPOFACIAL SYNDROME	0.00204918	0.07675322911312704
BARDET-BIEDL SYNDROME 4; BBS4	0.00204918	0.07675322911312704
RADIO-RENAL SYNDROME	0.00204918	0.07675322911312704
METAPHYSEAL CHONDRODYSPLASIA, SCHMID TYPE	0.00204918	0.07675322911312704
SYMPHALANGISM, DISTAL	0.00204918	0.07675322911312704
CRANIOECTODERMAL DYSPLASIA 3	0.00204918	0.07675322911312704
BRACHYDACTYLY, TYPE E2; BDE2	0.00204918	0.07675322911312704
ANAUXETIC DYSPLASIA 2; ANXD2	0.00204918	0.07675322911312704
SHORT-RIB THORACIC DYSPLASIA 1 WITH OR WITHOUT POLYDACTYLY; SRTD1	0.00204918	0.07675322911312704
MULTIPLE SYNOSTOSES SYNDROME	0.00204918	0.07675322911312704
PYCNODYSOSTOSIS	0.00204918	0.07675322911312704
OPSISMODYSPLASIA	0.00204918	0.07675322911312704
SMITH-MAGENIS SYNDROME	0.00204918	0.07675322911312704
WEILL-MARCHESANI SYNDROME 4; WMS4	0.00204918	0.07675322911312704
ASPHYXIATING THORACIC DYSTROPHY 2; ATD2	0.00204918	0.07675322911312704
SHORT-RIB THORACIC DYSPLASIA 6 WITH OR WITHOUT POLYDACTYLY; SRTD6	0.00204918	0.07675322911312704
SYNDACTYLY, TYPE V	0.00204918	0.07675322911312704
RETINITIS PIGMENTOSA-INTELLECTUAL DISABILITY-DEAFNESS-HYPOGONADISM SYNDROME	0.00204918	0.07675322911312704
SHORT-RIB THORACIC DYSPLASIA 17 WITH OR WITHOUT POLYDACTYLY; SRTD17	0.00204918	0.07675322911312704
CAMPTOBRACHYDACTYLY	0.00204918	0.07675322911312704
ACROFRONTOFACIONASAL DYSOSTOSIS	0.00204918	0.07675322911312704
CHST3-RELATED SKELETAL DYSPLASIA	0.00204918	0.07675322911312704
WEILL-MARCHESANI SYNDROME 1; WMS1	0.00204918	0.07675322911312704
MAL DE MELEDA	0.00204918	0.07675322911312704
HIRSCHSPRUNG DISEASE-TYPE D BRACHYDACTYLY SYNDROME	0.00204918	0.07675322911312704
FAMILIAL DIGITAL ARTHROPATHY-BRACHYDACTYLY	0.00204918	0.07675322911312704
300106 SPONDYLOEPIMETAPHYSEAL DYSPLASIA, X-LINKED;;SEMD, X-LINKED; SEMDX	0.00204918	0.07675322911312704
2Q37 MONOSOMY	0.00204918	0.07675322911312704
191482 UNCOMBABLE HAIR, RETINAL PIGMENTARY DYSTROPHY, DENTAL ANOMALIES, ANDBRACHYDACTYLY;;BORK SYNDROME	0.00204918	0.07675322911312704
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 2; COXPD2	0.00204918	0.07675322911312704
TRIPHALANGEAL THUMBS WITH BRACHYECTRODACTYLY	0.00204918	0.07675322911312704
OSTEOGLOSPHONIC DYSPLASIA	0.00204918	0.07675322911312704
ACROMESOMELIC DYSPLASIA, GREBE TYPE	0.00204918	0.07675322911312704
SPONDYLOEPIMETAPHYSEAL DYSPLASIA, AGGRECAN TYPE	0.00204918	0.07675322911312704
OSTEOCHONDRODYSPLASIA, BRACHYDACTYLY, AND OVERLAPPING MALFORMED DIGITS; OCBMD	0.00204918	0.07675322911312704
SHORT-RIB THORACIC DYSPLASIA 10 WITH OR WITHOUT POLYDACTYLY; SRTD10	0.00204918	0.07675322911312704
BARDET-BIEDL SYNDROME 5; BBS5	0.00204918	0.07675322911312704
BRACHYDACTYLY-SYNDACTYLY SYNDROME	0.00204918	0.07675322911312704
MICROCEPHALIC PRIMORDIAL DWARFISM, TORIELLO TYPE	0.00204918	0.07675322911312704
EIKEN SYNDROME	0.00204918	0.07675322911312704
PROGRESSIVE OSSEOUS HETEROPLASIA	0.00204918	0.07675322911312704
DEAFNESS-SMALL BOWEL DIVERTICULOSIS-NEUROPATHY SYNDROME	0.00204918	0.07675322911312704
LERI PLEONOSTEOSIS	0.00204918	0.07675322911312704
SHORT-RIB THORACIC DYSPLASIA 4 WITH OR WITHOUT POLYDACTYLY; SRTD4	0.00204918	0.07675322911312704
BRACHYDACTYLY, LONG-THUMB TYPE	0.00204918	0.07675322911312704
CRANIOFACIAL DYSOSTOSIS WITH DIAPHYSEAL HYPERPLASIA	0.00204918	0.07675322911312704
ACRODYSPLASIA SCOLIOSIS	0.00204918	0.07675322911312704
DYSOSTOSIS, STANESCU TYPE	0.00204918	0.07675322911312704
CHITAYAT SYNDROME	0.00204918	0.07675322911312704
PSEUDOACHONDROPLASIA	0.00204918	0.07675322911312704
EMERY-NELSON SYNDROME	0.00204918	0.07675322911312704
RHIZOMELIC SYNDROME, URBACH TYPE	0.00204918	0.07675322911312704
SCHNECKENBECKEN DYSPLASIA	0.00204918	0.07675322911312704
SYNOSTOSIS, CARPAL, WITH DYSPLASTIC ELBOW JOINTS AND BRACHYDACTYLY	0.00204918	0.07675322911312704
MACS SYNDROME	0.00204918	0.07675322911312704
SPONDYLOEPIMETAPHYSEAL DYSPLASIA, AGGRECAN TYPE; SEMDAG	0.00204918	0.07675322911312704
FGFR2-RELATED BENT BONE DYSPLASIA	0.00204918	0.07675322911312704
LOWRY-WOOD SYNDROME	0.00204918	0.07675322911312704
BRACHYOLMIA TYPE 4 WITH MILD EPIPHYSEAL AND METAPHYSEAL CHANGES; BCYM4	0.00204918	0.07675322911312704
ECTRODACTYLY-POLYDACTYLY SYNDROME	0.00204918	0.07675322911312704
PREAXIAL DEFICIENCY, POSTAXIAL POLYDACTYLY, AND HYPOSPADIAS	0.00204918	0.07675322911312704
272150 SUGARMAN BRACHYDACTYLY;;BRACHYDACTYLY WITH MAJOR PROXIMAL PHALANGEAL SHORTENING	0.00204918	0.07675322911312704
%112440 BRACHYDACTYLY, COMBINED B AND E TYPES;;PITT-WILLIAMS BRACHYDACTYLY;;BRACHYDACTYLY, BALLARD TYPE	0.00204918	0.07675322911312704
BRACHYDACTYLY-ECTRODACTYLY WITH FIBULAR APLASIA OR HYPOPLASIA	0.00204918	0.07675322911312704
BRACHYDACTYLY-NYSTAGMUS-CEREBELLAR ATAXIA	0.00204918	0.07675322911312704
THANATOPHORIC DYSPLASIA, TYPE II	0.00204918	0.07675322911312704
ACROMESOMELIC DYSPLASIA, HUNTER-THOMPSON TYPE	0.00204918	0.07675322911312704
BRACHYTELEPHALANGY-DYSMORPHISM-KALLMANN SYNDROME	0.00204918	0.07675322911312704
CAMPTOBRACHYDACTYLY	0.00204918	0.07675322911312704
ACROMICRIC DYSPLASIA	0.00204918	0.07675322911312704
CROUZON SYNDROME-ACANTHOSIS NIGRICANS SYNDROME	0.00204918	0.07675322911312704
SPONDYLOMETAPHYSEAL DYSPLASIA, EAST AFRICAN TYPE	0.00204918	0.07675322911312704
OSTEOPOROSIS-MACROCEPHALY-BLINDNESS-JOINT HYPERLAXITY SYNDROME	0.00204918	0.07675322911312704
PROGERIA-SHORT STATURE-PIGMENTED NEVI SYNDROME	0.00204918	0.07675322911312704
DYSOSTOSIS WITH BRACHYDACTYLY	0.00204918	0.07675322911312704
ADAMS-OLIVER SYNDROME 6; AOS6	0.00204918	0.07675322911312704
BRACHYDACTYLY-MESOMELIA-INTELLECTUAL DISABILITY-HEART DEFECTS SYNDROME	0.00204918	0.07675322911312704
BRACHYDACTYLY-ARTERIAL HYPERTENSION SYNDROME	0.00204918	0.07675322911312704
SHORT STATURE AND ADVANCED BONE AGE, WITH OR WITHOUT EARLY-ONSET OSTEOARTHRITIS AND/OR OSTEOCHONDRITIS DISSECANS; SSOAOD	0.00204918	0.07675322911312704
ERYTHROKERATODERMIA VARIABILIS	0.00204918	0.07675322911312704
TRICHO-RETINO-DENTO-DIGITAL SYNDROME	0.00204918	0.07675322911312704
PARAPLEGIA-INTELLECTUAL DISABILITY-HYPERKERATOSIS SYNDROME	0.00204918	0.07675322911312704
ENG-STROM SYNDROME	0.00204918	0.07675322911312704
SATOYOSHI SYNDROME	0.00204918	0.07675322911312704
LARON SYNDROME	0.00204918	0.07675322911312704
ACROCAPITOFEMORAL DYSPLASIA; ACFD	0.00204918	0.07675322911312704
SPONDYLOMEGAEPIPHYSEAL DYSPLASIA WITH UPPER LIMB MESOMELIA, PUNCTATECALCIFICATIONS, AND DEAFNESS	0.00204918	0.07675322911312704
WEILL-MARCHESANI SYNDROME 2; WMS2	0.00204918	0.07675322911312704
SPONDYLOMETAPHYSEAL DYSPLASIA, KOZLOWSKI TYPE	0.00204918	0.07675322911312704
RHIZOMELIC DYSPLASIA, PATTERSON-LOWRY TYPE	0.00204918	0.07675322911312704
HEART-HAND SYNDROME TYPE 3	0.00204918	0.07675322911312704
FEINGOLD SYNDROME 2; FGLDS2	0.00204918	0.07675322911312704
WEILL-MARCHESANI SYNDROME	0.00204918	0.07675322911312704
RIN2 SYNDROME	0.00204918	0.07675322911312704
TIBIAL APLASIA-ECTRODACTYLY SYNDROME	0.00204918	0.07675322911312704
THIEMANN DISEASE, FAMILIAL FORM	0.00204918	0.07675322911312704
INFANTILE SYSTEMIC HYALINOSIS	0.00204918	0.07675322911312704
PREMATURE AGING SYNDROME, PENTTINEN TYPE	0.00204918	0.07675322911312704
PSEUDOHYPOPARATHYROIDISM, TYPE IB	0.00204918	0.07675322911312704
COOKS SYNDROME	0.00204918	0.07675322911312704
HEART-HAND SYNDROME TYPE 2	0.00204918	0.07675322911312704
WEILL-MARCHESANI SYNDROME 3	0.00204918	0.07675322911312704
%609052 SPONDYLOMETAPHYSEAL DYSPLASIA, TYPE A4	0.00204918	0.07675322911312704
SHORT-RIB THORACIC DYSPLASIA 5 WITH OR WITHOUT POLYDACTYLY; SRTD5	0.00204918	0.07675322911312704
SPONDYLOEPIMETAPHYSEAL DYSPLASIA, MICROMELIC	0.00204918	0.07675322911312704
METAPHYSEAL DYSOSTOSIS, MENTAL RETARDATION, AND CONDUCTIVE DEAFNESS	0.00204918	0.07675322911312704
BARDET-BIEDL SYNDROME 18; BBS18	0.00204918	0.07675322911312704
ISOLATED BRACHYCEPHALY	0.00204918	0.07675322911312704
BENT BONE DYSPLASIA SYNDROME; BBDS	0.00204918	0.07675322911312704
GREENBERG DYSPLASIA	0.00204918	0.07675322911312704
CHROMOSOME 8Q22.1 DUPLICATION SYNDROME	0.00204918	0.07675322911312704
RHYNS SYNDROME; RHYNS	0.00204918	0.07675322911312704
SHORT STATURE-ADVANCED BONE AGE-EARLY-ONSET OSTEOARTHRITIS SYNDROME	0.00204918	0.07675322911312704
X-LINKED SKELETAL DYSPLASIA-INTELLECTUAL DISABILITY SYNDROME	0.00204918	0.07675322911312704
601957 ODONTOTRICHOUNGUAL-DIGITAL-PALMAR SYNDROME;;OTUDP SYNDROME	0.00204918	0.07675322911312704
MULTIPLE SYNOSTOSES SYNDROME 4; SYNS4	0.00204918	0.07675322911312704
METATROPIC DYSPLASIA	0.00204918	0.07675322911312704
DEAFNESS, CONGENITAL, AND ONYCHODYSTROPHY, AUTOSOMAL DOMINANT	0.00204918	0.07675322911312704
140450 HEART-HAND SYNDROME, SPANISH TYPE	0.00204918	0.07675322911312704
ALAR CARTILAGES HYPOPLASIA-COLOBOMA-TELECANTHUS SYNDROME	0.00196464	0.07358673422774668
DANDY-WALKER MALFORMATION WITH POSTAXIAL POLYDACTYLY	0.00196464	0.07358673422774668
OSTEOGENESIS IMPERFECTA, TYPE XVIII; OI18	0.00196464	0.07358673422774668
%601499 AXENFELD-RIEGER SYNDROME, TYPE 2; RIEG2;;RIEGER SYNDROME, TYPE 2	0.00196464	0.07358673422774668
CHOANAL ATRESIA-HEARING LOSS-CARDIAC DEFECTS-CRANIOFACIAL DYSMORPHISM SYNDROME	0.00196464	0.07358673422774668
CYSTIC FIBROSIS-GASTRITIS-MEGALOBLASTIC ANEMIA SYNDROME	0.00196464	0.07358673422774668
FRONTOMETAPHYSEAL DYSPLASIA	0.00196464	0.07358673422774668
WHITE MATTER HYPOPLASIA-CORPUS CALLOSUM AGENESIS-INTELLECTUAL DISABILITY SYNDROME	0.00196464	0.07358673422774668
MEGALENCEPHALY	0.00196464	0.07358673422774668
FLAT FACE-MICROSTOMIA-EAR ANOMALY SYNDROME	0.00196464	0.07358673422774668
DYSMORPHISM-SHORT STATURE-DEAFNESS-DISORDER OF SEX DEVELOPMENT SYNDROME	0.00196464	0.07358673422774668
DILATED CARDIOMYOPATHY-HYPERGONADOTROPIC HYPOGONADISM SYNDROME	0.00196464	0.07358673422774668
MANDIBULOFACIAL DYSOSTOSIS WITH MACROBLEPHARON AND MACROSTOMIA	0.00196464	0.07358673422774668
NEONATAL MARFAN SYNDROME	0.00196464	0.07358673422774668
DEAFNESS, X-LINKED 7; DFNX7	0.00196464	0.07358673422774668
MARSHALL SYNDROME	0.00196464	0.07358673422774668
BOOMERANG DYSPLASIA	0.00196464	0.07358673422774668
BEEMER-ERTBRUGGEN SYNDROME	0.00196464	0.07358673422774668
DIAMOND-BLACKFAN ANEMIA 8	0.00196464	0.07358673422774668
ADULT SYNDROME	0.00196464	0.07358673422774668
%265300 LYMPHANGIECTASIA, PULMONARY, CONGENITAL; CPL;;LYMPHANGIOMATOSIS, PULMONARY;;PULMONARY CYSTIC LYMPHANGIECTASIS	0.00196464	0.07358673422774668
OTOPALATODIGITAL SYNDROME TYPE 1	0.00196464	0.07358673422774668
OROFACIODIGITAL SYNDROME XV; OFD15	0.00196464	0.07358673422774668
RETINITIS PIGMENTOSA	0.00196464	0.07358673422774668
IMMUNODEFICIENCY 59 AND HYPOGLYCEMIA; IMD59	0.00196464	0.07358673422774668
MULTICENTRIC CARPO-TARSAL OSTEOLYSIS WITH OR WITHOUT NEPHROPATHY	0.00196464	0.07358673422774668
MULIBREY NANISM	0.00196464	0.07358673422774668
CRANIOLENTICULOSUTURAL DYSPLASIA	0.00196464	0.07358673422774668
TRICHORHINOPHALANGEAL SYNDROME, TYPE II	0.00196464	0.07358673422774668
PILODENTAL DYSPLASIA WITH REFRACTIVE ERRORS	0.00196464	0.07358673422774668
MULLERIAN DERIVATIVES, PERSISTENCE OF, WITH LYMPHANGIECTASIA AND POSTAXIAL POLYDACTYLY	0.00196464	0.07358673422774668
AXENFELD-RIEGER SYNDROME, TYPE 1; RIEG1	0.00196464	0.07358673422774668
CRANIOMETAPHYSEAL DYSPLASIA	0.00196464	0.07358673422774668
CLOVERLEAF SKULL-MULTIPLE CONGENITAL ANOMALIES SYNDROME	0.00196464	0.07358673422774668
WAARDENBURG SYNDROME TYPE 1	0.00196464	0.07358673422774668
CYSTIC FIBROSIS WITH HELICOBACTER PYLORI GASTRITIS, MEGALOBLASTIC ANEMIA, AND MENTAL RETARDATION	0.00196464	0.07358673422774668
DEAFNESS WITH LABYRINTHINE APLASIA, MICROTIA, AND MICRODONTIA	0.00196464	0.07358673422774668
MICROPHTHALMIA, SYNDROMIC 12	0.00196464	0.07358673422774668
INTELLECTUAL DISABILITY-CATARACTS-KYPHOSIS SYNDROME	0.00196464	0.07358673422774668
MICROPHTHALMIA, SYNDROMIC 9; MCOPS9	0.00196464	0.07358673422774668
DEAFNESS-CRANIOFACIAL SYNDROME	0.00196464	0.07358673422774668
WAARDENBURG-SHAH SYNDROME	0.00196464	0.07358673422774668
FRONTONASAL DYSPLASIA 2; FND2	0.00196464	0.07358673422774668
ISOLATED TRIGONOCEPHALY	0.00196464	0.07358673422774668
CRANIODIAPHYSEAL DYSPLASIA, AUTOSOMAL DOMINANT; CDD	0.00196464	0.07358673422774668
FACIAL DYSMORPHISM WITH MULTIPLE MALFORMATIONS	0.00196464	0.07358673422774668
HISTIDINURIA-RENAL TUBULAR DEFECT SYNDROME	0.00196464	0.07358673422774668
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 45; MRT45	0.00196464	0.07358673422774668
MANDIBULOFACIAL DYSOSTOSIS WITH ALOPECIA; MFDA	0.00196464	0.07358673422774668
MICROCEPHALY-FACIAL DYSMORPHISM-OCULAR ANOMALIES-MULTIPLE CONGENITAL ANOMALIES SYNDROME	0.00196464	0.07358673422774668
CUTIS LAXA, AUTOSOMAL RECESSIVE, TYPE IC; ARCL1C	0.00196464	0.07358673422774668
AUTOSOMAL DOMINANT SPONDYLOCOSTAL DYSOSTOSIS	0.00196464	0.07358673422774668
%309620 MENTAL RETARDATION, SKELETAL DYSPLASIA, AND ABDUCENS PALSY; MRSD;;CHRISTIAN SYNDROME; CHRS	0.00196464	0.07358673422774668
DEAFNESS-CRANIOFACIAL SYNDROME	0.00196464	0.07358673422774668
HYPERTELORISM-HYPOSPADIAS-POLYSYNDACTYLY SYNDROME	0.00196464	0.07358673422774668
CRANIODIAPHYSEAL DYSPLASIA	0.00196464	0.07358673422774668
WAARDENBURG SYNDROME, TYPE 1; WS1	0.00196464	0.07358673422774668
STROMME SYNDROME; STROMS	0.00196464	0.07358673422774668
ECTODERMAL DYSPLASIA 13, HAIR/TOOTH TYPE; ECTD13	0.00196464	0.07358673422774668
WAARDENBURG SYNDROME	0.00196464	0.07358673422774668
SCARF SYNDROME	0.00163132	0.06110203970213765
SCHOLTE SYNDROME; SHLTS	0.00163132	0.06110203970213765
CEREBROFACIOTHORACIC DYSPLASIA	0.00163132	0.06110203970213765
COSTELLO SYNDROME	0.00163132	0.06110203970213765
HYPERMOBILE EHLERS-DANLOS SYNDROME	0.00163132	0.06110203970213765
X-LINKED MANDIBULOFACIAL DYSOSTOSIS	0.00163132	0.06110203970213765
HYPOTONIA-CYSTINURIA SYNDROME	0.00163132	0.06110203970213765
DUANE-RADIAL RAY SYNDROME; DRRS	0.00163132	0.06110203970213765
CHROMOSOME 13Q14 DELETION SYNDROME	0.00163132	0.06110203970213765
PRIMARY PULMONARY HYPOPLASIA	0.00163132	0.06110203970213765
ACHALASIA-MICROCEPHALY SYNDROME	0.00163132	0.06110203970213765
PHAVER SYNDROME	0.00163132	0.06110203970213765
CRANIOSYNOSTOSIS-MENTAL RETARDATION SYNDROME OF LIN AND GETTIG	0.00163132	0.06110203970213765
PFEIFFER-PALM-TELLER SYNDROME	0.00163132	0.06110203970213765
RHIZOMELIC CHONDRODYSPLASIA PUNCTATA	0.00163132	0.06110203970213765
SIFRIM-HITZ-WEISS SYNDROME	0.00163132	0.06110203970213765
DEAFNESS-HYPOGONADISM SYNDROME	0.00163132	0.06110203970213765
AUTOSOMAL AGAMMAGLOBULINEMIA	0.00163132	0.06110203970213765
FETAL VALPROATE SYNDROME	0.00163132	0.06110203970213765
PTERYGIUM COLLI, ISOLATED	0.00163132	0.06110203970213765
138770 GMS SYNDROME;;GONIODYSGENESIS--MENTAL RETARDATION--SHORT STATURE SYNDROME	0.00163132	0.06110203970213765
FACIAL PARESIS, HEREDITARY CONGENITAL, 3; HCFP3	0.00163132	0.06110203970213765
MYOTONIA PERMANENS	0.00163132	0.06110203970213765
DYSMORPHISM-CLEFT PALATE-LOOSE SKIN SYNDROME	0.00163132	0.06110203970213765
BALLER-GEROLD SYNDROME	0.00163132	0.06110203970213765
HYPOGLOSSIA-HYPODACTYLIA	0.00163132	0.06110203970213765
SPONDYLOEPIMETAPHYSEAL DYSPLASIA, FADEN-ALKURAYA TYPE; SEMDFA	0.00163132	0.06110203970213765
PROGEROID SYNDROME, PETTY TYPE	0.00163132	0.06110203970213765
MICROCEPHALY-MICROCORNEA SYNDROME, SEEMANOVA TYPE	0.00163132	0.06110203970213765
SHORT RIB-POLYDACTYLY SYNDROME, VERMA-NAUMOFF TYPE	0.00163132	0.06110203970213765
BRITTLE CORNEA SYNDROME	0.00163132	0.06110203970213765
HYPERTRICHOSIS, CONGENITAL GENERALIZED, WITH OR WITHOUT GINGIVAL HYPERPLASIA	0.00163132	0.06110203970213765
133705 EXTERNAL AUDITORY CANAL, BILATERAL ATRESIA OF, WITH CONGENITAL VERTICALTALUS;;RASMUSSEN SYNDROME	0.00163132	0.06110203970213765
264475 PSEUDOPAPILLEDEMA, OCULAR HYPOTELORISM, BLEPHAROPHIMOSIS, AND HANDANOMALIES;;ACROOTOOCULAR SYNDROME;;AOO SYNDROME	0.00163132	0.06110203970213765
%312150 MULTIPLE PTERYGIUM SYNDROME, X-LINKED;;PTERYGIUM SYNDROME, MULTIPLE, X-LINKED	0.00163132	0.06110203970213765
EPICANTHUS	0.00163132	0.06110203970213765
FOCAL FACIAL DERMAL DYSPLASIA 3, SETLEIS TYPE	0.00163132	0.06110203970213765
STICKLER SYNDROME	0.00163132	0.06110203970213765
SKIN CREASES, CONGENITAL SYMMETRIC CIRCUMFERENTIAL, 1; CSCSC1	0.00163132	0.06110203970213765
IMMUNODEFICIENCY-CENTROMERIC INSTABILITY-FACIAL ANOMALIES SYNDROME	0.00163132	0.06110203970213765
SUBAORTIC STENOSIS-SHORT STATURE SYNDROME	0.00163132	0.06110203970213765
CATARACT-ABERRANT ORAL FRENULA-GROWTH DELAY SYNDROME	0.00163132	0.06110203970213765
8Q21.11 MICRODELETION SYNDROME	0.00163132	0.06110203970213765
CLEFT PALATE-SHORT STATURE-VERTEBRAL ANOMALIES SYNDROME	0.00163132	0.06110203970213765
MICROCORNEA-GLAUCOMA-ABSENT FRONTAL SINUSES SYNDROME	0.00163132	0.06110203970213765
JUBERG-MARSIDI SYNDROME	0.00163132	0.06110203970213765
HYDROCEPHALY-LOW INSERTION UMBILICUS SYNDROME	0.00163132	0.06110203970213765
PFEIFFER-PALM-TELLER SYNDROME	0.00163132	0.06110203970213765
BLEPHAROPHIMOSIS-EPICANTHUS INVERSUS-PTOSIS SYNDROME	0.00163132	0.06110203970213765
LYMPHEDEMA, PRIMARY, WITH MYELODYSPLASIA	0.00163132	0.06110203970213765
MICROCEPHALY-DEAFNESS-INTELLECTUAL DISABILITY SYNDROME	0.00163132	0.06110203970213765
MILROY DISEASE	0.00163132	0.06110203970213765
NOONAN SYNDROME 8; NS8	0.00163132	0.06110203970213765
LICHTENSTEIN SYNDROME	0.00163132	0.06110203970213765
LEGIUS SYNDROME	0.00163132	0.06110203970213765
115645 CATARACT, ABERRANT ORAL FRENULA, AND GROWTH RETARDATION	0.00163132	0.06110203970213765
COMBINED OXIDATIVE PHOSPHORYLATION DEFECT TYPE 23	0.001086973	0.04071320611599911
ISOVALERIC ACIDEMIA	0.001086973	0.04071320611599911
KETOADIPICACIDURIA	0.001086973	0.04071320611599911
MITOCHONDRIAL COMPLEX IV DEFICIENCY	0.001086973	0.04071320611599911
INFANTILE REFSUM DISEASE	0.001086973	0.04071320611599911
ANGELMAN SYNDROME	0.001086973	0.04071320611599911
AUTOSOMAL DOMINANT CHARCOT-MARIE-TOOTH DISEASE TYPE 2Z	0.001086973	0.04071320611599911
HOLOCARBOXYLASE SYNTHETASE DEFICIENCY	0.001086973	0.04071320611599911
FOLATE MALABSORPTION, HEREDITARY	0.001086973	0.04071320611599911
PALLISTER-HALL SYNDROME	0.001086973	0.04071320611599911
HOLOPROSENCEPHALY 1; HPE1	0.001086973	0.04071320611599911
NETHERTON SYNDROME	0.001086973	0.04071320611599911
X-LINKED INTELLECTUAL DISABILITY-CARDIOMEGALY-CONGESTIVE HEART FAILURE SYNDROME	0.001086973	0.04071320611599911
SEVERE CANAVAN DISEASE	0.001086973	0.04071320611599911
DISTAL MONOSOMY 19P13.3	0.001086973	0.04071320611599911
ARGININOSUCCINIC ACIDURIA	0.001086973	0.04071320611599911
BIOTINIDASE DEFICIENCYMULTIPLE CARBOXYLASE DEFICIENCY, LATE-ONSET	0.001086973	0.04071320611599911
METHYLMALONIC ACIDURIA AND HOMOCYSTINURIA, CBLC TYPE; MAHCC	0.001086973	0.04071320611599911
PRADER-WILLI-LIKE SYNDROME	0.001086973	0.04071320611599911
MACDERMOT-WINTER SYNDROME	0.001086973	0.04071320611599911
3-HYDROXY-3-METHYLGLUTARYL-COA LYASE DEFICIENCY; HMGCLD	0.001086973	0.04071320611599911
MICROLISSENCEPHALY-MICROMELIA SYNDROME	0.001086973	0.04071320611599911
HARTNUP DISORDER	0.001086973	0.04071320611599911
MITOCHONDRIAL COMPLEX III DEFICIENCY, NUCLEAR TYPE 1	0.001086973	0.04071320611599911
AUTOSOMAL RECESSIVE CUTIS LAXA TYPE 2, CLASSIC TYPE	0.001086973	0.04071320611599911
LANDAU-KLEFFNER SYNDROME	0.001086973	0.04071320611599911
NEUROECTODERMAL MELANOLYSOSOMAL DISEASE	0.001086973	0.04071320611599911
MALONYL-COA DECARBOXYLASE DEFICIENCY	0.001086973	0.04071320611599911
GMPPB-RELATED  LIMB-GIRDLE MUSCULAR DYSTROPHY R19	0.001086973	0.04071320611599911
INTELLECTUAL DISABILITY-AUTISM-SPEECH APRAXIA-CRANIOFACIAL DYSMORPHISM SYNDROME	0.001086973	0.04071320611599911
PHOSPHOENOLPYRUVATE CARBOXYKINASE DEFICIENCY, CYTOSOLIC; PCKDC	0.001086973	0.04071320611599911
X-LINKED INTELLECTUAL DISABILITY-HYPOTONIA-MOVEMENT DISORDER SYNDROME	0.001086973	0.04071320611599911
DYSTONIA-APHONIA SYNDROME	0.001086973	0.04071320611599911
HOMOCYSTINURIA WITHOUT METHYLMALONIC ACIDURIA	0.001086973	0.04071320611599911
MELANOSIS, NEUROCUTANEOUS; NCMS	0.001086973	0.04071320611599911
XQ28 (MECP2) DUPLICATION	0.001086973	0.04071320611599911
HYPERIMMUNOGLOBULINEMIA D WITH PERIODIC FEVER	0.001086973	0.04071320611599911
CRANIOPHARYNGIOMA	0.001086973	0.04071320611599911
HOLOPROSENCEPHALY 2; HPE2	0.001086973	0.04071320611599911
STT3A-CDG	0.001086973	0.04071320611599911
GALACTOSEMIA	0.001086973	0.04071320611599911
ACYL-COA DEHYDROGENASE, MEDIUM-CHAIN, DEFICIENCY OF	0.001086973	0.04071320611599911
NARP SYNDROME	0.001086973	0.04071320611599911
MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (CONGENITAL WITH BRAIN AND EYE	0.001086973	0.04071320611599911
%114100 BASAL GANGLIA CALCIFICATION, IDIOPATHIC, CHILDHOOD-ONSET;;IBGC, CHILDHOOD-ONSET;;STRIOPALLIDODENTATE CALCINOSIS, BILATERAL, CHILDHOOD-ONSET;;CEREBRAL CALCIFICATION, NONARTERIOSCLEROTIC, IDIOPATHIC, CHILDHOOD-ONSET	0.001086973	0.04071320611599911
GAUCHER DISEASE, TYPE II	0.001086973	0.04071320611599911
PYRUVATE CARBOXYLASE DEFICIENCY	0.001086973	0.04071320611599911
FATTY ACYL-COA REDUCTASE 1 DEFICIENCY	0.001086973	0.04071320611599911
CEREBELLAR ATAXIA, MENTAL RETARDATION, AND DYSEQUILIBRIUM SYNDROME 1; CAMRQ1	0.001086973	0.04071320611599911
GRISCELLI SYNDROME	0.001086973	0.04071320611599911
GRISCELLI SYNDROME, TYPE 1	0.001086973	0.04071320611599911
HEMOPHAGOCYTIC LYMPHOHISTIOCYTOSIS, FAMILIAL, 1	0.001086973	0.04071320611599911
STT3B-CDG	0.001086973	0.04071320611599911
CLASSIC PHENYLKETONURIA	0.001086973	0.04071320611599911
HOMOCYSTINURIA-MEGALOBLASTIC ANEMIA, CBLG COMPLEMENTATION TYPE	0.001086973	0.04071320611599911
SSR4-CDG	0.001086973	0.04071320611599911
SEPTO-OPTIC DYSPLASIA SPECTRUM	0.001086973	0.04071320611599911
CITRULLINEMIA, CLASSIC	0.001086973	0.04071320611599911
CONGENITAL MUSCULAR DYSTROPHY WITH CEREBELLAR INVOLVEMENT	0.001086973	0.04071320611599911
LEBER CONGENITAL AMAUROSIS	0.001086973	0.04071320611599911
CEROID LIPOFUSCINOSIS, NEURONAL, 1	0.001086973	0.04071320611599911
MAPLE SYRUP URINE DISEASE	0.001086973	0.04071320611599911
BERRY ANEURYSM, CIRRHOSIS, PULMONARY EMPHYSEMA, AND CEREBRAL CALCIFICATION	0.001086973	0.04071320611599911
CEDNIK SYNDROME	0.001086973	0.04071320611599911
MICROCEPHALY AND CHORIORETINOPATHY, AUTOSOMAL RECESSIVE, 1; MCCRP1	0.001086973	0.04071320611599911
WYBURN-MASON SYNDROME	0.001086973	0.04071320611599911
HOMOCYSTINURIA DUE TO CYSTATHIONINE BETA-SYNTHASE DEFICIENCY	0.001086973	0.04071320611599911
INTELLECTUAL DISABILITY-HYPERKINETIC MOVEMENT-TRUNCAL ATAXIA SYNDROME	0.001086973	0.04071320611599911
WILSON-TURNER SYNDROME	0.001086973	0.04071320611599911
3-METHYLCROTONYL-COA CARBOXYLASE 2 DEFICIENCY; MCC2D	0.001086973	0.04071320611599911
3-METHYLCROTONYL-COA CARBOXYLASE 1 DEFICIENCY; MCC1D	0.001086973	0.04071320611599911
VICI SYNDROME; VICIS	0.001086973	0.04071320611599911
3-METHYLGLUTACONIC ACIDURIA TYPE 4	0.001086973	0.04071320611599911
ISOLATED GLYCEROL KINASE DEFICIENCY	0.001086973	0.04071320611599911
ACYL-COA DEHYDROGENASE, SHORT-CHAIN, DEFICIENCY OF	0.001086973	0.04071320611599911
SULFOCYSTEINURIA	0.001086973	0.04071320611599911
HOMOCYSTINURIA-MEGALOBLASTIC ANEMIA, CBLE COMPLEMENTATION TYPE	0.001086973	0.04071320611599911
COACH SYNDROME	0.001086973	0.04071320611599911
MEND SYNDROME	0.001086973	0.04071320611599911
ELEJALDE DISEASE	0.001086973	0.04071320611599911
METHYLMALONIC ACIDURIA, CBLA TYPE	0.001086973	0.04071320611599911
HEREDITARY SENSORY AND AUTONOMIC NEUROPATHY DUE TO TECPR2 MUTATION	0.001086973	0.04071320611599911
LONG CHAIN 3-HYDROXYACYL-COA DEHYDROGENASE DEFICIENCY	0.001086973	0.04071320611599911
AHDC1-RELATED INTELLECTUAL DISABILITY-OBSTRUCTIVE SLEEP APNEA-MILD DYSMORPHISM SYNDROME	0.001086973	0.04071320611599911
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 52	0.001086973	0.04071320611599911
INFANTILE OSTEOPETROSIS WITH NEUROAXONAL DYSPLASIA	0.001086973	0.04071320611599911
XQ21 MICRODELETION SYNDROME	0.001086973	0.04071320611599911
SPINOCEREBELLAR ATAXIA, AUTOSOMAL RECESSIVE 13	0.001086973	0.04071320611599911
CONGENITAL DISORDER OF GLYCOSYLATION	0.001086973	0.04071320611599911
CEREBELLAR ATAXIA, NONPROGRESSIVE, WITH MENTAL RETARDATION; CANPMR	0.001086973	0.04071320611599911
NEUROLOGICAL CONDITIONS ASSOCIATED WITH AMINOACYLASE 1 DEFICIENCY	0.001086973	0.04071320611599911
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IIK	0.001086973	0.04071320611599911
PONTINE TEGMENTAL CAP DYSPLASIA	0.001086973	0.04071320611599911
17Q11.2 MICRODUPLICATION SYNDROME	0.001086973	0.04071320611599911
COFFIN-SIRIS SYNDROME 4; CSS4	0.001086973	0.04071320611599911
COFFIN-SIRIS SYNDROME 3; CSS3	0.001086973	0.04071320611599911
PSYCHOMOTOR RETARDATION, EPILEPSY, AND CRANIOFACIAL DYSMORPHISM	0.001086973	0.04071320611599911
6-PYRUVOYL-TETRAHYDROPTERIN SYNTHASE DEFICIENCY	0.001086973	0.04071320611599911
CONGENITAL CATARACTS, HEARING LOSS, AND NEURODEGENERATION; CCHLND	0.001086973	0.04071320611599911
MULTIPLE CARBOXYLASE DEFICIENCY	0.001086973	0.04071320611599911
VICI SYNDROME	0.001086973	0.04071320611599911
CORPUS CALLOSUM AGENESIS-NEURONOPATHY SYNDROME	0.001086973	0.04071320611599911
KEUTEL SYNDROME	0.001086973	0.04071320611599911
MENTAL RETARDATION, AUTOSOMAL DOMINANT 2	0.001086973	0.04071320611599911
N-ACETYLASPARTATE DEFICIENCY; NACED	0.001086973	0.04071320611599911
CARNITINE-ACYLCARNITINE TRANSLOCASE DEFICIENCY	0.001086973	0.04071320611599911
CORTICAL DYSPLASIA, COMPLEX, WITH OTHER BRAIN MALFORMATIONS 1	0.001086973	0.04071320611599911
PEROXISOME BIOGENESIS DISORDER 4B; PBD4B	0.001086973	0.04071320611599911
PEROXISOME BIOGENESIS DISORDER 11A (ZELLWEGER)	0.001086973	0.04071320611599911
LISSENCEPHALY 4	0.001086973	0.04071320611599911
X-LINKED INTELLECTUAL DISABILITY-EPILEPSY-PROGRESSIVE JOINT CONTRACTURES-DYSMORPHISM SYNDROME	0.001086973	0.04071320611599911
ARTHROGRYPOSIS, MENTAL RETARDATION, AND SEIZURES	0.001086973	0.04071320611599911
PERIVENTRICULAR NODULAR HETEROTOPIA 6; PVNH6	0.001086973	0.04071320611599911
BRAIN ABNORMALITIES, NEURODEGENERATION, AND DYSOSTEOSCLEROSIS; BANDDOS	0.001086973	0.04071320611599911
INTELLECTUAL DEVELOPMENTAL DISORDER, AUTOSOMAL RECESSIVE 71; MRT71	0.001086973	0.04071320611599911
X-LINKED NEURODEGENERATIVE SYNDROME, HAMEL TYPE	0.001086973	0.04071320611599911
X-LINKED INTELLECTUAL DISABILITY, TURNER TYPE	0.001086973	0.04071320611599911
INFANTILE LIVER FAILURE SYNDROME 1	0.001086973	0.04071320611599911
CORTICAL DYSPLASIA, COMPLEX, WITH OTHER BRAIN MALFORMATIONS 4; CDCBM4	0.001086973	0.04071320611599911
CORTICAL DYSPLASIA, COMPLEX, WITH OTHER BRAIN MALFORMATIONS 3; CDCBM3	0.001086973	0.04071320611599911
MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (CONGENITAL WITH MENTAL RETARDATION), TYPE B, 14; MDDGB14	0.001086973	0.04071320611599911
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 11; COXPD11	0.001086973	0.04071320611599911
MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (CONGENITAL WITH BRAIN AND EYE ANOMALIES), TYPE A, 13; MDDGA13	0.001086973	0.04071320611599911
CORTICAL DYSPLASIA, COMPLEX, WITH OTHER BRAIN MALFORMATIONS 2; CDCBM2	0.001086973	0.04071320611599911
CONGENITAL DISORDER OF DEGLYCOSYLATION; CDDG	0.001086973	0.04071320611599911
MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (CONGENITAL WITH BRAIN AND EYE ANOMALIES), TYPE A, 12; MDDGA12	0.001086973	0.04071320611599911
OSTEOSCLEROTIC METAPHYSEAL DYSPLASIA	0.001086973	0.04071320611599911
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IU; CDG1U	0.001086973	0.04071320611599911
SPASTIC PARAPLEGIA 49, AUTOSOMAL RECESSIVE	0.001086973	0.04071320611599911
SCHUURS-HOEIJMAKERS SYNDROME; SHMS	0.001086973	0.04071320611599911
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 15; COXPD15	0.001086973	0.04071320611599911
PHOSPHOSERINE PHOSPHATASE DEFICIENCY; PSPHD	0.001086973	0.04071320611599911
2P21 MICRODELETION SYNDROME	0.001086973	0.04071320611599911
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IX; CDG1X	0.001086973	0.04071320611599911
2-METHYLBUTYRYL-COA DEHYDROGENASE DEFICIENCY	0.001086973	0.04071320611599911
HOLOPROSENCEPHALY 7	0.001086973	0.04071320611599911
NEUTROPENIA, SEVERE CONGENITAL, 3, AUTOSOMAL RECESSIVE; SCN3	0.001086973	0.04071320611599911
GLYCOGEN STORAGE DISEASE DUE TO HEPATIC GLYCOGEN SYNTHASE DEFICIENCY	0.001086973	0.04071320611599911
LEUKODYSTROPHY, HYPOMYELINATING, 5; HLD5	0.001086973	0.04071320611599911
HARTNUP DISEASE	0.001086973	0.04071320611599911
PROGRESSIVE EXTERNAL OPHTHALMOPLEGIA WITH MITOCHONDRIAL DNA DELETIONS, AUTOSOMAL DOMINANT 4; PEOA4	0.001086973	0.04071320611599911
MICROPHTHALMIA, SYNDROMIC 5; MCOPS5	0.001086973	0.04071320611599911
HERNÁNDEZ-AGUIRRE NEGRETE SYNDROME	0.001086973	0.04071320611599911
CORTICAL DYSPLASIA, COMPLEX, WITH OTHER BRAIN MALFORMATIONS 7	0.001086973	0.04071320611599911
WILLIAMS-BEUREN REGION DUPLICATION SYNDROME	0.001086973	0.04071320611599911
FOIX-CHAVANY-MARIE SYNDROME	0.001086973	0.04071320611599911
CLASSIC PANTOTHENATE KINASE-ASSOCIATED NEURODEGENERATION	0.001086973	0.04071320611599911
HYDRANENCEPHALY	0.001086973	0.04071320611599911
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IF	0.001086973	0.04071320611599911
PERIPHERAL DEMYELINATING NEUROPATHY, CENTRAL DYSMYELINATION, WAARDENBURG SYNDROME, AND HIRSCHSPRUNG DISEASE; PCWH	0.001086973	0.04071320611599911
EMANUEL SYNDROME	0.001086973	0.04071320611599911
STOMATIN-DEFICIENT CRYOHYDROCYTOSIS WITH NEUROLOGIC DEFECTS; SDCHCN	0.001086973	0.04071320611599911
NEPHROGENIC DIABETES INSIPIDUS	0.001086973	0.04071320611599911
PYRUVATE DEHYDROGENASE PHOSPHATASE DEFICIENCY	0.001086973	0.04071320611599911
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IL; CDG1L	0.001086973	0.04071320611599911
PHOSPHOSERINE AMINOTRANSFERASE DEFICIENCY; PSATD	0.001086973	0.04071320611599911
PONTOCEREBELLAR HYPOPLASIA, TYPE 6	0.001086973	0.04071320611599911
PONTOCEREBELLAR HYPOPLASIA, TYPE 2D	0.001086973	0.04071320611599911
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 39	0.001086973	0.04071320611599911
X-LINKED CEREBRAL-CEREBELLAR-COLOBOMA SYNDROME	0.001086973	0.04071320611599911
BRAIN MALFORMATIONS WITH OR WITHOUT URINARY TRACT DEFECTS; BRMUTD	0.001086973	0.04071320611599911
CHROMOSOME 17Q11.2 DELETION SYNDROME, 1.4-MB	0.001086973	0.04071320611599911
MITOCHONDRIAL DNA DEPLETION SYNDROME 4B (MNGIE TYPE); MTDPS4B	0.001086973	0.04071320611599911
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IP; CDG1P	0.001086973	0.04071320611599911
CHROMOSOME 19P13.13 DELETION SYNDROME	0.001086973	0.04071320611599911
HYPERAMMONEMIA DUE TO N-ACETYLGLUTAMATE SYNTHASE DEFICIENCY	0.001086973	0.04071320611599911
GABA-TRANSAMINASE DEFICIENCY	0.001086973	0.04071320611599911
ENCEPHALOCRANIOCUTANEOUS LIPOMATOSIS; ECCL	0.001086973	0.04071320611599911
THORACIC DYSPLASIA-HYDROCEPHALUS SYNDROME	0.001086973	0.04071320611599911
EAST SYNDROME	0.001086973	0.04071320611599911
SEIZURES, SENSORINEURAL DEAFNESS, ATAXIA, MENTAL RETARDATION, AND ELECTROLYTE IMBALANCE	0.001086973	0.04071320611599911
CEREBRAL CREATINE DEFICIENCY SYNDROME 2	0.001086973	0.04071320611599911
THROMBOPHILIA DUE TO PROTEIN C DEFICIENCY, AUTOSOMAL RECESSIVE; THPH4	0.001086973	0.04071320611599911
MITOCHONDRIAL DNA DEPLETION SYNDROME, ENCEPHALOMYOPATHIC FORM WITH METHYLMALONIC ACIDURIA	0.001086973	0.04071320611599911
LEUKODYSTROPHY, HYPOMYELINATING, 4	0.001086973	0.04071320611599911
PFEIFFER SYNDROME TYPE 2	0.001086973	0.04071320611599911
COENZYME Q10 DEFICIENCY, PRIMARY, 4	0.001086973	0.04071320611599911
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IN	0.001086973	0.04071320611599911
CHROMOSOME 16P11.2 DELETION SYNDROME, 593-KB	0.001086973	0.04071320611599911
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IW; CDG1W	0.001086973	0.04071320611599911
CHROMOSOME 5Q12 DELETION SYNDROME	0.001086973	0.04071320611599911
MICROCEPHALY, PRIMARY AUTOSOMAL RECESSIVE, 6	0.001086973	0.04071320611599911
MOSAIC VARIEGATED ANEUPLOIDY SYNDROME 3; MVA3	0.001086973	0.04071320611599911
EPILEPSY, EARLY-ONSET, VITAMIN B6-DEPENDENT; EPVB6D	0.001086973	0.04071320611599911
EPILEPSY, HEARING LOSS, AND MENTAL RETARDATION SYNDROME; EHLMRS	0.001086973	0.04071320611599911
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 54; EIEE54	0.001086973	0.04071320611599911
NEURODEVELOPMENTAL DISORDER WITH EPILEPSY, CATARACTS, FEEDING DIFFICULTIES, AND DELAYED BRAIN MYELINATION	0.001086973	0.04071320611599911
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IIQ; CDG2Q	0.001086973	0.04071320611599911
MUSCULAR DYSTROPHY, CONGENITAL, WITH CATARACTS AND INTELLECTUAL DISABILITY	0.001086973	0.04071320611599911
STANKIEWICZ-ISIDOR SYNDROME; STISS	0.001086973	0.04071320611599911
NEURODEVELOPMENTAL DISORDER WITH HYPOTONIA, NEUROPATHY, AND DEAFNESS; NEDHND	0.001086973	0.04071320611599911
INTELLECTUAL DEVELOPMENTAL DISORDER WITH NEUROPSYCHIATRIC FEATURES; IDDNPF	0.001086973	0.04071320611599911
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 55; EIEE55	0.001086973	0.04071320611599911
IMMUNODEFICIENCY 49; IMD49	0.001086973	0.04071320611599911
MENTAL RETARDATION, AUTOSOMAL DOMINANT 46; MRD46	0.001086973	0.04071320611599911
SKRABAN-DEARDORFF SYNDROME; SKDEAS	0.001086973	0.04071320611599911
JOUBERT SYNDROME 30; JBTS30	0.001086973	0.04071320611599911
MENTAL RETARDATION, AUTOSOMAL DOMINANT 47; MRD47	0.001086973	0.04071320611599911
ACHONDROPLASIA, SEVERE, WITH DEVELOPMENTAL DELAY AND ACANTHOSIS NIGRICANS; SADDAN	0.001086973	0.04071320611599911
LEUKODYSTROPHY, HYPOMYELINATING, 10; HLD10	0.001086973	0.04071320611599911
HYPOMAGNESEMIA, SEIZURES, AND MENTAL RETARDATION; HOMGSMR	0.001086973	0.04071320611599911
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 33; EIEE33	0.001086973	0.04071320611599911
PILAROWSKI-BJORNSSON SYNDROME; PILBOS	0.001086973	0.04071320611599911
ARGININEMIA	0.001086973	0.04071320611599911
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 31	0.001086973	0.04071320611599911
NEURODEVELOPMENTAL DISORDER WITH MICROCEPHALY, ATAXIA, AND SEIZURES; NEDMAS	0.001086973	0.04071320611599911
MICROCEPHALY 17, PRIMARY, AUTOSOMAL RECESSIVE; MCPH17	0.001086973	0.04071320611599911
CHROMOSOME 11P13 DELETION SYNDROME, DISTAL	0.001086973	0.04071320611599911
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 53; MRT53	0.001086973	0.04071320611599911
COFFIN-SIRIS SYNDROME 5	0.001086973	0.04071320611599911
MENTAL RETARDATION, AUTOSOMAL DOMINANT 41	0.001086973	0.04071320611599911
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IIO	0.001086973	0.04071320611599911
MENTAL RETARDATION, AUTOSOMAL DOMINANT 42	0.001086973	0.04071320611599911
CEREBRAL PALSY, SPASTIC QUADRIPLEGIC, 3; CPSQ3	0.001086973	0.04071320611599911
WALKER-WARBURG SYNDROME	0.001086973	0.04071320611599911
ENCEPHALOPATHY DUE TO DEFECTIVE MITOCHONDRIAL AND PEROXISOMAL FISSION 2	0.001086973	0.04071320611599911
GROWTH RETARDATION, IMPAIRED INTELLECTUAL DEVELOPMENT, HYPOTONIA, AND HEPATOPATHY; GRIDHH	0.001086973	0.04071320611599911
SPASTIC TETRAPLEGIA, THIN CORPUS CALLOSUM, AND PROGRESSIVE MICROCEPHALY; SPATCCM	0.001086973	0.04071320611599911
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 42; EIEE42	0.001086973	0.04071320611599911
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 43	0.001086973	0.04071320611599911
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IIN	0.001086973	0.04071320611599911
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 46; EIEE46	0.001086973	0.04071320611599911
INTELLECTUAL DEVELOPMENTAL DISORDER WITH CARDIAC ARRHYTHMIA	0.001086973	0.04071320611599911
MICROCEPHALY 16, PRIMARY, AUTOSOMAL RECESSIVE	0.001086973	0.04071320611599911
SHASHI-PENA SYNDROME; SHAPNS	0.001086973	0.04071320611599911
PERIVENTRICULAR NODULAR HETEROTOPIA 7; PVNH7	0.001086973	0.04071320611599911
ENCEPHALOPATHY, PROGRESSIVE, WITH AMYOTROPHY AND OPTIC ATROPHY; PEAMO	0.001086973	0.04071320611599911
MICROCEPHALY 14, PRIMARY, AUTOSOMAL RECESSIVE; MCPH14	0.001086973	0.04071320611599911
GALLOWAY-MOWAT SYNDROME 4; GAMOS4	0.001086973	0.04071320611599911
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 72; EIEE72	0.001086973	0.04071320611599911
PONTOCEREBELLAR HYPOPLASIA, TYPE 2E; PCH2E	0.001086973	0.04071320611599911
BONE MARROW FAILURE SYNDROME 5; BMFS5	0.001086973	0.04071320611599911
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 44	0.001086973	0.04071320611599911
INFLAMMATORY BOWEL DISEASE, IMMUNODEFICIENCY, AND ENCEPHALOPATHY; IBDIMDE	0.001086973	0.04071320611599911
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 20	0.001086973	0.04071320611599911
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 10; MC1DN10	0.001086973	0.04071320611599911
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 13; MC1DN13	0.001086973	0.04071320611599911
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 18; MC1DN18	0.001086973	0.04071320611599911
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 19; MC1DN19	0.001086973	0.04071320611599911
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 31; MC1DN31	0.001086973	0.04071320611599911
MEGA-CORPUS-CALLOSUM SYNDROME WITH CEREBELLAR HYPOPLASIA AND CORTICAL MALFORMATIONS; MCCCHCM	0.001086973	0.04071320611599911
MITOCHONDRIAL COMPLEX V (ATP SYNTHASE) DEFICIENCY, NUCLEAR TYPE 5; MC5DN5	0.001086973	0.04071320611599911
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 21; EIEE21	0.001086973	0.04071320611599911
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 70; EIEE70	0.001086973	0.04071320611599911
CONGENITAL DISORDER OF GLYCOSYLATION WITH DEFECTIVE FUCOSYLATION 2; CDGF2	0.001086973	0.04071320611599911
LISSENCEPHALY 9 WITH COMPLEX BRAINSTEM MALFORMATION; LIS9	0.001086973	0.04071320611599911
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 37; COXPD37	0.001086973	0.04071320611599911
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 42; MRT42	0.001086973	0.04071320611599911
GALLOWAY-MOWAT SYNDROME 8; GAMOS8	0.001086973	0.04071320611599911
BRAIN SMALL VESSEL DISEASE 3; BSVD3	0.001086973	0.04071320611599911
NEURODEVELOPMENTAL DISORDER WITH MICROCEPHALY, EPILEPSY, AND HYPOMYELINATION; NEDMEHM	0.001086973	0.04071320611599911
INTELLECTUAL DEVELOPMENTAL DISORDER WITH MACROCEPHALY, SEIZURES, AND SPEECH DELAY; IDDMSSD	0.001086973	0.04071320611599911
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 64; MRT64	0.001086973	0.04071320611599911
HEREDITARY FOLATE MALABSORPTION	0.001086973	0.04071320611599911
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 28; EIEE28	0.001086973	0.04071320611599911
MENTAL RETARDATION, AUTOSOMAL DOMINANT 35; MRD35	0.001086973	0.04071320611599911
LISSENCEPHALY 7 WITH CEREBELLAR HYPOPLASIA; LIS7	0.001086973	0.04071320611599911
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 29; EIEE29	0.001086973	0.04071320611599911
MENTAL RETARDATION, AUTOSOMAL DOMINANT 52; MRD52	0.001086973	0.04071320611599911
NEURODEVELOPMENTAL DISORDER WITH MICROCEPHALY, SEIZURES, AND CORTICAL ATROPHY; NDMSCA	0.001086973	0.04071320611599911
GLYCOSYLPHOSPHATIDYLINOSITOL BIOSYNTHESIS DEFECT 16; GPIBD16	0.001086973	0.04071320611599911
MENTAL RETARDATION, AUTOSOMAL DOMINANT 56; MRD56	0.001086973	0.04071320611599911
NEURODEVELOPMENTAL DISORDER WITH MICROCEPHALY, EPILEPSY, AND BRAIN ATROPHY; NEDMEBA	0.001086973	0.04071320611599911
LISSENCEPHALY 6 WITH MICROCEPHALY; LIS6	0.001086973	0.04071320611599911
SIALIDOSIS TYPE 2	0.001086973	0.04071320611599911
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 26; EIEE26	0.001086973	0.04071320611599911
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 23	0.001086973	0.04071320611599911
MICROCEPHALY AND CHORIORETINOPATHY, AUTOSOMAL RECESSIVE, 2; MCCRP2	0.001086973	0.04071320611599911
EPILEPSY, FAMILIAL FOCAL, WITH VARIABLE FOCI 4; FFEVF4	0.001086973	0.04071320611599911
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 62; EIEE62	0.001086973	0.04071320611599911
PEROXISOMAL FATTY ACYL-COA REDUCTASE 1 DISORDER	0.001086973	0.04071320611599911
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 46	0.001086973	0.04071320611599911
EPILEPTIC ENCEPHALOPATHY, INFANTILE OR EARLY CHILDHOOD, 3; IECEE3	0.001086973	0.04071320611599911
INTELLECTUAL DEVELOPMENTAL DISORDER WITH OR WITHOUT EPILEPSY OR CEREBELLAR ATAXIA; IDDECA	0.001086973	0.04071320611599911
SIDEROBLASTIC ANEMIA WITH B-CELL IMMUNODEFICIENCY, PERIODIC FEVERS, AND DEVELOPMENTAL DELAY; SIFD	0.001086973	0.04071320611599911
RIBOSE 5-PHOSPHATE ISOMERASE DEFICIENCY; RPIAD	0.001086973	0.04071320611599911
CENTRAL BILATERAL MACROGYRIA	0.001086973	0.04071320611599911
NEUROPATHY, ATAXIA, AND RETINITIS PIGMENTOSA	0.001086973	0.04071320611599911
LISSENCEPHALY 1; LIS1	0.001086973	0.04071320611599911
MATERNAL UNIPARENTAL DISOMY OF CHROMOSOME X	0.001086973	0.04071320611599911
ALG3-CDG	0.001086973	0.04071320611599911
HEMOPHAGOCYTIC LYMPHOHISTIOCYTOSIS, FAMILIAL, 4	0.001086973	0.04071320611599911
METHYLMALONIC ACIDEMIA WITH HOMOCYSTINURIA	0.001086973	0.04071320611599911
15Q14 MICRODELETION SYNDROME	0.001086973	0.04071320611599911
WILSON-TURNER X-LINKED MENTAL RETARDATION SYNDROME; WTS	0.001086973	0.04071320611599911
MENTAL RETARDATION, X-LINKED 90	0.001086973	0.04071320611599911
MENTAL RETARDATION, X-LINKED 88	0.001086973	0.04071320611599911
CITRULLINEMIA TYPE II	0.001086973	0.04071320611599911
PROXIMAL 16P11.2 MICRODELETION SYNDROME	0.001086973	0.04071320611599911
MENTAL RETARDATION, X-LINKED 9	0.001086973	0.04071320611599911
AUTOSOMAL DOMINANT HYPERINSULINISM DUE TO SUR1 DEFICIENCY	0.001086973	0.04071320611599911
POLYMICROGYRIA, BILATERAL FRONTOPARIETAL	0.001086973	0.04071320611599911
L1 SYNDROME	0.001086973	0.04071320611599911
HEMOPHAGOCYTIC LYMPHOHISTIOCYTOSIS, FAMILIAL, 2	0.001086973	0.04071320611599911
GALLOWAY-MOWAT SYNDROME 2, X-LINKED; GAMOS2	0.001086973	0.04071320611599911
%300861 MENTAL RETARDATION, X-LINKED, SYNDROMIC, CHUDLEY-SCHWARTZ TYPE; MRXSCS;;MENTAL RETARDATION, X-LINKED, WITH SEIZURES, HYPOGAMMAGLOBULINEMIA,AND GAIT DISTURBANCE	0.001086973	0.04071320611599911
MICROCEPHALY, CORPUS CALLOSUM DYSGENESIS, AND CLEFT LIP/PALATE	0.001086973	0.04071320611599911
PHACE ASSOCIATION	0.001086973	0.04071320611599911
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IIB	0.001086973	0.04071320611599911
DISTAL 16P11.2 MICRODELETION SYNDROME	0.001086973	0.04071320611599911
CEREBRAL-CEREBELLAR-COLOBOMA SYNDROME, X-LINKED	0.001086973	0.04071320611599911
GLYCEROL KINASE DEFICIENCY; GKD	0.001086973	0.04071320611599911
HYPERINSULINISM DUE TO UCP2 DEFICIENCY	0.001086973	0.04071320611599911
SALLA DISEASE	0.001086973	0.04071320611599911
ENCEPHALOCRANIOCUTANEOUS LIPOMATOSIS	0.001086973	0.04071320611599911
MEVALONIC ACIDURIA	0.001086973	0.04071320611599911
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 36; EIEE36	0.001086973	0.04071320611599911
MENTAL RETARDATION, X-LINKED, SYNDROMIC, HOUGE TYPE; MRXSHG	0.001086973	0.04071320611599911
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 2; MRT2	0.001086973	0.04071320611599911
SCHIZENCEPHALY	0.001086973	0.04071320611599911
WAISMAN SYNDROME; WSMN	0.001086973	0.04071320611599911
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE II; CDG1I	0.001086973	0.04071320611599911
MENTAL RETARDATION, X-LINKED 101; MRX101	0.001086973	0.04071320611599911
MEND SYNDROME; MEND	0.001086973	0.04071320611599911
X-LINKED INTELLECTUAL DISABILITY-HYPOGONADISM-ICHTHYOSIS-OBESITY-SHORT STATURE SYNDROME	0.001086973	0.04071320611599911
AUTOSOMAL DOMINANT HYPERINSULINISM DUE TO KIR6.2 DEFICIENCY	0.001086973	0.04071320611599911
MENTAL RETARDATION, X-LINKED, SYNDROMIC 13	0.001086973	0.04071320611599911
VITAMIN B12-UNRESPONSIVE METHYLMALONIC ACIDEMIA	0.001086973	0.04071320611599911
RFT1-CDG	0.001086973	0.04071320611599911
RAYNAUD-CLAES SYNDROME; MRXSRC	0.001086973	0.04071320611599911
MEHMO SYNDROME; MEHMO	0.001086973	0.04071320611599911
SPINOCEREBELLAR ATAXIA, X-LINKED 3	0.001086973	0.04071320611599911
CODAS SYNDROME	0.001086973	0.04071320611599911
CHROMOSOME 2Q37 DELETION SYNDROME	0.001086973	0.04071320611599911
ALG11-CDG	0.001086973	0.04071320611599911
PERIVENTRICULAR HETEROTOPIA WITH MICROCEPHALY, AUTOSOMAL RECESSIVE; ARPHM	0.001086973	0.04071320611599911
PIGMENTARY DISORDER, RETICULATE, WITH SYSTEMIC MANIFESTATIONS, X-LINKED	0.001086973	0.04071320611599911
SHUKLA-VERNON SYNDROME; SHUVER	0.001086973	0.04071320611599911
MENTAL RETARDATION, X-LINKED 72	0.001086973	0.04071320611599911
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IC; CDG1C	0.001086973	0.04071320611599911
MENTAL RETARDATION, X-LINKED 103	0.001086973	0.04071320611599911
VAN ESCH-O'DRISCOLL SYNDROME; VEODS	0.001086973	0.04071320611599911
11P15.4 MICRODUPLICATION SYNDROME	0.001086973	0.04071320611599911
ALG1-CDG	0.001086973	0.04071320611599911
ALPHA-N-ACETYLGALACTOSAMINIDASE DEFICIENCY TYPE 3	0.001086973	0.04071320611599911
CEREBRAL PALSY, SPASTIC, SYMMETRIC, AUTOSOMAL RECESSIVE	0.001086973	0.04071320611599911
METHYLMALONIC ACIDEMIA WITH HOMOCYSTINURIA, TYPE CBLD	0.001086973	0.04071320611599911
CARDIAC-VALVULAR EHLERS-DANLOS SYNDROME	0.001086973	0.04071320611599911
SYNDROMIC RECESSIVE X-LINKED ICHTHYOSIS	0.001086973	0.04071320611599911
OSTEOPETROSIS WITH RENAL TUBULAR ACIDOSIS	0.000545554	0.02043404247337126
BARDET-BIEDL SYNDROME 8; BBS8	0.000545554	0.02043404247337126
ATAXIA-TELANGIECTASIA-LIKE DISORDER 2; ATLD2	0.000545554	0.02043404247337126
AUTOSOMAL RECESSIVE SPASTIC PARAPLEGIA TYPE 54	0.000545554	0.02043404247337126
BARDET-BIEDL SYNDROME 2	0.000545554	0.02043404247337126
OSTEOPOROSIS-PSEUDOGLIOMA SYNDROME	0.000545554	0.02043404247337126
METHYLMALONIC ACIDURIA DUE TO METHYLMALONYL-COA MUTASE DEFICIENCY	0.000545554	0.02043404247337126
JOUBERT SYNDROME 35; JBTS35	0.000545554	0.02043404247337126
CHONDRODYSPLASIA PUNCTATA 1, X-LINKED RECESSIVE	0.000545554	0.02043404247337126
MITOCHONDRIAL COMPLEX III DEFICIENCY, NUCLEAR TYPE 9	0.000545554	0.02043404247337126
GALACTOSE EPIMERASE DEFICIENCY	0.000545554	0.02043404247337126
RETINAL DYSTROPHY, JUVENILE CATARACTS, AND SHORT STATURE SYNDROME; RDJCSS	0.000545554	0.02043404247337126
MONOCARBOXYLATE TRANSPORTER 1 DEFICIENCY; MCT1D	0.000545554	0.02043404247337126
PARKINSONISM-DYSTONIA, INFANTILE, 2; PKDYS2	0.000545554	0.02043404247337126
VITAMIN B12-RESPONSIVE METHYLMALONIC ACIDEMIA	0.000545554	0.02043404247337126
MENTAL RETARDATION, AUTOSOMAL DOMINANT 30; MRD30	0.000545554	0.02043404247337126
PONTOCEREBELLAR HYPOPLASIA, TYPE 1C; PCH1C	0.000545554	0.02043404247337126
MICROCEPHALY, GROWTH RESTRICTION, AND INCREASED SISTER CHROMATID EXCHANGE 2; MGRISCE2	0.000545554	0.02043404247337126
OTOFACIOCERVICAL SYNDROME	0.000545554	0.02043404247337126
BONE MARROW FAILURE SYNDROME 4; BMFS4	0.000545554	0.02043404247337126
ADULT-ONSET AUTOSOMAL DOMINANT LEUKODYSTROPHY	0.000545554	0.02043404247337126
BARDET-BIEDL SYNDROME 16; BBS16	0.000545554	0.02043404247337126
LIPODYSTROPHY-INTELLECTUAL DISABILITY-DEAFNESS SYNDROME	0.000545554	0.02043404247337126
BARDET-BIEDL SYNDROME 14; BBS14	0.000545554	0.02043404247337126
MULTIPLE ENDOCRINE NEOPLASIA, TYPE IIB; MEN2B	0.000545554	0.02043404247337126
PURINE NUCLEOSIDE PHOSPHORYLASE DEFICIENCY	0.000545554	0.02043404247337126
BARDET-BIEDL SYNDROME 13; BBS13	0.000545554	0.02043404247337126
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 21	0.000545554	0.02043404247337126
XIA-GIBBS SYNDROME	0.000545554	0.02043404247337126
AUTOSOMAL RECESSIVE SPASTIC PARAPLEGIA TYPE 45	0.000545554	0.02043404247337126
DYSKERATOSIS CONGENITA, X-LINKED; DKCX	0.000545554	0.02043404247337126
CORTICAL DYSPLASIA, COMPLEX, WITH OTHER BRAIN MALFORMATIONS 6; CDCBM6	0.000545554	0.02043404247337126
SHORT STATURE, AMELOGENESIS IMPERFECTA, AND SKELETAL DYSPLASIA WITH SCOLIOSIS; SSASKS	0.000545554	0.02043404247337126
PINEAL HYPERPLASIA, INSULIN-RESISTANT DIABETES MELLITUS, AND SOMATIC ABNORMALITIES	0.000545554	0.02043404247337126
MENTAL RETARDATION, AUTOSOMAL DOMINANT 23; MRD23	0.000545554	0.02043404247337126
CARBONIC ANHYDRASE VA DEFICIENCY, HYPERAMMONEMIA DUE TO	0.000545554	0.02043404247337126
TERATOCARCINOMA-DERIVED GROWTH FACTOR 1; TDGF1	0.000545554	0.02043404247337126
THANATOPHORIC DYSPLASIA, TYPE I	0.000545554	0.02043404247337126
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 38; COXPD38	0.000545554	0.02043404247337126
BOSCH-BOONSTRA-SCHAAF OPTIC ATROPHY SYNDROME; BBSOAS	0.000545554	0.02043404247337126
INTELLECTUAL DEVELOPMENTAL DISORDER, AUTOSOMAL RECESSIVE 69; MRT69	0.000545554	0.02043404247337126
JOUBERT SYNDROME 21	0.000545554	0.02043404247337126
OPHTHALMOPLEGIA-INTELLECTUAL DISABILITY-LINGUA SCROTALIS SYNDROME	0.000545554	0.02043404247337126
IMMUNODEFICIENCY, COMMON VARIABLE, 10; CVID10	0.000545554	0.02043404247337126
OCULO-PALATO-CEREBRAL SYNDROME	0.000545554	0.02043404247337126
HYDROXYKYNURENINURIA	0.000545554	0.02043404247337126
NOONAN SYNDROME 11; NS11	0.000545554	0.02043404247337126
CEREBELLAR ATROPHY WITH SEIZURES AND VARIABLE DEVELOPMENTAL DELAY; CASVDD	0.000545554	0.02043404247337126
ALACRIMA, ACHALASIA, AND MENTAL RETARDATION SYNDROME	0.000545554	0.02043404247337126
STRIATONIGRAL DEGENERATION, INFANTILE, MITOCHONDRIAL	0.000545554	0.02043404247337126
SEVERE INTELLECTUAL DISABILITY-CORPUS CALLOSUM AGENESIS-FACIAL DYSMORPHISM-CEREBELLAR ATAXIA SYNDROME	0.000545554	0.02043404247337126
FRIED SYNDROME	0.000545554	0.02043404247337126
MICROCEPHALY 25, PRIMARY, AUTOSOMAL RECESSIVE; MCPH25	0.000545554	0.02043404247337126
CONGENITAL CATARACTS-FACIAL DYSMORPHISM-NEUROPATHY SYNDROME	0.000545554	0.02043404247337126
SECKEL SYNDROME 8; SCKL8	0.000545554	0.02043404247337126
10Q22.3Q23.3 MICRODUPLICATION SYNDROME	0.000545554	0.02043404247337126
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 11; MC1DN11	0.000545554	0.02043404247337126
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 22; MC1DN22	0.000545554	0.02043404247337126
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 27; MC1DN27	0.000545554	0.02043404247337126
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 28; MC1DN28	0.000545554	0.02043404247337126
NEUTRAL LIPID STORAGE DISEASE WITH ICHTHYOSIS	0.000545554	0.02043404247337126
WIEDEMANN-RAUTENSTRAUCH SYNDROME; WDRTS	0.000545554	0.02043404247337126
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 33; MC1DN33	0.000545554	0.02043404247337126
CULLER-JONES SYNDROME; CJS	0.000545554	0.02043404247337126
GLOBAL DEVELOPMENTAL DELAY, LUNG CYSTS, OVERGROWTH, AND WILMS TUMOR; GLOW	0.000545554	0.02043404247337126
SPINOCEREBELLAR ATAXIA, AUTOSOMAL RECESSIVE 17; SCAR17	0.000545554	0.02043404247337126
GLOBAL DEVELOPMENTAL DELAY WITH OR WITHOUT IMPAIRED INTELLECTUAL DEVELOPMENT; GDDI	0.000545554	0.02043404247337126
CURRARINO SYNDROME	0.000545554	0.02043404247337126
MENTAL RETARDATION, AUTOSOMAL DOMINANT 24; MRD24	0.000545554	0.02043404247337126
CONDUCTIVE DEAFNESS-MALFORMED EXTERNAL EAR SYNDROME	0.000545554	0.02043404247337126
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 43; MRT43	0.000545554	0.02043404247337126
TRANSKETOLASE DEFICIENCY	0.000545554	0.02043404247337126
IMMUNODEFICIENCY 23; IMD23	0.000545554	0.02043404247337126
SEPTOOPTIC DYSPLASIA	0.000545554	0.02043404247337126
LYSOSOMAL ACID LIPASE DEFICIENCY	0.000545554	0.02043404247337126
DUCHENNE MUSCULAR DYSTROPHY	0.000545554	0.02043404247337126
X-LINKED SIDEROBLASTIC ANEMIA AND SPINOCEREBELLAR ATAXIA	0.000545554	0.02043404247337126
MENTAL RETARDATION, X-LINKED 107; MRX107	0.000545554	0.02043404247337126
LEUKODYSTROPHY, HYPOMYELINATING, 9; HLD9	0.000545554	0.02043404247337126
SPASTIC PARAPLEGIA 9B, AUTOSOMAL RECESSIVE; SPG9B	0.000545554	0.02043404247337126
1P21.3 MICRODELETION SYNDROME	0.000545554	0.02043404247337126
METHYLMALONIC ACIDEMIA WITHOUT HOMOCYSTINURIA	0.000545554	0.02043404247337126
SPASTIC PARAPLEGIA 75, AUTOSOMAL RECESSIVE	0.000545554	0.02043404247337126
PREAXIAL POLYDACTYLY-COLOBOMATA-INTELLECTUAL DISABILITY SYNDROME	0.000545554	0.02043404247337126
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 58; MRT58	0.000545554	0.02043404247337126
SENIOR-LOKEN SYNDROME 9	0.000545554	0.02043404247337126
%300858 MENTAL RETARDATION, X-LINKED, SYNDROMIC 17; MRXS17;;MENTAL RETARDATION, X-LINKED, WITH ALACRIMA AND ACHALASIA	0.000545554	0.02043404247337126
OPTIC ATROPHY 11; OPA11	0.000545554	0.02043404247337126
HEREDITARY SENSORY AND AUTONOMIC NEUROPATHY TYPE 4	0.000545554	0.02043404247337126
BILE ACID SYNTHESIS DEFECT, CONGENITAL, 6	0.000545554	0.02043404247337126
LANGUAGE DELAY AND ATTENTION DEFICIT-HYPERACTIVITY DISORDER/COGNITIVE IMPAIRMENT WITH OR WITHOUT CARDIAC ARRHYTHMIA; LADCI	0.000545554	0.02043404247337126
PEROXISOME BIOGENESIS DISORDER 10B	0.000545554	0.02043404247337126
HYPERPHENYLALANINEMIA, MILD, NON-BH4-DEFICIENT; HPANBH4	0.000545554	0.02043404247337126
NOONAN SYNDROME 9; NS9	0.000545554	0.02043404247337126
CONGENITAL VARICELLA SYNDROME	0.000545554	0.02043404247337126
CHROMOSOME XQ27.3-Q28 DUPLICATION SYNDROME	0.000545554	0.02043404247337126
DYSKERATOSIS CONGENITA, AUTOSOMAL DOMINANT 6; DKCA6	0.000545554	0.02043404247337126
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 26; COXPD26	0.000545554	0.02043404247337126
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 60	0.000545554	0.02043404247337126
MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (CONGENITAL WITH BRAIN AND EYE ANOMALIES), TYPE A, 9; MDDGA9	0.000545554	0.02043404247337126
273730 THORACIC DYSPLASIA-HYDROCEPHALUS SYNDROME	0.000545554	0.02043404247337126
SPINOCEREBELLAR ATAXIA TYPE 7	0.000545554	0.02043404247337126
MENTAL RETARDATION, AUTOSOMAL DOMINANT 39	0.000545554	0.02043404247337126
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 28	0.000545554	0.02043404247337126
CHROMOSOME 15Q14 DELETION SYNDROME	0.000545554	0.02043404247337126
MICROCEPHALY, CONGENITAL CATARACT, AND PSORIASIFORM DERMATITIS	0.000545554	0.02043404247337126
CHOREA, CHILDHOOD-ONSET, WITH PSYCHOMOTOR RETARDATION	0.000545554	0.02043404247337126
GLYCOGEN STORAGE DISEASE DUE TO PHOSPHOGLYCERATE KINASE 1 DEFICIENCY	0.000545554	0.02043404247337126
8P23.1 DUPLICATION SYNDROME	0.000545554	0.02043404247337126
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IIP	0.000545554	0.02043404247337126
CORPUS CALLOSUM, AGENESIS OF, WITH FACIAL ANOMALIES AND CEREBELLAR ATAXIA; CCAFCA	0.000545554	0.02043404247337126
OSSIFICATION ANOMALIES-PSYCHOMOTOR DEVELOPMENTAL DELAY SYNDROME	0.000545554	0.02043404247337126
HYPOTONIA, INFANTILE, WITH PSYCHOMOTOR RETARDATION; IHPMR	0.000545554	0.02043404247337126
JOUBERT SYNDROME 25	0.000545554	0.02043404247337126
CHARCOT-MARIE-TOOTH DISEASE, AXONAL, TYPE 2Z; CMT2Z	0.000545554	0.02043404247337126
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 55	0.000545554	0.02043404247337126
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 51	0.000545554	0.02043404247337126
MEIER-GORLIN SYNDROME 7	0.000545554	0.02043404247337126
VISCERAL NEUROPATHY-BRAIN ANOMALIES-FACIAL DYSMORPHISM-DEVELOPMENTAL DELAY SYNDROME	0.000545554	0.02043404247337126
OROFACIODIGITAL SYNDROME VIII; OFD8	0.000545554	0.02043404247337126
JOUBERT SYNDROME 27	0.000545554	0.02043404247337126
JOUBERT SYNDROME 28	0.000545554	0.02043404247337126
ALAZAMI-YUAN SYNDROME	0.000545554	0.02043404247337126
THUMB, HYPOPLASTIC, WITH CHOROID COLOBOMA, POORLY DEVELOPED ANTIHELIX,AND DEAFNESS	0.000545554	0.02043404247337126
MEDULLOBLASTOMA	0.000545554	0.02043404247337126
NEUROPATHY, HEREDITARY MOTOR AND SENSORY, TYPE VIB; HMSN6B	0.000545554	0.02043404247337126
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 36; COXPD36	0.000545554	0.02043404247337126
MICROCEPHALY 19, PRIMARY, AUTOSOMAL RECESSIVE; MCPH19	0.000545554	0.02043404247337126
JOUBERT SYNDROME 31; JBTS31	0.000545554	0.02043404247337126
JOUBERT SYNDROME 33; JBTS33	0.000545554	0.02043404247337126
REVESZ SYNDROME	0.000545554	0.02043404247337126
CLASSICAL-LIKE EHLERS-DANLOS SYNDROME TYPE 2	0.000545554	0.02043404247337126
MICROCEPHALY AND CHORIORETINOPATHY, AUTOSOMAL RECESSIVE, 3; MCCRP3	0.000545554	0.02043404247337126
HOLOPROSENCEPHALY 3; HPE3	0.000545554	0.02043404247337126
RETINITIS PIGMENTOSA 80; RP80	0.000545554	0.02043404247337126
MENTAL RETARDATION, AUTOSOMAL DOMINANT 50; MRD50	0.000545554	0.02043404247337126
OMPHALOCELE SYNDROME, SHPRINTZEN-GOLDBERG TYPE	0.000545554	0.02043404247337126
MYASTHENIC SYNDROME, CONGENITAL, 18; CMS18	0.000545554	0.02043404247337126
DYSKERATOSIS CONGENITA, AUTOSOMAL RECESSIVE 6	0.000545554	0.02043404247337126
ALG6-CDG	0.000545554	0.02043404247337126
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 48; MRT48	0.000545554	0.02043404247337126
CHARCOT-MARIE-TOOTH DISEASE-DEAFNESS-INTELLECTUAL DISABILITY SYNDROME	0.000545554	0.02043404247337126
SPINOCEREBELLAR ATAXIA, AUTOSOMAL RECESSIVE 18	0.000545554	0.02043404247337126
CEREBELLOFACIODENTAL SYNDROME	0.000545554	0.02043404247337126
PEROXISOME BIOGENESIS DISORDER 3B	0.000545554	0.02043404247337126
ARTHROGRYPOSIS, ECTODERMAL DYSPLASIA, CLEFT LIP/PALATE, AND DEVELOPMENTAL DELAY	0.000545554	0.02043404247337126
RADIOULNAR SYNOSTOSIS, UNILATERAL, WITH DEVELOPMENTAL RETARDATIONAND HYPOTONIA	0.000545554	0.02043404247337126
SHWACHMAN-DIAMOND SYNDROME 2; SDS2	0.000545554	0.02043404247337126
JOUBERT SYNDROME 32; JBTS32	0.000545554	0.02043404247337126
SENIOR-LOKEN SYNDROME	0.000545554	0.02043404247337126
MEGALENCEPHALY-CAPILLARY MALFORMATION-POLYMICROGYRIA SYNDROME	0.000545554	0.02043404247337126
SPINOCEREBELLAR ATAXIA, AUTOSOMAL RECESSIVE 25; SCAR25	0.000545554	0.02043404247337126
ATAXIA, SPASTIC, CHILDHOOD-ONSET, AUTOSOMAL RECESSIVE, WITH OPTIC ATROPHY AND MENTAL RETARDATION	0.000545554	0.02043404247337126
LINEAR SKIN DEFECTS WITH MULTIPLE CONGENITAL ANOMALIES 2; LSDMCA2	0.000545554	0.02043404247337126
GAZE PALSY, FAMILIAL HORIZONTAL, WITH PROGRESSIVE SCOLIOSIS 2, WITH IMPAIRED INTELLECTUAL DEVELOPMENT; HGPPS2	0.000545554	0.02043404247337126
BEARE-STEVENSON CUTIS GYRATA SYNDROME; BSTVS	0.000545554	0.02043404247337126
LEUKODYSTROPHY, HYPOMYELINATING, 11; HLD11	0.000545554	0.02043404247337126
MECKEL SYNDROME 13; MKS13	0.000545554	0.02043404247337126
WOLMAN DISEASE	0.000545554	0.02043404247337126
OROFACIODIGITAL SYNDROME XVI; OFD16	0.000545554	0.02043404247337126
JOUBERT SYNDROME 23; JBTS23	0.000545554	0.02043404247337126
THYROID HEMIAGENESIS	0.000545554	0.02043404247337126
IMMUNODEFICIENCY, DEVELOPMENTAL DELAY, AND HYPOHOMOCYSTEINEMIA; IMDDHH	0.000545554	0.02043404247337126
INTELLECTUAL DISABILITY-ALACRIMA-ACHALASIA SYNDROME	0.000545554	0.02043404247337126
PILI TORTI-DEVELOPMENTAL DELAY-NEUROLOGICAL ABNORMALITIES SYNDROME	0.000545554	0.02043404247337126
NEPHROGENIC DIABETES INSIPIDUS-INTRACRANIAL CALCIFICATION SYNDROME	0.000545554	0.02043404247337126
CEREBELLAR ATAXIA, CAYMAN TYPE	0.000545554	0.02043404247337126
DUPLICATION OF THE PITUITARY GLAND	0.000545554	0.02043404247337126
INFANTILE-ONSET AUTOSOMAL RECESSIVE NONPROGRESSIVE CEREBELLAR ATAXIA	0.000545554	0.02043404247337126
3-METHYLGLUTACONIC ACIDURIA, TYPE IX; MGCA9	0.000545554	0.02043404247337126
AUTOSOMAL RECESSIVE CEREBELLAR ATAXIA-PSYCHOMOTOR DELAY SYNDROME	0.000545554	0.02043404247337126
MENTAL RETARDATION, X-LINKED 106; MRX106	0.000545554	0.02043404247337126
DIHYDROPTERIDINE REDUCTASE DEFICIENCY	0.000545554	0.02043404247337126
X-LINKED INTELLECTUAL DISABILITY-HYPOTONIA-FACIAL DYSMORPHISM-AGGRESSIVE BEHAVIOR SYNDROME	0.000545554	0.02043404247337126
2-AMINOADIPIC 2-OXOADIPIC ACIDURIA; AMOXAD	0.000545554	0.02043404247337126
MULTIPLE MITOCHONDRIAL DYSFUNCTIONS SYNDROME 1; MMDS1	0.000545554	0.02043404247337126
DISTAL TRISOMY 6P	0.000545554	0.02043404247337126
HYPOMYELINATION-CONGENITAL CATARACT SYNDROME	0.000545554	0.02043404247337126
DYSKERATOSIS CONGENITA	0.000545554	0.02043404247337126
MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (CONGENITAL WITH MENTAL RETARDATION), TYPE B, 1; MDDGB1	0.000545554	0.02043404247337126
PARKINSONISM-DYSTONIA, INFANTILE, 1; PKDYS1	0.000545554	0.02043404247337126
NOONAN SYNDROME 2; NS2	0.000545554	0.02043404247337126
AICARDI-GOUTIERES SYNDROME 5	0.000545554	0.02043404247337126
MACROCEPHALY/AUTISM SYNDROME	0.000545554	0.02043404247337126
MARFANOID HABITUS-AUTOSOMAL RECESSIVE INTELLECTUAL DISABILITY SYNDROME	0.000545554	0.02043404247337126
SEVERE INTELLECTUAL DISABILITY-SHORT STATURE-BEHAVIORAL ABNORMALITIES-FACIAL DYSMORPHISM SYNDROME	0.000545554	0.02043404247337126
CEREBRAL CREATINE DEFICIENCY SYNDROME 3	0.000545554	0.02043404247337126
606156 SENER SYNDROME;;FRONTONASAL DYSPLASIA AND DILATED VIRCHOW-ROBIN SPACES	0.000545554	0.02043404247337126
HYDROCEPHALUS, NORMAL-PRESSURE	0.000545554	0.02043404247337126
DIAMOND-BLACKFAN ANEMIA 5	0.000545554	0.02043404247337126
RIGID SPINE SYNDROME	0.000545554	0.02043404247337126
LIGNEOUS CONJUNCTIVITIS	0.000545554	0.02043404247337126
JOUBERT SYNDROME 8	0.000545554	0.02043404247337126
HYPERTELORISM, MICROTIA, FACIAL CLEFTING SYNDROME	0.000545554	0.02043404247337126
CONGENITAL MUSCULAR DYSTROPHY WITH INTELLECTUAL DISABILITY	0.000545554	0.02043404247337126
GLUTAMATE-CYSTEINE LIGASE DEFICIENCY	0.000545554	0.02043404247337126
CHROMOSOME 10Q22.3-Q23.2 DELETION SYNDROME	0.000545554	0.02043404247337126
INTELLECTUAL DEVELOPMENTAL DISORDER WITH AUTISM AND SPEECH DELAY; IDDAS	0.000545554	0.02043404247337126
CHROMOSOME 16P13.3 DUPLICATION SYNDROME	0.000545554	0.02043404247337126
CARDIOENCEPHALOMYOPATHY, FATAL INFANTILE, DUE TO CYTOCHROME C OXIDASE DEFICIENCY 1; CEMCOX1	0.000545554	0.02043404247337126
17P11.2 MICRODUPLICATION SYNDROME	0.000545554	0.02043404247337126
CHROMOSOME 4Q21 DELETION SYNDROME	0.000545554	0.02043404247337126
INSENSITIVITY TO PAIN, CONGENITAL, WITH ANHIDROSIS; CIPA	0.000545554	0.02043404247337126
LEUKOTRIENE C4 SYNTHASE DEFICIENCY	0.000545554	0.02043404247337126
GALACTOSE EPIMERASE DEFICIENCY	0.000545554	0.02043404247337126
ANOPHTHALMIA/MICROPHTHALMIA-ESOPHAGEAL ATRESIA SYNDROME	0.000545554	0.02043404247337126
DYSKERATOSIS CONGENITA, AUTOSOMAL DOMINANT 2; DKCA2	0.000545554	0.02043404247337126
AUTOSOMAL RECESSIVE PRIMARY MICROCEPHALY	0.000545554	0.02043404247337126
MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (LIMB-GIRDLE), TYPE C, 9; MDDGC9	0.000545554	0.02043404247337126
HOYERAAL-HREIDARSSON SYNDROME	0.000545554	0.02043404247337126
GROWTH RETARDATION, SMALL AND PUFFY HANDS AND FEET, AND ECZEMA	0.000545554	0.02043404247337126
RUBINSTEIN-TAYBI SYNDROME 2; RSTS2	0.000545554	0.02043404247337126
INTELLECTUAL DISABILITY, BIRK-BAREL TYPE	0.000545554	0.02043404247337126
X-LINKED INTELLECTUAL DISABILITY, STEVENSON TYPE	0.000545554	0.02043404247337126
AUTOSOMAL RECESSIVE SPASTIC PARAPLEGIA TYPE 70	0.000545554	0.02043404247337126
AUTOSOMAL RECESSIVE SPASTIC PARAPLEGIA TYPE 69	0.000545554	0.02043404247337126
AUTOSOMAL RECESSIVE SPASTIC PARAPLEGIA TYPE 67	0.000545554	0.02043404247337126
MENTAL RETARDATION, ANTERIOR MAXILLARY PROTRUSION, AND STRABISMUS; MRAMS	0.000545554	0.02043404247337126
MITOCHONDRIAL COMPLEX V (ATP SYNTHASE) DEFICIENCY, NUCLEAR TYPE 1; MC5DN1	0.000545554	0.02043404247337126
FARBER DISEASE	0.000545554	0.02043404247337126
SPASTIC PARAPLEGIA 48, AUTOSOMAL RECESSIVE; SPG48	0.000545554	0.02043404247337126
FORSYTHE-WAKELING SYNDROME; FWS	0.000545554	0.02043404247337126
NEPHRONOPHTHISIS 11; NPHP11	0.000545554	0.02043404247337126
LEUKODYSTROPHY, HYPOMYELINATING, 13; HLD13	0.000545554	0.02043404247337126
HYPOTONIA-CYSTINURIA SYNDROME	0.000545554	0.02043404247337126
ACETYL-COA ACETYLTRANSFERASE-2 DEFICIENCY	0.000545554	0.02043404247337126
HYPERTELORISM-MICROTIA-FACIAL CLEFTING SYNDROME	0.000545554	0.02043404247337126
FRIAS SYNDROME	0.000545554	0.02043404247337126
HOLOPROSENCEPHALY 5; HPE5	0.000545554	0.02043404247337126
MICROVILLUS INCLUSION DISEASE	0.000545554	0.02043404247337126
MYOPATHY, AUTOPHAGIC VACUOLAR, INFANTILE-ONSET	0.000545554	0.02043404247337126
MARFANOID MENTAL RETARDATION SYNDROME, AUTOSOMAL	0.000545554	0.02043404247337126
MARINESCO-SJOGREN SYNDROME; MSS	0.000545554	0.02043404247337126
ALDH18A1-RELATED DE BARSY SYNDROME	0.000545554	0.02043404247337126
MENTAL RETARDATION, ENTEROPATHY, DEAFNESS, PERIPHERAL NEUROPATHY, ICHTHYOSIS, AND KERATODERMA	0.000545554	0.02043404247337126
XERODERMA PIGMENTOSUM-COCKAYNE SYNDROME COMPLEX	0.000545554	0.02043404247337126
MATERNAL UNIPARENTAL DISOMY OF CHROMOSOME 9	0.000545554	0.02043404247337126
METHYLMALONIC ACIDURIA, CBLB TYPE	0.000545554	0.02043404247337126
CHROMOSOME 22Q11.2 DELETION SYNDROME, DISTAL	0.000545554	0.02043404247337126
608227 CRANIOFACIAL ABNORMALITIES, CATARACTS, CONGENITAL HEART DISEASE, SACRALNEURAL TUBE DEFECTS, AND GROWTH AND DEVELOPMENTAL RETARDATION	0.000545554	0.02043404247337126
SPECTRIN-ASSOCIATED AUTOSOMAL RECESSIVE CEREBELLAR ATAXIA	0.000545554	0.02043404247337126
MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (CONGENITAL WITH MENTAL RETARDATION), TYPE B, 6	0.000545554	0.02043404247337126
ICHTHYOSIS-ALOPECIA-ECLABION-ECTROPION-INTELLECTUAL DISABILITY SYNDROME	0.000545554	0.02043404247337126
CONGENITAL HYPOTHYROIDISM DUE TO MATERNAL INTAKE OF ANTITHYROID DRUGS	0.000545554	0.02043404247337126
SHWACHMAN-DIAMOND SYNDROME	0.000545554	0.02043404247337126
METHEMOGLOBINEMIA DUE TO DEFICIENCY OF METHEMOGLOBIN REDUCTASE	0.000545554	0.02043404247337126
THUMB DEFORMITY-ALOPECIA-PIGMENTATION ANOMALY SYNDROME	0.000545554	0.02043404247337126
PROPIONIC ACIDEMIA	0.000545554	0.02043404247337126
YUNIS-VARON SYNDROME	0.000545554	0.02043404247337126
NATURAL KILLER CELL AND GLUCOCORTICOID DEFICIENCY WITH DNA REPAIR DEFECT	0.000545554	0.02043404247337126
USHER SYNDROME TYPE 1	0.000545554	0.02043404247337126
SPONDYLOEPIMETAPHYSEAL DYSPLASIA WITH MULTIPLE DISLOCATIONS	0.000545554	0.02043404247337126
AUTOSOMAL RECESSIVE CEREBELLAR ATAXIA-PYRAMIDAL SIGNS-NYSTAGMUS-OCULOMOTOR APRAXIA SYNDROME	0.000545554	0.02043404247337126
WAARDENBURG SYNDROME, TYPE 2E; WS2E	0.000545554	0.02043404247337126
ATAXIA-INTELLECTUAL DISABILITY-OCULOMOTOR APRAXIA-CEREBELLAR CYSTS SYNDROME	0.000545554	0.02043404247337126
JOUBERT SYNDROME 7	0.000545554	0.02043404247337126
DYGGVE-MELCHIOR-CLAUSEN DISEASE	0.000545554	0.02043404247337126
OBESITY DUE TO SIM1 DEFICIENCY	0.000545554	0.02043404247337126
CLEFT PALATE-LARGE EARS-SMALL HEAD SYNDROME	0.000545554	0.02043404247337126
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 4	0.000545554	0.02043404247337126
ARIMA SYNDROME	0.000545554	0.02043404247337126
COLE-CARPENTER SYNDROME	0.000545554	0.02043404247337126
CREE MENTAL RETARDATION SYNDROME	0.000545554	0.02043404247337126
POMT2-RELATED  LIMB-GIRDLE MUSCULAR DYSTROPHY R14	0.000545554	0.02043404247337126
PYRUVATE DEHYDROGENASE E2 DEFICIENCY; PDHDD	0.000545554	0.02043404247337126
CEREBROOCULOFACIOSKELETAL SYNDROME 2; COFS2	0.000545554	0.02043404247337126
HURLER SYNDROME	0.000545554	0.02043404247337126
JOUBERT SYNDROME 6	0.000545554	0.02043404247337126
SPINOCEREBELLAR ATAXIA TYPE 29	0.000545554	0.02043404247337126
INFANTILE DYSTONIA-PARKINSONISM	0.000545554	0.02043404247337126
DEVELOPMENTAL MALFORMATIONS-DEAFNESS-DYSTONIA SYNDROME	0.000545554	0.02043404247337126
CAMPTODACTYLY, TALL STATURE, AND HEARING LOSS SYNDROME	0.000545554	0.02043404247337126
MEVALONIC ACIDURIA; MEVA	0.000545554	0.02043404247337126
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IID	0.000545554	0.02043404247337126
CDAGS SYNDROME	0.000545554	0.02043404247337126
AUTOSOMAL RECESSIVE SPASTIC PARAPLEGIA TYPE 71	0.000545554	0.02043404247337126
CHROMOSOMAL INSTABILITY WITH TISSUE-SPECIFIC RADIOSENSITIVITY	0.000545554	0.02043404247337126
XQ27.3Q28 DUPLICATION SYNDROME	0.000545554	0.02043404247337126
PELLAGRA-LIKE SYNDROME	0.000545554	0.02043404247337126
CEREBELLAR HYPOPLASIA WITH ENDOSTEAL SCLEROSIS	0.000545554	0.02043404247337126
16P13.11 MICRODUPLICATION SYNDROME	0.000545554	0.02043404247337126
AUTOSOMAL RECESSIVE SPASTIC PARAPLEGIA TYPE 9B	0.000545554	0.02043404247337126
SPINOCEREBELLAR ATAXIA, AUTOSOMAL RECESSIVE 2; SCAR2	0.000545554	0.02043404247337126
PEROXISOME BIOGENESIS DISORDER 8B; PBD8B	0.000545554	0.02043404247337126
PEROXISOME BIOGENESIS DISORDER 6B	0.000545554	0.02043404247337126
PEROXISOME BIOGENESIS DISORDER 5B	0.000545554	0.02043404247337126
SHWACHMAN-DIAMOND SYNDROME 1; SDS1	0.000545554	0.02043404247337126
METHYLMALONIC ACIDURIA AND HOMOCYSTINURIA, CBLJ TYPE	0.000545554	0.02043404247337126
X-LINKED INTELLECTUAL DISABILITY, SCHIMKE TYPE	0.000545554	0.02043404247337126
NIEMANN-PICK DISEASE, TYPE A	0.000545554	0.02043404247337126
MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (CONGENITAL WITH BRAIN AND EYE ANOMALIES), TYPE A, 8	0.000545554	0.02043404247337126
ADAMS-OLIVER SYNDROME 3; AOS3	0.000545554	0.02043404247337126
RADIOULNAR SYNOSTOSIS-DEVELOPMENTAL DELAY-HYPOTONIA SYNDROME	0.000545554	0.02043404247337126
AURICULOCONDYLAR SYNDROME	0.000545554	0.02043404247337126
PCNA-RELATED PROGRESSIVE NEURODEGENERATIVE PHOTOSENSITIVITY SYNDROME	0.000545554	0.02043404247337126
OROTIC ACIDURIA	0.000545554	0.02043404247337126
ISOLATED COMPLEX I DEFICIENCY	0.000545554	0.02043404247337126
FANCONI ANEMIA, COMPLEMENTATION GROUP E; FANCE	0.000545554	0.02043404247337126
LETHAL ATAXIA WITH DEAFNESS AND OPTIC ATROPHY	0.000545554	0.02043404247337126
JOUBERT SYNDROME 17; JBTS17	0.000545554	0.02043404247337126
NEURODEVELOPMENTAL DISORDER WITH SPASTIC DIPLEGIA AND VISUAL DEFECTS; NEDSDV	0.000545554	0.02043404247337126
MICROPHTHALMIA, SYNDROMIC 3	0.000545554	0.02043404247337126
AUTOSOMAL RECESSIVE SPASTIC PARAPLEGIA TYPE 21	0.000545554	0.02043404247337126
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 17	0.000545554	0.02043404247337126
TRANSALDOLASE DEFICIENCY	0.000545554	0.02043404247337126
SPINOCEREBELLAR ATAXIA 5; SCA5	0.000545554	0.02043404247337126
LOWRY-MACLEAN SYNDROME	0.000545554	0.02043404247337126
AUSTRALIA ANTIGEN	0.000545554	0.02043404247337126
SPINOCEREBELLAR ATAXIA, AUTOSOMAL RECESSIVE 14	0.000545554	0.02043404247337126
AUTOSOMAL RECESSIVE SPASTIC PARAPLEGIA TYPE 75	0.000545554	0.02043404247337126
600460 CLEFT PALATE, CARDIAC DEFECT, GENITAL ANOMALIES, AND ECTRODACTYLY;;CCGE;;ACROCARDIOFACIAL SYNDROME; ACFS	0.000545554	0.02043404247337126
ABETAL34V AMYLOIDOSIS	0.000545554	0.02043404247337126
X-LINKED SPINOCEREBELLAR ATAXIA TYPE 3	0.000545554	0.02043404247337126
NEUTROPENIA, SEVERE CONGENITAL, 5, AUTOSOMAL RECESSIVE; SCN5	0.000545554	0.02043404247337126
INTRAUTERINE GROWTH RETARDATION WITH INCREASED MITOMYCIN C SENSITIVITY	0.000545554	0.02043404247337126
HYPERTRYPTOPHANEMIA; HYPTRP	0.000545554	0.02043404247337126
DYSKERATOSIS CONGENITA, AUTOSOMAL RECESSIVE 5; DKCB5	0.000545554	0.02043404247337126
ARACHNODACTYLY-ABNORMAL OSSIFICATION-INTELLECTUAL DISABILITY SYNDROME	0.000545554	0.02043404247337126
MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (CONGENITAL WITH BRAIN AND EYE ANOMALIES), TYPE A, 11; MDDGA11	0.000545554	0.02043404247337126
MICROPHTHALMIA, ISOLATED, WITH COLOBOMA 9; MCOPCB9	0.000545554	0.02043404247337126
LEUKOENCEPHALOPATHY WITH BILATERAL ANTERIOR TEMPORAL LOBE CYSTS	0.000545554	0.02043404247337126
277465 VITILIGO, PROGRESSIVE, WITH MENTAL RETARDATION AND URETHRAL DUPLICATION	0.000545554	0.02043404247337126
CRANIOTELENCEPHALIC DYSPLASIA	0.000545554	0.02043404247337126
PLECTIN-RELATED  LIMB-GIRDLE MUSCULAR DYSTROPHY R17	0.000545554	0.02043404247337126
RITSCHER-SCHINZEL SYNDROME 1	0.000545554	0.02043404247337126
CURRY-JONES SYNDROME	0.000545554	0.02043404247337126
CRANIOTELENCEPHALIC DYSPLASIA	0.000545554	0.02043404247337126
HOLOPROSENCEPHALY 11	0.000545554	0.02043404247337126
JOUBERT SYNDROME 15	0.000545554	0.02043404247337126
SPINOCEREBELLAR ATAXIA, AUTOSOMAL RECESSIVE 11; SCAR11	0.000545554	0.02043404247337126
CONTRACTURES-ECTODERMAL DYSPLASIA-CLEFT LIP/PALATE SYNDROME	0.000545554	0.02043404247337126
RIDDLE SYNDROME	0.000545554	0.02043404247337126
CONGENITAL CATARACT-PROGRESSIVE MUSCULAR HYPOTONIA-HEARING LOSS-DEVELOPMENTAL DELAY SYNDROME	0.000545554	0.02043404247337126
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 27	0.000545554	0.02043404247337126
OROFACIODIGITAL SYNDROME TYPE 14	0.000545554	0.02043404247337126
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IR	0.000545554	0.02043404247337126
FAMILIAL HYPERTHYROIDISM DUE TO MUTATIONS IN TSH RECEPTOR	0.000545554	0.02043404247337126
EPIPHYSEAL DYSPLASIA, MULTIPLE, WITH EARLY-ONSET DIABETES MELLITUS	0.000545554	0.02043404247337126
WAARDENBURG-SHAH SYNDROME	0.000545554	0.02043404247337126
OROFACIODIGITAL SYNDROME IX; OFD9	0.000545554	0.02043404247337126
COGNITIVE IMPAIRMENT WITH OR WITHOUT CEREBELLAR ATAXIA; CIAT	0.000545554	0.02043404247337126
NEURODEGENERATION WITH BRAIN IRON ACCUMULATION 4; NBIA4	0.000545554	0.02043404247337126
HERMANSKY-PUDLAK SYNDROME 6; HPS6	0.000545554	0.02043404247337126
CEREBELLAR ATAXIA, CAYMAN TYPE; ATCAY	0.000545554	0.02043404247337126
CHROMOSOME 15Q25 DELETION SYNDROME	0.000545554	0.02043404247337126
OCULOCEREBRAL HYPOPIGMENTATION SYNDROME OF PREUS	0.000545554	0.02043404247337126
MICROCEPHALY-CLEFT PALATE-ABNORMAL RETINAL PIGMENTATION SYNDROME	0.000545554	0.02043404247337126
SJÖGREN-LARSSON SYNDROME	0.000541419	0.02027916364262785
3-HYDROXYISOBUTYRIC ACIDURIA	0.000541419	0.02027916364262785
IMMUNOGLOBULIN A VASCULITIS	0.000541419	0.02027916364262785
ACUTE ADRENAL INSUFFICIENCY	0.000541419	0.02027916364262785
SCLERODERMA	0.000541419	0.02027916364262785
METHYLMALONIC ACIDEMIA WITH HOMOCYSTINURIA, TYPE CBLC	0.000541419	0.02027916364262785
SPINOCEREBELLAR ATAXIA WITH AXONAL NEUROPATHY TYPE 1	0.000541419	0.02027916364262785
NON-FUNCTIONING PITUITARY ADENOMA	0.000541419	0.02027916364262785
PORPHYRIA VARIEGATA	0.000541419	0.02027916364262785
MIXED CONNECTIVE TISSUE DISEASE	0.000541419	0.02027916364262785
POSTENCEPHALITIC PARKINSONISM	0.000541419	0.02027916364262785
HEREDITARY COPROPORPHYRIA	0.000541419	0.02027916364262785
ACUTE INTERMITTENT PORPHYRIA	0.000541419	0.02027916364262785
SYSTEMIC SCLEROSIS	0.000541419	0.02027916364262785
GRISCELLI SYNDROME TYPE 2	0.000541419	0.02027916364262785
ACQUIRED PARTIAL LIPODYSTROPHY	0.000541419	0.02027916364262785
MOGS-CDG	0.000541419	0.02027916364262785
X-LINKED INTELLECTUAL DISABILITY-HYPOGAMMAGLOBULINEMIA-PROGRESSIVE NEUROLOGICAL DETERIORATION SYNDROME	0.000541419	0.02027916364262785
TSH-SECRETING PITUITARY ADENOMA	0.000541419	0.02027916364262785
INFANTILE NEURONAL CEROID LIPOFUSCINOSIS	0.000541419	0.02027916364262785
INSULINOMA	0.000541419	0.02027916364262785
PITUITARY DEFICIENCY DUE TO EMPTY SELLA TURCICA SYNDROME	0.000541419	0.02027916364262785
ALG9-CDG	0.000541419	0.02027916364262785
SECONDARY SYRINGOMYELIA	0.000541419	0.02027916364262785
CRIGLER-NAJJAR SYNDROME TYPE 1	0.000541419	0.02027916364262785
JERVELL AND LANGE-NIELSEN SYNDROME	0.000541419	0.02027916364262785
POSTERIOR COLUMN ATAXIA-RETINITIS PIGMENTOSA SYNDROME	0.000541419	0.02027916364262785
X-LINKED INTELLECTUAL DISABILITY, WILSON TYPE	0.000541419	0.02027916364262785
PRIMARY INTESTINAL LYMPHANGIECTASIA	0.000541419	0.02027916364262785
X-LINKED EPILEPSY-LEARNING DISABILITIES-BEHAVIOR DISORDERS SYNDROME	0.000541419	0.02027916364262785
AUTOSOMAL DOMINANT DEAFNESS-ONYCHODYSTROPHY SYNDROME	0.000541419	0.02027916364262785
PEDIATRIC SYSTEMIC LUPUS ERYTHEMATOSUS	0.000541419	0.02027916364262785
PFEIFFER SYNDROME TYPE 3	0.000541419	0.02027916364262785
SHIGA TOXIN-ASSOCIATED HEMOLYTIC UREMIC SYNDROME	0.000541419	0.02027916364262785
HEREDITARY CONTINUOUS MUSCLE FIBER ACTIVITY	0.000541419	0.02027916364262785
X-LINKED INTELLECTUAL DISABILITY-CUBITUS VALGUS-DYSMORPHISM SYNDROME	0.000541419	0.02027916364262785
MITOCHONDRIAL TRIFUNCTIONAL PROTEIN DEFICIENCY	0.000541419	0.02027916364262785
NIPAH VIRUS DISEASE	0.000541419	0.02027916364262785
ECTODERMAL DYSPLASIA SYNDROME	0.000541419	0.02027916364262785
FRAGILE X SYNDROME	0.000541419	0.02027916364262785
L-2-HYDROXYGLUTARIC ACIDURIA	0.000541419	0.02027916364262785
RIBOFLAVIN TRANSPORTER DEFICIENCY	0.000541419	0.02027916364262785
ALG2-CDG	0.000541419	0.02027916364262785
MPDU1-CDG	0.000541419	0.02027916364262785
PRESYNAPTIC CONGENITAL MYASTHENIC SYNDROMES	0.000541419	0.02027916364262785
ADDISON DISEASE	0.000541419	0.02027916364262785
ENCEPHALITIS LETHARGICA	0.000541419	0.02027916364262785
X-LINKED INTELLECTUAL DISABILITY, SHASHI TYPE	0.000541419	0.02027916364262785
DERMOTRICHIC SYNDROME	0.000541419	0.02027916364262785
PORPHYRIA	0.000541419	0.02027916364262785
FETAL GAUCHER DISEASE	0.000541419	0.02027916364262785
PARTINGTON SYNDROME	0.000541419	0.02027916364262785
RECESSIVE MITOCHONDRIAL ATAXIA SYNDROME	0.000541419	0.02027916364262785
RABIES	0.000541419	0.02027916364262785
HYPERINSULINISM DUE TO GLUCOKINASE DEFICIENCY	0.000541419	0.02027916364262785
RENIER-GABREELS-JASPER SYNDROME	0.000541419	0.02027916364262785
MEGALENCEPHALY-POLYMICROGYRIA-POSTAXIAL POLYDACTYLY-HYDROCEPHALUS SYNDROME	0.000541419	0.02027916364262785
HEREDITARY HEMORRHAGIC TELANGIECTASIA	0.000541419	0.02027916364262785
EPISODIC ATAXIA TYPE 3	0.000541419	0.02027916364262785
SCRUB TYPHUS	0.000541419	0.02027916364262785
ACROMEGALOID FACIAL APPEARANCE SYNDROME	0.000541419	0.02027916364262785
CAMOS SYNDROME	0.000541419	0.02027916364262785
7Q11.23 MICRODUPLICATION SYNDROME	0.000541419	0.02027916364262785
HOLOCARBOXYLASE SYNTHETASE DEFICIENCY	0.000541419	0.02027916364262785
WOLF-HIRSCHHORN SYNDROME	0.000541419	0.02027916364262785
ANGELMAN SYNDROME	0.000541419	0.02027916364262785
CARNITINE PALMITOYLTRANSFERASE II DEFICIENCY, INFANTILE	0.000541419	0.02027916364262785
MENTAL RETARDATION ASSOCIATED WITH PSORIASIS	0.000541419	0.02027916364262785
MENTAL RETARDATION, X-LINKED 1	0.000541419	0.02027916364262785
METHYLMALONIC ACIDEMIA AND HOMOCYSTEINEMIA, CBLX TYPE	0.000541419	0.02027916364262785
%309545 MENTAL RETARDATION, X-LINKED, SYNDROMIC 12; MRXS12	0.000541419	0.02027916364262785
MENTAL RETARDATION WITH OPTIC ATROPHY, DEAFNESS, AND SEIZURES	0.000541419	0.02027916364262785
MUCOPOLYSACCHARIDOSIS, TYPE II	0.000541419	0.02027916364262785
CYCLIC VOMITING SYNDROME	0.000541419	0.02027916364262785
KEARNS-SAYRE SYNDROME; KSS	0.000541419	0.02027916364262785
600302 FRYNS MACROCEPHALY;;MACROCEPHALY WITH SPASTIC PARAPLEGIA AND DISTINCTIVE CRANIOFACIALAPPEARANCE	0.000541419	0.02027916364262785
SPASTIC PARAPLEGIA 6, AUTOSOMAL DOMINANT	0.000541419	0.02027916364262785
TELANGIECTASIA, HEREDITARY HEMORRHAGIC, TYPE 2; HHT2	0.000541419	0.02027916364262785
GURRIERI SYNDROME	0.000541419	0.02027916364262785
SPINOCEREBELLAR ATAXIA, AUTOSOMAL RECESSIVE, WITH AXONAL NEUROPATHY 1; SCAN1	0.000541419	0.02027916364262785
HYPOCALCEMIA, AUTOSOMAL DOMINANT 1	0.000541419	0.02027916364262785
MENTAL RETARDATION, MICROCEPHALY, EPILEPSY, AND COARSE FACE	0.000541419	0.02027916364262785
CEROID LIPOFUSCINOSIS, NEURONAL, 6	0.000541419	0.02027916364262785
PHOSPHOGLYCERATE DEHYDROGENASE DEFICIENCY	0.000541419	0.02027916364262785
GOMEZ-LOPEZ-HERNANDEZ SYNDROME; GLHS	0.000541419	0.02027916364262785
HYPOMAGNESEMIA 1, INTESTINAL; HOMG1	0.000541419	0.02027916364262785
MIGRAINE, FAMILIAL HEMIPLEGIC, 2; FHM2	0.000541419	0.02027916364262785
CEREBRAL CAVERNOUS MALFORMATIONS 2	0.000541419	0.02027916364262785
ENCEPHALOPATHY, FAMILIAL, WITH NEUROSERPIN INCLUSION BODIES; FENIB	0.000541419	0.02027916364262785
VENTRICULAR TACHYCARDIA, CATECHOLAMINERGIC POLYMORPHIC, 1, WITH OR WITHOUT ATRIAL DYSFUNCTION AND/OR DILATED CARDIOMYOPATHY; CPVT1	0.000541419	0.02027916364262785
ALZHEIMER DISEASE, FAMILIAL EARLY-ONSET, WITH COEXISTING AMYLOID AND PRION PATHOLOGY	0.000541419	0.02027916364262785
LOWE OCULOCEREBRORENAL SYNDROME	0.000541419	0.02027916364262785
INCONTINENTIA PIGMENTI; IP	0.000541419	0.02027916364262785
ICHTHYOSIS AND MALE HYPOGONADISM	0.000541419	0.02027916364262785
DIABETES INSIPIDUS, NEPHROGENIC, X-LINKED	0.000541419	0.02027916364262785
DIHYDROPYRIMIDINE DEHYDROGENASE DEFICIENCY	0.000541419	0.02027916364262785
XYLOSIDASE DEFICIENCY	0.000541419	0.02027916364262785
INTESTINAL PSEUDOOBSTRUCTION, NEURONAL, CHRONIC IDIOPATHIC, X-LINKED	0.000541419	0.02027916364262785
MENTAL RETARDATION, X-LINKED 14	0.000541419	0.02027916364262785
LISSENCEPHALY, X-LINKED, 1; LISX1	0.000541419	0.02027916364262785
ADRENOLEUKODYSTROPHY	0.000541419	0.02027916364262785
MENTAL RETARDATION, X-LINKED 21	0.000541419	0.02027916364262785
MENTAL RETARDATION, X-LINKED, WITH OR WITHOUT SEIZURES, ARX-RELATED	0.000541419	0.02027916364262785
AUTISM, SUSCEPTIBILITY TO, X-LINKED 1; AUTSX1	0.000541419	0.02027916364262785
CUBITUS VALGUS WITH MENTAL RETARDATION AND UNUSUAL FACIES	0.000541419	0.02027916364262785
AUTISM, SUSCEPTIBILITY TO, X-LINKED 2; AUTSX2	0.000541419	0.02027916364262785
AUTISM, SUSCEPTIBILITY TO, X-LINKED 3; AUTSX3	0.000541419	0.02027916364262785
MENTAL RETARDATION, X-LINKED 82	0.000541419	0.02027916364262785
NEPHROGENIC SYNDROME OF INAPPROPRIATE ANTIDIURESIS; NSIAD	0.000541419	0.02027916364262785
FRAGILE X MENTAL RETARDATION SYNDROME	0.000541419	0.02027916364262785
MENTAL RETARDATION, X-LINKED, SYNDROMIC, WU TYPE; MRXSW	0.000541419	0.02027916364262785
MENTAL RETARDATION, X-LINKED 96; MRX96	0.000541419	0.02027916364262785
MENTAL RETARDATION, X-LINKED 100	0.000541419	0.02027916364262785
LINEAR SKIN DEFECTS WITH MULTIPLE CONGENITAL ANOMALIES 3; LSDMCA3	0.000541419	0.02027916364262785
MENTAL RETARDATION, X-LINKED 102	0.000541419	0.02027916364262785
IMMUNODEFICIENCY 47	0.000541419	0.02027916364262785
BORJESON-FORSSMAN-LEHMANN SYNDROME; BFLS	0.000541419	0.02027916364262785
CORPUS CALLOSUM, PARTIAL AGENESIS OF, X-LINKED	0.000541419	0.02027916364262785
GLYCINE ENCEPHALOPATHY; GCE	0.000541419	0.02027916364262785
AUTISM, SUSCEPTIBILITY TO, 8; AUTS8	0.000541419	0.02027916364262785
IMMUNODEFICIENCY 38 WITH BASAL GANGLIA CALCIFICATION; IMD38	0.000541419	0.02027916364262785
AUTISM, SUSCEPTIBILITY TO, 18	0.000541419	0.02027916364262785
INFECTIONS, RECURRENT, WITH ENCEPHALOPATHY, HEPATIC DYSFUNCTION, AND CARDIOVASCULAR MALFORMATIONS	0.000541419	0.02027916364262785
RETINITIS PIGMENTOSA 59; RP59	0.000541419	0.02027916364262785
MEGALENCEPHALIC LEUKOENCEPHALOPATHY WITH SUBCORTICAL CYSTS 2A; MLC2A	0.000541419	0.02027916364262785
PERRAULT SYNDROME 3	0.000541419	0.02027916364262785
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 16	0.000541419	0.02027916364262785
ENCEPHALOPATHY, ACUTE, INFECTION-INDUCED, SUSCEPTIBILITY TO, 4; IIAE4	0.000541419	0.02027916364262785
NEURODEVELOPMENTAL DISORDER WITH OR WITHOUT HYPERKINETIC MOVEMENTS AND SEIZURES, AUTOSOMAL DOMINANT; NDHMSD	0.000541419	0.02027916364262785
EPILEPSY, FAMILIAL TEMPORAL LOBE, 5	0.000541419	0.02027916364262785
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 34, WITH VARIANT LISSENCEPHALY; MRT34	0.000541419	0.02027916364262785
GLUCOCORTICOID DEFICIENCY 4 WITH OR WITHOUT MINERALOCORTICOID DEFICIENCY; GCCD4	0.000541419	0.02027916364262785
MICROCEPHALY, SHORT STATURE, AND POLYMICROGYRIA WITH OR WITHOUT SEIZURES; MSSP	0.000541419	0.02027916364262785
HYDROCEPHALUS, CONGENITAL, 2, WITH OR WITHOUT BRAIN OR EYE ANOMALIES; HYC2	0.000541419	0.02027916364262785
COENZYME Q10 DEFICIENCY, PRIMARY, 1; COQ10D1	0.000541419	0.02027916364262785
MITOCHONDRIAL COMPLEX V (ATP SYNTHASE) DEFICIENCY, NUCLEAR TYPE 4; MC5DN4	0.000541419	0.02027916364262785
NEPHROTIC SYNDROME, TYPE 8; NPHS8	0.000541419	0.02027916364262785
MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (LIMB-GIRDLE), TYPE C, 14; MDDGC14	0.000541419	0.02027916364262785
CEROID LIPOFUSCINOSIS, NEURONAL, 13; CLN13	0.000541419	0.02027916364262785
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 37	0.000541419	0.02027916364262785
MOYAMOYA DISEASE 6 WITH ACHALASIA	0.000541419	0.02027916364262785
TATTON-BROWN-RAHMAN SYNDROME; TBRS	0.000541419	0.02027916364262785
MICROCEPHALY, SHORT STATURE, AND IMPAIRED GLUCOSE METABOLISM 1; MSSGM1	0.000541419	0.02027916364262785
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 22	0.000541419	0.02027916364262785
MICROCEPHALY 13, PRIMARY, AUTOSOMAL RECESSIVE; MCPH13	0.000541419	0.02027916364262785
MENTAL RETARDATION, AUTOSOMAL DOMINANT 29; MRD29	0.000541419	0.02027916364262785
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IIJ; CDG2J	0.000541419	0.02027916364262785
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 5	0.000541419	0.02027916364262785
MENTAL RETARDATION, AUTOSOMAL DOMINANT 20	0.000541419	0.02027916364262785
MICROCEPHALY, SEIZURES, AND DEVELOPMENTAL DELAY	0.000541419	0.02027916364262785
SENSORY ATAXIC NEUROPATHY, DYSARTHRIA, AND OPHTHALMOPARESIS; SANDO	0.000541419	0.02027916364262785
GRISCELLI SYNDROME, TYPE 2; GS2	0.000541419	0.02027916364262785
MUSCULAR DYSTROPHY, CONGENITAL MEROSIN-DEFICIENT, 1A; MDC1A	0.000541419	0.02027916364262785
AUTISM, SUSCEPTIBILITY TO, 3; AUTS3	0.000541419	0.02027916364262785
LIPODYSTROPHY, GENERALIZED, WITH MENTAL RETARDATION, DEAFNESS, SHORT STATURE, AND SLENDER BONES	0.000541419	0.02027916364262785
CHROMOSOME 15Q11-Q13 DUPLICATION SYNDROME	0.000541419	0.02027916364262785
MICROCEPHALY 5, PRIMARY, AUTOSOMAL RECESSIVE	0.000541419	0.02027916364262785
CEROID LIPOFUSCINOSIS, NEURONAL, 9	0.000541419	0.02027916364262785
MITOCHONDRIAL DNA DEPLETION SYNDROME 2 (MYOPATHIC TYPE)	0.000541419	0.02027916364262785
MIGRAINE, FAMILIAL HEMIPLEGIC, 3	0.000541419	0.02027916364262785
PONTOCEREBELLAR HYPOPLASIA, TYPE 5; PCH5	0.000541419	0.02027916364262785
PACHYGYRIA, FRONTOTEMPORAL	0.000541419	0.02027916364262785
HYPOGONADOTROPIC HYPOGONADISM 4 WITH OR WITHOUT ANOSMIA; HH4	0.000541419	0.02027916364262785
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 10	0.000541419	0.02027916364262785
PAROXYSMAL NONKINESIGENIC DYSKINESIA 2	0.000541419	0.02027916364262785
SPASTIC PARAPLEGIA 18, AUTOSOMAL RECESSIVE; SPG18	0.000541419	0.02027916364262785
LISSENCEPHALY 3; LIS3	0.000541419	0.02027916364262785
VENTRICULAR TACHYCARDIA, CATECHOLAMINERGIC POLYMORPHIC, 2; CPVT2	0.000541419	0.02027916364262785
MITOCHONDRIAL DNA DEPLETION SYNDROME 8A (ENCEPHALOMYOPATHIC TYPE WITH RENAL TUBULOPATHY)	0.000541419	0.02027916364262785
EPISODIC ATAXIA, TYPE 6	0.000541419	0.02027916364262785
ENCEPHALOPATHY, ACUTE, INFECTION-INDUCED (HERPES-SPECIFIC), SUSCEPTIBILITY TO, 2; IIAE2	0.000541419	0.02027916364262785
NEPHRONOPHTHISIS-LIKE NEPHROPATHY 1	0.000541419	0.02027916364262785
SPASTIC PARAPLEGIA 44, AUTOSOMAL RECESSIVE; SPG44	0.000541419	0.02027916364262785
THYROCEREBRORETINAL SYNDROME	0.000541419	0.02027916364262785
THREONINEMIA	0.000541419	0.02027916364262785
TAY-SACHS DISEASE; TSD	0.000541419	0.02027916364262785
203600 ALOPECIA-EPILEPSY-OLIGOPHRENIA SYNDROME OF MOYNAHAN;;MOYNAHAN ALOPECIA SYNDROME	0.000541419	0.02027916364262785
OCULOCEREBROCUTANEOUS SYNDROME	0.000541419	0.02027916364262785
PARIETAL FORAMINA	0.000541419	0.02027916364262785
PATTERSON PSEUDOLEPRECHAUNISM SYNDROME	0.000541419	0.02027916364262785
BRAIN SMALL VESSEL DISEASE 1 WITH OR WITHOUT OCULAR ANOMALIES; BSVD1	0.000541419	0.02027916364262785
SNEDDON SYNDROME	0.000541419	0.02027916364262785
182610 SPASTIC PARAPLEGIA, EPILEPSY, AND MENTAL RETARDATION; SPEMR	0.000541419	0.02027916364262785
STURGE-WEBER SYNDROME	0.000541419	0.02027916364262785
SUPRABULBAR PARESIS, CONGENITAL	0.000541419	0.02027916364262785
PREECLAMPSIA/ECLAMPSIA 1	0.000541419	0.02027916364262785
VASCULOPATHY, RETINAL, WITH CEREBRAL LEUKODYSTROPHY; RVCL	0.000541419	0.02027916364262785
ACTH DEFICIENCY, ISOLATED; IAD	0.000541419	0.02027916364262785
CEROID LIPOFUSCINOSIS, NEURONAL, 3; CLN3	0.000541419	0.02027916364262785
SJOGREN-LARSSON SYNDROME; SLS	0.000541419	0.02027916364262785
CEROID LIPOFUSCINOSIS, NEURONAL, 4A, AUTOSOMAL RECESSIVE	0.000541419	0.02027916364262785
ANGIOMATOSIS, DIFFUSE CORTICOMENINGEAL, OF DIVRY AND VAN BOGAERT	0.000541419	0.02027916364262785
AUTISM	0.000541419	0.02027916364262785
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IIA; CDG2A	0.000541419	0.02027916364262785
CARNITINE-ACYLCARNITINE TRANSLOCASE DEFICIENCY	0.000541419	0.02027916364262785
CELIAC DISEASE, SUSCEPTIBILITY TO, 1; CELIAC1	0.000541419	0.02027916364262785
CEREBELLOPARENCHYMAL DISORDER II	0.000541419	0.02027916364262785
CEREBROTENDINOUS XANTHOMATOSIS; CTX	0.000541419	0.02027916364262785
215480 CHOROID PLEXUS CALCIFICATION AND MENTAL RETARDATION	0.000541419	0.02027916364262785
COHEN SYNDROME	0.000541419	0.02027916364262785
CONVULSIVE DISORDER, FAMILIAL, WITH PRENATAL OR EARLY ONSET	0.000541419	0.02027916364262785
CEROID LIPOFUSCINOSIS, NEURONAL, 4B, AUTOSOMAL DOMINANT; CLN4B	0.000541419	0.02027916364262785
NEUROFIBROMATOSIS, TYPE I	0.000541419	0.02027916364262785
HYPOMAGNESEMIA 2, RENAL	0.000541419	0.02027916364262785
BANNAYAN-RILEY-RUVALCABA SYNDROME	0.000541419	0.02027916364262785
1P36 MICRODELETION SYNDROME	0.000541419	0.02027916364262785
ANGELMAN SYNDROME (TYPE 1)	0.000541419	0.02027916364262785
2Q33.1 DELETION SYNDROME	0.000541419	0.02027916364262785
ANGELMAN SYNDROME (TYPE 2)	0.000541419	0.02027916364262785
NEUROFIBROMATOSIS, TYPE II	0.000541419	0.02027916364262785
%104130 ALOPECIA, PSYCHOMOTOR EPILEPSY, PYORRHEA, AND MENTAL SUBNORMALITY;;SHOKEIR SYNDROME	0.000541419	0.02027916364262785
AMYLOIDOSIS, HEREDITARY, TRANSTHYRETIN-RELATED	0.000541419	0.02027916364262785
ARTERITIS, FAMILIAL GRANULOMATOUS, WITH JUVENILE POLYARTHRITIS	0.000541419	0.02027916364262785
CHOREOATHETOSIS, FAMILIAL INVERTED	0.000541419	0.02027916364262785
PAPILLORENAL SYNDROME	0.000541419	0.02027916364262785
CROUZON SYNDROME	0.000541419	0.02027916364262785
DARIER-WHITE DISEASE; DAR	0.000541419	0.02027916364262785
DENTATORUBRAL-PALLIDOLUYSIAN ATROPHY NAITO-OYANAGI DISEASE HAW RIVER SYNDROME ATAXIA, CHOREA, SEIZURES, AND DEMENTIA	0.000541419	0.02027916364262785
DIABETES INSIPIDUS, NEPHROGENIC, AUTOSOMAL	0.000541419	0.02027916364262785
EPILEPSY, BENIGN OCCIPITAL	0.000541419	0.02027916364262785
EPILEPSY, READING	0.000541419	0.02027916364262785
FLYNN-AIRD SYNDROME	0.000541419	0.02027916364262785
MENTAL RETARDATION, FRA12A TYPE	0.000541419	0.02027916364262785
HEMIFACIAL ATROPHY, PROGRESSIVE; HFA	0.000541419	0.02027916364262785
HUNTINGTON DISEASE; HD	0.000541419	0.02027916364262785
HYPOPARATHYROIDISM, FAMILIAL ISOLATED; FIH	0.000541419	0.02027916364262785
%149000 KLIPPEL-TRENAUNAY-WEBER SYNDROME;;KTW SYNDROME;;KLIPPEL-TRENAUNAY SYNDROME; KTS;;ANGIOOSTEOHYPERTROPHY SYNDROME	0.000541419	0.02027916364262785
SYSTEMIC LUPUS ERYTHEMATOSUS; SLE	0.000541419	0.02027916364262785
CRANIOFACIAL DYSSYNOSTOSIS WITH SHORT STATURE	0.000541419	0.02027916364262785
CRANIOSYNOSTOSIS-MENTAL RETARDATION-CLEFTING SYNDROME	0.000541419	0.02027916364262785
CUTIS LAXA, AUTOSOMAL RECESSIVE, TYPE IIA; ARCL2A	0.000541419	0.02027916364262785
MAPLE SYRUP URINE DISEASE; MSUD	0.000541419	0.02027916364262785
MENTAL RETARDATION SYNDROME, BELGIAN TYPE	0.000541419	0.02027916364262785
%250900 METHIONINE MALABSORPTION SYNDROME;;SMITH-STRANG DISEASE;;OASTHOUSE URINE DISEASE	0.000541419	0.02027916364262785
MICROCEPHALY, PRIMARY AUTOSOMAL RECESSIVE, 1	0.000541419	0.02027916364262785
MITOCHONDRIAL DNA DEPLETION SYNDROME 3 (HEPATOCEREBRAL TYPE)	0.000541419	0.02027916364262785
MOLYBDENUM COFACTOR DEFICIENCY, COMPLEMENTATION GROUP A; MOCODA	0.000541419	0.02027916364262785
MOLYBDENUM COFACTOR DEFICIENCY, COMPLEMENTATION GROUP B; MOCODB	0.000541419	0.02027916364262785
MUCOPOLYSACCHARIDOSIS TYPE IIIA	0.000541419	0.02027916364262785
MUCOPOLYSACCHARIDOSIS TYPE IIIB	0.000541419	0.02027916364262785
MUSCULAR DYSTROPHY, ADULT-ONSET, WITH LEUKOENCEPHALOPATHY	0.000541419	0.02027916364262785
MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (CONGENITAL WITH BRAIN AND EYE ANOMALIES), TYPE A, 4; MDDGA4	0.000541419	0.02027916364262785
CARNITINE PALMITOYLTRANSFERASE I DEFICIENCY	0.000541419	0.02027916364262785
PROTEASOME-ASSOCIATED AUTOINFLAMMATORY SYNDROME 1; PRAAS1	0.000541419	0.02027916364262785
NEURAMINIDASE DEFICIENCY WITH BETA-GALACTOSIDASE DEFICIENCY	0.000541419	0.02027916364262785
NEURAMINIDASE DEFICIENCY	0.000541419	0.02027916364262785
OSTEOPETROSIS, AUTOSOMAL RECESSIVE 1; OPTB1	0.000541419	0.02027916364262785
PAPILLOMA OF CHOROID PLEXUS	0.000541419	0.02027916364262785
PHENYLKETONURIA	0.000541419	0.02027916364262785
GLYCOGEN STORAGE DISEASE OF HEART, LETHAL CONGENITAL	0.000541419	0.02027916364262785
GITELMAN SYNDROME	0.000541419	0.02027916364262785
GLUTATHIONE SYNTHETASE DEFICIENCY	0.000541419	0.02027916364262785
RAMON SYNDROME	0.000541419	0.02027916364262785
RETINAL DEGENERATION AND EPILEPSY	0.000541419	0.02027916364262785
KNOBLOCH SYNDROME 1; KNO1	0.000541419	0.02027916364262785
MEGALENCEPHALY WITH DYSMYELINATION	0.000541419	0.02027916364262785
MANNOSIDOSIS, BETA A, LYSOSOMAL	0.000541419	0.02027916364262785
DIAMINOPENTANURIA	0.000541419	0.02027916364262785
LIPOID PROTEINOSIS OF URBACH AND WIETHE	0.000541419	0.02027916364262785
224250 DYSMYELINATION WITH JAUNDICE	0.000541419	0.02027916364262785
EPILEPSY-TELANGIECTASIA	0.000541419	0.02027916364262785
VISCERAL STEATOSIS, CONGENITAL	0.000541419	0.02027916364262785
FOUNTAIN SYNDROME	0.000541419	0.02027916364262785
FRUCTOSE AND GALACTOSE INTOLERANCE	0.000541419	0.02027916364262785
FRUCTOSE-1,6-BISPHOSPHATASE DEFICIENCY	0.000541419	0.02027916364262785
GAPO SYNDROME; GAPOS	0.000541419	0.02027916364262785
GAUCHER DISEASE, TYPE IIIC	0.000541419	0.02027916364262785
BERNARD-SOULIER SYNDROME	0.000541419	0.02027916364262785
N-ACETYLGLUTAMATE SYNTHASE DEFICIENCY	0.000541419	0.02027916364262785
HYPER-BETA-ALANINEMIA	0.000541419	0.02027916364262785
HYPERLEUCINE-ISOLEUCINEMIA	0.000541419	0.02027916364262785
HYPERLYSINEMIA, TYPE I	0.000541419	0.02027916364262785
HYPERPHOSPHATEMIA, POLYURIA, AND SEIZURES	0.000541419	0.02027916364262785
HYPERPROLINEMIA, TYPE II	0.000541419	0.02027916364262785
HYPOADRENOCORTICISM, FAMILIAL	0.000541419	0.02027916364262785
GLYCOGEN STORAGE DISEASE 0, LIVER	0.000541419	0.02027916364262785
HYPOGLYCEMIA, LEUCINE-INDUCED; LIH	0.000541419	0.02027916364262785
HYPOPHOSPHATASIA, INFANTILE	0.000541419	0.02027916364262785
HYPOPHOSPHATASIA, CHILDHOOD	0.000541419	0.02027916364262785
HYPOGONADOTROPIC HYPOGONADISM 3 WITH OR WITHOUT ANOSMIA; HH3	0.000541419	0.02027916364262785
KAPUR-TORIELLO SYNDROME	0.000541419	0.02027916364262785
KIFAFA SEIZURE DISORDER	0.000541419	0.02027916364262785
IMMUNODEFICIENCY 37; IMD37	0.000541419	0.02027916364262785
PERRAULT SYNDROME 5; PRLTS5	0.000541419	0.02027916364262785
SENSORY ATAXIC NEUROPATHY-DYSARTHRIA-OPHTHALMOPARESIS SYNDROME	0.000541419	0.02027916364262785
X-LINKED INTELLECTUAL DISABILITY-SEIZURES-PSORIASIS SYNDROME	0.000541419	0.02027916364262785
INHERITED CREUTZFELDT-JAKOB DISEASE	0.000541419	0.02027916364262785
AUTOSOMAL RECESSIVE SPASTIC PARAPLEGIA TYPE 11	0.000541419	0.02027916364262785
TYROSINEMIA TYPE 2	0.000541419	0.02027916364262785
PHAKOMATOSIS PIGMENTOVASCULARIS	0.000541419	0.02027916364262785
CONGENITAL RUBELLA SYNDROME	0.000541419	0.02027916364262785
CRONKHITE-CANADA SYNDROME	0.000541419	0.02027916364262785
PORENCEPHALY	0.000541419	0.02027916364262785
PROLACTINOMA	0.000541419	0.02027916364262785
LEUKOCYTE ADHESION DEFICIENCY	0.000541419	0.02027916364262785
SPONTANEOUS PERIODIC HYPOTHERMIA	0.000541419	0.02027916364262785
RAMON SYNDROME	0.000541419	0.02027916364262785
BENIGN FAMILIAL INFANTILE EPILEPSY	0.000541419	0.02027916364262785
AUTOSOMAL RECESSIVE CONGENITAL CEREBELLAR ATAXIA DUE TO MGLUR1 DEFICIENCY	0.000541419	0.02027916364262785
FADD-RELATED IMMUNODEFICIENCY	0.000541419	0.02027916364262785
X-LINKED INTELLECTUAL DISABILITY-PSYCHOSIS-MACROORCHIDISM SYNDROME	0.000541419	0.02027916364262785
SEVERE X-LINKED INTELLECTUAL DISABILITY, GUSTAVSON TYPE	0.000541419	0.02027916364262785
NOCARDIOSIS	0.000541419	0.02027916364262785
INFANTILE SPASMS-BROAD THUMBS SYNDROME	0.000541419	0.02027916364262785
LUJO HEMORRHAGIC FEVER	0.000541419	0.02027916364262785
EBOLA HEMORRHAGIC FEVER	0.000541419	0.02027916364262785
RIFT VALLEY FEVER	0.000541419	0.02027916364262785
HEREDITARY HYPEREKPLEXIA	0.000541419	0.02027916364262785
AUTOSOMAL RECESSIVE SPASTIC PARAPLEGIA TYPE 44	0.000541419	0.02027916364262785
STURGE-WEBER SYNDROME	0.000541419	0.02027916364262785
PAPILLOMA OF CHOROID PLEXUS	0.000541419	0.02027916364262785
SYMPTOMATIC FORM OF COFFIN-LOWRY SYNDROME IN FEMALE CARRIERS	0.000541419	0.02027916364262785
ADULT-ONSET NON-INSULINOMA PERSISTENT HYPERINSULINEMIC HYPOGLYCEMIA	0.000541419	0.02027916364262785
HORIZONTAL GAZE PALSY WITH PROGRESSIVE SCOLIOSIS	0.000541419	0.02027916364262785
FAMILIAL CEREBRAL SACCULAR ANEURYSM	0.000541419	0.02027916364262785
KABUKI SYNDROME	0.000541419	0.02027916364262785
SANJAD-SAKATI SYNDROME	0.000541419	0.02027916364262785
OSTEOPENIA-INTELLECTUAL DISABILITY-SPARSE HAIR SYNDROME	0.000541419	0.02027916364262785
ANGIOOSTEOHYPERTROPHIC SYNDROME	0.000541419	0.02027916364262785
MACROCEPHALY-SPASTIC PARAPLEGIA-DYSMORPHISM SYNDROME	0.000541419	0.02027916364262785
RETINAL VASCULOPATHY WITH CEREBRAL LEUKOENCEPHALOPATHY AND SYSTEMIC MANIFESTATIONS	0.000541419	0.02027916364262785
NEUROCUTANEOUS MELANOCYTOSIS	0.000541419	0.02027916364262785
PATERNAL UNIPARENTAL DISOMY OF CHROMOSOME 1	0.000541419	0.02027916364262785
EPENDYMOMA	0.000541419	0.02027916364262785
SUBEPENDYMOMA	0.000541419	0.02027916364262785
PINEOBLASTOMA	0.000541419	0.02027916364262785
DISTAL 7Q11.23 MICRODELETION SYNDROME	0.000541419	0.02027916364262785
MICROSPORIDIOSIS	0.000541419	0.02027916364262785
MOYAMOYA DISEASE	0.000541419	0.02027916364262785
MOYNAHAN SYNDROME	0.000541419	0.02027916364262785
MITOCHONDRIAL MYOPATHY-LACTIC ACIDOSIS-DEAFNESS SYNDROME	0.000541419	0.02027916364262785
MYOPATHY-GROWTH DELAY-INTELLECTUAL DISABILITY-HYPOSPADIAS SYNDROME	0.000541419	0.02027916364262785
17Q12 MICRODUPLICATION SYNDROME	0.000541419	0.02027916364262785
HYPERINSULINISM DUE TO HNF4A DEFICIENCY	0.000541419	0.02027916364262785
HYPERINSULINISM DUE TO INSR DEFICIENCY	0.000541419	0.02027916364262785
PORT-WINE NEVI-MEGA CISTERNA MAGNA-HYDROCEPHALUS SYNDROME	0.000541419	0.02027916364262785
OLIVOPONTOCEREBELLAR ATROPHY-DEAFNESS SYNDROME	0.000541419	0.02027916364262785
COCHLEOSACCULAR DEGENERATION-CATARACT SYNDROME	0.000541419	0.02027916364262785
EARLY-ONSET LAFORA BODY DISEASE	0.000541419	0.02027916364262785
EPILEPSY, PROGRESSIVE MYOCLONIC 7; EPM7	0.000541419	0.02027916364262785
THROMBOTIC THROMBOCYTOPENIC PURPURA	0.000541419	0.02027916364262785
AUTOSOMAL DOMINANT SPASTIC PARAPLEGIA TYPE 9A	0.000541419	0.02027916364262785
PAROXYSMAL EXTREME PAIN DISORDER	0.000541419	0.02027916364262785
ACQUIRED METHEMOGLOBINEMIA	0.000541419	0.02027916364262785
HEREDITARY FRUCTOSE INTOLERANCE	0.000541419	0.02027916364262785
KALLMANN SYNDROME	0.000541419	0.02027916364262785
AUTOSOMAL RECESSIVE COMPLEX SPASTIC PARAPLEGIA DUE TO KENNEDY PATHWAY DYSFUNCTION	0.000541419	0.02027916364262785
WHIM SYNDROME	0.000541419	0.02027916364262785
ACUTE BILIRUBIN ENCEPHALOPATHY	0.000541419	0.02027916364262785
CHRONIC BILIRUBIN ENCEPHALOPATHY	0.000541419	0.02027916364262785
OCULOCEREBRORENAL SYNDROME OF LOWE	0.000541419	0.02027916364262785
LYMPHANGIOLEIOMYOMATOSIS	0.000541419	0.02027916364262785
MUSCLE-EYE-BRAIN DISEASE	0.000541419	0.02027916364262785
HYPERINSULINISM DUE TO HNF1A DEFICIENCY	0.000541419	0.02027916364262785
MYASTHENIA GRAVIS	0.000541419	0.02027916364262785
CONGENITAL MYASTHENIC SYNDROME	0.000541419	0.02027916364262785
CENTRONUCLEAR MYOPATHY	0.000541419	0.02027916364262785
X-LINKED CENTRONUCLEAR MYOPATHY	0.000541419	0.02027916364262785
LARGE CONGENITAL MELANOCYTIC NEVUS	0.000541419	0.02027916364262785
RECURRENT ACUTE PANCREATITIS	0.000541419	0.02027916364262785
LHERMITTE-DUCLOS DISEASE	0.000541419	0.02027916364262785
MUTILATING PALMOPLANTAR KERATODERMA WITH PERIORIFICIAL KERATOTIC PLAQUES	0.000541419	0.02027916364262785
ONDINE SYNDROME	0.000541419	0.02027916364262785
PRIMARY CUTIS VERTICIS GYRATA	0.000541419	0.02027916364262785
MALIGNANT ATROPHIC PAPULOSIS	0.000541419	0.02027916364262785
INTELLECTUAL DISABILITY-EXPRESSIVE APHASIA-FACIAL DYSMORPHISM SYNDROME	0.000541419	0.02027916364262785
SEVERE INTELLECTUAL DISABILITY-HYPOTONIA-STRABISMUS-COARSE FACE-PLANOVALGUS SYNDROME	0.000541419	0.02027916364262785
HYPOPHOSPHATASIA	0.000541419	0.02027916364262785
X-LINKED MICROCEPHALY-GROWTH RETARDATION-PROGNATHISM-CRYPTORCHIDISM SYNDROME	0.000541419	0.02027916364262785
ABETA AMYLOIDOSIS, ITALIAN TYPE	0.000541419	0.02027916364262785
IDIOPATHIC HYPEREOSINOPHILIC SYNDROME	0.000541419	0.02027916364262785
AUTOIMMUNE LYMPHOPROLIFERATIVE SYNDROME	0.000541419	0.02027916364262785
TAKAYASU ARTERITIS	0.000541419	0.02027916364262785
THYROCEREBRORENAL SYNDROME	0.000541419	0.02027916364262785
FAMILIAL MEDITERRANEAN FEVER	0.000541419	0.02027916364262785
WORSTER-DROUGHT SYNDROME	0.000541419	0.02027916364262785
ZIMMERMANN-LABAND SYNDROME	0.000541419	0.02027916364262785
FRUCTOSE-1,6-BISPHOSPHATASE DEFICIENCY	0.000541419	0.02027916364262785
GALACTOSIALIDOSIS	0.000541419	0.02027916364262785
GM1 GANGLIOSIDOSIS	0.000541419	0.02027916364262785
ANK3-RELATED INTELLECTUAL DISABILITY-SLEEP DISTURBANCE SYNDROME	0.000541419	0.02027916364262785
3-HYDROXY-3-METHYLGLUTARYL-COA SYNTHASE DEFICIENCY	0.000541419	0.02027916364262785
GLIOBLASTOMA	0.000541419	0.02027916364262785
X-LINKED PARKINSONISM-SPASTICITY SYNDROME	0.000541419	0.02027916364262785
GLYCOGEN STORAGE DISEASE DUE TO GLUCOSE-6-PHOSPHATASE DEFICIENCY	0.000541419	0.02027916364262785
HYPOCOMPLEMENTEMIC URTICARIAL VASCULITIS	0.000541419	0.02027916364262785
GLYCOGEN STORAGE DISEASE DUE TO ACID MALTASE DEFICIENCY	0.000541419	0.02027916364262785
CLASSIC HOMOCYSTINURIA	0.000541419	0.02027916364262785
PERIPHERAL NEUROPATHY-MYOPATHY-HOARSENESS-HEARING LOSS SYNDROME	0.000541419	0.02027916364262785
AUTOSOMAL RECESSIVE CEREBELLAR ATAXIA-EPILEPSY-INTELLECTUAL DISABILITY SYNDROME DUE TO TUD DEFICIENCY	0.000541419	0.02027916364262785
AUTOSOMAL RECESSIVE CEREBELLAR ATAXIA-EPILEPSY-INTELLECTUAL DISABILITY SYNDROME DUE TO RUBCN DEFICIENCY	0.000541419	0.02027916364262785
HYPERPROLINEMIA TYPE 1	0.000541419	0.02027916364262785
NEURONAL INTRANUCLEAR INCLUSION DISEASE	0.000541419	0.02027916364262785
5Q35 MICRODUPLICATION SYNDROME	0.000541419	0.02027916364262785
5Q14.3 MICRODELETION SYNDROME	0.000541419	0.02027916364262785
COFFIN-SIRIS SYNDROME 8; CSS8	0.000541419	0.02027916364262785
LEUKODYSTROPHY, HYPOMYELINATING, 17; HLD17	0.000541419	0.02027916364262785
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 65; EIEE65	0.000541419	0.02027916364262785
NEURODEVELOPMENTAL DISORDER WITH SPASTICITY AND POOR GROWTH; NEDSG	0.000541419	0.02027916364262785
ENCEPHALITIS/ENCEPHALOPATHY, MILD, WITH REVERSIBLE MYELIN VACUOLIZATION; MMERV	0.000541419	0.02027916364262785
MUSCULAR DYSTROPHY, LIMB-GIRDLE, AUTOSOMAL RECESSIVE 23; LGMDR23	0.000541419	0.02027916364262785
PERIVENTRICULAR NODULAR HETEROTOPIA 8; PVNH8	0.000541419	0.02027916364262785
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 9; MC1DN9	0.000541419	0.02027916364262785
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 14; MC1DN14	0.000541419	0.02027916364262785
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 32; MC1DN32	0.000541419	0.02027916364262785
INTELLECTUAL DEVELOPMENTAL DISORDER, AUTOSOMAL RECESSIVE 67; MRT67	0.000541419	0.02027916364262785
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 71; EIEE71	0.000541419	0.02027916364262785
ATAXIA-TELANGIECTASIA	0.000541419	0.02027916364262785
CARNITINE PALMITOYL TRANSFERASE II DEFICIENCY, SEVERE INFANTILE FORM	0.000541419	0.02027916364262785
ABETA AMYLOIDOSIS, DUTCH TYPE	0.000541419	0.02027916364262785
ALOPECIA-EPILEPSY-PYORRHEA-INTELLECTUAL DISABILITY SYNDROME	0.000541419	0.02027916364262785
PORPHYRIA DUE TO ALA DEHYDRATASE DEFICIENCY	0.000541419	0.02027916364262785
AUTOSOMAL DOMINANT SPASTIC PARAPLEGIA TYPE 4	0.000541419	0.02027916364262785
AUTOSOMAL RECESSIVE SPASTIC PARAPLEGIA TYPE 15	0.000541419	0.02027916364262785
DENTATORUBRAL PALLIDOLUYSIAN ATROPHY	0.000541419	0.02027916364262785
AUTOSOMAL RECESSIVE SPASTIC PARAPLEGIA TYPE 23	0.000541419	0.02027916364262785
AUTOSOMAL DOMINANT SPASTIC PARAPLEGIA TYPE 29	0.000541419	0.02027916364262785
X-LINKED CHARCOT-MARIE-TOOTH DISEASE TYPE 2	0.000541419	0.02027916364262785
EARLY-ONSET AUTOSOMAL DOMINANT ALZHEIMER DISEASE	0.000541419	0.02027916364262785
BETA-MERCAPTOLACTATE CYSTEINE DISULFIDURIA	0.000541419	0.02027916364262785
MICROCEPHALY 22, PRIMARY, AUTOSOMAL RECESSIVE; MCPH22	0.000541419	0.02027916364262785
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 61; EIEE61	0.000541419	0.02027916364262785
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 60; EIEE60	0.000541419	0.02027916364262785
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 59; EIEE59	0.000541419	0.02027916364262785
TENORIO SYNDROME; TNORS	0.000541419	0.02027916364262785
COENZYME Q10 DEFICIENCY, PRIMARY, 7; COQ10D7	0.000541419	0.02027916364262785
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 32; EIEE32	0.000541419	0.02027916364262785
BASAL GANGLIA CALCIFICATION, IDIOPATHIC, 6; IBGC6	0.000541419	0.02027916364262785
INFANTILE LIVER FAILURE SYNDROME 2	0.000541419	0.02027916364262785
ENCEPHALOPATHY, ACUTE, INFECTION-INDUCED (HERPES-SPECIFIC), SUSCEPTIBILITY TO, 7; IIAE7	0.000541419	0.02027916364262785
SEIZURES, CORTICAL BLINDNESS, AND MICROCEPHALY SYNDROME	0.000541419	0.02027916364262785
SMITH-KINGSMORE SYNDROME; SKS	0.000541419	0.02027916364262785
CEREBRAL ARTERIOPATHY, AUTOSOMAL DOMINANT, WITH SUBCORTICAL INFARCTS AND LEUKOENCEPHALOPATHY, TYPE 2; CADASIL2	0.000541419	0.02027916364262785
SPASTICITY, CHILDHOOD-ONSET, WITH HYPERGLYCINEMIA	0.000541419	0.02027916364262785
DYSKINESIA, LIMB AND OROFACIAL, INFANTILE-ONSET; IOLOD	0.000541419	0.02027916364262785
SPINOCEREBELLAR ATAXIA, AUTOSOMAL RECESSIVE 23; SCAR23	0.000541419	0.02027916364262785
PONTOCEREBELLAR HYPOPLASIA, TYPE 2F	0.000541419	0.02027916364262785
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 40	0.000541419	0.02027916364262785
EPILEPSY, FAMILIAL FOCAL, WITH VARIABLE FOCI 2; FFEVF2	0.000541419	0.02027916364262785
EPILEPSY, FAMILIAL FOCAL, WITH VARIABLE FOCI 3; FFEVF3	0.000541419	0.02027916364262785
SHORT STATURE, RHIZOMELIC, WITH MICROCEPHALY, MICROGNATHIA, AND DEVELOPMENTAL DELAY; SRMMD	0.000541419	0.02027916364262785
SUDDEN CARDIAC FAILURE, INFANTILE	0.000541419	0.02027916364262785
MYOCLONUS, INTRACTABLE, NEONATAL; NEIMY	0.000541419	0.02027916364262785
PSEUDO-TORCH SYNDROME 2	0.000541419	0.02027916364262785
COMBINED IMMUNODEFICIENCY AND MEGALOBLASTIC ANEMIA WITH OR WITHOUT HYPERHOMOCYSTEINEMIA; CIMAH	0.000541419	0.02027916364262785
MENTAL RETARDATION, AUTOSOMAL DOMINANT 54; MRD54	0.000541419	0.02027916364262785
ENCEPHALOPATHY, ACUTE, INFECTION-INDUCED (HERPES-SPECIFIC), SUSCEPTIBILITY TO, 8; IIAE8	0.000541419	0.02027916364262785
HEREDITARY NEUROCUTANEOUS MALFORMATION	0.000541419	0.02027916364262785
BANNAYAN-RILEY-RUVALCABA SYNDROME	0.000541419	0.02027916364262785
LUNG AGENESIS-HEART DEFECT-THUMB ANOMALIES SYNDROME	0.000541419	0.02027916364262785
EDINBURGH MALFORMATION SYNDROME	0.000541419	0.02027916364262785
EPILEPSY-MICROCEPHALY-SKELETAL DYSPLASIA SYNDROME	0.000541419	0.02027916364262785
BENIGN FAMILIAL NEONATAL EPILEPSY	0.000541419	0.02027916364262785
EPILEPSY-TELANGIECTASIA SYNDROME	0.000541419	0.02027916364262785
BILATERAL STRIOPALLIDODENTATE CALCINOSIS	0.000541419	0.02027916364262785
FAMILIAL MULTIPLE LIPOMATOSIS	0.000541419	0.02027916364262785
LATE-ONSET ISOLATED ACTH DEFICIENCY	0.000541419	0.02027916364262785
3-HYDROXY-3-METHYLGLUTARIC ACIDURIA	0.000541419	0.02027916364262785
ENDOCARDIAL FIBROELASTOSIS	0.000541419	0.02027916364262785
GINGIVAL FIBROMATOSIS-HYPERTRICHOSIS SYNDROME	0.000541419	0.02027916364262785
PULMONARY ARTERIOVENOUS MALFORMATION	0.000541419	0.02027916364262785
CRIGLER-NAJJAR SYNDROME	0.000541419	0.02027916364262785
GAUCHER DISEASE-OPHTHALMOPLEGIA-CARDIOVASCULAR CALCIFICATION SYNDROME	0.000541419	0.02027916364262785
X-LINKED INTELLECTUAL DISABILITY-EPILEPSY SYNDROME	0.000541419	0.02027916364262785
AUTOSOMAL RECESSIVE SPASTIC PARAPLEGIA TYPE 18	0.000541419	0.02027916364262785
EPISODIC ATAXIA TYPE 6	0.000541419	0.02027916364262785
LISSENCEPHALY TYPE 1 DUE TO DOUBLECORTIN GENE MUTATION	0.000541419	0.02027916364262785
NODULAR NEURONAL HETEROTOPIA	0.000541419	0.02027916364262785
HIRSCHSPRUNG DISEASE-GANGLIONEUROBLASTOMA SYNDROME	0.000541419	0.02027916364262785
MICRODUPLICATION XP11.22P11.23 SYNDROME	0.000541419	0.02027916364262785
HYDROCEPHALUS WITH STENOSIS OF THE AQUEDUCT OF SYLVIUS	0.000541419	0.02027916364262785
CONGENITAL HYDROCEPHALUS	0.000541419	0.02027916364262785
FAMILIAL CEREBRAL CAVERNOUS MALFORMATION	0.000541419	0.02027916364262785
FAMILIAL ISOLATED HYPOPARATHYROIDISM	0.000541419	0.02027916364262785
FRONTAL ENCEPHALOCELE	0.000541419	0.02027916364262785
CENTRAL DIABETES INSIPIDUS	0.000541419	0.02027916364262785
BETA-MANNOSIDOSIS	0.000541419	0.02027916364262785
DYSEQUILIBRIUM SYNDROME	0.000541419	0.02027916364262785
SPASTIC ATAXIA WITH CONGENITAL MIOSIS	0.000541419	0.02027916364262785
CONGENITAL INTRAUTERINE INFECTION-LIKE SYNDROME	0.000541419	0.02027916364262785
INFANTILE CHOROIDOCEREBRAL CALCIFICATION SYNDROME	0.000541419	0.02027916364262785
SYMMETRICAL THALAMIC CALCIFICATIONS	0.000541419	0.02027916364262785
CHRONIC MUCOCUTANEOUS CANDIDIASIS	0.000541419	0.02027916364262785
BETA-KETOTHIOLASE DEFICIENCY	0.000541419	0.02027916364262785
HISTIOCYTOID CARDIOMYOPATHY	0.000541419	0.02027916364262785
LEUKOENCEPHALOPATHY WITH BRAIN STEM AND SPINAL CORD INVOLVEMENT-HIGH LACTATE SYNDROME	0.000541419	0.02027916364262785
CATARACT-NEPHROPATHY-ENCEPHALOPATHY SYNDROME	0.000541419	0.02027916364262785
PRIMARY ANGIITIS OF THE CENTRAL NERVOUS SYSTEM	0.000541419	0.02027916364262785
FAMILIAL CALCIUM PYROPHOSPHATE DEPOSITION	0.000541419	0.02027916364262785
CARBAMOYL-PHOSPHATE SYNTHETASE 1 DEFICIENCY	0.000541419	0.02027916364262785
X-LINKED COMPLICATED CORPUS CALLOSUM DYSGENESIS	0.000541419	0.02027916364262785
CRISPONI SYNDROME	0.000541419	0.02027916364262785
CARNITINE PALMITOYL TRANSFERASE 1A DEFICIENCY	0.000541419	0.02027916364262785
CARNITINE PALMITOYLTRANSFERASE II DEFICIENCY	0.000541419	0.02027916364262785
HUNTINGTON DISEASE-LIKE 1	0.000541419	0.02027916364262785
ROSAÏ-DORFMAN DISEASE	0.000541419	0.02027916364262785
PONTOCEREBELLAR HYPOPLASIA TYPE 4	0.000541419	0.02027916364262785
CONGENITAL NEURONAL CEROID LIPOFUSCINOSIS	0.000541419	0.02027916364262785
DISTAL TRISOMY 15Q	0.000541419	0.02027916364262785
CRANIOSYNOSTOSIS-HYDROCEPHALUS-ARNOLD-CHIARI MALFORMATION TYPE I-RADIOULNAR SYNOSTOSIS SYNDROME	0.000541419	0.02027916364262785
FAMILIAL DYSAUTONOMIA	0.000541419	0.02027916364262785
ATYPICAL TERATOID RHABDOID TUMOR	0.000541419	0.02027916364262785
